
<html lang="en"     class="pb-page"  data-request-id="4acaab9b-cf21-4d3a-90d5-fd0a91bf774c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c01771;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2" /></meta><meta name="dc.Creator" content="Michael J.  Roy" /></meta><meta name="dc.Creator" content="Amelia  Vom" /></meta><meta name="dc.Creator" content="Toru  Okamoto" /></meta><meta name="dc.Creator" content="Brian J.  Smith" /></meta><meta name="dc.Creator" content="Richard W.  Birkinshaw" /></meta><meta name="dc.Creator" content="Hong  Yang" /></meta><meta name="dc.Creator" content="Houda  Abdo" /></meta><meta name="dc.Creator" content="Christine. A.  White" /></meta><meta name="dc.Creator" content="David  Segal" /></meta><meta name="dc.Creator" content="David C. S.  Huang" /></meta><meta name="dc.Creator" content="Jonathan B.  Baell" /></meta><meta name="dc.Creator" content="Peter M.  Colman" /></meta><meta name="dc.Creator" content="Peter E.  Czabotar" /></meta><meta name="dc.Creator" content="Guillaume  Lessene" /></meta><meta name="dc.Description" content="The BCL-2 family of proteins (including the prosurvival proteins BCL-2, BCL-XL, and MCL-1) is an important target for the development of novel anticancer therapeutics. Despite the challenges of tar..." /></meta><meta name="Description" content="The BCL-2 family of proteins (including the prosurvival proteins BCL-2, BCL-XL, and MCL-1) is an important target for the development of novel anticancer therapeutics. Despite the challenges of tar..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 27, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01771" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01771" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01771" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01771" /></link>
        
    
    

<title>Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01771" /></meta><meta property="og:title" content="Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0012.jpeg" /></meta><meta property="og:description" content="The BCL-2 family of proteins (including the prosurvival proteins BCL-2, BCL-XL, and MCL-1) is an important target for the development of novel anticancer therapeutics. Despite the challenges of targeting protein–protein interaction (PPI) interfaces with small molecules, a number of inhibitors (called BH3 mimetics) have entered the clinic and the BCL-2 inhibitor, ABT-199/venetoclax, is already proving transformative. For BCL-XL, new validated chemical series are desirable. Here, we outline the crystallography-guided development of a structurally distinct series of BCL-XL/BCL-2 inhibitors based on a benzoylurea scaffold, originally proposed as α-helix mimetics. We describe structure-guided exploration of a cryptic “p5” pocket identified in BCL-XL. This work yields novel inhibitors with submicromolar binding, with marked selectivity toward BCL-XL. Extension into the hydrophobic p2 pocket yielded the most potent inhibitor in the series, binding strongly to BCL-XL and BCL-2 (nanomolar-range half-maximal inhibitory concentration (IC50)) and displaying mechanism-based killing in cells engineered to depend on BCL-XL for survival." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01771"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01771">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01771&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01771&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01771&amp;href=/doi/10.1021/acs.jmedchem.0c01771" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5447-5469</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01601" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01918" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-X<sub>L</sub> and BCL-2</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Michael J. Roy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael J. Roy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Roy">Michael J. Roy</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0198-9108" title="Orcid link">http://orcid.org/0000-0003-0198-9108</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amelia Vom</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amelia Vom</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amelia++Vom">Amelia Vom</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Toru Okamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Toru Okamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Toru++Okamoto">Toru Okamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian J. Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian J. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+J.++Smith">Brian J. Smith</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0498-1910" title="Orcid link">http://orcid.org/0000-0003-0498-1910</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard W. Birkinshaw</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard W. Birkinshaw</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+W.++Birkinshaw">Richard W. Birkinshaw</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Yang">Hong Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Houda Abdo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Houda Abdo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Houda++Abdo">Houda Abdo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christine. A. White</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine. A. White</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine.+A.++White">Christine. A. White</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Segal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Segal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Segal">David Segal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David C. S. Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David C. S. Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+C.+S.++Huang">David C. S. Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan B. Baell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan B. Baell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+B.++Baell">Jonathan B. Baell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2114-8242" title="Orcid link">http://orcid.org/0000-0003-2114-8242</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter M. Colman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter M. Colman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+M.++Colman">Peter M. Colman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter E. Czabotar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter E. Czabotar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f1928b90939e859083b186949998df949584df9084"><span class="__cf_email__" data-cfemail="d7b4adb6b5b8a3b6a597a0b2bfbef9b2b3a2f9b6a2">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+E.++Czabotar">Peter E. Czabotar</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Guillaume Lessene</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guillaume Lessene</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</div><div class="loa-info-affiliations-info">Department of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</div><div class="loa-info-affiliations-info">Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, VIC 3050, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#73141f160000161d163304161b1a5d1617065d1206"><span class="__cf_email__" data-cfemail="91f6fdf4e2e2f4fff4d1e6f4f9f8bff4f5e4bff0e4">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guillaume++Lessene">Guillaume Lessene</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1193-8147" title="Orcid link">http://orcid.org/0000-0002-1193-8147</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01771&amp;href=/doi/10.1021%2Facs.jmedchem.0c01771" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5447–5469</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 27, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 October 2020</li><li><span class="item_label"><b>Published</b> online</span>27 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01771" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01771</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5447%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BJ.%2BRoy%252C%2BAmelia%2BVom%252C%2BToru%2BOkamoto%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.0c01771%26title%3DStructure-Guided%2BDevelopment%2Bof%2BPotent%2BBenzoylurea%2BInhibitors%2Bof%2BBCL-XL%2Band%2BBCL-2%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5469%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01771"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1105</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01771" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Roy&quot;},{&quot;first_name&quot;:&quot;Amelia&quot;,&quot;last_name&quot;:&quot;Vom&quot;},{&quot;first_name&quot;:&quot;Toru&quot;,&quot;last_name&quot;:&quot;Okamoto&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;J. Smith&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;W. Birkinshaw&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Houda&quot;,&quot;last_name&quot;:&quot;Abdo&quot;},{&quot;first_name&quot;:&quot;Christine.&quot;,&quot;last_name&quot;:&quot;A. White&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Segal&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. S. Huang&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;B. Baell&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;M. Colman&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;E. Czabotar&quot;},{&quot;first_name&quot;:&quot;Guillaume&quot;,&quot;last_name&quot;:&quot;Lessene&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5447-5469&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01771&quot;},&quot;abstract&quot;:&quot;The BCL-2 family of proteins (including the prosurvival proteins BCL-2, BCL-XL, and MCL-1) is an important target for the development of novel anticancer therapeutics. Despite the challenges of targeting protein–protein interaction (PPI) interfaces with small molecules, a number of inhibitors (called BH3 mimetics) have entered the clinic and the BCL-2 inhibitor, ABT-199/venetoclax, is already proving transformative. For BCL-XL, new validated chemical series are desirable. Here, we outline the crystallography-guided development of a structurally distinct series of BCL-XL/BCL-2 inhibitors based on a benzoylurea scaffold, originally proposed as α-helix mimetics. We describe structure-guided exploration of a cryptic “p5” pocket identified in BCL-XL. This work yields novel inhibitors with submicromolar binding, with marked selectivity toward BCL-XL. Extension into the hydrophobic p2 pocket yielded the most potent inhibitor in the series, binding strongly to BCL-XL and BCL-2 (nanomolar-range half-maximal inhibitory&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01771&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01771" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01771&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01771" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01771&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01771" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01771&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01771&amp;href=/doi/10.1021/acs.jmedchem.0c01771" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01771" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01771" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01771%26sid%3Dliteratum%253Aachs%26pmid%3D33904752%26genre%3Darticle%26aulast%3DRoy%26date%3D2021%26atitle%3DStructure-Guided%2BDevelopment%2Bof%2BPotent%2BBenzoylurea%2BInhibitors%2Bof%2BBCL-XL%2Band%2BBCL-2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5447%26epage%3D5469%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292078" title="Inorganic compounds">Inorganic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291994" title="Group 13 compounds">Group 13 compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The BCL-2 family of proteins (including the prosurvival proteins BCL-2, BCL-X<sub>L</sub>, and MCL-1) is an important target for the development of novel anticancer therapeutics. Despite the challenges of targeting protein–protein interaction (PPI) interfaces with small molecules, a number of inhibitors (called BH3 mimetics) have entered the clinic and the BCL-2 inhibitor, ABT-199/venetoclax, is already proving transformative. For BCL-X<sub>L</sub>, new validated chemical series are desirable. Here, we outline the crystallography-guided development of a structurally distinct series of BCL-X<sub>L</sub>/BCL-2 inhibitors based on a benzoylurea scaffold, originally proposed as α-helix mimetics. We describe structure-guided exploration of a cryptic “p5” pocket identified in BCL-X<sub>L</sub>. This work yields novel inhibitors with submicromolar binding, with marked selectivity toward BCL-X<sub>L</sub>. Extension into the hydrophobic p2 pocket yielded the most potent inhibitor in the series, binding strongly to BCL-X<sub>L</sub> and BCL-2 (nanomolar-range half-maximal inhibitory concentration (IC<sub>50</sub>)) and displaying mechanism-based killing in cells engineered to depend on BCL-X<sub>L</sub> for survival.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The BCL-2 family of proteins is widely recognized as an attractive set of cancer therapeutic targets. The balance between pro- and antiapoptotic members of this family mediates intra- and extracellular stress signals through a cascade of protein–protein interactions (PPIs), leading to a key mitochondrial permeabilization event and subsequent caspase activation that ultimately results in cell demolition. Decreased apoptotic signaling, due to overexpression of prosurvival proteins such as BCL-2, BCL-X<sub>L</sub>, and MCL-1, is a key driver in tumorigenesis and in resistance to chemotherapy, as most anticancer drugs rely on a functional BCL-2 family-mediated apoptotic cascade.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a></div><div class="NLM_p">Targeting prosurvival proteins to reactivate a blunted apoptotic response in cancer cells has been a longstanding and ambitious goal of a number of pharmaceutical and academic research programs.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Just as the expression levels of individual BCL-2 proteins in different cell types vary,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> so do their individual contributions to different cancers. Recent developments also support the therapeutic potential of selectively targeting individual BCL-2 family proteins: a first-in-class selective BCL-2 inhibitor, venetoclax, is now approved for patients with chronic lymphocytic leukemias<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and three selective MCL-1 inhibitors have entered the clinic.<a onclick="showRef(event, 'ref5 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref5 ref8 ref9 ref10 ref11 ref12">(5,8−12)</a></div><div class="NLM_p">The PPI interfaces underpinning the interactions between BCL-2 family proteins are typified by large, shallow, and mainly hydrophobic interaction surfaces that represent challenging targets for medicinal chemistry. Foremost among these are the binding interfaces formed by amphipathic BH3 domains and the flexible surface grooves formed on their binding partners (reviewed extensively elsewhere<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>). In addition, many studies have overlooked the complexity of the BCL-2 family biology, leading to questionable conclusions regarding the mechanism of action.<a onclick="showRef(event, 'ref4 ref14'); return false;" href="javascript:void(0);" class="ref ref4 ref14">(4,14)</a> Despite many putative BCL-2 inhibitors being published, the number of mechanistically well-validated and structurally distinct series of selective inhibitor molecules remains relatively limited (e.g., <b>ABT-737</b> (<b>1</b>), <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and clinical relatives <b>ABT-263</b> and venetoclax;<a onclick="showRef(event, 'ref7 ref16'); return false;" href="javascript:void(0);" class="ref ref7 ref16">(7,16)</a> molecules based on the AbbVie scaffold;<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a><b>WEHI-539</b> and related derivatives;<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21−24)</a><b>S63845</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>). In the case of BCL-X<sub>L</sub>, the recent development of targeted protein degraders (also known as proteolysis-targeting chimeras, PROTACs) that aim to target BCL-X<sub>L</sub> for proteasomal degradation,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> including in a tissue-specific manner, offers new potential to ameliorate the known on-target platelet toxicity of BCL-X<sub>L</sub> inhibition.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> BCL-X<sub>L</sub> targeting prodrugs<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and antibody–drug conjugates (ADCs)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> are also being developed with this aim. To date, these molecules all derive from similar chemotypes (either <b>ABT-263</b> or structural relatives of <b>WEHI-539</b>). New structural knowledge and novel chemical series are thus desirable to support the next generation of selective BCL-2 family inhibitors and degraders, particularly in light of recently published structural insights to guide PROTAC development targeting BCL-X<sub>L</sub>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structures of <b>ABT-737</b> (<b>1</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and novel benzoylurea hit <b>2</b>. (b) Crystal structure of <b>2</b> in complex with BCL-X<sub>L</sub>, determined to 2.15 Å (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, carbon: light blue, BCL-X<sub>L</sub> in surface representation in gray), showing canonical hydrophobic pockets p2 and p4 and a cryptic pocket p5 along the BH3-binding groove. (c) Overlaid crystal structures of <b>2</b> (from the BCL-X<sub>L</sub>:<b>2</b> complex) with the BIM BH3 peptide (from the BCL-X<sub>L</sub>:BIM<sup>BH3</sup> complex, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FDL">3FDL</a>, magenta),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> highlighting key conserved residues of the BH3 domain including hydrophobic amino acids h1–h4 and Asp99 (that form an important salt bridge interaction with Arg139 of BCL-X<sub>L</sub>). (d) Compounds <b>3</b>–<b>6</b> were synthesized to explore the negative structure–activity relationship (SAR) and validate the observed binding mode of <b>2</b> with BCL-X<sub>L</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We had previously outlined a structure-guided de novo design strategy, using a benzoylurea scaffold to spatially reproduce the projections of α-helical peptide pharmacophores, such as those of BH3 domains within BH3:groove interactions characteristic of the BCL-2 family (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S1</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> That initial work led to benzoylurea inhibitors of BCL-X<sub>L</sub> in the low micromolar range.</div><div class="NLM_p last">Herein, we report another series initially developed toward targeting BCL-X<sub>L</sub>, based on a different benzoylurea hit, compound <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a). Using the crystal structure of <b>2</b> bound to BCL-X<sub>L</sub>, including an unexpected interaction in a binding site we have termed the “cryptic p5” pocket (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), we outline the rational elaboration of <b>2</b> to target the p2 and cryptic p5 pockets of BCL-X<sub>L</sub>, leading to potent benzoylurea molecules with half-maximal inhibitory concentration (IC<sub>50</sub>) values in the nanomolar range for both BCL-X<sub>L</sub> and BCL-2. We show that the most potent molecule in the series can elicit mechanism-based cell killing of cells dependent on BCL-X<sub>L</sub> for survival, proceeding via release of cytochrome <i>c</i> from  mitochondria.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As part of our previous work, a modular synthesis strategy was used to prepare a library of benzoylurea molecules (∼130 compounds) encompassing multiple orientations of various side chains to explore a relatively wide structure–activity relationship (SAR) space (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S1</a>, Supporting Information). This library was subsequently screened using a bead-based AlphaSCREEN (AS) assay for displacement of the BCL-X<sub>L</sub>/BIM<sup>BH3</sup> or MCL-1/BAK<sup>BH3</sup> interactions (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32,34)</a> In this screen, we identified benzoylurea hit <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a) with a promising IC<sub>50</sub> value for BCL-X<sub>L</sub> in the submicromolar range (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The comparatively weaker IC<sub>50</sub> value of <b>2</b> for MCL-1 also hinted at selectivity across the family of proteins.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values for Compounds <b>2</b>–<b>8</b> Determined by AlphaSCREEN (AS) Assay</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM, AS)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">BCL-X<sub>L</sub></th><th class="colsep0 rowsep0" align="center">MCL-1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ABT-737</b> (<b>1</b>)</td><td class="colsep0 rowsep0" align="left">0.004 ± 0.005<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">40 ± 60<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.51 ± 0.07</td><td class="colsep0 rowsep0" align="left">7.7 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">13.1 ± 0.3<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">44 ± 9<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">31 ± 5</td><td class="colsep0 rowsep0" align="left">28 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.24 ± 0.02</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.21 ± 0.05</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are reported in micromolar units. Unless noted, all data are reported as mean ± standard error of mean (SEM) from <i>N</i> = 3 independent experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data are mean ± standard deviation (SD) from <i>N</i> = 2 independent experiments.</p></div></div></div><div class="NLM_p">We next obtained a crystal structure of <b>2</b> in complex with BCL-X<sub>L</sub> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), which confirmed binding to the hydrophobic groove of BCL-X<sub>L</sub> responsible for interacting with BH3 domains (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). Two binding orientations of <b>2</b> were observed in this structure. One of these we considered to be a “secondary” mode, as the binding appeared to be influenced by its location at a crystal packing interface (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S2</a>). The other binding mode we have termed the “primary” mode (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), as subsequent data suggest that it is more likely to reflect the predominant bound conformation in solution. This mode exhibited some key features of the original benzoylurea scaffold “peptidomimetic” design, including formation of an intramolecular hydrogen bond (pseudo-six-membered ring) to partially preorganize the molecule.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Displacement of the side chain of Tyr195 of BCL-X<sub>L</sub> creates the cryptic p5 binding pocket. (a) The side chain of Tyr195 is displaced by the <i>S</i>-benzyl moiety of <b>2</b> in the BCL-X<sub>L</sub>:<b>2</b> complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, carbon: light blue), forming a cryptic p5 pocket that is lined by the C-terminus of the α8 helix and side chains of Trp137, Phe191, Leu194, and Tyr195 of BCL-X<sub>L</sub>. (b, c) Crystal structure of <i>apo</i> BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAZ">1MAZ</a>), (b) surface representation and (c) colored by <i>B</i>-factor (dark blue, low <i>B</i>-factor; red, high <i>B</i>-factor),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the side chain of Tyr195 lines the hydrophobic groove adjacent to the p2, p3, and p4 ligand binding pockets. <i>B</i>-factor analysis suggests that the region of BCL-X<sub>L</sub> in which Tyr195 lies (extending from the C-terminal end of the α8 helix), in addition to the α3 helix and α2–3 hinge regions, all exhibit some structural flexibility. (d) The cryptic p5 pocket is not present in any structure of BCL-X<sub>L</sub> bound to native ligands such as in the BCL-X<sub>L</sub>:BAX<sup>BH3</sup> structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PL7">3PL7</a>; overlaid with <b>2</b> from the BCL-X<sub>L</sub>:<b>2</b> complex).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In many of these structures, a pocket that could be termed the “canonical p5” pocket exists, into which residues turn up from the h4 residue inset, in this case Met74 of the BAX<sup>BH3</sup>. The cryptic p5 pocket is adjacent to this as demonstrated by the position of the <i>S</i>-phenyl moiety of <b>2</b> in this overlay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Surprisingly, the orientation of the bound compound in the primary mode was in the opposite direction along the groove to that intended in our original design and to that observed in our previously reported series of BCL-X<sub>L</sub> inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S1</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Nonetheless, many of the interactions of <b>2</b> with BCL-X<sub>L</sub> in this binding mode also resembled those observed for BH3 domains bound to BCL-X<sub>L</sub> (e.g., BCL-X<sub>L</sub>:BIM<sup>BH3</sup> complex, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). In particular, the biphenyl and tolyl moieties of <b>2</b> (that engage the p2 and p4 pockets of BCL-X<sub>L</sub>, respectively) form similar interactions as those of Leu94 and Phe101 of the BIM<sup>BH3</sup> peptide with BCL-X<sub>L</sub>. Interestingly, the carboxylic acid moiety of <b>2</b> also lies proximal to Asp99 of BIM<sup>BH3</sup> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c), a conserved acidic residue in all BH3 domains that mediates a key salt bridge interaction, with residue Arg139 in the case of BCL-X<sub>L</sub>. However, it does not precisely align with Asp99 of BIM<sup>BH3</sup>, nor does it directly engage Arg139 of BCL-X<sub>L</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S2b</a>), but rather aligns to a position one helix-turn further along the BIM<sup>BH3</sup> peptide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). Notably, the <i>S</i>-benzyl moiety of <b>2</b> bound unexpectedly in a relatively unexplored pocket (adjacent to p4, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b) that is created by the displacement of Tyr195 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). We refer to this binding site as the cryptic p5 pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). This pocket is not present in unliganded BCL-X<sub>L</sub> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b,c), nor is it observed with BH3 peptides (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d) or the BCL-X<sub>L</sub> inhibitor <b>ABT-737</b> (<b>1</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S3a</a>). Interestingly, the triflone moiety of <b>ABT-263</b> does occupy a similar pocket when bound to BCL-X<sub>L</sub> and also BCL-2 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S3b</a>), as does the methoxy substituent of <b>A-1342192</b> when bound to BCL-X<sub>L</sub>, which was first described while this manuscript was under review (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S3c</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><b>A-1342192</b> (referred to as compound <b>14</b> in the relevant publication) is a BCL-X<sub>L</sub> inhibitor, structurally related to <b>WEHI-539</b> and <b>A-1155463</b>.</div><div class="NLM_p">To help validate the binding mode of <b>2</b> observed in the crystal structure, we next generated a series of analogues to ascertain the role of the acid moiety of <b>2</b> and the relative importance of interactions in the p4 and cryptic p5 pockets. Thus, compounds <b>3</b>–<b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d) were evaluated in an AlphaSCREEN (AS) assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and revealed the acidic moiety of <b>2</b> to be essential, as its removal or methylation (compounds <b>4</b> and <b>5</b>) completely abrogated binding to both BCL-X<sub>L</sub> and MCL-1, similar to the importance of the conserved acidic residue on BH3 domains. The carboxylate of <b>2</b> does not appear to directly engage Arg139 of BCL-X<sub>L</sub> in the bound structure, instead interacting with Asn136 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). A similar result was also observed in the <b>ABT-737</b> series where the acid isostere acylsulfonamide is key for binding but lies away from Arg139 in the bound state, instead interacting with the backbone amide −NH of Gly138 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Protein/ligand interactions are not static; in addition, charge–charge interactions can operate over relatively long distances in molecular interactions (e.g., up to 5–10 Å) including to enhance the kinetics favoring complex formation.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Thus, the effect of the acidic moiety on binding in this context may not be particularly sensitive to the charge spacing.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key interactions between acidic moieties of <b>2</b> and <b>ABT-737</b> (<b>1</b>) with BCL-X<sub>L</sub>. (a) Key interactions of compound <b>2</b> with Asn136 of BCL-X<sub>L</sub>. (b, c) Side-by-side comparison of the crystal structures of <b>ABT-737</b> (<b>1</b>) with BCL-X<sub>L</sub> (magenta, shown in stick conformation, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ">2YXJ</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and the primary conformation of <b>2</b> with BCL-X<sub>L</sub> (light blue). A hydrogen-bond interaction is apparent between the backbone −NH atom of Gly138 of BCL-X<sub>L</sub> and the carbonyl oxygen atom of the acylsulfonamide moiety of <b>ABT-737</b> (<b>1</b>). Notably, the thioether of the <i>S</i>-benzyl moiety of <b>2</b> (primary conformation, light blue) occupies a similar position, which suggested possibilities for further elaboration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The negative SAR study also revealed the relative importance of interactions in the cryptic p5 and the p4 pockets for the binding of <b>2</b> to BCL-X<sub>L</sub>: pruning back the p5 <i>S</i>-benzyl moiety of <b>2</b> to an <i>S</i>-methyl weakened the IC<sub>50</sub> for BCL-X<sub>L</sub> by 25-fold (compound <b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d), while replacing the p4 tolyl moiety of <b>2</b> for an <i>n</i>-propyl had a more significant effect on BCL-X<sub>L</sub> binding (60-fold weaker IC<sub>50</sub> value of <b>6</b> for BCL-X<sub>L</sub> relative to <b>2</b>) than MCL-1 (only 4–5-fold weaker IC<sub>50</sub> of <b>6</b> for MCL-1 relative to <b>2</b>). This result was also consistent with mutagenesis studies, which showed that mutation of the corresponding “h4” Phe101 residue of BIM to Ala diminishes the affinity of human BIM for BCL-X<sub>L</sub> by 90-fold but is less important for MCL-1 binding.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Combined, these results validated that the crystal structure of the BCL-X<sub>L</sub>:<b>2</b> complex does indeed reflect the binding of <b>2</b> to BCL-X<sub>L</sub> in solution. We therefore next looked to utilize this structure for the rational optimization of <b>2</b> to improve the affinity of the series for BCL-X<sub>L</sub>.</div><div class="NLM_p">Previous work by our team as well as by researchers at AbbVie has described the significant gains in potency toward BCL-X<sub>L</sub>/BCL-2 achievable via interactions targeted to the p2 pocket.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Using an overlay of the BCL-X<sub>L</sub>:<b>2</b> X-ray crystal structure with that of the BCL-X<sub>L</sub>:<b>ABT-737</b> (<b>1</b>) complex (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a), we noticed two suitable positions of <b>2</b> to redesign the scaffold and grow the molecule toward a cryptic pocket of BCL-X<sub>L</sub>/BCL-2 (in the region of the the p2 pocket) that is engaged by the chlorobiphenyl moiety of <b>ABT-737</b> (<b>1</b>). Bis-biphenyl compound <b>7</b> and tetrahydroisoquinoline (THIQ) <b>8</b> were the outcomes of this scaffold redesign (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). These two target compounds were prepared, and their binding modes in complex with BCL-X<sub>L</sub> were elucidated through X-ray crystal structures (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>c,d). Overlays of each of these structures with those of <b>2</b> or <b>1</b> in complex with BCL-X<sub>L</sub> highlight the success of our molecular grafting strategy in achieving the designed binding mode (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>e). However, while <b>7</b> and <b>8</b> displayed improved binding toward BCL-X<sub>L</sub> (based on IC<sub>50</sub> determined by the AlphaSCREEN assay), they were both still significantly weaker than <b>ABT-737</b> (<b>1</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Overlaid X-ray crystal structures of compound <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, carbon: light blue) and <b>ABT-737</b> (<b>1</b>) (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ">2YXJ</a>, carbon: magenta)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> both bound to BCL-X<sub>L</sub>, indicating sites for scaffold grafting (BCL-X<sub>L</sub> from the BCL-X<sub>L</sub>:<b>ABT-737</b> (<b>1</b>) complex is shown in surface representation in gray). (b) Bis-biphenyl compound <b>7</b> and tetrahydroisoquinoline <b>8</b> designed with a chlorobiphenyl extension to access the cryptic p2 pocket. (c) X-ray crystal structure of compound <b>7</b> bound to BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVE">6UVE</a>, carbon: dark blue). (d) X-ray crystal structure of compound <b>8</b> bound to BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVC">6UVC</a>, carbon: light orange). (e) Overlays of compounds <b>7</b> with <b>2</b> and <b>8</b> with <b>ABT-737</b> (<b>1</b>), all in their BCL-X<sub>L</sub> bound poise.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next turned our attention to the cryptic p5 pocket to explore whether the interactions of <b>2</b> with BCL-X<sub>L</sub> in this region could be further optimized either by modifying the thioether linker of <b>2</b> (bridging the p4 and cryptic p5 pockets) or by conferring greater three-dimensionality to the hydrophobic <i>S</i>-benzyl moiety to better fill the cryptic p5 pocket. The X-ray crystal structure of BCL-X<sub>L</sub>:<b>ABT-737</b> (<b>1</b>) suggested that a suitable hydrogen-bond acceptor introduced into the thioether linker region of <b>2</b> might form an additional interaction with the backbone NH of Gly138 of BCL-X<sub>L</sub> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,c).</div><div class="NLM_p">An analogue of <b>2</b> with an all-carbon linker was found to retain equivalent BCL-X<sub>L</sub> binding (compound <b>9</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>); similarly, additional hydrogen-bond acceptors could also be accommodated into the bridging linker (compounds <b>10</b>, <b>11</b>), albeit with little overall improvement in binding to BCL-X<sub>L</sub>, based on AlphaSCREEN-determined IC<sub>50</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This may be understood partially due to the linker location, at the rim of the BH3 groove, being highly solvent-exposed (often rationalized in terms of entropy/enthalpy compensation);<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> in addition to this, sulfones are generally regarded as weak hydrogen-bond acceptors.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> To explore the effect of size/shape in the cryptic p5 pocket, cyclohexyl and adamantyl analogues <b>12</b> and <b>13</b> were generated; however, for these direct analogues of <b>2</b>, any improvement in BCL-X<sub>L</sub> binding was also modest at best (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Compounds Determined by the AlphaSCREEN (AS) Assay and the Surface Plasmon Resonance (SPR) Competition Assay<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S4</a>, Supporting Information.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values are reported in micromolar units. Unless noted, all data are reported as mean ± standard error of mean (SEM) from <i>N</i> = 3 independent experiments. For each independent experiment, duplicate technical replicates were performed.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Data are mean ± standard deviation (SD) from <i>N</i> = 2 independent experiments.</p></div></div><div></div></div><div class="NLM_p">We also made similar changes for the tetrahydroisoquinoline <b>8</b> to see whether modifications in the cryptic p5 pocket and the p2 extension would have any combined effect. In this case, while replacing the thioether linker of <b>8</b> with a sulfonyl moiety again did not, on its own, improve binding to BCL-X<sub>L</sub> (compound <b>11</b>), additional replacement of the benzyl group of <b>11</b> with a cyclohexyl (compound <b>15</b>) or adamantyl (compound <b>16</b>) led to >4-fold improvement in IC<sub>50</sub> for BCL-X<sub>L</sub> (and left the binding to MCL-1 relatively unaffected). Together, these changes resulted in the most potent analogues in the series (<b>15</b> and <b>16</b>), which showed nanomolar IC<sub>50</sub> for BCL-X<sub>L</sub> in the AlphaSCREEN assay.</div><div class="NLM_p">We next sought to validate these binding results using another complementary biophysical assay technique and to assess binding to other BCL-2 family members, including BCL-2. We had previously described a surface plasmon resonance (SPR)-based competition experiment to detect groove-specific binding to various BCL-2 family proteins, including BCL-X<sub>L</sub>, BCL-2, BCL-W, MCL-1, and A1.<a onclick="showRef(event, 'ref21 ref23 ref34 ref46'); return false;" href="javascript:void(0);" class="ref ref21 ref23 ref34 ref46">(21,23,34,46)</a> Using this assay, we found that for the benzoylurea series, the trends for BCL-X<sub>L</sub> binding observed in the primary AlphaSCREEN screening assay were maintained (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S4</a>, Supporting Information). For the positive control <b>ABT-737</b> (<b>1</b>), the IC<sub>50</sub> for BCL-X<sub>L</sub> was tighter in the SPR competition assay (SPR IC<sub>50</sub> < 0.25 nM) than in the AlphaSCREEN assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, but in line with the reported <i>K</i><sub>i</sub> of <b>ABT-737</b> (<b>1</b>) for BCL-X<sub>L,</sub><i>K</i><sub>i</sub> < 1 nM).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In this case, the AlphaSCREEN may perhaps underestimate the “true” IC<sub>50</sub>, falling outside the lower measurable limit of the assay. For the benzoylurea analogues, consistent with the AlphaSCREEN results, compounds <b>15</b> and <b>16</b> showed the tightest binding to BCL-X<sub>L</sub> in the SPR competition assay, with IC<sub>50</sub> values for BCL-X<sub>L</sub> of 41 and 44 nM, respectively. Strikingly, SPR competition experiments also revealed that a number of analogues also showed marked binding to BCL-2, in particular <b>15</b>, which binds BCL-2 with an IC<sub>50</sub> value of 18 nM. This reflected a broader trend, whereby analogues based on the simpler biphenyl scaffold (<b>11</b>, <b>12</b>, <b>13</b>) showed negligible binding to BCL-2, whereas incorporation of the chlorobiphenyl extension designed to interact with the cryptic p2 pocket of BCL-X<sub>L</sub>/BCL-2 substantially enhanced BCL-2 binding (extended THIQ scaffold analogues <b>8</b>, <b>14</b>–<b>16</b>). Comparing analogues <b>11</b> and <b>14</b>, or <b>12</b> and <b>15</b>, being matched pairs on the simple biphenyl and extended THIQ scaffolds, this additional p2 interaction led to >189-fold and >690-fold enhancements in BCL-2 binding, respectively. This highlights the critical importance of engaging the cryptic p2 pocket for development of inhibitors targeting BCL-2. For BCL-X<sub>L</sub>, this requirement appears less marked, although it remains to be seen whether high-affinity BCL-X<sub>L</sub> inhibitors could be generated that do not make use of the p2 pocket. As was observed for the AlphaSCREEN assay, binding of all compounds to MCL-1 was relatively weaker and via SPR no measurable binding was observed over the concentration range tested (in all cases IC<sub>50</sub> > 12.5 μM). The differences in the observed binding affinities for MCL-1 across technology likely reflect the use of a BAK competitor BH3 peptide in the AlphaSCREEN assay, as compared to a BIM BH3 peptide used in the SPR assay. All compounds showed weak or undetectable binding to BCL-W and A1 in the SPR competition assay over the concentration range tested (in all cases IC<sub>50</sub> > 4.5 μM). These results reveal <b>15</b> and <b>16</b> to be bona fide binders of both BCL-X<sub>L</sub> and BCL-2 (nanomolar-range IC<sub>50</sub>) and the most potent described to date utilizing the modular benzoylurea scaffold.</div><div class="NLM_p">X-ray crystal structures were also solved for each of compounds <b>12</b>, <b>13</b>, and <b>15</b> in complex with BCL-X<sub>L</sub> in an attempt to better understand the basis of the improvement in binding (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a–c). In all cases, these structures confirmed that one of the sulfonyl oxygens within the linker moiety did in fact form an additional hydrogen bond to the backbone NH of Gly138 of BCL-X<sub>L</sub> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">S5d</a>; compare to <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,c), in spite of being a relatively weak hydrogen-bond acceptor. In addition, as anticipated, the structures confirmed that the modified p5 substituents (cyclohexyl or adamantyl) could be accommodated in the hydrophobic cryptic p5 pocket (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S5a–c,e</a>). This study suggests that sp<sup>3</sup>-rich groups with the necessary flexibility, rather than aromatic, are preferred for optimal binding in this pocket of both BCL-X<sub>L</sub> and BCL-2 with complementary close-packing hydrophobic interactions. Combined with subtle conformational effects in the case of the THIQ scaffold of <b>15</b> and <b>16</b>, this effect results in the improved binding (IC<sub>50</sub>) observed for these two compounds for BCL-X<sub>L</sub>/BCL-2. The weaker binding of <b>16</b> for BCL-2 relative to <b>15</b> may point toward a more restricted cryptic p5 pocket in BCL-2.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray crystal structure of <b>12</b> in complex with BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVF">6UVF</a>, carbon: light green). (b) X-ray crystal structure of <b>13</b> in complex with BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVG">6UVG</a>, carbon: dark green). (c) X-ray crystal structure of tetrahydroisoquinoline <b>15</b> in complex with BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVH">6UVH</a>, carbon: orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using the most potent compound <b>15</b>, we next sought to evaluate whether this compound could demonstrate mechanism-based cellular killing via inhibition of one or more BCL-2 family proteins. We first decided to utilize cells engineered to be reliant on BCL-X<sub>L</sub> for survival. <i>MCL-1</i>-deficient mouse embryo fibroblast cells have been shown to be sensitive to BCL-X<sub>L</sub> inhibition and undergo apoptosis in a BAX-/BAK-dependent manner when BCL-X<sub>L</sub> is neutralized, and so this has become a robust and widely used cellular model to evaluate on-target inhibition of BCL-X<sub>L</sub>.<a onclick="showRef(event, 'ref14 ref21 ref24 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref14 ref21 ref24 ref47 ref48">(14,21,24,47,48)</a> Thus, <b>ABT-737</b> (<b>1</b>) induced potent killing of <i>MCL-1</i><sup>–/–</sup> mouse embryonic fibroblasts (MEFs) (EC<sub>50</sub> = 13 nM) but not wild-type (WT) or <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup> MEFs (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). Similarly, compound <b>15</b> showed on-target activity, albeit at significantly higher concentrations, killing <i>MCL-1</i><sup>–/–</sup> MEFs (EC<sub>50</sub> = 19 μM) but not WT or <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup> MEFs (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). These results strongly suggest that killing of <i>MCL-1</i><sup>–/–</sup> MEFs following treatment with <b>15</b>, as for <b>ABT-737</b> (<b>1</b>), results primarily from on-target inhibition of BCL-X<sub>L</sub>, as it requires BAX/BAK (i.e., proceeds via the intrinsic apoptotic pathway) and sensitivity to both molecules is lost in WT MEFs in which a nontargeted prosurvival protein (MCL-1) is present. In comparison, benzoylurea compound <b>6</b>, which only binds weakly to BCL-X<sub>L</sub>, did not induce killing of <i>MCL-1</i><sup>–/–</sup> MEFs over the concentration range tested. The significantly weaker cellular activity of <b>15</b> relative to <b>ABT-737</b> (<b>1</b>) reflects the weaker binding of <b>15</b> to BCL-X<sub>L</sub>/BCL-2 (SPR-derived IC<sub>50</sub> for BCL-X<sub>L</sub> and BCL-2 suggest >100-fold difference in binding), modest solubility of <b>15</b>, as well as the likelihood that <b>15</b> is highly serum bound. We observed that <b>15</b> lost all activity in this MEF viability assay if 10% fetal calf serum (FCS) is used rather than 1% FCS (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S6a</a>, Supporting Information). Relevantly, extensive optimization was undertaken during the development of <b>ABT-737</b> (<b>1</b>) to reduce the extent of serum binding (which improved BCL-X<sub>L</sub> binding of this series by up to 70-fold in the presence of 1% serum and decreased binding to domain III of human albumin).<a onclick="showRef(event, 'ref43 ref49'); return false;" href="javascript:void(0);" class="ref ref43 ref49">(43,49)</a> In comparison, compound <b>15</b>, unlike <b>ABT-737</b> (<b>1</b>), has not yet been optimized in this manner to reduce serum binding or to optimize solubility. We also evaluated <b>15</b> in the BCL-X<sub>L</sub>-dependent cancer cell line COLO205 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S6b,c</a>, Supporting Information); however, no effect on viability was observed over the concentration range tested. As the threshold affinity required to show effects on the viability of cancer cell lines would typically be higher than in <i>MCL-1</i><sup>–/–</sup> MEFs,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> lack of activity in this context is not surprising; more potent molecules will be required.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MEFs (wild-type, WT; <i>MCL-1</i><sup>–/–</sup>; or <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup>) were cultured for 24 h in the presence of varying concentrations of (a) <b>ABT-737</b> (<b>1</b>), (b) <b>6</b>, or (c) <b>15</b> in an FMA medium containing 1% fetal calf serum (FCS) and then harvested, stained using propidium iodide (PI), and analyzed by flow cytometry. Viability plots for each titration series depict the percentage of live cells (PI negative, normalized to vehicle control, mean ± SEM of three independent experiments), which were fitted using nonlinear regression to determine the corresponding EC<sub>50</sub> values. (d) Plot showing the percentage of cells with released cytochrome <i>c</i> from mitochondria. Data are shown as mean ± SEM and are representative of four independent experiments ***<i>p</i> < 0.001 (multiple unpaired <i>t</i> test, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S7</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To verify mechanistically whether the BAX-/BAK-dependent activity on the viability of <i>MCL-1</i><sup>–/–</sup> MEFs correlated with the release of cytochrome <i>c</i> from mitochondria, we adopted an assay to measure mitochondrial retention of cytochrome <i>c</i> by intracellular staining. Briefly, cells were treated for 18 h with compound <b>ABT-737</b> (<b>1</b>), <b>6</b>, <b>15</b>, or vehicle; then, the outer membrane was permeabilized with digitonin (leaving mitochondria intact), washed, fixed, and stained for cytochrome <i>c</i> using an anticytochrome <i>c</i> primary and phycoerythrin (PE)-conjugated secondary antibody, and then analyzed using fluorescence-assisted cell sorting (FACS, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b). While treatment of <i>MCL-1</i><sup>–/–</sup> MEFs with the less potent benzoylurea analogue <b>6</b> (25 μM), or with a vehicle control, did not show evidence of cytochrome <i>c</i> loss from mitochondria, treatment with <b>ABT-737</b> (<b>1</b>) (2.5 μM) as expected caused virtually all cells to lose cytochrome <i>c</i> (>90% of <i>MCL-1</i><sup>–/–</sup> MEFs). Similarly, treatment with compound <b>15</b> (25 μM, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>c) caused a statistically significant proportion of cells to have lost cytochrome <i>c</i> from mitochondria (approximately 30% of <i>MCL-1</i><sup>–/–</sup> MEFs with released cytochrome <i>c</i>). No loss of cytochrome <i>c</i> from mitochondria was observed for wild-type or <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup> MEFs treated with either <b>6</b> or <b>15</b>. This suggests that <b>15</b> selectively induces cytochrome <i>c</i> release in <i>MCL-1</i><sup>–/–</sup> MEFs relative to either WT or <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup> MEFs (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>c and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">S7</a>). Thus, the BCL-X<sub>L</sub>-dependent cell killing exhibited by <b>15</b> appears to be on-target, both requiring BAX/BAK and proceeding mechanistically via loss of cytochrome <i>c</i> from mitochondria.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Some analogues in this study necessitated the preparation of amino acids not commercially available (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). We prepared the methyl-protected version of <i>S</i>-benzyl-cysteine (<b>19</b>) through a simple sequence involving a thionyl chloride-mediated conversion of the carboxylic acid of compound <b>17</b> into the methyl ester <b>18</b> followed by deprotection of the <i>t</i>-Boc group.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) thionyl chloride, MeOH, 0 °C to room temperature (r.t.); (b) HCl (4 M) in dioxane; (c) (bromomethyl)cyclohexane, tetrabutylammonium iodide (TBAI) (3 mol %), NaOH (2 N, aq)/EtOH (1:1); (d) <i>meta</i>-chloroperoxybenzoic acid (<i>m</i>-CPBA), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (e) triflic anhydride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.; (f) trimethylphosphine, tetrahydrofuran (THF); (g) <b>25</b>, K<sub>2</sub>CO<sub>3</sub>, 18-crown-6, CH<sub>3</sub>CN; (h) trifluoroacetic acid (TFA).</p></p></figure><div class="NLM_p">The cyclohexylmethylsulfonyl cysteine derivative <b>23</b> was obtained first by alkylation of <i>t</i>-Boc-protected cysteine with (bromomethyl)cyclohexane in the presence of the phase-transfer reagent, subsequent oxidation with m-CPBA, and <i>t</i>-Boc deprotection to obtain the HCl salt <b>23</b>.</div><div class="NLM_p">The final unnatural amino acid required, bearing an adamantylmethylsulfonyl side chain (<b>30</b>), was a more challenging target to prepare. After a number of attempts, the successful approach entailed first the preparation of triflated adamantylmethanol <b>25</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) using triflic anhydride in the presence of pyridine. Our strategy also required a version of cysteine protected on both the amino and carboxylic acid groups by acid-labile protecting groups (<i>t</i>-Boc and <i>t</i>-Bu, respectively). We obtained compound <b>27</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) by reducing the disulfide bond from the suitably protected cystine. The thiol group was then alkylated using triflate <b>25</b>, using K<sub>2</sub>CO<sub>3</sub> as a base. This alkylation required the addition of 18-crown-6 to achieve reasonable yields (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The resulting compound was then doubly deprotected, to obtain amino acid <b>30</b>.</div><div class="NLM_p">The synthesis of the compounds described in this work relies on the formation of the core benzoylurea, which we have reported previously.<a onclick="showRef(event, 'ref32 ref35 ref50'); return false;" href="javascript:void(0);" class="ref ref32 ref35 ref50">(32,35,50)</a> This two-step multicomponent reaction involves first the preparation of a carbamoyl chloride from a corresponding amide and the reaction of this reactive intermediate onto a transiently protected amino acid. Specifically, for this work, preparation of compounds <b>2</b>–<b>6</b> and <b>9</b>–<b>13</b> followed this general principle (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), using either amide <b>32</b> or <b>46</b> and the required amino acid (either commercially available or prepared in the lab, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA) and then 4-methylbenzylamine and dimethylformamide (DMF); (b) (i) trimethylsilyl trifluoromethanesulfonate (TMSOTf), NEt<sub>3</sub>, Et<sub>2</sub>O; (ii) COCl<sub>2</sub> 20% in toluene, 0 °C to r.t.; (c) 2-(benzylthio)ethanaminium chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (d) <b>19</b>, NEt<sub>3</sub>, propylene oxide, CH<sub>2</sub>Cl<sub>2</sub>; (e) NEt<sub>3</sub>, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (f) <i>N</i>,<i>O</i>-bistrimethylsilylacetamide, propylene oxide, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (g) <b>39</b>, <b>40</b>, <b>41</b>, <b>42</b>, <b>43</b>, <b>44</b>, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.; (h) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (i) 4-bromo-<i>N</i>-propylbenzamide, phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, sat Na<sub>2</sub>CO<sub>3</sub> EtOH. (j) CH<sub>3</sub>CN or CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.</p></p></figure><div class="NLM_p">For the preparation of the extended scaffold compounds <b>7</b>, <b>8</b>, and <b>14</b>, we chose to have the corresponding amino acid starting materials on hand before initiating the synthesis. This was particularly important for the sulfonyl version of <i>S</i>-benzylcysteine (compound <b>49</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) as late-stage oxidation could potentially impact the stability of this set of more complex target compounds. Thus, compound <b>49</b> was easily obtained using an oxidation/deprotection sequence used above (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Compounds <b>7</b>, <b>8</b>, and <b>14</b> also required more complex amide starting intermediates. We successfully obtained the THIQ analogue by first generating the chloro-biphenylaldehyde <b>51</b> with a Suzuki coupling from <b>50</b>, followed by a reductive amination onto 1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride. This THIQ intermediate was then easily converted into tolylmehtyl amide compound <b>54</b> in two steps (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: conditions: (a) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) HCl (4 M) in dioxane; (c) 4-chloro-phenylboronic acid, Pd(OAc)<sub>2</sub> (5 mol %), tetra-<i>n</i>-butylammonium bromide (1 mol %), K<sub>2</sub>CO<sub>3</sub>, acetone/water (1:1), 40 °C; (d) 1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride, NEt<sub>3</sub>, sodium triacetoxyborohydride, CH<sub>2</sub>Cl<sub>2</sub>, r.t.; (e) LiOH, MeOH/water/THF (1:1:3), r.t.; (f) HBTU, DIEA and then 4-methylbenzylamine, DMF; (g) (1) TMSOTf, NEt<sub>3</sub>, Et<sub>2</sub>O; (2) COCl<sub>2</sub> 20% in toluene, 0 °C to r.t.; (h) NEt<sub>3</sub>, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (i) <i>N</i>,<i>O</i>-bistrimethylsilylacetamide, propylene oxide, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (j) <b>56</b> or <b>57</b>, CH<sub>3</sub>CN or CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.; (k) CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.</p></p></figure><div class="NLM_p">In parallel, the bis-biphenyl structure <b>55</b> was sourced externally and used directly in the construction of the benzoylurea core. The final compounds <b>7</b>, <b>8</b>, and <b>14</b> were prepared using the standard protocol using amino acids <b>34</b> or <b>58</b>. Yields for the synthesis of the THIQ derivatives <b>8</b> and <b>14</b> were more variable as we observed some debenzylation of the tertiary amine, an issue that was partially resolved by carefully controlling the amount of phosgene added to the reaction.</div><div class="NLM_p last">Our most optimized compounds, <b>15</b> and <b>16</b>, were prepared according to the same protocol reacting the carbamoyl chloride <b>57</b> with the trimethylsilyl (TMS)-protected amino acids <b>41</b> or <b>44</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, this work describes a novel series of inhibitors of BCL-X<sub>L</sub> as well as potent dual inhibitors of BCL-X<sub>L</sub> and BCL-2 that exhibit a number of structurally distinct features from existing series of potent inhibitors published to date, including use of the benzoylurea scaffold and the specific targeting of interactions in a cryptic p5 pocket of BCL-X<sub>L</sub>/BCL-2. To our knowledge, this pocket is only present in two other published BCL-X<sub>L</sub> structures, that of the BCL-X<sub>L</sub>:<b>ABT-263</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S3b</a>, Supporting Information) and the BCL-X<sub>L</sub>:<b>A-1342192</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S3c</a>, Supporting Information),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> recently published while this manuscript was under review. In the case of <b>ABT-263</b>, pocket formation likely occurs unintentionally through the presence of the triflone electron-withdrawing group specific to <b>ABT-263</b>, and for <b>A-1342192</b>, the methoxy-adamantane only addresses part of this pocket and variations of the methoxy are not explored. As such, this pocket has not previously been specifically targeted with hydrophobic moieties in this manner.</div><div class="NLM_p last">These new benzoylurea molecules have binding IC<sub>50</sub> values from the micromolar to nanomolar range for BCL-X<sub>L</sub> and BCL-2. Structure-guided modifications generated new interactions within the p2 and cryptic p5 pockets of BCL-X<sub>L</sub>/BCL-2, leading to the most potent analogue in the series, <b>15</b>, with an SPR-determined IC<sub>50</sub> value of around 40 nM for BCL-X<sub>L</sub> and 20 nM for BCL-2, and significantly weaker binding to other prosurvival proteins, including BCL-W, MCL-1, and A1. Consistent with its potent inhibition of both BCL-X<sub>L</sub> and BCL-2 in the SPR competitive binding assay, we showed that <b>15</b> displays a window of mechanism-based cytochrome <i>c</i> release and killing activity in MEF cells that are engineered to depend on BCL-X<sub>L</sub> for survival. This work also illustrates the versatility of our benzoylurea library to target challenging protein–protein interfaces. It adds a new structural class to the limited series of BH3 mimetics targeting BCL-X<sub>L</sub> and BCL-2 that have a mechanistically validated mode of action and provides new structural insights into the development of either selective inhibitors of BCL-X<sub>L</sub> or dual inhibitors of BCL-X<sub>L</sub>/BCL-2. This has the potential to guide the development of further selective inhibitors or protein degraders targeting this family in the future.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Materials and Methods</h4><div class="NLM_p">All nonaqueous reactions were performed in oven-dried glassware under an inert atmosphere, unless otherwise specified. Tetrahydrofuran, dichloromethane, diethyl ether, and ethanol were obtained from a solvent drying apparatus (MBraun). Anhydrous dimethylformamide (DMF), dioxane, and acetonitrile were obtained from Aldrich and used without further purification. All other solvents were of reagent grade. Petroleum ether describes a mixture of hexanes in the bp range 40–60 °C. Analytical thin-layer chromatography was performed on Merck silica gel 60F<sub>254</sub> aluminum-backed plates and were visualized by fluorescence quenching under UV light or by ninhydrin or KMnO<sub>4</sub> staining. Flash chromatography was performed with silica gel 60 (particle size 0.040–0.063 mm) either manually or using a Combiflash platform. Some of the final compounds described herein were purified using mass-directed preparative high-performance liquid chromatography (HPLC) using a mixture of 0.1% formic acid in water and acetonitrile.</div><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance DRX 300 (<sup>1</sup>H NMR at 300 MHz, <sup>13</sup>C NMR at 75 MHz), Varian 600 (<sup>1</sup>H NMR at 600 MHz), or a Bruker AVANCE III 600 MHz (<sup>1</sup>H NMR at 600 MHz, <sup>13</sup>C NMR at 151 MHz) using the solvents indicated. Chemical shifts (δ) for all <sup>1</sup>H are reported in parts per million (ppm) and were referenced to proteo-solvent residual peaks, such as δ 7.26 ppm for deuterated chloroform (CDCl<sub>3</sub>), δ 2.50 ppm for <i>d</i><sub>6</sub>-dimethyl sulfoxide (<i>d</i><sub>6</sub>-DMSO), or δ 3.31 for <i>d</i><sub>4</sub>-methanol (CD<sub>3</sub>OD). Each proton resonance was assigned according to the following convention: chemical shift (δ), multiplicity, coupling constant(s) (<i>J</i> Hz), and number of protons. Multiplicities are denoted as s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; sext, sextet; m, multiplet; br, broad; and app, apparent.</div><div class="NLM_p">Liquid chromatography–mass spectrometry (LCMS) was recorded on either a Waters ZQ 3100 using a 2996 diode array detector (Waters, Milford, MA) or an Agilent G6120B coupled to an Agilent 1260 Infinity G4212B diode array detector (Agilent, Palo Alto, CA). LCMS conditions used to assess purity of compounds were as follows: for the Waters system, column: XBridge TM C18 5 μm 4.6 × 100 mm; injection volume: 10 μL; gradient: 10–100% B over 10 min (solvent A: water 0.1% formic acid; solvent B: acetonitrile 0.1% formic acid); flow rate: 1.5 mL/min; detection: 100–600 nm; for the Agilent system, column: Poroshell 120 EC-C18, 2.7 μm 3.0 × 50 mm; injection volume: 5 μL; gradient: 5–100% B over 3 min (solvent A: water 0.1% formic acid; solvent B: acetonitrile 0.1% formic acid); flow rate: 0.8 mL/min; detection: 254 nm. All final compounds were analyzed using ultrahigh-performance liquid chromatography/ultraviolet/evaporative light-scattering detection coupled to mass spectrometry. Unless otherwise noted, all compounds were found to be >95% pure by this method.</div><div class="NLM_p">High-resolution mass spectrometry (HRMS) analyses were carried out at the Monash University Mass Spectrometry Facility using an Agilent 6224 TOF LC/MS mass spectrometer coupled to an Agilent 1290 Infinity (Agilent, Palo Alto, CA). All data were acquired and reference-mass-corrected via a dual-spray electrospray ionization (ESI) source. Acquisition was performed using Agilent Mass Hunter Data Acquisition software version B.06.01 Build 6.01.6157, and analysis was performed using Mass Hunter Qualitative Analysis version B.07.00 Build Service Pack 1.</div><div class="NLM_p last">Compound <b>55</b> was provided by AMT (Dr. Seb Marcuccio, Melbourne).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis and Characterization of Compounds</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Synthesis of Compound (<b>2</b>)</h4><div id="sec5_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13"> <i>N</i>-[(4-Methylphenyl)methyl]-4-phenylbenzamide (<b>32</b>)</h5><div class="NLM_p last">To a stirred solution of biphenyl-4-carboxylic acid <b>31</b> (1.0 g, 5.0 mmol) in 12.5 mL of anhydrous DMF were added HBTU (3.8 g, 10 mmol) and DIEA (1.74 mL, 10 mmol) and the reaction was stirred under N<sub>2</sub> at room temperature for 15 min. 4-Methylbenzylamine (1.30 mL, 10 mmol) was then added, and the reaction was allowed to proceed at room temperature for 18 h. After this time, the reaction mixture was poured over an ice/water mixture and the off-white solid precipitate formed was collected by vacuum filtration, washed copiously with cold water, and then dried in a 30 °C oven in vacuo. The resulting solid was purified via flash chromatography and eluted with ethyl acetate (EtOAc)/hexane (25:75) to afford compound <b>32</b> as fine white needles (1.46 g, 97%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.86 (d, <i>J</i> = 8.67 Hz, 2H), 7.65 (d, <i>J</i> = 8.58 Hz, 2H), 7.61 (dd, <i>J</i> = 8.25, 1.32 Hz, 2H), 7.49–7.43 (m, 2H), 7.41–7.36 (m, 1H), 7.27 (d, <i>J</i> = 7.92 Hz, 2H), 7.18 (d, <i>J</i> = 7.92 Hz, 2H), 6.41 (br s, 1H), 4.63 (d, <i>J</i> = 5.52 Hz, 2H), 2.36 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 166.9, 144.4, 140.0, 137.4, 135.2, 133.1, 129.5, 128.9, 128.0, 127.5, 127.2, 127.2, 44.0, 21.1. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 302.1, (M + H). HRMS (ES<sup>+</sup> time-of-flight (TOF)) calcd for C<sub>21</sub>H<sub>19</sub>NO (M + H): 302.1539; found 302.1532.</div></div><div id="sec5_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i14" class="anchor-spacer"></div><h5 class="article-section__title" id="_i14"> Biphenylcarbonyl(4-methylbenzyl)carbamic Chloride (<b>33</b>)</h5><div class="NLM_p last">To a stirred solution of amide <b>32</b> (100 mg, 0.33 mmol) in 1 mL of anhydrous Et<sub>2</sub>O was added triethylamine (50 μL, 0.36 mmol), followed by TMSOTf (65 μL, 0.36 mmol), and the reaction was stirred under N<sub>2</sub> at room temperature for 30 min. After this time, phosgene (660 μL, 2 mL/mmol amide starting material, 20% w/v in toluene, CAUTION!) was added to the yellow-brown solution at 0 °C, which was then allowed to warm to room temperature and stirred under N<sub>2</sub> for 1.5 h. After this time, concentration in vacuo (using an in-line solvent trap) over a room-temperature water bath afforded the off-white solid carbamoyl chloride residue. This compound was used in the next step without further purification.</div></div><div id="sec5_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> <i>O</i>-Trimethylsilyl-<i>S</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-cysteine (<b>39</b>)</h5><div class="NLM_p last">To a stirred suspension of <i>S</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-cysteine (<b>34</b>, 105 mg, 0.50 mmol) in 2 mL of anhydrous acetonitrile was added 1 mL of propylene oxide and bistrimethylsilylacetamide (183 μL, 0.75 mmol) and the reaction was stirred under N<sub>2</sub> at room temperature for 1.5 h. This compound was used in the next step without further purification.</div></div><div id="sec5_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> (2<i>R</i>)-3-(Benzylsulfanyl)-2-({[(4-methylphenyl)methyl][(4-phenylphenyl)carbonyl]carbamoyl}amino)propanoic Acid (<b>2</b>)</h5><div class="NLM_p last">Under a N<sub>2</sub> atmosphere, the carbamoyl chloride <b>33</b> was redissolved in 1 mL of anhydrous acetonitrile and then transferred to the stirred suspension of the in situ-protected amino acid <b>39</b> at 0 °C. The reaction was allowed to warm to room temperature and stirred at room temperature for 1.5 h. After this time, the reaction was diluted with EtOAc and poured onto aqueous 1 M HCl. The reaction mixture was extracted three times with EtOAc. The combined organic layers were washed with water and then brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification via flash chromatography and eluting with methanol/dichloromethane (0:100 to 0.5:99.5 to 1:99 to 2:98, etc. to 4:96) afforded benzoylurea <b>2</b> as a colorless glassy solid (149.1 mg, 83%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.68 (d, <i>J</i> = 6.9 Hz, 1H), 7.63–7.54 (m, 4H), 7.50–7.35 (m, 5H), 7.35–7.19 (m, 5H), 7.06 (d, <i>J</i> = 7.8 Hz, 2H), 6.95 (d, <i>J</i> = 8.0 Hz, 2H), 5.00 (s, 2H), 4.77 (dd, <i>J</i> = 12.1, 6.6 Hz, 1H), 3.78 (s, 2H), 3.02 (dd, <i>J</i> = 14.2, 5.3 Hz, 1H), 2.93 (dd, <i>J</i> = 14.0, 6.7 Hz, 1H), 2.29 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 175.3, 174.2, 155.5, 143.9, 140.0, 137.7, 137.2, 134.6, 134.5, 129.5, 129.2, 129.1, 128.8, 128.3, 127.4, 127.4, 127.3, 127.3, 126.7, 53.6, 50.2, 36.8, 32.9, 21.2. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 539.1, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>32</sub>H<sub>30</sub>N<sub>2</sub>O<sub>4</sub>S (M + H): 539.1999; found 539.2000.</div></div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Synthesis of Compound (<b>3</b>)</h4><div id="sec5_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 2(<i>R</i>)-(3-(Biphenylcarbonyl)-3-(4-methylbenzyl)ureido)-3-(methylthio)propanoic Acid (<b>3</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>32</b> (301 mg, 1.0 mmol) and <i>S</i>-methyl-<span class="smallcaps smallerCapital">l</span>-cysteine (<b>37</b>, 136 mg, 1.0 mmol). The crude material was purified by mass-directed preparative HPLC. An orange oil was obtained (57 mg, 12%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.70 (d, <i>J</i> = 7.0 Hz, 1H), 8.01 (br s, 1H), 7.60–7.57 (m, 4H), 7.49–7.43 (m, 2H), 7.41–7.36 (m, 1H), 7.08 (d, <i>J</i> = 7.9 Hz, 2H), 6.96 (d, <i>J</i> = 9.1 Hz, 2H), 5.01 (s, 2H), 4.83 (q, <i>J</i> = 7.0 Hz, 1H), 3.14–3.01 (m, 2H), 2.31 (s, 3H), 2.18 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 175.2, 155.2, 143.8, 139.8, 137.0, 134.5, 134.3, 129.3, 129.0, 128.1, 127.3, 127.2, 127.1, 126.5, 53.4, 50.1, 35.9, 21.1, 16.2. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 463.1 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>S (M + H): 463.1686; found 463.1691.</div></div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Synthesis of Compound (<b>4</b>)</h4><div id="sec5_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> <i>N</i>-(2-(Benzylthio)ethylcarbamoyl)-<i>N</i>-(4-methylbenzyl)biphenyl-4-carboxamide (<b>4</b>)</h5><div class="NLM_p last">Compound <b>33</b> was prepared according to the method described for compound <b>2</b> using <b>32</b> (301 mg, 1.0 mmol). <b>33</b> was dissolved in 2.5 mL of anhydrous acetonitrile and added to a solution of 2-(benzylthio)ethanaminium chloride (204 mg, 1.0 mmol) and triethylamine (279 μL, 2 mmol) in 2.5 mL of anhydrous dichloromethane at 0 °C. The reaction was warmed to room temperature and stirred for 1 h. After this time, the reaction was diluted with EtOAc and poured onto aqueous 1 M HCl. The reaction mixture was extracted three times with EtOAc. The combined organic layers were washed with water and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude material was purified by mass-directed preparative HPLC. A white solid was obtained (85 mg, 17%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.17 (t, <i>J</i> = 5.3 Hz, 2H), 7.60–7.57 (m, 4H), 7.49–7.22 (m, 10H), 7.07 (d, <i>J</i> = 7.9 Hz, 2H), 6.95 (d, <i>J</i> = 8.1 Hz, 2H), 4.98 (s, 2H), 3.75 (s, 2H), 3.52 (q, <i>J</i> = 5.7 Hz, 2H), 2.64 (t, <i>J</i> = 6.8 Hz, 2H), 2.31 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 175.0, 155.0, 143.5, 139.9, 138.1, 136.9, 134.9, 134.8, 129.2, 129.0, 128.9, 128.6, 128.1, 127.2, 127.1, 127.1, 126.6, 49.9, 39.8, 35.9, 30.9, 21.1. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 495.1 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>31</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>S (M + H): 495.2101; found 495.2110.</div></div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Synthesis of Compound (<b>5</b>)</h4><div id="sec5_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <span class="smallcaps smallerCapital">l</span>-Cysteine, <i>N</i>-[(1,1-Dimethylethoxy)carbonyl]-<i>S</i>-(phenylmethyl)-, Methyl Ester (<b>18</b>)</h5><div class="NLM_p last">To a stirred solution of Boc-<i>S</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-cysteine (<b>17</b>, 623 mg, 2.00 mmol) in anhydrous MeOH (3.00 mL) at 0 °C was added thionyl chloride (219 μL, 3.00 mmol); then, the reaction was allowed to warm to room temperature and proceed for 1 h. After this time, di-<i>tert</i>-butyl dicarbonate (459 μL, 2.00 mmol) was added, and the reaction was allowed to proceed for a further 6 h at room temperature. After this time, the reaction mixture was concentrated under reduced pressure, and the residue was taken in EtOAc (10 mL) and poured over water (20 mL). The two phases were separated, and the aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with aqueous saturated NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford the title compound as a yellow oil (607 mg, 93%). Spectral data obtained corresponded to those reported in the literature.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec5_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (<i>R</i>)-Methyl 2-Amino-3-(benzylthio)propanoate Hydrochloride (<b>19</b>)</h5><div class="NLM_p last">To a sample of <b>18</b> (247 mg, 0.76 mmol) at room temperature under N<sub>2</sub> was added a solution of HCl (4 M) in 1,4-dioxane (1.5 mL). The reaction was allowed to proceed for 1.5 h at room temperature; then, the reaction mixture was carefully concentrated under reduced pressure to yield the title compound as an off-white powdery solid (192 mg, 97%). Spectral data obtained corresponded to those reported in the literature.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec5_2_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (<i>R</i>)-Methyl 2-(3-([1,1′-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-(benzylthio)propanoate (<b>5</b>)</h5><div class="NLM_p last">Compound <b>33</b> was prepared according to the method described for compound <b>2</b> using <b>32</b> (30 mg, 0.10 mmol). <b>33</b> was dissolved in 400 μL of anhydrous dichloromethane and transferred dropwise to a stirred solution of <b>19</b> (30 mg, 0.12 mmol), triethylamine (30 μL, 0.22 mmol), and propylene oxide (192 μL, 2.4 mmol) in 460 μL of anhydrous dichloromethane at 0 °C. The reaction was allowed to warm to room temperature and stirred for 0.5 h. After this time, the reaction was diluted with dichloromethane and poured onto an aqueous 10% citric acid solution. The reaction mixture was extracted three times with dichloromethane. The combined organic layers were washed with water and then brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified via flash chromatography and eluted with EtOAc/cyclohexane (0:100–10:90), followed by further purification via mass-directed preparative HPLC. A white solid was obtained (27 mg, 51%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.64 (d, <i>J</i> = 7.3 Hz, 1H), 7.64–7.53 (m, 4H), 7.53–7.20 (m, 11H), 7.07 (d, <i>J</i> = 7.9 Hz, 2H), 6.97 (d, <i>J</i> = 8.1 Hz, 2H), 5.00 (s, 2H), 4.80 (td, <i>J</i> = 6.6, 5.1 Hz, 1H), 3.77 (s, 3H), 3.76 (s, 2H), 2.94 (qd, <i>J</i> = 14.0, 5.8 Hz, 2H), 2.30 ppm (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 175.2, 171.1, 155.0, 143.8, 140.0, 137.8, 137.0, 134.8, 134.7, 129.4, 129.2, 129.1, 128.7, 128.2, 127.4, 127.3, 127.2, 126.7, 53.7, 52.8, 50.1, 36.7, 33.4, 21.2 ppm. One Ar–CH peak is not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 553.2 (M + H), HRMS (ES<sup>+</sup> TOF) calcd for C<sub>33</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub>S (M + H): 553.2156; found 553.2166.</div></div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Synthesis of Compound (<b>6</b>)</h4><div id="sec5_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>N</i>-Propylbiphenyl-4-carboxamide (<b>46</b>)</h5><div class="NLM_p last">4-Bromo-<i>N</i>-propylbenzamide (<b>45</b>, 484 mg, 2 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (120 mg, 0.1 mmol), phenylboronic acid (270 mg, 2.2 mmol), and 2 mL of an aqueous Na<sub>2</sub>CO<sub>3</sub> solution were stirred for 20 h at 100 °C in 1 mL of ethanol. After this time, EtOAc was added along with an ammonia solution (25% aqueous). The mixture was extracted three times with EtOAc. The combined organic layers were washed twice with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification via flash chromatography and eluting with petroleum ether/dichloromethane (20:80–100:0) and then petroleum ether/EtOAc (100:0–80:20) afforded the title compound as a white crystalline solid (338 mg, 71%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.85 (d, <i>J</i> = 7.8 Hz, 2H), 7.63 (d, <i>J</i> = 7.8 Hz, 2H), 7.59 (d, <i>J</i> = 7.5 Hz, 2H), 7.45 (t, <i>J</i> = 7.4 Hz, 2H), 7.38 (t, <i>J</i> = 7.0 Hz, 1H), 6.40 (br s, 1H), 3.44 (dd, <i>J</i> = 13.0, 6.4 Hz, 2H), 1.66 (sext, <i>J</i> = 7.2 Hz, 2H), 1.00 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 167.4, 144.2, 140.2, 133.7, 129.0, 128.0, 127.5, 127.3, 41.9, 23.1, 11.6. One Ar–CH peak is not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 240.5 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>16</sub>H<sub>17</sub>NO (M + H): 240.1383; found 240.1384.</div></div><div id="sec5_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (<i>R</i>)-3-(Benzylthio)-2-(3-(biphenylcarbonyl)-3-propylureido)propanoic Acid (<b>6</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>46</b> (96 mg, 0.50 mmol) and <i>S</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-cysteine (127 mg, 0.55 mmol). Purification via flash chromatography and eluting with methanol/dichloromethane/acetic acid (0.5:99:0.5) afforded benzoylurea <b>6</b> as a colorless glass (196 mg, 82%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 10.29 (br s, 1H), 9.66 (d, <i>J</i> = 7.0 Hz, 1H), 7.67 (d, <i>J</i> = 8.1 Hz, 2H), 7.61 (d, <i>J</i> = 7.3 Hz, 2H), 7.54 (d, <i>J</i> = 8.1 Hz, 2H), 7.46 (t, <i>J</i> = 7.7 Hz, 2H), 7.42–7.36 (m, 1H), 7.36–7.27 (m, 4H), 7.27–7.21 (m, 1H), 4.76 (td, <i>J</i> = 6.9, 5.0 Hz, 1H), 3.79 (s, 2H), 3.77–3.70 (m, 2H), 3.00 (dd, <i>J</i> = 14.1, 4.9 Hz, 1H), 2.91 (dd, <i>J</i> = 14.1 Hz, 6.8, 1H), 1.58 (sext., <i>J</i> = 7.5 Hz, 2H), 0.76 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 175.5, 175.2, 155.2, 143.7, 139.9, 137.6, 134.8, 129.2, 129.1, 128.7, 128.2, 127.4, 127.4, 127.3, 127.2, 53.5, 49.1, 36.7, 32.9, 23.1, 11.1. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 476.8 (M + H), 99% pure. HRMS (ES<sup>+</sup> TOF) calcd for C<sub>27</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub>S (M + H): 477.1843; found 477.1849.</div></div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Synthesis of Compound (<b>7</b>)</h4><div id="sec5_2_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>R</i>)-3-(Benzylthio)-2-(3-(4-chloro-[1,1′:2′,1″:3″,1″′-quaterphenyl]-4″′-carbonyl)-3-(4-methylbenzyl)ureido)propanoic Acid (<b>7</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>55</b> (125 mg, 0.26 mmol) and <i>S</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-cysteine (<b>34</b>, 65 mg, 0.31 mmol). The crude material was purified by mass-directed preparative HPLC to afford the title product as a white solid (53 mg, 28%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.70 (d, <i>J</i> = 7.0 Hz, 1H), 7.52–7.16 (m, 19H), 7.13–7.03 (m, 4H), 6.94 (d, <i>J</i> = 8.1 Hz, 2H), 4.98 (s, 2H), 4.75 (td, <i>J</i> = 6.7, 5.1 Hz, 1H), 3.78 (d, <i>J</i> = 1.3 Hz, 2H), 2.97 (qd, <i>J</i> = 14.1, 5.9 Hz, 2H), 2.30 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 175.3, 173.0, 155.6, 143.7, 141.8, 140.2, 139.6, 139.6, 137.7, 137.2, 134.6, 134.4, 132.9, 131.4, 130.7, 130.6, 129.6, 129.5, 129.2, 128.9, 128.8, 128.4, 128.2, 128.0, 127.4, 127.2, 126.6, 125.6, 77.4, 53.5, 50.2, 36.8, 32.8, 21.2. Four Ar–CH peaks are not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 726 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>44</sub>H<sub>37</sub>ClN<sub>2</sub>O<sub>4</sub>S (M + H): 725.2235; found 725.2258.</div></div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Synthesis of Compound (<b>8</b>)</h4><div id="sec5_2_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 4′-Chloro-[1,1′-biphenyl]-2-carbaldehyde (<b>51</b>)</h5><div class="NLM_p last">2-Bromobenzaldehyde (<b>50</b>, 740 mg, 4.0 mmol), 4-chloro-phenylboronic acid (751 mg, 4.8 mmol), tetra-<i>n</i>-butylammonium bromide (13 mg, 1 mol %), and K<sub>2</sub>CO<sub>3</sub> (1.66 g, 12.0 mmol) in 8 mL of a solution of acetone/water (1:1) were flushed with N<sub>2</sub> and stirred at room temperature for 30 min. Pd(OAc)<sub>2</sub> (45 mg, 5 mol %) was then added, and the reaction was allowed to stir for 30 min at 40 °C. After this time, the reaction mixture was concentrated under reduced pressure and filtered through celite; then, water (20 mL) and diethyl ether (20 mL) were added and the two layers were separated. The aqueous phase was extracted with diethyl ether (2 × 20 mL), and the combined organic phases were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the crude material via flash chromatography and eluting with a gradient of EtOAc/cyclohexane (0:100–5:95) afforded the title product as a yellow oil (703 mg, 81%). Analytical data obtained corresponded to reported literature values.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec5_2_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Methyl 2-((4′-Chlorobiphenyl-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylate (<b>52</b>)</h5><div class="NLM_p last">To a stirred solution of 1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride (300 mg, 1.3 mmol) and triethylamine (367 μL, 2.6 mmol) in anhydrous dichloromethane (3 mL) at room temperature under a N<sub>2</sub> atmosphere was added <b>51</b> (285 mg, 1.3 mmol) followed by sodium triacetoxyborohydride (559 mg, 2.6 mmol). The reaction was allowed to proceed for 18 h at room temperature, after which time aqueous saturated NaHCO<sub>3</sub> (10 mL) was added, followed by EtOAc (20 mL). The layers were separated, and the aqueous phase was further extracted with EtOAc (2 × 20 mL). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the crude material via flash chromatography and eluting with petroleum ether/EtOAc (100:0–90:10) afforded the title compound as a colorless oil (492 mg, 95%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.80–7.76 (m, 2H), 7.65 (br d, <i>J</i> = 6.5 Hz, 1H), 7.43–7.38 (m, 6H), 7.29–7.26 (m, 1H), 7.03 (d, <i>J</i> = 7.8 Hz, 1H), 3.91 (s, 3H), 3.63 (br s, 4H), 2.92 (t, <i>J</i> = 5.6 Hz, 2H), 2.72 (t, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 167.1, 141.6, 139.7, 134.5, 133.4, 133.1, 130.9, 130.9, 130.5, 130.2, 130.1, 130.0, 128.5, 128.5, 127.7, 127.3, 126.8, 126.6, 59.4, 55.5, 52.0, 50.1, 29.0. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 392.1 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>24</sub>H<sub>22</sub>ClNO<sub>2</sub> (M + H): 392.1412; found 392.1428.</div></div><div id="sec5_2_7_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2-((4′-Chlorobiphenyl-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic Acid (<b>53</b>)</h5><div class="NLM_p last">LiOH·H<sub>2</sub>O (80 mg, 1.91 mmol) was added to a solution of <b>52</b> (188 mg, 0.48 mmol) in a mixture of methanol (0.60 mL), water (0.60 mL), and THF (1.8 mL). The reaction was stirred at room temperature for 16 h. TLC (petroleum ether/EtOAc 90:10) indicated full conversion. The reaction mixture was concentrated under reduced pressure; then, water (10 mL) was added and the reaction was acidified to pH ∼1.0 with ∼1.9 mL of 1 M HCl. The resulting off-white precipitate was filtered, washed with a small volume of water, and dried in a vacuum oven at 40 °C overnight. This afforded the HCl salt of <b>53</b> as an off-white powdery solid (146 mg, 74%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.83 (d, <i>J</i> = 8.1 Hz, 1H), 7.81 (s, 1H), 7.78–7.75 (m, 1H), 7.60–7.54 (m, 2H), 7.45 (dd, <i>J</i> = 8.3, 0.9 Hz, 2H), 7.43–7.40 (m, 1H), 7.35 (dd, <i>J</i> = 8.2, 0.8 Hz, 2H), 7.12 (d, <i>J</i> = 8.1 Hz, 1H), 4.46 (s, 2H), 4.16 (s, 2H), 3.36 (t, <i>J</i> = 5.6 Hz, 2H), 3.08 (t, <i>J</i> = 6.3 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 167.6, 142.8, 138.2, 133.8, 132.4, 131.1, 130.9, 130.8, 130.5, 129.7, 129.7, 128.6, 128.6, 127.7, 127.5, 126.8, 55.6, 52.4, 49.2, 24.6. One Ar–CH peak is not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 378.2 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>23</sub>H<sub>20</sub>ClNO<sub>2</sub> (M + H): 378.1255; found 378.1254.</div></div><div id="sec5_2_7_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 2-((4′-Chlorobiphenyl-2-yl)methyl)-<i>N</i>-(4-methylbenzyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxamide (<b>54</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>33</b> was followed using compound <b>53</b> (99 mg, 0.26 mmol), DIEA (183 μL, 1.05 mmol), and 4-methylbenzylamine (67 μL, 0.52 mmol). The reaction mixture was poured onto ice-water whereupon an orange solid precipitated. This compound was taken up in EtOAc, and the two phases separated. The aqueous phase was further extracted twice with EtOAc; then, the pooled organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting crude brown oil was purified via flash chromatography and eluted with petroleum ether/EtOAc (100:0–0:100) affording the title compound as a white solid (105 mg, 83%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.53–7.45 (m, 1H), 7.43 (s, 1H), 7.39 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.31–7.19 (m, 6H), 7.19–7.10 (m, 3H), 7.06 (d, <i>J</i> = 7.9 Hz, 2H), 6.89 (d, <i>J</i> = 8.0 Hz, 1H), 6.28 (t, <i>J</i> = 5.3 Hz, 1H), 4.48 (d, <i>J</i> = 5.6 Hz, 2H), 3.46 (d, <i>J</i> = 4.4 Hz, 4H), 2.75 (t, <i>J</i> = 5.7 Hz, 2H), 2.56 (t, <i>J</i> = 5.8 Hz, 2H), 2.24 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 167.4, 141.6, 139.9, 138.9, 137.4, 135.6, 135.4, 135.1, 133.2, 132.4, 131.0, 130.2, 130.2, 129.6, 128.2, 128.1, 127.7, 127.6, 127.3, 126.9, 124.1, 59.8, 55.7, 50.3, 44.0, 29.4, 21.2. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 481.0 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>31</sub>H<sub>29</sub>ClN<sub>2</sub>O (M + H): 481.2041; found 481.2021.</div></div><div id="sec5_2_7_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (<i>R</i>)-3-(Benzylthio)-2-(3-(2-((4′-chloro-[1,1′-biphenyl]-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(4-methylbenzyl)ureido)propanoic Acid (<b>8</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>54</b> (125 mg, 0.25 mmol) and <i>S</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-cysteine (<b>34</b>, 65 mg, 0.31 mmol), with the following modifications: the reaction times following addition of TMSOTf and phosgene were lengthened to 1.5 and 3 h, respectively, and a small amount of the yellow oil that formed in the reaction mixture was removed prior to phosgene addition. Purification via mass-directed preparative HPLC afforded benzoylurea <b>8</b> as a white glassy solid (6 mg, 3%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.85–6.91 (m, 20H), 4.89 (dd, <i>J</i> = 32.7, 15.7 Hz, 2H), 4.47 (dd, <i>J</i> = 6.7, 4.9 Hz, 1H), 4.36 (s, 2H), 4.03 (s, 2H), 3.69 (q, <i>J</i> = 13.0 Hz, 2H), 3.25–3.13 (m, 2H), 2.98–2.85 (m, 3H), 2.80 (dd, <i>J</i> = 13.9, 7.1 Hz, 1H), 2.26 (s, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 174.5, 173.8, 157.0, 144.1, 139.9, 139.4, 138.2, 137.0, 135.8, 135.1, 132.9, 132.6, 132.3, 132.2, 132.1, 130.9, 130.1, 130.1, 130.0, 129.9, 129.5, 129.5, 128.5, 128.3, 128.1, 128.0, 126.6, 57.7, 55.1, 54.1, 50.6, 49.6, 37.2, 34.1, 26.5, 21.1. One Ar–CH peak is not observed due to overlap. HRMS (ES<sup>+</sup> TOF) calcd for C<sub>42</sub>H<sub>40</sub>ClN<sub>3</sub>O<sub>4</sub>S (M + H): 718.2501; found 718.2495.</div></div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Synthesis of Compound (<b>9</b>)</h4><div id="sec5_2_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (<i>S</i>)-2-(3-([1,1′-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-5-phenylpentanoic Acid (<b>9</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>32</b> (50 mg, 0.16 mmol) and <span class="smallcaps smallerCapital">l</span>-2-amino-5-phenylpentanoic acid (<b>35</b>, 46 mg, 0.24 mmol). Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–4:96) afforded benzoylurea <b>9</b> as a colorless glass (60 mg, 72%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.46 (d, <i>J</i> = 6.9 Hz, 1H), 7.70–7.50 (m, 4H), 7.50–7.33 (m, 5H), 7.24 (dt, <i>J</i> = 16.9 Hz, 7.8, 5H), 7.05 (d, <i>J</i> = 7.9 Hz, 2H), 6.92 (d, <i>J</i> = 7.9 Hz, 2H), 4.99 (s, 2H), 4.61 (dd, <i>J</i> = 12.7, 7.3 Hz, 1H), 2.73–2.61 (m, 2H), 2.30 (s, 3H), 2.07–1.83 (m, 2H), 1.83–1.73 (m, 2H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 176.5, 175.4, 155.3, 143.8, 141.6, 139.9, 137.1, 134.7, 134.6, 129.4, 129.1, 128.6, 128.2, 127.3, 127.3, 126.6, 126.1, 53.8, 50.1, 35.5, 31.5, 27.4, 21.2. Two Ar–CH peaks (range δ 129.8–126.0 ppm) are not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 521.4 (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>33</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub> (M + H): 521.2435; found 521.2440.</div></div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Synthesis of Compound (<b>10</b>)</h4><div id="sec5_2_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (<i>S</i>)-2-(3-([1,1′-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-(benzyloxy)propanoic Acid (<b>10</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>32</b> (100 mg, 0.33 mmol) and <i>O</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-serine (<b>38</b>, 97 mg, 0.50 mmol), with the following modification: due to the presence of a white insoluble residue in the carbamoyl chloride/acetonitrile suspension, the solution of in situ-protected amino acid was instead transferred to the carbamoyl chloride solution at 0 °C, and the reaction was allowed to proceed for 3 days. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–5:95) afforded benzoylurea <b>10</b> as a colorless glass (140 mg, 81%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.61 (d, <i>J</i> = 7.3 Hz, 1H), 7.59 (dd, <i>J</i> = 7.0, 1.4 Hz, 4H), 7.52–7.22 (m, 10H), 7.06 (d, <i>J</i> = 7.8 Hz, 2H), 6.95 (d, <i>J</i> = 6.9 Hz, 2H), 5.00 (s, <i>J</i> = 17.4 Hz, 2H), 4.86–4.69 (m, 1H), 4.59 (s, 2H), 3.99 (dd, <i>J</i> = 9.5, 3.8 Hz, 1H), 3.79 (dd, <i>J</i> = 9.7, 3.9 Hz, 1H), 2.30 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.9, 173.9, 155.4, 143.7, 139.9, 137.3, 136.9, 134.6, 134.5, 129.3, 128.9, 128.5, 128.0, 127.9, 127.8, 127.2, 127.2, 127.1, 126.5, 73.5, 68.9, 54.1, 50.0, 21.1. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 523.1, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>32</sub>H<sub>30</sub>N<sub>2</sub>O<sub>5</sub> (M + H): 523.2227; found 523.2234.</div></div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Synthesis of Compound (<b>11</b>)</h4><div id="sec5_2_10_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> (<i>R</i>)-2-(3-([1,1′-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-(benzylsulfonyl)propanoic Acid (<b>11</b>)</h5><div class="NLM_p last">To a stirred solution of compound <b>2</b> (151 mg, 0.28 mmol) in anhydrous THF (1 mL) at room temperature was added <i>m-</i>CPBA (77% max, 69 mg, approx. 0.31 mmol). The reaction was stirred at 0 °C for 20 min, forming a mixture of sulfoxide and sulfone products. Concentration of the reaction mixture in vacuo followed by purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–3:97) afforded the sulfone product <b>11</b> as a colorless glass (58 mg, 36%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.87 (d, <i>J</i> = 6.8 Hz, 1H), 7.57 (dd, <i>J</i> = 7.6, 2.0 Hz, 4H), 7.51–7.32 (m, 10H), 7.03 (d, <i>J</i> = 8.2 Hz, 2H), 6.95 (d, <i>J</i> = 8.0 Hz, 2H), 5.09–4.86 (m, 3H), 4.26 (s, 2H), 3.79–3.49 (m, 2H), 2.25 (s, 3H).<sup>[a] 13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 175.2, 171.7, 155.4, 144.0, 139.7, 137.1, 134.2, 133.9, 130.9, 129.4, 129.2, 129.0, 128.9, 128.1, 127.5, 127.2, 127.1, 126.5, 61.2, 51.9, 50.2, 49.6, 21.0. One Ar–CH peak is not observed due to overlap. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 571.2, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>32</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub>S (M + H): 571.1897; found 571.1882.</div></div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Synthesis of Compound (<b>12</b>)</h4><div id="sec5_2_11_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (<i>R</i>)-2-((<i>tert</i>-Butoxycarbonyl)amino)-3-((cyclohexylmethyl)thio)propanoic Acid (<b>21</b>)</h5><div class="NLM_p last">Compound <b>21</b> was prepared according to a literature procedure.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Briefly, to a stirred solution of <span class="smallcaps smallerCapital">l</span>-cysteine (<b>20</b>, 200 mg, 1.65 mmol) in a 1:1 solution of NaOH (2 N) and EtOH (total 3.4 mL) was added (bromomethyl)cyclohexane (0.253 mL, 1.82 mmol) followed by tetrabutylammonium iodide (TBAI) (18 mg, 3 mol %). The reaction was allowed to proceed for 3 days at room temperature; then, di-<i>tert-</i>butyl dicarbonate (0.417 mL, 1.82 mmol) was added and the reaction was stirred for a further 24 h at room temperature. Ethanol was removed under reduced pressure, the residue was taken up in EtOAc (20 mL), and then 10% aqueous citric acid solution (20 mL) was added. The two phases were separated, the aqueous phase was further extracted with EtOAc (2 × 10 mL), and the combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield the title compound as a colorless oil (378 mg, 72%). Spectral data obtained corresponded to those reported in the literature.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div></div><div id="sec5_2_11_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>R</i>)-2-((<i>tert</i>-Butoxycarbonyl)amino)-3-((cyclohexylmethyl)sulfonyl)propanoic Acid (<b>22</b>)</h5><div class="NLM_p last">To a stirred solution of compound <b>21</b> (314 mg, 0.99 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at 0 °C was added <i>m</i>-CPBA (max 77%, 444 mg, approx. 1.98 mmol), and the reaction allowed to warm to room temperature and proceed for 3 h. After this time, the reaction was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL); washed with 10% aqueous sodium metabisulfite, 10% aqueous NaHCO<sub>3</sub>, and brine; dried over MgSO<sub>4</sub>; filtered; and concentrated under reduced pressure. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100 to 5:95 to 1:90) afforded the title compound as a colorless oil (307 mg, 89%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.07 (br s, 1H), 5.77 (d, <i>J</i> = 6.3 Hz, 1H), 4.68 (dd, <i>J</i> = 12.1, 5.1 Hz, 1H), 3.66 (d, <i>J</i> = 3.8 Hz, 2H), 2.95 (d, <i>J</i> = 6.4 Hz, 2H), 2.07 (qdd, <i>J</i> = 9.9, 6.5, 3.6 Hz, 1H), 1.92 (d, <i>J</i> = 12.7 Hz, 2H), 1.78–1.58 (m, 3H), 1.45 (s, <i>J</i> = 19.9, 9H), 1.39–0.97 (m, 5H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 172.6, 155.8, 81.4, 77.4, 61.7, 54.8, 49.9, 33.3, 32.4, 28.4, 25.9, 25.8. MS (ES<sup>–</sup>), <i>m</i>/<i>z</i> 348.2 (M – H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>15</sub>H<sub>27</sub>NO<sub>6</sub>S (M + Na): 372.1451; found 372.1452.</div></div><div id="sec5_2_11_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>R</i>)-1-Carboxy-2-((cyclohexylmethyl)sulfonyl)ethanaminium Chloride (<b>23</b>)</h5><div class="NLM_p last">To a sample of <b>22</b> (261 mg, 0.75 mmol) at room temperature under N<sub>2</sub> was added a solution of HCl (4 M) in 1,4-dioxane (2.0 mL), and the stirred reaction was allowed to proceed for 14 h at room temperature. The fine white precipitate was filtered, washed with a small volume of Et<sub>2</sub>O, and then dried in vacuo for 24 h to afford the title compound as a fine off-white powder (165 mg, 77%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 4.57 (d, <i>J</i> = 6.6 Hz, 1H), 3.89 (d, <i>J</i> = 14.7 Hz, 1H), 3.60 (dd, <i>J</i> = 13.5, 9.0 Hz, 1H), 3.20 (d, <i>J</i> = 6.1 Hz, 2H), 2.09 (br s, 1H), 1.96 (d, <i>J</i> = 12.2 Hz, 2H), 1.72 (t, <i>J</i> = 16.7 Hz, 3H), 1.47–1.08 (m, 5H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 60.9, 53.8, 34.1, 34.0, 33.5, 26.9, 26.9. One peak is not observed due to overlap. MS (ES<sup>–</sup>), <i>m</i>/<i>z</i> 248.3 (M – H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>10</sub>H<sub>19</sub>NO<sub>4</sub>S (M + H): 250.1108; found 250.1100.</div></div><div id="sec5_2_11_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (<i>R</i>)-2-(3-([1,1′-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-((cyclohexylmethyl)sulfonyl)propanoic Acid (<b>12</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>32</b> (100 mg, 0.33 mmol). Compound <b>23</b> (67 mg, 0.24 mmol) was protected in situ using the method described for compound <b>19</b>, with the modification that anhydrous dichloromethane was used as the reaction solvent and triethylamine (33 μL, 0.24 mmol) was first added to neutralize the amino acid. Compound <b>33</b> was dissolved in anhydrous dichloromethane (1.0 mL) and transferred to the in situ-protected amino acid <b>41</b> at 0 °C, and the reaction was allowed to warm to room temperature and proceed for 2 h. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–5:95) afforded compound <b>12</b> as a colorless glass (85.1 mg, 94%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.89 (d, <i>J</i> = 6.8 Hz, 1H), 9.76 (br s, 1H), 7.57 (d, <i>J</i> = 7.9 Hz, 4H), 7.48–7.36 (m, 5H), 7.06 (d, <i>J</i> = 7.7 Hz, 2H), 6.95 (d, <i>J</i> = 7.7 Hz, 2H), 5.09–4.91 (m, 3H), 3.72 (qd, <i>J</i> = 14.8, 5.4 Hz, 2H), 2.94 (d, <i>J</i> = 6.4 Hz, 2H), 2.29 (s, 3H), 2.14–2.04 (m, 1H), 1.91 (d, <i>J</i> = 12.1 Hz, 2H), 1.69 (dd, <i>J</i> = 12.6, 2.5 Hz, 2H), 1.64 (d, <i>J</i> = 12.8 Hz, 1H), 1.30 (ddd, <i>J</i> = 25.5, 12.6, 2.6 Hz, 2H), 1.14 (ddt, <i>J</i> = 25.1, 12.6, 3.3 Hz, 1H), 1.06 (dd, <i>J</i> = 24.0, 12.1 Hz, 2H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 175.3, 172.5, 155.5, 144.0, 139.9, 137.1, 134.4, 134.1, 129.5, 129.1, 128.2, 127.5, 127.3, 127.2, 126.6, 61.3, 54.5, 50.2, 49.8, 33.2, 32.3, 25.9, 25.8, 21.2. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 577.9, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>32</sub>H<sub>36</sub>N<sub>2</sub>O<sub>6</sub>S (M + H): 577.2367; found 577.2375.</div></div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Synthesis of Compound (<b>13</b>)</h4><div id="sec5_2_12_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-ylmethyl Trifluoromethanesulfonate (<b>25</b>)</h5><div class="NLM_p last">Compound <b>25</b> was synthesized according to a literature procedure.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Briefly, to a stirred solution of 1-adamantanemethanol (<b>24</b>, 233 mg, 1.40 mmol) and pyridine (0.886 mL, 9.29 mmol) in anhydrous dichloromethane (8.0 mL) at 0 °C was added dropwise over a period of 10 min a solution of trifluoromethane sulfonic anhydride (0.471 mL, 2.80 mmol) in anhydrous dichloromethane (8.0 mL). The reaction was allowed to proceed for 2 h at room temperature; diluted with dichloromethane (10 mL); washed with 1 M aqueous HCl, 5% aqueous NaHCO<sub>3</sub>, and brine; dried over MgSO<sub>4</sub>; filtered; and concentrated under reduced pressure to yield the title compound as a pale-yellow oil (408 mg, 98%). The crude material was used directly in the next step without further purification. Spectral data obtained corresponded to those reported in the literature.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec5_2_12_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (<i>R</i>)-<i>tert</i>-Butyl 2-((<i>tert</i>-Butoxycarbonyl)amino)-3-mercaptopropanoate (<b>27</b>)</h5><div class="NLM_p last">Compound <b>27</b> was synthesized based on a literature procedure, but substituting trimethylphosphine solution in THF for tri-<i>n</i>-butylphosphine.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Briefly, to a solution of <span class="smallcaps smallerCapital">l</span>-cystine, <i>N</i>,<i>N</i>′-bis[(1,1-dimethylethoxy)carbonyl]-1,1′-bis(1,1-dimethylethyl) ester (<b>26</b>, 723 mg, 1.31 mmol) in THF (6.5 mL) was added trimethylphosphine (1.1 equiv, 1.44 mL of a 1 M solution in THF). The mixture was allowed to stir at room temperature for 2 min, and then water (158 μL) was added. After stirring overnight, the reaction mixture was concentrated under reduced pressure. Purification of the crude oil via flash chromatography and eluting with a gradient of EtOAc/cyclohexane (0:100–5:95) afforded the title compound as a colorless oil, which formed colorless needles on standing (683 mg, 94%). Spectral data obtained corresponded to those reported in the literature.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The compound was used directly in the next step to avoid oxidation over time.</div></div><div id="sec5_2_12_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (<i>R</i>)-<i>tert</i>-Butyl 3-(((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-ylmethyl)thio)-2-((<i>tert</i>-butoxycarbonyl)amino)propanoate (<b>28</b>)</h5><div class="NLM_p last">To a solution of <b>27</b> (429 mg, 1.55 mmol) in anhydrous acetonitrile (31 mL) was added <b>25</b> (553 mg, 1.85 mmol) followed by K<sub>2</sub>CO<sub>3</sub> (641 mg, 4.64 mmol) and 18-crown-6 (1.22 g, 6.64 mmol). The mixture was stirred at room temperature for 16 h, diluted with water (30 mL), and extracted with EtOAc (3 × 20 mL), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting brown-orange oil was purified via flash chromatography, and eluting with a gradient of EtOAc/cyclohexane (0:100–5:95) afforded the title compound as a colorless oil (418 mg, 64%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 5.34 (d, <i>J</i> = 7.5 Hz, 1H), 4.42–4.33 (m, 1H), 2.99–2.84 (m, 2H), 2.36 (q, <i>J</i> = 12.4 Hz, 2H), 1.96 (br s, 3H), 1.69 (d, <i>J</i> = 12.1 Hz, 3H), 1.61 (d, <i>J</i> = 12.5 Hz, 3H), 1.53 (d, <i>J</i> = 2.3 Hz, 6H), 1.48 (s, 9H), 1.45 (s, 9H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 170.3, 155.3, 82.5, 79.9, 77.4, 54.2, 48.6, 41.9, 37.0, 36.9, 34.3, 28.7, 28.5, 28.2. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 426.4, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>23</sub>H<sub>39</sub>NO<sub>4</sub>S (2M + Na): 873.5092; found 873.5108.</div></div><div id="sec5_2_12_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (<i>R</i>)-<i>tert</i>-Butyl 3-(((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-ylmethyl)sulfonyl)-2-((<i>tert</i>-butoxycarbonyl)amino)propanoate (<b>29</b>)</h5><div class="NLM_p last">To a stirred solution of <b>28</b> (204 mg, 0.48 mmol) in anhydrous dichloromethane (3 mL) at 0 °C was added <i>m-</i>CPBA (max 77%) (215 mg, approx. 0.96 mmol, as a solution in 2 mL of dichloromethane) dropwise over 5 min. The solution was allowed to stir at 0 °C for 1 h and then at room temperature for 17 h. After this time, the reaction was diluted with dichloromethane (50 mL), washed with 10% aqueous sodium metabisulfite (2 × 40 mL) to ensure any remaining <i>m</i>-CPBA was destroyed and then twice with 10% aqueous NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield the title compound as a colorless oil, containing minor impurities (231 mg, quant.). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 5.59 (d, <i>J</i> = 5.5 Hz, 1H), 4.48 (d, <i>J</i> = 5.5 Hz, 1H), 3.66–3.50 (m, 2H), 2.84 (s, 2H), 2.00 (br s, 3H), 1.92–1.76 (m, 6H), 1.69 (dd, <i>J</i> = 24.6, 12.1 Hz, 6H), 1.53–1.39 (m, 18H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 168.3, 155.4, 83.6, 80.6, 67.5, 57.3, 50.8, 42.2, 36.6, 34.7, 28.5, 28.0, 27.1. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 457.9, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>23</sub>H<sub>39</sub>NO<sub>6</sub>S (M + Na): 480.2390; found 480.2390. This compound was used directly in the next step without further purification.</div></div><div id="sec5_2_12_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (<i>R</i>)-3-(((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-ylmethyl)sulfonyl)-2-aminopropanoic Acid (<b>30</b>)</h5><div class="NLM_p last">A sample of <b>29</b> (215 mg, 0.47 mmol) was dissolved in neat TFA (2.0 mL) in a small glass vial, and the reaction was allowed to proceed at room temperature for 1 h, swirling every 15 min. The pale-yellow reaction mixture was then carefully concentrated under a fine stream of N<sub>2</sub> over a 40 °C heat block (caution!) and then under reduced pressure. The off-white residue was taken up in methanol (4 mL) and then purified via capture/release by passing over a cation-exchange column (MEGA BE-SCX, 1 g, Varian), the column was washed with methanol (2 × 4 mL), and the product was eluted with 2 M ammonia in methanol (15 mL). The eluent was concentrated under reduced pressure to yield compound <b>30</b> as the free amine as a fine white powder (131 mg, 92%). <sup>1</sup>H NMR (300 MHz, <i>d</i><sub>6</sub>-DMSO) δ 3.77–3.57 (m, 2H), 3.53–2.91 (m, 5H), 1.94 (s, 3H), 1.79 (d, <i>J</i> = 2.4 Hz, 6H), 1.72–1.52 (m, 6H). <sup>13</sup>C NMR (75 MHz, <i>d</i><sub>6</sub>-DMSO) δ 63.6, 56.9, 48.3, 41.5, 41.3, 36.1, 33.7, 27.8. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 302.2, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>14</sub>H<sub>23</sub>NO<sub>4</sub>S (M + H): 302.1421; found 302.1427.</div></div><div id="sec5_2_12_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (<i>R</i>)-2-(3-([1,1′-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-(((3<i>R</i>,5<i>R</i>,7<i>R</i>)-adamantan-1-ylmethyl)sulfonyl)propanoic Acid (<b>13</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>32</b> (30 mg, 0.10 mmol). Compound <b>30</b> (45 mg, 0.15 mmol) was protected in situ using the method described for compound <b>39</b> using anhydrous dichloromethane as the reaction solvent. Compound <b>33</b> was dissolved in 1.0 mL of anhydrous dichloromethane and transferred to the in situ-protected amino acid at 0 °C, and the reaction was allowed to warm to room temperature and proceed for 0.5 h. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–5:95) afforded compound <b>13</b> as a colorless glass (51 mg, 81%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) d 9.87 (d, <i>J</i> = 6.7 Hz, 1H), 7.57 (d, <i>J</i> = 8.1 Hz, 4H), 7.45 (t, <i>J</i> = 6.8 Hz, 4H), 7.38 (t, <i>J</i> = 7.3 Hz, 1H), 7.07 (d, <i>J</i> = 7.3 Hz, 2H), 6.95 (d, <i>J</i> = 7.0 Hz, 2H), 5.00 (s, 2H), 4.97 (dd, <i>J</i> = 12.1, 5.9 Hz, 1H), 3.69 (qd, <i>J</i> = 14.9, 5.1 Hz, 2H), 2.88 (s, 2H), 2.30 (s, 3H), 1.98 (s, 3H), 1.83 (s, 6H), 1.68 (q, <i>J</i> = 12.2 Hz, 6H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 175.3, 172.2, 155.5, 144.0, 139.9, 137.2, 134.4, 134.1, 129.5, 129.1, 128.3, 127.6, 127.3, 127.2, 126.6, 66.8, 56.3, 50.2, 49.8, 42.1, 36.5, 34.7, 28.5, 21.2. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 629.3, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>36</sub>H<sub>40</sub>N<sub>2</sub>O<sub>6</sub>S (M + H): 629.2680; found 629.2694.</div></div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Synthesis of Compound (<b>14</b>)</h4><div id="sec5_2_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (<i>R</i>)-3-(Benzylsulfonyl)-2-((<i>tert</i>-butoxycarbonyl)amino)propanoic Acid (<b>48</b>)</h5><div class="NLM_p last">To a stirred solution of Boc<i>-S</i>-benzyl-L-cysteine (<b>17</b>, 500 mg, 1.61 mmol) in anhydrous dichloromethane (15 mL) at 0 °C was added <i>m-</i>CPBA (max 77%) (720 mg, approx. 3.21 mmol, as a solution in 10 mL of dichloromethane) dropwise over 10 min. The solution was allowed to stir at 0 °C for 1 h and then at room temperature for 17 h. After this time, the reaction was concentrated under reduced pressure directly onto silica. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–10:90) afforded the title compound as a white crystalline solid (418 mg, 76%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.40 (s, 5H), 5.73 (d, <i>J</i> = 4.7 Hz, 1H), 4.72 (br s, 1H), 4.36–4.24 (m, 2H), 3.55 (ddd, <i>J</i> = 18.2, 15.5, 4.2 Hz, 2H), 1.46 (s, 9H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 172.7, 155.8, 131.0, 129.4, 129.3, 127.3, 81.6, 61.8, 52.1, 49.8, 28.4. MS (ES<sup>–</sup>), <i>m</i>/<i>z</i> 342.4, (M – H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>15</sub>H<sub>21</sub>NO<sub>6</sub>S (M + Na): 366.0982; found 366.0988.</div></div><div id="sec5_2_13_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (<i>R</i>)-2-Amino-3-(benzylsulfonyl)propanoic Acid Hydrochloride (<b>49</b>)</h5><div class="NLM_p last">A sample of <b>48</b> (304 mg, 0.89 mmol) was dissolved in anhydrous 1,4-dioxane (15 mL), and HCl (g) was bubbled through the solution, produced by adding conc. H<sub>2</sub>SO<sub>4</sub> dropwise to NaCl in a separate flask. The reaction was allowed to proceed at room temperature under N<sub>2</sub> for 1.5 h, and then N<sub>2</sub> (g) was bubbled through the solution overnight to concentrate. A fine white solid precipitated, which was filtered, washed with a small volume of 1,4-dioxane, and dried in a vacuum oven to yield the title compound as a fine white powder (144 mg, 51%). <sup>1</sup>H NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO) δ 8.95 (br s, 1H), 7.52–7.33 (m, 5H), 4.71 (dd, <i>J</i> = 35.7, 13.7, 2H), 4.14 (d, <i>J</i> = 3.1, 1H), 3.79 (dd, <i>J</i> = 15.0, 3.8, 1H), 3.46 (dd, <i>J</i> = 15.0, 7.8, 1H). <sup>13</sup>C NMR (151 MHz, <i>d</i><sub>6</sub>-DMSO) δ 167.8, 131.2, 128.5, 128.0, 58.6, 51.5, 47.6. One Ar–CH peak is not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 244.4, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>10</sub>H<sub>13</sub>NO<sub>4</sub>S (M + H): 244.0638; found 244.0637.</div></div><div id="sec5_2_13_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (<i>R</i>)-3-(Benzylsulfonyl)-2-(3-(2-((4′-chloro-[1,1′-biphenyl]-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(4-methylbenzyl)ureido)propanoic Acid (<b>14</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compounds <b>54</b> (50 mg, 0.10 mmol) and <b>49</b> (44 mg, 0.16 mmol), with the following modifications: the reaction times following addition of TMSOTf and phosgene were lengthened to 1 and 3 h, respectively, and anhydrous dichloromethane was utilized as the reaction solvent for resuspension of the carbamoyl chloride intermediate and in situ protection of the amino acid. The crude material was purified via flash chromatography and eluting with methanol/dichloromethane (0:100 to 5:95 to 15:85), followed by further purification via mass-directed preparative HPLC. This afforded compound <b>14</b> as a white solid (6 mg, 8%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.74–7.64 (m, 1H), 7.63–7.27 (m, 12H), 7.23 (dd, <i>J</i> = 8.0, 1.6, 1H), 7.15 (d, <i>J</i> = 1.1, 1H), 7.11–6.92 (m, 5H), 5.04–4.77 (m, 2H), 4.68 (dd, <i>J</i> = 7.5, 4.0, 1H), 4.29 (s, 2H), 4.15 (s, 2H), 3.87 (s, 2H), 3.59 (dd, <i>J</i> = 14.8, 4.0, 1H), 3.42 (dd, <i>J</i> = 14.7, 7.6, 1H), 3.00 (t, <i>J</i> = 6.2, 2H), 2.85 (t, <i>J</i> = 6.0, 2H), 2.20 (s, 3H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 174.6, 173.6, 157.0, 143.8, 140.4, 138.1, 136.4, 136.0, 134.8, 134.4, 133.8, 132.5, 132.3, 132.0, 131.8, 131.4, 130.2, 129.8, 129.7, 129.6, 129.1, 128.5, 128.3, 127.9, 126.3, 60.7, 58.5, 54.8, 54.7, 52.2, 50.7, 50.5, 48.7, 48.4, 48.2, 27.4, 21.1. Two Ar–CH peaks are not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 750.1 (M + H). HRMS (ES<sup>–</sup> TOF) calcd for C<sub>42</sub>H<sub>40</sub>ClN<sub>3</sub>O<sub>6</sub>S (M – H): 748.2254; found 748.2227.</div></div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Synthesis of Compound (<b>15</b>)</h4><div id="sec5_2_14_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (<i>R</i>)-2-(3-(2-((4′-Chloro-[1,1′-biphenyl]-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(4-methylbenzyl)ureido)-3-((cyclohexylmethyl)sulfonyl)propanoic Acid (<b>15</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>54</b> (47 mg, 0.10 mmol). Compound <b>23</b> (41 mg, 0.45 mmol) was protected in situ using the method described for compound <b>12</b>, with the modifications that anhydrous dichloromethane as the reaction solvent and triethylamine (20 μL, 0.15 mmol) were first added to neutralize the amino acid. Compound <b>57</b> was dissolved in anhydrous dichloromethane (1.0 mL) and transferred to the in situ-protected amino acid <b>41</b> at 0 °C, and the reaction was allowed to warm to room temperature and proceed for 0.5 h. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–5:95) afforded compound <b>15</b> as a colorless glass (44 mg, 60%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.72–7.65 (m, 1H), 7.53–7.28 (m, 7H), 7.21 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.12 (d, <i>J</i> = 1.2 Hz, 1H), 7.09–7.01 (m, 4H), 6.99 (d, <i>J</i> = 8.1 Hz, 1H), 4.99–4.77 (m, 2H), 4.67 (dd, <i>J</i> = 7.6, 4.0 Hz, 1H), 4.10 (s, 2H), 3.85 (s, 2H), 3.62 (dd, <i>J</i> = 14.9, 4.0 Hz, 1H), 3.47 (dd, <i>J</i> = 14.8, 7.6 Hz, 1H), 3.08–2.92 (m, 4H), 2.85 (t, <i>J</i> = 5.5 Hz, 2H), 2.28 (s, <i>J</i> = 6.5 Hz, 3H), 2.08–1.93 (m, 1H), 1.88 (d, <i>J</i> = 12.5 Hz, 2H), 1.66 (dd, <i>J</i> = 18.4, 8.7 Hz, 3H), 1.40–0.99 (m, 5H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 174.9, 173.7, 156.9, 143.7, 140.5, 138.0, 136.3, 136.1, 135.0, 134.8, 134.0, 132.3, 132.0, 131.9, 131.8, 130.1, 130.0, 129.7, 129.5, 128.4, 128.2, 127.9, 126.1, 61.0, 58.7, 56.5, 55.1, 52.2, 50.8, 50.5, 34.2, 34.1, 33.4, 27.7, 27.0, 26.9, 21.1. One additional CH peak is observed due to apparent peak splitting. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 756.9, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>42</sub>H<sub>46</sub>ClN<sub>3</sub>O<sub>6</sub>S (M + H): 756.2869; found 756.2881.</div></div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Synthesis of Compound (<b>16</b>)</h4><div id="sec5_2_15_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> (<i>R</i>)-3-(((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-ylmethyl)sulfonyl)-2-(3-(2-((4′-chloro-[1,1′-biphenyl]-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(4-methylbenzyl)ureido)propanoic Acid (<b>16</b>)</h5><div class="NLM_p last">The procedure used to prepare compound <b>2</b> was followed using compound <b>54</b> (150 mg, 0.31 mmol) but using a reduced volume of phosgene (200 μL, 0.64 mL/mmol amide starting material, 20% w/v in toluene, CAUTION!). Compound <b>30</b> (141 mg, 0.45 mmol) was protected in situ using the method described for <b>39</b> using anhydrous dichloromethane as the reaction solvent. Compound <b>57</b> was dissolved in anhydrous dichloromethane (1.0 mL) and transferred to the in situ-protected amino acid <b>44</b> at 0 °C; then, the reaction was allowed to warm to room temperature and proceed for 0.5 h. Purification via flash chromatography and eluting with a gradient of methanol/dichloromethane (0:100–5:95), followed by further purification via mass-directed preparative HPLC, afforded compound <b>16</b> as an opaque white glassy solid (32 mg, 13%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.10 (br s, 1H), 7.85 (d, <i>J</i> = 7.3 Hz, 1H), 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.41 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (dd, <i>J</i> = 8.2, 1.5 Hz, 2H), 7.27 (d, <i>J</i> = 8.9 Hz, 2H), 7.23 (dd, <i>J</i> = 8.2, 1.4 Hz, 2H), 7.06–6.88 (m, 6H), 6.84 (d, <i>J</i> = 7.8 Hz, 1H), 4.73 (dd, <i>J</i> = 52.1, 15.4 Hz, 2H), 4.64 (dd, <i>J</i> = 10.3, 5.5 Hz, 1H), 4.30 (d, <i>J</i> = 11.5 Hz, 1H), 4.10 (d, <i>J</i> = 11.9, 1H), 3.85–3.64 (m, 3H), 3.60 (dd, <i>J</i> = 14.1, 5.4 Hz, 1H), 3.06–2.74 (m, 6H), 2.27 (s, 3H), 1.95 (br s, 3H), 1.79 (br s, 6H), 1.71–1.60 (m, 6H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 173.7, 172.9, 154.8, 142.2, 139.1, 136.8, 135.1, 134.9, 133.9, 132.8, 131.6, 131.0, 130.5, 129.3, 129.0, 128.9, 127.1, 126.9, 126.8, 124.6, 66.7, 57.1, 57.0, 53.1, 51.4, 49.7, 49.3, 42.1, 36.6, 34.5, 28.5, 26.6, 21.2. Three Ar–CH peaks are not observed due to overlap. MS (ES<sup>+</sup>), <i>m</i>/<i>z</i> 808.3, (M + H). HRMS (ES<sup>+</sup> TOF) calcd for C<sub>46</sub>H<sub>50</sub>ClN<sub>3</sub>O<sub>6</sub>S (M + H): 808.3182; found 808.3198.</div></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Recombinant Proteins and Synthetic Peptides</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Protein Expression and Purification</h4><div class="NLM_p last">Human BCL-X<sub>L</sub> (ΔC25), human/mouse chimeric MCL-1 (ΔN170, ΔC23), human BCL-2 (ΔC22), human BCL-W (ΔC23, C29S/A128E), and mouse A1 (ΔC20, P104K/C113S) were expressed and purified as described previously.<a onclick="showRef(event, 'ref32 ref34 ref46 ref57 ref58 ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref32 ref34 ref46 ref57 ref58 ref59 ref60 ref61 ref62">(32,34,46,57−62)</a> BCL-X<sub>L</sub>, MCL-1, and A1 were expressed as glutathione <i>S</i>-transferase (GST)-fusion proteins in the pGEX-6P-3 vector (Amersham Biosciences). BCL-2 and BCL-W were expressed with an N-terminal 6-His tag in the pQE-9 vector (Qiagen). For use in the AlphaSCREEN assay, GST-BCL-X<sub>L</sub> and GST-MCL-1 were purified as intact fusion proteins, whereas for the SPR assay, the GST tag was first removed via on-column cleavage on glutathione–sepharose columns using PreScission protease prior to gel filtration. Purified proteins were snap-frozen and stored at −80 °C prior to use, with the exception of BCL-2, which was briefly stored at 4 °C for immediate use in SPR experiments. Expression and purification of human BCL-X<sub>L</sub> (ΔC24), human/mouse chimeric MCL-1 (ΔN170, ΔC23), and loop-deleted human BCL-X<sub>L</sub> (Δ27-82, ΔC24) for crystallization studies were performed as described previously.<a onclick="showRef(event, 'ref32 ref34 ref46 ref57 ref58 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref32 ref34 ref46 ref57 ref58 ref63 ref64">(32,34,46,57,58,63,64)</a></div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Synthetic Peptides</h4><div class="NLM_p last">Biotinylated wild-type mouse BIM<sup>BH3</sup> 26mer peptide (Biotin-DLRPEIRIAQELRRIGDEFNETYTRR) for use in the AlphaSCREEN assay was purchased from Auspep. Wild-type mBIM<sup>BH3</sup> (DLRPEIRIAQELRRIGDEFNETYTRR) peptide (“mBIM”) and an inert mBIM<sup>BH3</sup> (DLRPEIR<b>E</b>AQE<b>E</b>RR<b>E</b>GDE<b>E</b>NETYTRR) mutant peptide (“mBIM4E”) for use in SPR studies were purchased from Mimotopes. All synthetic peptides were purified by reverse-phase HPLC to >90% purity.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> AlphaSCREEN Assay</h3><div class="NLM_p">Relative binding affinities of compounds for GST-BCL-X<sub>L</sub> and GST-MCL-1 were determined using a solution competition assay based on an AlphaSCREEN GST donor/acceptor detection system (PerkinElmer Lifesciences) as described in detail elsewhere.<a onclick="showRef(event, 'ref21 ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref21 ref32 ref34">(21,32,34)</a></div><div class="NLM_p">GST-BCL-X<sub>L</sub> and GST-MCL-1 proteins were expressed and purified as described earlier, and biotinylated-GST (for the counter-screen) was purchased (PerkinElmer). These were stored as stock solutions at −80 °C. Biotinylated-BAK and biotinylated-BIM 26mer peptides (Auspep) were stored as 500 μM stock solutions in 100% DMSO at −20 °C. AlphaSCREEN glutathione <i>S</i>-transferase (GST) detection kits were obtained from PerkinElmer Lifesciences. White, 384, low-volume assay plates and polypropylene, 384, compound storage plates were obtained from Greiner Bio One and Matrical, respectively. Optical-grade, adhesive plate seals for assay plates were obtained from Applied Biosystems, while adhesive aluminum foil seals used for compound plate storage were obtained from Beckman-Coulter. DMSO was purchased from AnalaR. Assay buffer (25 mM hydroxyethyl piperazineethanesulfonic acid (HEPES)/25 mM Tris–HCl/50 mM NaCl, pH 7.5) stock was warmed to room temperature from 4 °C, followed by the addition of 5 mM 1,4-dithiothreitol (DTT), 0.1 mg/mL casein sodium salt, and 0.03% v/v Tween 20 (all final concentrations).</div><div class="NLM_p">Screening of the test compounds was performed using the AlphaSCREEN glutathione <i>S</i>-transferase (GST) detection kit system (PerkinElmer Lifesciences). Assays were performed in 384-well white Optiplates (PerkinElmer Lifesciences), in an assay buffer consisting of 50 mM HEPES pH 7.4, 10 mM DTT, 100 mM NaCl, 0.05% Tween 20, and 0.1 mg/mL casein, with a final DMSO concentration of 1.0% (v/v). All bead solutions were prepared under green light.</div><div class="NLM_p">Briefly, test compounds were titrated in an assay buffer (5 μL per well, from 20 mM compound stock in 100% DMSO). To each well was then added 10 μL of a prosurvial protein/acceptor bead solution (containing GST-tagged BCL-X<sub>L</sub> ΔC25 protein and anti-GST acceptor beads, coincubated previously for 30 min at room temperature, and final assay concentrations of 0.6 nM and 15 μg/mL, respectively). Plates were sealed and incubated at room temperature for 30 min. Next was added 10 μL of a BH3 peptide/donor bead solution containing biotinylated-BIM<sup>BH3</sup>-26mer peptide, biotin-DLRPEIRIAQELRRIGDEFNETYTRR (final concentration: 5.0 nM), and streptavidin donor beads (final concentration: 15 μg/mL), coincubated previously for 30 min at room temperature respectively). Plates were sealed with foil and incubated in the dark for a further 4 h at room temperature before reading on a PerkinElmer Fusion Alpha plate reader (Ex 680, Em 520–620 nM).</div><div class="NLM_p last">The conditions for the assay with GST-MCL-1 were essentially the same using the following final concentrations: GST-MCL-1 (0.8 nM) and biotinylated-BAK peptide (4 nM). The counter-screen assay was performed using the donor and acceptor beads in the presence of biotinylated-GST (final concentration 2 nM).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> SPR Competition Assay</h3><div class="NLM_p last">Solution competition assays to determine IC<sub>50</sub> values for BCL-X<sub>L</sub>, BCL-2, BCL-W, MCL-1, and A1 were performed using a Biacore 3000 instrument as described previously.<a onclick="showRef(event, 'ref21 ref32 ref46 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref21 ref32 ref46 ref65 ref66">(21,32,46,65,66)</a> Briefly, prosurvival proteins (10 nM) were incubated with varying concentrations of compounds (12.5–0.0001 μM, 10-step half-log-fold serial dilution) for 2 h in running buffer [10 mM HEPES, 150 mM NaCl, 3.4 mM ethylenediaminetetraacetic acid (EDTA), and 0.005% (v/v) Tween 20, pH 7.4] prior to injection onto a CM5 sensor chip onto which either a wild-type mBIM<sup>BH3</sup> (DLRPEIRIAQELRRIGDEFNETYTRR) peptide or an inert mBIM<sup>BH3</sup> (DLRPEIR<b>E</b>AQE<b>E</b>RR<b>E</b>GDE<b>E</b>NETYTRR) mutant peptide (“BIM4E”) (mutations in bold) was immobilized (via <i>N</i>-hydroxysuccinimide coupling) to a density of approximately 100 RU. Specific binding of the prosurvival protein to the surface in the presence and absence of compounds was quantified by subtracting the signal from the BIM4E mutant channel from that obtained on the wild-type BIM channel, following the “global analysis” baseline correction for each using BIAevaluation software (version 4.1, Biacore). IC<sub>50</sub> values were calculated by nonlinear curve-fitting of the data with Prism software (version 6.0h for Macintosh OS X, GraphPad).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Cell Culture and Cell Viability Assay: MEFs</h3><div class="NLM_p">Cultured wild-type (WT), <i>MCL-1</i><sup>–/–</sup>, and <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup> mouse embryonic fibroblast (MEFs) cells were maintained at 37 °C in a humidified 5% CO<sub>2</sub> incubator, in FMA medium—a high-glucose DME medium supplemented with 10% (v/v) fetal calf serum (FCS) (Bovogen), 250 mM <span class="smallcaps smallerCapital">l</span>-asparagine (Sigma), and 50 mM 2-mercaptoethanol (Sigma).</div><div class="NLM_p">Cells were seeded in 24-well cell culture plates (Corning) at a concentration of 1 × 10<sup>4</sup> cells/well in 500 μL of FMA medium as described above but containing only 1% FCS. Cells were incubated for 24 h prior to compound addition. A titration series was prepared for all compounds at twice the final assay concentration, by first diluting compound stocks (in 100% DMSO) 250-fold in the FMA medium containing 1% FCS, followed by serial dilution in FMA medium containing 1% FCS and 0.4% DMSO. For <b>ABT-737</b> (<b>1</b>), a four-point 15-fold serial dilution was used (final assay concentrations 0.168–0.00005 μM), and for all other compounds, a four-point 2-fold serial dilution was used (final assay concentrations 25–3.13 μM). A DMSO-only vehicle control was also included. Diluted test compounds were then added to the cells in the existing media (500 μL per well, in duplicate, final DMSO concentration 0.2%), and test plates were incubated for a further 24 h. After this time, the total media from each well (containing dead cells) was aspirated and transferred to fluorescence-assisted cell sorting (FACS) tubes (on ice). Trypsin (200 μL per well, 0.5% trypsin) was added to each well, and once cells had detached (∼5 min), the FMA medium was added (200 μL per well) and cells were resuspended and transferred to each corresponding FACS tube. FACS buffer (5 mL) was added to all tubes, and tubes were centrifuged (1500 rpm, 5 min, 4 °C). The FACS buffer consisted of KDS BSS (150 mM NaCl, 3.7 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 7.4 mM HEPES·NaOH, 1.2 mM KH<sub>2</sub>PO<sub>4</sub>, and 0.8 mM K<sub>2</sub>HPO<sub>4</sub>) supplemented with 2% FCS. After centrifugation, the supernatant was decanted, propidium iodide (PI) (Sigma) was added (100 μL per tube, 0.1% (v/v) diluted in FACS buffer), and cells were resuspended ready for FACS analysis.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Flow Cytometry Analysis</h4><div class="NLM_p last">Cells were identified by forward and side scatter and assessed for PI positivity (FL3 channel) using a FACSCalibur cytometer. In sum, 1000 events were acquired (Cell Quest), and data were analyzed with FlowJo software (Treestar). The percentage of live cells (PI negative) in duplicate wells was determined, normalized to 100% based on an internal DMSO-only vehicle control for each compound titration series and cell type, and plotted (mean of three independent experiments ± SEM) as a function of compound concentration using Prism software (version 6.0h for Macintosh OS X, GraphPad). EC<sub>50</sub> values were determined by curve-fitting using nonlinear regression.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Cytochrome <i>c</i> Release Assay (FACS)</h3><div class="NLM_p">Cells were seeded in 12-well cell culture plates (Corning) at a concentration of 1.5 × 10<sup>5</sup> cells/well in 1 mL of FMA medium containing only 1% FCS. Cells were incubated for 3 h prior to compound addition. Test compounds were prepared by diluting compound stocks (1 mM for <b>ABT-737</b> (<b>1</b>) and 10 mM for all other compounds, in neat DMSO) in FMA medium containing 1% FCS (final DMSO concentration 0.25%). A DMSO-only vehicle control was also included. Following aspiration of the media, diluted test compounds were added to the cells (1 mL per well) and test plates were incubated for a further 18 h. After this time, the media from each well (containing dead cells) was aspirated and transferred to fluorescence-assisted cell sorting (FACS) tubes (on ice). Trypsin (200 μL per well, 0.5% trypsin) was added to each well, and once cells had detached (∼5 min), the FMA medium was added (200 μL per well) and cells were resuspended and transferred to each corresponding FACS tube. FACS buffer KDS BSS (150 mM NaCl, 3.7 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 7.4 mM HEPES·NaOH, 1.2 mM KH<sub>2</sub>PO<sub>4</sub>, and 0.8 mM K<sub>2</sub>HPO<sub>4</sub>) (1 mL) was added to all tubes, and tubes were centrifuged (1500 rpm, 5 min, 4 °C). After centrifugation, the supernatant was decanted and cells were permeabilized by gently resuspending in a permeabilization buffer (200 μL per sample) (consisting of 0.025% digitionin (Calbiochem) in 20 mM HEPES pH 7.2, 100 mM KCl, 5 mM MgCl<sub>2</sub>, 1 mM EDTA, 1 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA), and 250 mM sucrose, supplemented with a protease inhibitor (cOmplete, Roche)) and incubating for 5 min on ice. Cells were washed with ice-cold FACS buffer (1 mL) and then centrifuged (1500 rpm, 5 min, 4 °C). The supernatant was decanted, and cells were fixed by resuspending in 1% paraformaldehyde in phosphate-buffered saline (Gibco PBS, ThermoFisher) (100 μL per sample) and incubating at room temperature for 5 min. Cells were washed twice with ice-cold FACS buffer (1 mL), each time pelleting cells via centrifugation (1500 rpm, 5 min, 4 °C) and decanting the supernatant. Cells were then incubated with the primary antibody, mouse anticytochrome <i>c</i> (1:100, clone 6H2.B4, #556423, BD Pharmingen), in Saponin buffer (100 μL per sample) (consisting of a 1/3 volume of 1% saponin (Sigma) in phosphate-buffered saline (Gibco PBS, ThermoFisher) and a 2/3 volume of the FACS buffer) for 45 min on ice. After this time, Saponin buffer (3 mL) was added to each sample, cells were pelleted by centrifugation (1500 rpm, 5 min, 4 °C), and the supernatant was decanted. Cells were then incubated with the secondary antibody, PE (R-phycoerythrin) conjugated goat antimouse IgG (#1031-09, SouthernBiotech) in Saponin buffer (100 μL per sample) for 45 min on ice. After this time, Saponin buffer (3 mL) was added to each sample, cells were pelleted by centrifugation (1500 rpm, 5 min, 4 °C), and the supernatant was decanted. Cells were resuspended in FACS buffer (150 μL per sample) ready for FACS analysis.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Flow Cytometry Analysis</h4><div class="NLM_p last">Cells were identified by forward and side scatter and assessed for the level of intracellular cytochrome <i>c</i> (high/low) based on PE fluorescence (FL2 channel) using a FACSCalibur cytometer. In sum, 10 000 events were acquired (Cell Quest), and data were analyzed with FlowJo software (Treestar). For each treatment, the percentage of cells for which cytochrome <i>c</i> had been released from mitochondria (PE low) was determined and plotted and analyzed using Prism software (version 6.0h for Macintosh OS X, GraphPad). Using data from four independent experiments, statistical significance was determined by performing a multiple unpaired <i>t</i> test using the Holm–Šídák method, with α = 0.01. Each row was analyzed individually, without assuming a consistent SD.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Cell Culture and Cell Viability Assay: COLO205 Cells</h3><div class="NLM_p">Wild-type (WT) COLO205 (ATCC CCL222) and <i>BAK</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup> COLO205 were maintained at 37 °C in a humidified 5% CO<sub>2</sub> incubator, in Roswell Park Memorial Institute (RPMI)-1640 medium supplemented with 1% penicillin–streptomycin (base medium) and 10% fetal calf serum (FCS, SAFC Biosciences #F9423).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Cell line identity was verified using the CellBank Australia short tandem repeat (STR) profiling service and confirmed to be mycoplasma-free using the MycoAlert mycoplasma detection kit (Lonza #LT-07).</div><div class="NLM_p last">Cells were seeded in 96-well white polystyrene flat-bottom plates (Greiner #655083) at 3 × 10<sup>3</sup> cells/well in the base medium containing either 10 or 1% fetal calf serum (FCS) and treated one day later with serially diluted concentrations of BH3 mimetics (0.0003–10 μM, six-point, 1:8 dilutions) or benzoylurea compounds <b>6</b> or <b>15</b> (0.1–25 μM, six-point, 1:3 dilutions). BH3 mimetics used were <b>A-1331852</b> (synthesized by D Nhu and G Lessene, WEHI),<a onclick="showRef(event, 'ref24 ref36'); return false;" href="javascript:void(0);" class="ref ref24 ref36">(24,36)</a><b>ABT-199</b> (venetoclax, Chemgood #C-1008), <b>S63845</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (Active Biochem #A-6044), or <b>ABT-737</b> (<b>1</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (Chemgood #C-1010). Cell viability was determined 48 h later using the CellTiter-Glo reagent (Promega #G9241) according to the manufacturer’s instructions. Percentage cell viability was calculated by normalizing to the viability of cells treated with an equivalent concentration of DMSO (vehicle control). GraphPad Prism software was used to calculate the half-maximal effective concentration (EC<sub>50</sub>).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Protein Crystallization, Data Collection, and Structure Determination</h3><div class="NLM_p">Complexes of compounds with BCL-X<sub>L</sub> for crystallization were prepared as described previously.<a onclick="showRef(event, 'ref21 ref32 ref37 ref63'); return false;" href="javascript:void(0);" class="ref ref21 ref32 ref37 ref63">(21,32,37,63)</a> BCL-X<sub>L</sub>, a C-terminally truncated, “loop-deleted” form of human BCL-X<sub>L</sub> (Δ27-82 ΔC24),<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> was combined with a 1.5 molar excess of the relevant compound in 20 mM Tris–HCl, pH 8.0, 150 mM NaCl, supplemented with 2% DMSO. In general, the complex was then concentrated to approximately 10 mg/mL (10 kDa molecular weight cutoff (MWCO) Amicon Ultra-0.5 Concentrator) for crystallization experiments.</div><div class="NLM_p">The “loop-deleted” BCL-X<sub>L</sub> construct (with the large, flexible, and disordered α1–2 loop removed) crystallizes in the form of a domain-swapped dimer, involving a reciprocal exchange of the α1-helix of one monomer of BCL-X<sub>L</sub> into the neighboring monomer (on the opposite face of the protein from the canonical hydrophobic groove to which small molecules are targeted).<a onclick="showRef(event, 'ref63 ref64 ref68'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref68">(63,64,68)</a> The increased symmetry and stability of these dimers appear to facilitate crystallization.</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Structure Determination of the BCL-X<sub>L</sub>:<b>2</b> Complex</h4><div class="NLM_p">Crystals of the BCL-X<sub>L</sub>:<b>2</b> complex were obtained by the vapor diffusion (hanging drop) method at 295 K by mixing 1 μL of the complex at 10 mg/mL with 1 μL of reservoir solution containing 1.4 M ammonium sulfate and 0.1 M HEPES pH 6.5. Crystals were equilibrated into a cryoprotectant consisting of a reservoir solution supplemented with 25% (v/v) ethylene glycol and flash-frozen in N<sub>2</sub> (liq). X-ray data were collected at 100 K using an in-house RAXIS-IV++ detector with a micro-max007 rotating anode X-ray source. The crystal of the BCL-X<sub>L</sub>:<b>2</b> complex diffracted to 2.15 Å resolution. Data were processed using HKL2000.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Each structure was solved by molecular replacement with PHASER<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> using the BCL-X<sub>L</sub> coordinates (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAZ">1MAZ</a>)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> as a search model. The model was further improved using several iterative rounds of manual model building in COOT<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> followed by refinement with PHENIX<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and BUSTER<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> incorporating an initial round of simulated annealing in the PHENIX refinement protocol to minimize model bias.</div><div class="NLM_p last">Ligand geometry restraint (cif) files for compounds were generated from SMILES strings using the GRADE web server<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> using automatic geometry optimization, except for compounds <b>2</b> and <b>8</b>, for which ligand geometries were first minimized using Sybyl 7.0 software (Tripos Associates); from these geometries, ligand parameters were generated using the CCP4 program libcheck. Parameters were then manually curated to ensure accurate molecular representation. The overall structure was validated using MOLPROBITY.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> All graphical depictions of crystal structures were created using Pymol (The PyMOL Molecular Graphics System, Version 1.7.4.0, Schrödinger, LLC) unless otherwise indicated.</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Structure Determination of the BCL-X<sub>L</sub>:<b>7</b> Complex</h4><div class="NLM_p last">Crystals of the BCL-X<sub>L</sub>:<b>7</b> complex were optimized from an initial screening hit obtained in a cocrystallization screen at the CSIRO C3 facility. Subsequent in-house fine-screening using the hanging drop method as for the BCL-X<sub>L</sub>:<b>2</b> complex and optimization using streak-seeding ultimately yielded diffraction-quality crystals. The reservoir solution consisted of 0.9 M trisodium citrate and 0.1 M 2-(<i>N</i>-morpholino)ethanesulfonic acid (MES) pH 6.0, 5% (v/v) PEG400. Crystals were equilibrated into a cryoprotectant consisting of a reservoir solution supplemented with 25% (v/v) ethylene glycol and flash-frozen in N<sub>2</sub> (liq). X-ray diffraction data were collected on the MX2 beamline at the Australian Synchrotron.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Diffraction data were processed using XDS.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The structure was solved and the model was built, refined, and validated as described for the BCL-X<sub>L</sub>:<b>2</b> complex, with the exception that the search model used for molecular replacement was BCL-X<sub>L</sub> from the previously solved BCL-X<sub>L</sub>:<b>8</b> complex (with the ligand removed). The asymmetric unit contained three copies of the BCL-X<sub>L</sub> monomer (one domain-swapped dimer within the asymmetric unit and a further domain-swapped dimer between the third copy of BCL-X<sub>L</sub> and its symmetry mate), each with a single copy of compound <b>7</b> occupying the hydrophobic groove in essentially identical conformations.</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Structure Determination of the BCL-X<sub>L</sub>:<b>8</b> Complex</h4><div class="NLM_p last">Crystals of the BCL-X<sub>L</sub>:<b>8</b> complex were grown by the hanging drop method with a reservoir solution consisting of 1.3 M ammonium sulfate and 0.1 M HEPES pH 6.5. Crystals were equilibrated into cryoprotectant consisting of a reservoir solution supplemented with 25% (v/v) ethylene glycol and flash-frozen in N<sub>2</sub> (liq). X-ray diffraction data were collected on the MX2 beamline at the Australian Synchrotron. The crystal of the BCL-X<sub>L</sub>:<b>8</b> complex diffracted to 1.9 Å resolution. Diffraction data were processed using HKL2000.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The structure was solved with Phaser and the model was built, refined, and validated as described for the BCL-X<sub>L</sub>:<b>2</b> complex, with the exception that the search model for molecular replacement was BCL-X<sub>L</sub> from the BCL-X<sub>L</sub>:<b>ABT-737</b> (<b>1</b>) complex (with the ligand removed) (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ">2YXJ</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The asymmetric unit contained two copies of the BCL-X<sub>L</sub> monomer, arranged as domain-swapped dimers within the asymmetric unit, each with a single copy of compound <b>8</b> occupying the hydrophobic groove in essentially the same conformation.</div></div><div id="sec5_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Structure Determination of the BCL-X<sub>L</sub>:<b>12</b> Complex</h4><div class="NLM_p last">Crystals of the BCL-X<sub>L</sub>:<b>12</b> complex were obtained using the hanging drop method as for the BCL-X<sub>L</sub>:<b>2</b> complex, using a reservoir solution consisting of 1.4 M ammonium sulfate and 0.1 M MES pH 6.0. X-ray diffraction data were collected, the structure was solved, and the model was built, refined, and validated as described for the BCL-X<sub>L</sub>:<b>7</b> complex, but using the BCL-X<sub>L</sub> coordinates from the BCL-X<sub>L</sub>:<b>2</b> complex (with the ligand removed) as the search model for molecular replacement. The asymmetric unit contained 12 copies of the BCL-X<sub>L</sub> monomer, arranged as six domain-swapped dimers. In each monomer, a single copy of the ligand was observed to occupy the hydrophobic groove in essentially identical conformations.</div></div><div id="sec5_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Structure Determination of the BCL-X<sub>L</sub>:<b>13</b> Complex</h4><div class="NLM_p last">Crystals of the BCL-X<sub>L</sub>:<b>13</b> complex were obtained using the hanging drop method as for the BCL-X<sub>L</sub>:<b>2</b> complex, using a reservoir solution consisting of 1.7 M ammonium sulfate and 0.1 M MES pH 6.0. X-ray diffraction data were collected, the structure was solved, and the model was built, refined, and validated as described for the BCL-X<sub>L</sub>:<b>12</b> complex. The asymmetric unit contained 12 copies of the BCL-X<sub>L</sub> monomer, arranged as six domain-swapped dimers. In 11 of the 12 copies, the ligand was observed to occupy the groove in a conformation similar to that of compound <b>12</b> in the BCL-X<sub>L</sub>:<b>12</b> complex; in the final copy, the ligand was observed to occupy an alternative conformation in which the adamantyl moiety did not bind into the cryptic p5 pocket of BCL-X<sub>L</sub> but rather bridged across to another BCL-X<sub>L</sub> monomer. This interaction mediated a crystal contact between two BCL-X<sub>L</sub> monomers and appeared to be a result of crystallization, unlikely to represent the structure in solution.</div></div><div id="sec5_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Structure Determination of the BCL-X<sub>L</sub>:<b>15</b> Complex</h4><div class="NLM_p last">Crystals of the BCL-X<sub>L</sub>:<b>15</b> complex were obtained using the hanging drop method as for the BCL-X<sub>L</sub>:<b>2</b> complex using a reservoir solution consisting of 1.3 M ammonium sulfate and 0.1 M Tris pH 7.0. X-ray diffraction data were collected, the structure was solved, and the model was built, refined, and validated as described for the BCL-X<sub>L</sub>:<b>12</b> complex. The asymmetric unit contained four copies of the BCL-X<sub>L</sub> monomer, arranged as two domain-swapped dimers. In each monomer, a single copy of the ligand was observed to occupy the hydrophobic groove in essentially identical conformations.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01771" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01771?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01771</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Overview of the benzoylurea scaffold (Figure S1), detailed overview of the BCL-X<sub>L</sub>:<b>2</b> complex (Figure S2), overview of the SPR competition experiment (Figure S3), detailed overview of adamantyl substituent binding in the cryptic p5 pocket of BCL-X<sub>L</sub> (Figure S5), additional cellular data for inhibitors (Figure S6); cytochrome <i>c</i> release assay using MEFs (Figure S7); describing data collection and refinement statistics for protein crystallography (Tables S1 and S2); chemistry, <sup>1</sup>H and <sup>13</sup>C NMR spectra; and purity of key compounds by HPLC-UV (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula SMILES strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf">jm0c01771_si_001.pdf (13.14 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_002.csv">jm0c01771_si_002.csv (7.97 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB accession codes for BCL-X<sub>L</sub> in complex with <b>2</b>, <b>7</b>, <b>8</b>, <b>12</b>, <b>13</b>, and <b>15</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVE">6UVE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVC">6UVC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVF">6UVF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVG">6UVG</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVH">6UVH</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01771" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter E. Czabotar</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2b48514a49445f4a596b5c4e4342054e4f5e054a5e"><span class="__cf_email__" data-cfemail="d3b0a9b2b1bca7b2a193a4b6bbbafdb6b7a6fdb2a6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guillaume Lessene</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Therapeutics, The University
of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1193-8147" title="Orcid link">http://orcid.org/0000-0002-1193-8147</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#355259504646505b507542505d5c1b5051401b5440"><span class="__cf_email__" data-cfemail="6e09020b1d1d0b000b2e190b0607400b0a1b400f1b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Roy</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0198-9108" title="Orcid link">http://orcid.org/0000-0003-0198-9108</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amelia Vom</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toru Okamoto</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span>Present Address:
                        Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian J. Smith</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span>Present Address:
                        School of Molecular Sciences, La Trobe University, Bundoora, VIC 3086, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0498-1910" title="Orcid link">http://orcid.org/0000-0003-0498-1910</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard W. Birkinshaw</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Yang</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span>Present Address:
                        Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Level 1, Building 404, Parkville Campus, 381 Royal Parade, Parkville, VIC 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Houda Abdo</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine. A. White</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Segal</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. S. Huang</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan B. Baell</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span>; 
    <span>Present Address:
                        Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Level 1, Building 404, Parkville Campus, 381 Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2114-8242" title="Orcid link">http://orcid.org/0000-0003-2114-8242</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter M. Colman</span> - <span class="hlFld-Affiliation affiliation">The
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medical Biology, The University of Melbourne, Parkville, VIC 3050, Australia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.L., P.E.C., and P.M.C. devised and supervised the project. M.J.R., A.V., and G.L. designed and synthesized inhibitors. M.J.R., T.O., R.W.B., H.Y., H.A. performed binding studies and biophysical characterization. M.J.R. and P.E.C. performed the crystallization and solved the crystal structures. M.J.R. and C.A.W. performed cellular studies, under guidance by D.S. and D.C.S.H. B.J.S. performed modeling. M.J.R. wrote the manuscript with contributions from other authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by fellowships and grants from the Australian Government (Australian Postgraduate Award to M.J.R.), the Australian Research Council (fellowship to P.E.C.), the National Health and Medical Research Council (NHMRC, fellowships to P.E.C., G.L., D.C.S.H., B.J.S., J.B.B., P.M.C.; Project Grant GNT1025138; Development Grant 305536; and Program Grants 257502, 461221, and 1016701), the Leukemia and Lymphoma Society (Specialized Center of Research Grants 7015 and 7413), the Cancer Council of Victoria (fellowship to P.M.C., Grant-in-Aid 461239), and the Australian Cancer Research Foundation. Infrastructure support from the NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646 and a Victorian State Government OIS grant is gratefully acknowledged.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): M.J.R., A.V., B.J.S., R.W.B., H.Y., H.A., C.A.W., D.S., D.C.S.H., J.B.B., P.M.C., P.E.C., and G.L. are, or have been, employees of the Walter and Eliza Hall Institute, which has an agreement with Genentech and AbbVie and receives milestone and royalty payments related to venetoclax. Employees of Walter and Eliza Hall Institute may be eligible for financial benefits related to these payments. M.J.R., R.W.B., B.J.S., H.Y., H.A., C.A.W., D.S., D.C.S.H., J.B.B., P.M.C., P.E.C., and G.L. receive such a financial benefit as a result of previous research related to venetoclax. D.C.S.H., P.M.C., P.E.C., and G.L. have received research funding from Genentech.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6385-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge our colleagues at WEHI and elsewhere for their pioneering work into the BCL-2 family. We would like to thank Grant Dewson, Nadia Kershaw, Adeline Robin, Mark van Delft, Ryan Brady, Romina Lessene, Brad Sleebs, Paul Stupple, Stef Chappaz, and Ben Kile for discussions; Ahmad Wardak, Chris Riffkin, Dana Buczek, Wilco Kersten, Pat Novello, and Kate Jarman for technical assistance; Seb Marcuccio (AMT); Jason Dang and colleagues at the Monash University Mass Spectrometry Facility; and Janet Newman and colleagues at the CSIRO C3 crystallization facility. This research was undertaken in part using the MX1 and MX2 crystallography beamlines at the Australian Synchrotron, Victoria, Australia, and made use of the ACRF detector.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">BCL-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">BCL-X<sub>L</sub></td><td class="NLM_def"><p class="first last">B-cell lymphoma extralarge</p></td></tr><tr><td class="NLM_term">MCL-1</td><td class="NLM_def"><p class="first last">myeloid cell leukemia 1</p></td></tr><tr><td class="NLM_term">BH3</td><td class="NLM_def"><p class="first last">Bcl-2 homology domain 3</p></td></tr><tr><td class="NLM_term">BAX</td><td class="NLM_def"><p class="first last">Bcl-2-associated X protein</p></td></tr><tr><td class="NLM_term">BAK</td><td class="NLM_def"><p class="first last">Bcl-2 homologous antagonist killer</p></td></tr><tr><td class="NLM_term">BIM</td><td class="NLM_def"><p class="first last">BCL-2-interacting mediator of cell death</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">PROTAC</td><td class="NLM_def"><p class="first last">proteolysis-targeting chimera</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">α</td><td class="NLM_def"><p class="first last">amplified luminescent proximity homogenous assay</p></td></tr><tr><td class="NLM_term">AS</td><td class="NLM_def"><p class="first last">AlphaSCREEN</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">MEF</td><td class="NLM_def"><p class="first last">mouse embryonic fibroblast</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">TBAB</td><td class="NLM_def"><p class="first last">tetrabutylammonium bromide</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">TMSOTf</td><td class="NLM_def"><p class="first last">trimethylsilyl trifluoromethanesulfonate</p></td></tr><tr><td class="NLM_term"><i>m</i>-CPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">hydroxyethyl piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">1,4-dithiothreitol</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 77 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span> <span> </span><span class="NLM_article-title">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1038/nrm3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnrm3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=24355989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=49-63&author=P.+E.+Czabotarauthor=G.+Lesseneauthor=A.+Strasserauthor=J.+M.+Adams&title=Control+of+apoptosis+by+the+BCL-2+protein+family%3A+implications+for+physiology+and+therapy&doi=10.1038%2Fnrm3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume; Strasser, Andreas; Adams, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-63</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The BCL-2 protein family dets. the commitment of cells to apoptosis, an ancient cell suicide program that is essential for development, tissue homeostasis and immunity.  Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischemic conditions and drive neurodegeneration.  We discuss the biochem., structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold.  These mechanistic insights into the functions of the BCL-2 family are illuminating the physiol. control of apoptosis, the pathol. consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVpm2heUGBbVg90H21EOLACvtfcHk0li78JUQXxcBBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI&md5=c18d528c2819c2df93b6798e62132372</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3722%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DControl%2520of%2520apoptosis%2520by%2520the%2520BCL-2%2520protein%2520family%253A%2520implications%2520for%2520physiology%2520and%2520therapy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D49%26epage%3D63%26doi%3D10.1038%2Fnrm3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amundson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornace, A. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6101</span>– <span class="NLM_lpage">6110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=11085534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6101-6110&author=S.+A.+Amundsonauthor=T.+G.+Myersauthor=D.+Scudieroauthor=S.+Kitadaauthor=J.+C.+Reedauthor=A.+J.+Fornace&title=An+informatics+approach+identifying+markers+of+chemosensitivity+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span></div><div class="casAuthors">Amundson, Sally A.; Myers, Timothy G.; Scudiero, Dominic; Kitada, Shinichi; Reed, John C.; Fornace, Albert J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6101-6110</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have used a sensitive and reproducible method of measuring mRNA expression to compare basal levels of 10 transcripts in the 60 cell lines of the National Cancer Institute's in vitro anticancer drug screen (NCI-ACDS) under conditions of exponential growth.  The strongest correlation among these target genes was between levels of CIP1/WAF1 and BAX.  Levels of the three major growth arrest and DNA damage-inducible gene transcripts, (GADD34, GADD45, and GADD153), which are coordinately regulated in response to many stresses, were also correlated across the 60 cell lines.  Although the stress induction of several of the transcripts studied here has been shown to be dependent on wild-type p53 status, basal levels of only CIP1/WAF1 and BAX were found to correlate with p53 status.  As expected, basal expression of O6 alkyl guanine alkyl-transferase correlated well with resistance to O6-alkylating agents (r = -0.44) but not with resistance to alkylators with different mechanisms of action (r = -0.04).  When basal expression levels of the 10 genes across the NCI-ACDS panel were compared with sensitivities to a panel of 122 std. chemotherapy agents, the most striking relationship was a strong neg. correlation (r = -0.3) between basal BCL-X levels and sensitivity to drugs in all of the mechanistic classes except one class of antimetabolites.  Sensitivities to a maximally diverse sample of 1200 from 70,000 compds. tested in the NCI-ACDS of agents were also neg. correlated with BCL-X levels.  A novel application of factor anal. revealed that the newly discovered assocns. were independent of previously demonstrated sensitivity factors such as p53 mutation status and native population doubling time.  A similar pattern of correlation was seen for Bcl-XL protein levels.  Conversely, BAX and BCL2, two other genes assocd. with regulation of apoptosis, showed no overall correlation with drug sensitivities.  This suggests that BCL-X may play a unique role in general resistance to cytotoxic agents, with the cell lines demonstrating relative resistance to 70,000 cytotoxic agents in the NCI-ACDS being characterized by high BCL-X expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDcpza2WFJbVg90H21EOLACvtfcHk0li78JUQXxcBBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D&md5=0da385ff6e48e7351d16036c1a8fcf2e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmundson%26aufirst%3DS.%2BA.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DFornace%26aufirst%3DA.%2BJ.%26atitle%3DAn%2520informatics%2520approach%2520identifying%2520markers%2520of%2520chemosensitivity%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D6101%26epage%3D6110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlacher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span> <span> </span><span class="NLM_article-title">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fsj.cdd.4401940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=16645634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1325-1338&author=V.+Labiauthor=M.+Erlacherauthor=S.+Kiesslingauthor=A.+Villunger&title=BH3-only+proteins+in+cell+death+initiation%2C+malignant+disease+and+anticancer+therapy&doi=10.1038%2Fsj.cdd.4401940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span></div><div class="casAuthors">Labi, V.; Erlacher, M.; Kiessling, S.; Villunger, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1325-1338</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Induction of apoptosis in tumor cells, either by direct activation of the death receptor pathway using agonistic antibodies or recombinant ligands, or direct triggering of the Bcl-2-regulated intrinsic apoptosis pathway by small mol. drugs, carries high hopes to overcome the shortcomings of current anticancer therapies.  The latter therapy concept builds on a more detailed understanding of how Bcl-2-like mols. maintain mitochondrial integrity and how BH3-only proteins and Bax/Bak-like mols. can undermine it.  Means to unleash the apoptotic potential of BH3-only proteins in tumor cells, or bypass the need for BH3-only proteins by blocking possible interactions of Bcl-2-like prosurvival mols. with Bax and/or Bak allowing their direct activation, constitute interesting options for the design of novel anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpeJbnadPqLVg90H21EOLACvtfcHk0li78JUQXxcBBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D&md5=c714f82592b1c8fe9df9d385c104414d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401940%26sid%3Dliteratum%253Aachs%26aulast%3DLabi%26aufirst%3DV.%26aulast%3DErlacher%26aufirst%3DM.%26aulast%3DKiessling%26aufirst%3DS.%26aulast%3DVillunger%26aufirst%3DA.%26atitle%3DBH3-only%2520proteins%2520in%2520cell%2520death%2520initiation%252C%2520malignant%2520disease%2520and%2520anticancer%2520therapy%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2006%26volume%3D13%26spage%3D1325%26epage%3D1338%26doi%3D10.1038%2Fsj.cdd.4401940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">BCL-2 family antagonists for cancer therapy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1038/nrd2658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnrd2658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=19043450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVenu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=989-1000&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=P.+M.+Colman&title=BCL-2+family+antagonists+for+cancer+therapy&doi=10.1038%2Fnrd2658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">BCL-2 family antagonists for cancer therapy</span></div><div class="casAuthors">Lessene, Guillaume; Czabotar, Peter E.; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">989-1000</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Overexpression of members of the BCL-2 family of pro-survival proteins is commonly assocd. with unfavorable pathogenesis in cancer.  The convergence of cytotoxic stress signals on the extended BCL-2 protein family provides the biol. rationale for directly targeting this family to induce apoptotic cell death.  Recently, several compds. have been described that inhibit the interaction between BCL-2 family members and their natural ligand, a helical peptide sequence known as the BH3 domain.  Here, we review preclin. and clin. data on these compds., and recommend four criteria that define antagonists of the BCL-2 protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov_A5gU_EESbVg90H21EOLACvtfcHk0lilSt4jTHbITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVenu73P&md5=14886161a66c3ed7f754061fa964e1ed</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd2658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2658%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DBCL-2%2520family%2520antagonists%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D989%26epage%3D1000%26doi%3D10.1038%2Fnrd2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnrd.2016.253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28209992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=A.+Ashkenaziauthor=W.+J.+Fairbrotherauthor=J.+D.+Leversonauthor=A.+J.+Souers&title=From+basic+apoptosis+discoveries+to+advanced+selective+BCL-2+family+inhibitors&doi=10.1038%2Fnrd.2016.253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span></div><div class="casAuthors">Ashkenazi, Avi; Fairbrother, Wayne J.; Leverson, Joel D.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the B cell lymphoma 2 (BCL-2) gene family have a central role in regulating programmed cell death by controlling pro-apoptotic and anti-apoptotic intracellular signals.  In cancer, apoptosis evasion through dysregulation of specific BCL-2 family genes is a recurring event; accordingly, selective inhibition of specific anti-apoptotic BCL-2 family proteins represents an exciting therapeutic opportunity.  A combination of NMR (NMR)-based screening and structure-based drug design has yielded the first bona fide BCL-2 homol. 3 (BH3) mimetics, including the BCL-2 and BCL-XL dual antagonist navitoclax, which is the first BCL-2 family inhibitor to show efficacy in patients with cancer.  Clin. experience with navitoclax prompted the generation of the highly selective BCL-2 inhibitor venetoclax, which is now approved in the United States for the treatment of patients with chronic lymphocytic leukemia with 17p deletion who have received at least one prior therapy.  Recent advances have also been made in the development of potent and selective inhibitors of BCL-XL and myeloid cell leukemia 1 (MCL1), which are addnl. BCL-2 family members with established anti-apoptotic roles in cancer.  Here we review the latest progress in direct and selective targeting of BCL-2 family proteins for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXzAZwyiZQ9LVg90H21EOLACvtfcHk0lilSt4jTHbITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D&md5=ac65b9fbff59988cafb9e381dc0de405</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.253%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DFrom%2520basic%2520apoptosis%2520discoveries%2520to%2520advanced%2520selective%2520BCL-2%2520family%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1038%2Fnrd.2016.253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrington, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarlinton, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntington, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, A. M.</span></span> <span> </span><span class="NLM_article-title">The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1038/icb.2017.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Ficb.2017.72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28875977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kgtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=870-877&author=E.+M.+Carringtonauthor=D.+M.+Tarlintonauthor=D.+H.+Grayauthor=N.+D.+Huntingtonauthor=Y.+Zhanauthor=A.+M.+Lew&title=The+life+and+death+of+immune+cell+types%3A+the+role+of+BCL-2+anti-apoptotic+molecules&doi=10.1038%2Ficb.2017.72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules</span></div><div class="casAuthors">Carrington, Emma M.; Tarlinton, David M.; Gray, Daniel H.; Huntington, Nicholas D.; Zhan, Yifan; Lew, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">870-877</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Targeting survival mechanisms of immune cells may provide an avenue for immune intervention to dampen unwanted responses (e.g. autoimmunity, immunopathol. and transplant rejection) or enhance beneficial ones (e.g. immune deficiency, microbial defense and cancer immunotherapy).  The selective survival mechanisms of the various immune cell types also avails the possibility of specific tailoring of such interventions.  Here, we review the role of the BCL-2 anti-apoptotic family members (BCL-2, BCL-XL, BCL-W, MCL-1 and A1) on cell death/survival of the major immune cell types, for example, T, NK, B, dendritic cell (DC) lineages.  There is both selectivity and redundancy among this family.  Selectivity comes partly from the expression levels in each of the cell types.  For example, plasmacytoid DC express abundant BCL-2 and are susceptible to BCL-2 antagonism or deficiency, whereas conventional DC express abundant A1 and are susceptible to A1 deficiency.  There is, however, also functional redundancy; for example, overexpression of MCL-1 can override BCL-2 antagonism in plasmacytoid DC.  Moreover, susceptibility to another anti-apoptotic family member can be unmasked, when one or other member is removed.  These dual principles of selectivity and redundancy should guide the use of antagonists for manipulating immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYUxL7-EGOA7Vg90H21EOLACvtfcHk0lilSt4jTHbITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kgtr%252FM&md5=7e248871ae81ea1c9749af9a210d9960</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Ficb.2017.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.2017.72%26sid%3Dliteratum%253Aachs%26aulast%3DCarrington%26aufirst%3DE.%2BM.%26aulast%3DTarlinton%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DD.%2BH.%26aulast%3DHuntington%26aufirst%3DN.%2BD.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DLew%26aufirst%3DA.%2BM.%26atitle%3DThe%2520life%2520and%2520death%2520of%2520immune%2520cell%2520types%253A%2520the%2520role%2520of%2520BCL-2%2520anti-apoptotic%2520molecules%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D95%26spage%3D870%26epage%3D877%26doi%3D10.1038%2Ficb.2017.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0ljq4-aKioFCEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szlavik, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragno, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Toumelin-Braizat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanrion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moujalled, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csekei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paczal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radics, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proszenyak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studeny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lysiak-Auvity, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grave, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galbraith, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guasconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauquil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guigal-Stephan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geneste, O.</span></span> <span> </span><span class="NLM_article-title">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>538</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1038/nature19830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnature19830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=27760111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=538&publication_year=2016&pages=477-482&author=A.+Kotschyauthor=Z.+Szlavikauthor=J.+Murrayauthor=J.+Davidsonauthor=A.+L.+Maragnoauthor=G.+Le+Toumelin-Braizatauthor=M.+Chanrionauthor=G.+L.+Kellyauthor=J.+N.+Gongauthor=D.+M.+Moujalledauthor=A.+Brunoauthor=M.+Csekeiauthor=A.+Paczalauthor=Z.+B.+Szaboauthor=S.+Siposauthor=G.+Radicsauthor=A.+Proszenyakauthor=B.+Balintauthor=L.+Ondiauthor=G.+Blaskoauthor=A.+Robertsonauthor=A.+Surgenorauthor=P.+Dokurnoauthor=I.+Chenauthor=N.+Matassovaauthor=J.+Smithauthor=C.+Pedderauthor=C.+Grahamauthor=A.+Studenyauthor=G.+Lysiak-Auvityauthor=A.+M.+Girardauthor=F.+Graveauthor=D.+Segalauthor=C.+D.+Riffkinauthor=G.+Pomilioauthor=L.+C.+Galbraithauthor=B.+J.+Aubreyauthor=M.+S.+Brennanauthor=M.+J.+Heroldauthor=C.+Changauthor=G.+Guasconiauthor=N.+Cauquilauthor=F.+Melchioreauthor=N.+Guigal-Stephanauthor=B.+Lockhartauthor=F.+Collandauthor=J.+A.+Hickmanauthor=A.+W.+Robertsauthor=D.+C.+Huangauthor=A.+H.+Weiauthor=A.+Strasserauthor=G.+Lesseneauthor=O.+Geneste&title=The+MCL1+inhibitor+S63845+is+tolerable+and+effective+in+diverse+cancer+models&doi=10.1038%2Fnature19830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span></div><div class="casAuthors">Kotschy Andras; Szlavik Zoltan; Csekei Marton; Paczal Attila; Szabo Zoltan B; Sipos Szabolcs; Radics Gabor; Proszenyak Agnes; Balint Balazs; Ondi Levente; Blasko Gabor; Murray James; Davidson James; Robertson Alan; Surgenor Allan; Dokurno Pawel; Chen Ijen; Matassova Natalia; Smith Julia; Pedder Christopher; Graham Christopher; Maragno Ana Leticia; Le Toumelin-Braizat Gaetane; Chanrion Maia; Bruno Alain; Studeny Aurelie; Lysiak-Auvity Gaelle; Girard Anne-Marie; Grave Fabienne; Guasconi Ghislaine; Cauquil Nicolas; Colland Frederic; Hickman John A; Geneste Olivier; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Moujalled Donia M; Pomilio Giovanna; Wei Andrew H; Aubrey Brandon J; Roberts Andrew W; Melchiore Fabien; Guigal-Stephan Nolwen; Lockhart Brian; Roberts Andrew W; Wei Andrew H; Lessene Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">538</span>
        (<span class="NLM_cas:issue">7626</span>),
    <span class="NLM_cas:pages">477-482</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Avoidance of apoptosis is critical for the development and sustained growth of tumours.  The pro-survival protein myeloid cell leukemia 1 (MCL1) is overexpressed in many cancers, but the development of small molecules targeting this protein that are amenable for clinical testing has been challenging.  Here we describe S63845, a small molecule that specifically binds with high affinity to the BH3-binding groove of MCL1.  Our mechanistic studies demonstrate that S63845 potently kills MCL1-dependent cancer cells, including multiple myeloma, leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway.  In vivo, S63845 shows potent anti-tumour activity with an acceptable safety margin as a single agent in several cancers.  Moreover, MCL1 inhibition, either alone or in combination with other anti-cancer drugs, proved effective against several solid cancer-derived cell lines.  These results point towards MCL1 as a target for the treatment of a wide range of tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7C_gQBh3bx0EgZCMqtRBifW6udTcc2eYtjID9TgY5dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D&md5=c435a7621b84063133e41e0cdbad3ac8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature19830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19830%26sid%3Dliteratum%253Aachs%26aulast%3DKotschy%26aufirst%3DA.%26aulast%3DSzlavik%26aufirst%3DZ.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DJ.%26aulast%3DMaragno%26aufirst%3DA.%2BL.%26aulast%3DLe%2BToumelin-Braizat%26aufirst%3DG.%26aulast%3DChanrion%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DGong%26aufirst%3DJ.%2BN.%26aulast%3DMoujalled%26aufirst%3DD.%2BM.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DCsekei%26aufirst%3DM.%26aulast%3DPaczal%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DZ.%2BB.%26aulast%3DSipos%26aufirst%3DS.%26aulast%3DRadics%26aufirst%3DG.%26aulast%3DProszenyak%26aufirst%3DA.%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DOndi%26aufirst%3DL.%26aulast%3DBlasko%26aufirst%3DG.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DPedder%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DC.%26aulast%3DStudeny%26aufirst%3DA.%26aulast%3DLysiak-Auvity%26aufirst%3DG.%26aulast%3DGirard%26aufirst%3DA.%2BM.%26aulast%3DGrave%26aufirst%3DF.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DGalbraith%26aufirst%3DL.%2BC.%26aulast%3DAubrey%26aufirst%3DB.%2BJ.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGuasconi%26aufirst%3DG.%26aulast%3DCauquil%26aufirst%3DN.%26aulast%3DMelchiore%26aufirst%3DF.%26aulast%3DGuigal-Stephan%26aufirst%3DN.%26aulast%3DLockhart%26aufirst%3DB.%26aulast%3DColland%26aufirst%3DF.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DGeneste%26aufirst%3DO.%26atitle%3DThe%2520MCL1%2520inhibitor%2520S63845%2520is%2520tolerable%2520and%2520effective%2520in%2520diverse%2520cancer%2520models%26jtitle%3DNature%26date%3D2016%26volume%3D538%26spage%3D477%26epage%3D482%26doi%3D10.1038%2Fnature19830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragno, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanrion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalaoui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geneste, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visvader, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindeman, G. J.</span></span> <span> </span><span class="NLM_article-title">Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaam7049</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aam7049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1126%2Fscitranslmed.aam7049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28768804" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=D.+Merinoauthor=J.+R.+Whittleauthor=F.+Vaillantauthor=A.+Serranoauthor=J.+N.+Gongauthor=G.+Ginerauthor=A.+L.+Maragnoauthor=M.+Chanrionauthor=E.+Schneiderauthor=B.+Palauthor=X.+Liauthor=G.+Dewsonauthor=J.+Graselauthor=K.+Liuauthor=N.+Lalaouiauthor=D.+Segalauthor=M.+J.+Heroldauthor=D.+C.+S.+Huangauthor=G.+K.+Smythauthor=O.+Genesteauthor=G.+Lesseneauthor=J.+E.+Visvaderauthor=G.+J.+Lindeman&title=Synergistic+action+of+the+MCL-1+inhibitor+S63845+with+current+therapies+in+preclinical+models+of+triple-negative+and+HER2-amplified+breast+cancer&doi=10.1126%2Fscitranslmed.aam7049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aam7049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aam7049%26sid%3Dliteratum%253Aachs%26aulast%3DMerino%26aufirst%3DD.%26aulast%3DWhittle%26aufirst%3DJ.%2BR.%26aulast%3DVaillant%26aufirst%3DF.%26aulast%3DSerrano%26aufirst%3DA.%26aulast%3DGong%26aufirst%3DJ.%2BN.%26aulast%3DGiner%26aufirst%3DG.%26aulast%3DMaragno%26aufirst%3DA.%2BL.%26aulast%3DChanrion%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DPal%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDewson%26aufirst%3DG.%26aulast%3DGrasel%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLalaoui%26aufirst%3DN.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DSmyth%26aufirst%3DG.%2BK.%26aulast%3DGeneste%26aufirst%3DO.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DVisvader%26aufirst%3DJ.%2BE.%26aulast%3DLindeman%26aufirst%3DG.%2BJ.%26atitle%3DSynergistic%2520action%2520of%2520the%2520MCL-1%2520inhibitor%2520S63845%2520with%2520current%2520therapies%2520in%2520preclinical%2520models%2520of%2520triple-negative%2520and%2520HER2-amplified%2520breast%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aam7049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caenepeel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmontes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poppe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paras, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taygerly, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vimolratana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zancanella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cajulis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greninger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanaghan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moujalled, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. E.</span></span> <span> </span><span class="NLM_article-title">AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1597</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-18-0387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1158%2F2159-8290.CD-18-0387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=30254093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFOmsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1582-1597&author=S.+Caenepeelauthor=S.+P.+Brownauthor=B.+Belmontesauthor=G.+Moodyauthor=K.+S.+Keeganauthor=D.+Chuiauthor=D.+A.+Whittingtonauthor=X.+Huangauthor=L.+Poppeauthor=A.+C.+Chengauthor=M.+Cardozoauthor=J.+Houzeauthor=Y.+Liauthor=B.+Lucasauthor=N.+A.+Parasauthor=X.+Wangauthor=J.+P.+Taygerlyauthor=M.+Vimolratanaauthor=M.+Zancanellaauthor=L.+Zhuauthor=E.+Cajulisauthor=T.+Osgoodauthor=J.+Sunauthor=L.+Damonauthor=R.+K.+Eganauthor=P.+Greningerauthor=J.+D.+McClanaghanauthor=J.+Gongauthor=D.+Moujalledauthor=G.+Pomilioauthor=P.+Beltranauthor=C.+H.+Benesauthor=A.+W.+Robertsauthor=D.+C.+Huangauthor=A.+Weiauthor=J.+Canonauthor=A.+Coxonauthor=P.+E.+Hughes&title=AMG+176%2C+a+Selective+MCL1+Inhibitor%2C+Is+Effective+in+Hematologic+Cancer+Models+Alone+and+in+Combination+with+Established+Therapies&doi=10.1158%2F2159-8290.CD-18-0387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies</span></div><div class="casAuthors">Caenepeel, Sean; Brown, Sean P.; Belmontes, Brian; Moody, Gordon; Keegan, Kathleen S.; Chui, Danny; Whittington, Douglas A.; Huang, Xin; Poppe, Leszek; Cheng, Alan C.; Cardozo, Mario; Houze, Jonathan; Li, Yunxiao; Lucas, Brian; Paras, Nick A.; Wang, Xianghong; Taygerly, Joshua P.; Vimolratana, Marc; Zancanella, Manuel; Zhu, Liusheng; Cajulis, Elaina; Osgood, Tao; Sun, Jan; Damon, Leah; Egan, Regina K.; Greninger, Patricia; McClanaghan, Joseph D.; Gong, Jianan; Moujalled, Donia; Pomilio, Giovanna; Beltran, Pedro; Benes, Cyril H.; Roberts, Andrew W.; Huang, David C.; Wei, Andrew; Canon, Jude; Coxon, Angela; Hughes, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1582-1597</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The prosurvival BCL2 family member MCL1 is frequently dysregulated in cancer.  To overcome the significant challenges assocd. with inhibition of MCL1 protein-protein interactions, we rigorously applied small-mol. conformational restriction, which culminated in the discovery of AMG 176, the first selective MCL1 inhibitor to be studied in humans.  We demonstrate that MCL1 inhibition induces a rapid and committed step toward apoptosis in subsets of hematol. cancer cell lines, tumor xenograft models, and primary patient samples.  With the use of a human MCL1 knock-in mouse, we demonstrate that MCL1 inhibition at active doses of AMG 176 is tolerated and correlates with clear pharmacodynamic effects, demonstrated by redns. in B cells, monocytes, and neutrophils.  Furthermore, the combination of AMG 176 and venetoclax is synergistic in acute myeloid leukemia (AML) tumor models and in primary patient samples at tolerated doses.  These results highlight the therapeutic promise of AMG 176 and the potential for combinations with other BH3 mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUtMExVVtn5rVg90H21EOLACvtfcHk0lgfa678mWgeYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOmsb7E&md5=795a713908c3635bbd5e9fc3d95f3ae0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-18-0387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-18-0387%26sid%3Dliteratum%253Aachs%26aulast%3DCaenepeel%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DBelmontes%26aufirst%3DB.%26aulast%3DMoody%26aufirst%3DG.%26aulast%3DKeegan%26aufirst%3DK.%2BS.%26aulast%3DChui%26aufirst%3DD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DPoppe%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DParas%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTaygerly%26aufirst%3DJ.%2BP.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DZancanella%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DCajulis%26aufirst%3DE.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DDamon%26aufirst%3DL.%26aulast%3DEgan%26aufirst%3DR.%2BK.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DMcClanaghan%26aufirst%3DJ.%2BD.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DMoujalled%26aufirst%3DD.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DBeltran%26aufirst%3DP.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DP.%2BE.%26atitle%3DAMG%2520176%252C%2520a%2520Selective%2520MCL1%2520Inhibitor%252C%2520Is%2520Effective%2520in%2520Hematologic%2520Cancer%2520Models%2520Alone%2520and%2520in%2520Combination%2520with%2520Established%2520Therapies%26jtitle%3DCancer%2520Discovery%26date%3D2018%26volume%3D8%26spage%3D1582%26epage%3D1597%26doi%3D10.1158%2F2159-8290.CD-18-0387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">Clinical trials: AMG176 (NCT02675452) and S64315 (NCT02992483 and NCT02979366).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span> <span> </span><span class="NLM_article-title">BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.ccell.2018.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=30537511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVygsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=879-891&author=D.+Merinoauthor=G.+L.+Kellyauthor=G.+Lesseneauthor=A.+H.+Weiauthor=A.+W.+Robertsauthor=A.+Strasser&title=BH3-Mimetic+Drugs%3A+Blazing+the+Trail+for+New+Cancer+Medicines&doi=10.1016%2Fj.ccell.2018.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines</span></div><div class="casAuthors">Merino, Delphine; Kelly, Gemma L.; Lessene, Guillaume; Wei, Andrew H.; Roberts, Andrew W.; Strasser, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-891</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Defects in apoptotic cell death can promote cancer and impair responses of malignant cells to anti-cancer therapy.  Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell death effectors, BAX and BAK, in check.  The BH3-only proteins initiate apoptosis by neutralizing the pro-survival BCL-2 proteins.  Structural anal. and medicinal chem. led to the development of small-mol. drugs that mimic the function of the BH3-only proteins to kill cancer cells.  The BCL-2 inhibitor venetoclax has been approved for treatment of refractory chronic lymphocytic leukemia and this drug and inhibitors of pro-survival MCL-1 and BCL-XL are being tested in diverse malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN0ldhkK5l4rVg90H21EOLACvtfcHk0lgfa678mWgeYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVygsLjL&md5=7e7676b1b19255208900c38dc6c4b028</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMerino%26aufirst%3DD.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DBH3-Mimetic%2520Drugs%253A%2520Blazing%2520the%2520Trail%2520for%2520New%2520Cancer%2520Medicines%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D879%26epage%3D891%26doi%3D10.1016%2Fj.ccell.2018.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1987</span>, <span class="refDoi"> DOI: 10.1111/bph.12431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1111%2Fbph.12431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=24117105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=1973-1987&author=M.+J.+Royauthor=A.+Vomauthor=P.+E.+Czabotarauthor=G.+Lessene&title=Cell+death+and+the+mitochondria%3A+therapeutic+targeting+of+the+BCL-2+family-driven+pathway&doi=10.1111%2Fbph.12431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span></div><div class="casAuthors">Roy, M. J.; Vom, A.; Czabotar, P. E.; Lessene, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1973-1987</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The principal biol. role of mitochondria is to supply energy to cells; although intriguingly, evolution has bestowed another essential function upon these cellular organelles: under physiol. stress, mitochondria become the cornerstone of apoptotic cell death.  Specifically, mitochondrial outer membrane permeabilization (MOMP) allows cell death factors such as cytochrome c to be released into the cytoplasm, thus inducing caspase activation and the eventual destruction of essential cellular components.  Proteins of the B-cell lymphoma 2 (BCL-2) family control the tightly regulated pathway that causes MOMP.  The equil. between pro-survival and pro-apoptotic members of the BCL-2 family dictates the fate of cells, the homeostasis of organs and, by extension, the health of whole organisms.  Dysregulation of this equil. is involved in a large no. of diseases such as cancer, autoimmunity and neurodegenerative conditions.  Modulating the activity of the BCL-2 family of proteins with small mols. or peptides is an attractive but challenging therapeutic goal.  This review highlights the latest developments in this field and provides evidence that this strategy is likely to have a pos. effect on the treatment of still poorly addressed medical conditions.  Linked Articles : This article is part of a themed issue on Mitochondrial Pharmacol.: Energy, Injury & Beyond.  To view the other articles in this issue visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6jmhqr3darVg90H21EOLACvtfcHk0lgfa678mWgeYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D&md5=001a31bfa87a2f4864bd8606a9e61ab4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fbph.12431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12431%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BJ.%26aulast%3DVom%26aufirst%3DA.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DCell%2520death%2520and%2520the%2520mitochondria%253A%2520therapeutic%2520targeting%2520of%2520the%2520BCL-2%2520family-driven%2520pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D1973%26epage%3D1987%26doi%3D10.1111%2Fbph.12431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderquist, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, A.</span></span> <span> </span><span class="NLM_article-title">BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2011</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1158%2F1535-7163.MCT-16-0031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=27535975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=2011-2017&author=R.+S.+Soderquistauthor=A.+Eastman&title=BCL2+Inhibitors+as+Anticancer+Drugs%3A+A+Plethora+of+Misleading+BH3+Mimetics&doi=10.1158%2F1535-7163.MCT-16-0031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0031%26sid%3Dliteratum%253Aachs%26aulast%3DSoderquist%26aufirst%3DR.%2BS.%26aulast%3DEastman%26aufirst%3DA.%26atitle%3DBCL2%2520Inhibitors%2520as%2520Anticancer%2520Drugs%253A%2520A%2520Plethora%2520of%2520Misleading%2520BH3%2520Mimetics%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D2011%26epage%3D2017%26doi%3D10.1158%2F1535-7163.MCT-16-0031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckwerth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsmeyer, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1038/nature03579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+L.+Wangauthor=M.+D.+Wendtauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+Bcl-2+family+proteins+induces+regression+of+solid+tumours&doi=10.1038%2Fnature03579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0lhB1V278vgVrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%2BL.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681%26doi%3D10.1038%2Fnature03579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adickes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6902</span>– <span class="NLM_lpage">6915</span>, <span class="refDoi"> DOI: 10.1021/jm800669s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800669s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6902-6915&author=C.+M.+Parkauthor=M.+Brunckoauthor=J.+Adickesauthor=J.+Bauchauthor=H.+Dingauthor=A.+Kunzerauthor=K.+C.+Marshauthor=P.+Nimmerauthor=A.+R.+Shoemakerauthor=X.+Songauthor=S.+K.+Tahirauthor=C.+Tseauthor=X.+Wangauthor=M.+D.+Wendtauthor=X.+Yangauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+of+an+orally+bioavailable+small+molecule+inhibitor+of+prosurvival+B-cell+lymphoma+2+proteins&doi=10.1021%2Fjm800669s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins</span></div><div class="casAuthors">Park, Cheol-Min; Bruncko, Milan; Adickes, Jessica; Bauch, Joy; Ding, Hong; Kunzer, Aaron; Marsh, Kennan C.; Nimmer, Paul; Shoemaker, Alexander R.; Song, Xiaohong; Tahir, Stephen K.; Tse, Christin; Wang, Xilu; Wendt, Michael D.; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6902-6915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of prosurvival proteins such as Bcl-2 and Bcl-XL has been correlated with tumorigenesis and resistance to chemotherapy, and thus, the development of antagonists of these proteins may provide a novel means for the treatment of cancer.  We recently described the discovery of 1 (ABT-737), which binds Bcl-2, Bcl-XL, and Bcl-w with high affinity, shows robust antitumor activity in murine tumor xenograft models, but is not orally bioavailable.  Herein, we report that targeted modifications at three key positions of 1 resulted in a 20-fold improvement in the pharmacokinetic/pharmacodynamic relationship (PK/PD) between oral exposure (AUC) and in vitro efficacy in human tumor cell lines (EC50).  The resulting compd., 2 (ABT-263), is orally efficacious in an established xenograft model of human small cell lung cancer, inducing complete tumor regressions in all animals.  Compd. 2 is currently in multiple phase 1 clin. trials in patients with small cell lung cancer and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF1JFNLCqAULVg90H21EOLACvtfcHk0lhB1V278vgVrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE&md5=83975ec5e8f642abc3507d35d00c9e14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800669s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800669s%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520prosurvival%2520B-cell%2520lymphoma%25202%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6902%26epage%3D6915%26doi%3D10.1021%2Fjm800669s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">A potent and highly efficacious Bcl-2/Bcl-xL inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3048</span>– <span class="NLM_lpage">3067</span>, <span class="refDoi"> DOI: 10.1021/jm4001105</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3048-3067&author=A.+Aguilarauthor=H.+Zhouauthor=J.+Chenauthor=L.+Liuauthor=L.+Baiauthor=D.+McEachernauthor=C.+Y.+Yangauthor=J.+Meagherauthor=J.+Stuckeyauthor=S.+Wang&title=A+potent+and+highly+efficacious+Bcl-2%2FBcl-xL+inhibitor&doi=10.1021%2Fjm4001105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Highly Efficacious Bcl-2/Bcl-xL Inhibitor</span></div><div class="casAuthors">Aguilar, Angelo; Zhou, Haibin; Chen, Jianfang; Liu, Liu; Bai, Longchuan; McEachern, Donna; Yang, Chao-Yie; Meagher, Jennifer; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3048-3067</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our previously reported Bcl-2/Bcl-xL inhibitor, 4 (IV), effectively inhibited tumor growth but failed to achieve complete regression in vivo.  We have now performed extensive modifications on its pyrrole core structure, which has culminated in the discovery of 32 (XXXII, BM-1074).  Compd. 32 binds to Bcl-2 and Bcl-xL proteins with Ki values of <1 nM and inhibits cancer cell growth with IC50 values of 1-2 nM in four small-cell lung cancer cell lines sensitive to potent and specific Bcl-2/Bcl-xL inhibitors.  Compd. 32 is capable of achieving rapid, complete, and durable tumor regression in vivo at a well-tolerated dose schedule.  Compd. 32 is the most potent and efficacious Bcl-2/Bcl-xL inhibitor reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK3lfcoeXrKrVg90H21EOLACvtfcHk0lgjIIpfqOWpVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgt7s%253D&md5=d53c2ee284a4f02d63fb225cf70c840a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm4001105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001105%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DMeagher%26aufirst%3DJ.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520highly%2520efficacious%2520Bcl-2%252FBcl-xL%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3048%26epage%3D3067%26doi%3D10.1021%2Fjm4001105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mceachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6149</span>– <span class="NLM_lpage">6161</span>, <span class="refDoi"> DOI: 10.1021/jm300608w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300608w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2nsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6149-6161&author=H.+Zhouauthor=A.+Aguilarauthor=J.+Chenauthor=L.+Baiauthor=L.+Liuauthor=J.+L.+Meagherauthor=C.-Y.+Yangauthor=D.+Mceachernauthor=X.+Congauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Structure-based+design+of+potent+Bcl-2%2FBcl-xL+inhibitors+with+strong+in+vivo+antitumor+activity&doi=10.1021%2Fjm300608w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent Bcl-2/Bcl-xL Inhibitors with Strong in Vivo Antitumor Activity</span></div><div class="casAuthors">Zhou, Haibin; Aguilar, Angelo; Chen, Jianfang; Bai, Longchuan; Liu, Liu; Meagher, Jennifer L.; Yang, Chao-Yie; McEachern, Donna; Cong, Xin; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6149-6161</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bcl-2 and Bcl-xL are key apoptosis regulators and attractive cancer therapeutic targets.  We have designed and optimized a class of small-mol. inhibitors of Bcl-2 and Bcl-xL contg. a 4,5-diphenyl-1H-pyrrole-3-carboxylic acid core structure.  A 1.4 Å resoln. crystal structure of a lead compd., 12 (I), complexed with Bcl-xL has provided a basis for our optimization.  The most potent compds., 14 and 15, bind to Bcl-2 and Bcl-xL with subnanomolar Ki values and are potent antagonists of Bcl-2 and Bcl-xL in functional assays.  Compds. 14 and 15 inhibit cell growth with low nanomolar IC50 values in multiple small-cell lung cancer cell lines and induce robust apoptosis in cancer cells at concns. as low as 10 nM.  Compd. 14 also achieves strong antitumor activity in an animal model of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiUKfevMz_HLVg90H21EOLACvtfcHk0lgjIIpfqOWpVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2nsrw%253D&md5=3583461cedaaba286dcdd972b6a4d2ee</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm300608w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300608w%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMceachern%26aufirst%3DD.%26aulast%3DCong%26aufirst%3DX.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520Bcl-2%252FBcl-xL%2520inhibitors%2520with%2520strong%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6149%26epage%3D6161%26doi%3D10.1021%2Fjm300608w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogoe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span> <span> </span><span class="NLM_article-title">Towards the next generation of dual Bcl-2/Bcl-xL inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3026</span>– <span class="NLM_lpage">3033</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.bmcl.2014.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=24881567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslKnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3026-3033&author=J.+G.+Varnesauthor=T.+Geroauthor=S.+Huangauthor=R.+B.+Dieboldauthor=C.+Ogoeauthor=P.+T.+Groverauthor=M.+Suauthor=P.+Mukherjeeauthor=J.+C.+Saehauthor=T.+MacIntyreauthor=G.+Repikauthor=K.+Dillmanauthor=K.+Bythauthor=D.+J.+Russellauthor=S.+Ioannidis&title=Towards+the+next+generation+of+dual+Bcl-2%2FBcl-xL+inhibitors&doi=10.1016%2Fj.bmcl.2014.05.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the next generation of dual Bcl-2/Bcl-xL inhibitors</span></div><div class="casAuthors">Varnes, Jeffrey G.; Gero, Thomas; Huang, Shan; Diebold, R. Bruce; Ogoe, Claude; Grover, Paul T.; Su, Mei; Mukherjee, Prasenjit; Saeh, Jamal Carlos; MacIntyre, Terry; Repik, Galina; Dillman, Keith; Byth, Kate; Russell, Daniel John; Ioannidis, Stephanos</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3026-3033</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structural modifications of the left-hand side of compd. 1 were identified which retained or improved potent binding to Bcl-2 and Bcl-xL in in vitro biochem. assays and had strong activity in an RS4;11 apoptotic cellular assay.  For example, sulfoxide diastereomer 13 maintained good binding affinity and comparable cellular potency to 1 while improving aq. soly.  The corresponding diastereomer (14) was significantly less potent in the cell, and docking studies suggest that this is due to a stereochem. preference for the RS vs. SS sulfoxide.  Appending a dimethylaminoethoxy side chain (27) adjacent to the benzylic position of the biphenyl moiety of 1 improved cellular activity by approx. three-fold, and this activity was corroborated in cell lines overexpressing Bcl-2 and Bcl-xL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUiUWy_AfaB7Vg90H21EOLACvtfcHk0lgjIIpfqOWpVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslKnsLo%253D&md5=d5648bae79edddff5f6181c88e605ffc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DGero%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DDiebold%26aufirst%3DR.%2BB.%26aulast%3DOgoe%26aufirst%3DC.%26aulast%3DGrover%26aufirst%3DP.%2BT.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DRepik%26aufirst%3DG.%26aulast%3DDillman%26aufirst%3DK.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DRussell%26aufirst%3DD.%2BJ.%26aulast%3DIoannidis%26aufirst%3DS.%26atitle%3DTowards%2520the%2520next%2520generation%2520of%2520dual%2520Bcl-2%252FBcl-xL%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3026%26epage%3D3033%26doi%3D10.1016%2Fj.bmcl.2014.05.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balachander, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criscione, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubinski, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWeeney, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaaks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coker, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newbold, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secrist, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, F. D.</span></span> <span> </span><span class="NLM_article-title">AZD4320, a dual inhibitor of Bcl-2 and Bcl-xL, induces tumor regression in hematological cancer models without dose-limiting thrombocytopenia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">6535</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-20-0863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1158%2F1078-0432.CCR-20-0863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=32988967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3MXotVGnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=6535&author=S.+B.+Balachanderauthor=S.+W.+Criscioneauthor=K.+F.+Bythauthor=J.+Cidadoauthor=A.+Adamauthor=T.+MacIntyreauthor=S.+Wenauthor=D.+Lawsonauthor=K.+Burkeauthor=T.+J.+Lubinskiauthor=J.+W.+Tynerauthor=S.+E.+Kurtzauthor=S.+K.+McWeeneyauthor=J.+Varnesauthor=R.+B.+Dieboldauthor=T.+W.+Geroauthor=S.+Ioannidisauthor=E.+J.+Hennessyauthor=W.+McCoullauthor=J.+C.+Saehauthor=P.+Lewisauthor=A.+Tabatabaiauthor=O.+Tavanaauthor=N.+Suauthor=A.+Schullerauthor=M.+J.+Garnettauthor=P.+Jaaksauthor=E.+A.+Cokerauthor=G.+P.+Gregoryauthor=A.+Newboldauthor=R.+W.+Johnstoneauthor=E.+Ganglauthor=M.+Wildauthor=M.+Zindaauthor=J.+P.+Secristauthor=B.+R.+Daviesauthor=S.+E.+Fawellauthor=F.+D.+Gibbons&title=AZD4320%2C+a+dual+inhibitor+of+Bcl-2+and+Bcl-xL%2C+induces+tumor+regression+in+hematological+cancer+models+without+dose-limiting+thrombocytopenia&doi=10.1158%2F1078-0432.CCR-20-0863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">AZD4320, a dual inhibitor of Bcl-2 and Bcl-xL induces tumor regression in hematologic cancer models without dose-limiting thrombocytopenia</span></div><div class="casAuthors">Balachander, Srividya B.; Criscione, Steven W.; Byth, Kate F.; Cidado, Justin; Adam, Ammar; Lewis, Paula; Macintyre, Terry; Wen, Shenghua; Lawson, Deborah; Burke, Kathleen; Lubinski, Tristan; Tyner, Jeffrey W.; Kurtz, Stephen E.; McWeeney, Shannon K.; Varnes, Jeffrey; Diebold, R. Bruce; Gero, Thomas; Ioannidis, Stephanos; Hennessy, Edward J.; McCouII, William; Saeh, Jamal C.; Tabatabai, Areya; Tavana, Omid; Su, Nancy; Schuller, Alwin; Garnett, Mathew J.; Jaaks, Patricia; Coker, Elizabeth A.; Gregory, Gareth P.; Newbold, Andrea; Johnstone, Ricky W.; Wild, Eric Gangl Martin; Zinda, Michael; Secrist, J. Paul; Davies, Barry R.; Fawell, Stephen E.; Gibbons, Francis D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6535-6549</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Targeting Bcl-2 family members upregulated in multiple cancers has emerged as an important area of cancer therapeutics.  While venetoclax, a Bd-2-selective inhibitor, has had success in the clinic, another family member, Bcl-xL, has also emerged as an important target and as a mechanism of resistance.  Therefore we developed a dual Bcl-2/Bcl-xL inhibitor that broadens the therapeutic activity while minimizing Bcl-xL-mediated thrombocytopenia.  Exptl. Design: We used structure-based chem. to design a small-mol. inhibitor of Bcl-2 and Bcl-xL and assessed the activity against in vitro cell lines, patient samples, and in vivo models.  We applied pharmacokinetic/pharmacodynamic (PK/PD) modeling to integrate our understanding of on-target activity of the dual inhibitor in tumors and platelets across dose levels and over time.  Results: We discovered AZD4320, which has nanomolar affinity for Bcl-2 and Bcl-xL, and mechanistically drives cell death through the mitochondrial apoptotic pathway.  AZD4320 demonstrates activity in both Bcl-2- and Bcl-xL-dependent hematol. cancer cell lines and enhanced activity in acute myeloid leukemia (AML) patient samples compared with the Bcl-2-selective agent venetoclax.  A single i.v. bolus dose of AZD4320 induces tumor regression with transient thrombocytopenia, which recovers in less than a week, suggesting a clin. weekly schedule would enable targeting of Bcl-2/Bcl-xL-dependent tumors without incurring dose-limiting thrombocytopenia.  AZD4320 demonstrates monotherapy activity in patient-derived AML and venetoclax-resistant xenograft models.  Conclusions: AZD4320 is a potent mol. with manageable thrombocytopenia risk to explore the utility of a dual Bcl-2/Bcl-xL inhibitor across a broad range of tumor types with dysregulation of Bcl-2 prosurvival proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5tdvs9jbok7Vg90H21EOLACvtfcHk0liH0CkWu-rScg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXotVGnt74%253D&md5=901f40195f0307681862db007936afcb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-20-0863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-20-0863%26sid%3Dliteratum%253Aachs%26aulast%3DBalachander%26aufirst%3DS.%2BB.%26aulast%3DCriscione%26aufirst%3DS.%2BW.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DCidado%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DK.%26aulast%3DLubinski%26aufirst%3DT.%2BJ.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DKurtz%26aufirst%3DS.%2BE.%26aulast%3DMcWeeney%26aufirst%3DS.%2BK.%26aulast%3DVarnes%26aufirst%3DJ.%26aulast%3DDiebold%26aufirst%3DR.%2BB.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DTabatabai%26aufirst%3DA.%26aulast%3DTavana%26aufirst%3DO.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DSchuller%26aufirst%3DA.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DJaaks%26aufirst%3DP.%26aulast%3DCoker%26aufirst%3DE.%2BA.%26aulast%3DGregory%26aufirst%3DG.%2BP.%26aulast%3DNewbold%26aufirst%3DA.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DWild%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26atitle%3DAZD4320%252C%2520a%2520dual%2520inhibitor%2520of%2520Bcl-2%2520and%2520Bcl-xL%252C%2520induces%2520tumor%2520regression%2520in%2520hematological%2520cancer%2520models%2520without%2520dose-limiting%2520thrombocytopenia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2020%26spage%3D6535%26doi%3D10.1158%2F1078-0432.CCR-20-0863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulasegaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of a selective BCL-XL inhibitor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnchembio.1246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=23603658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=390-397&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=B.+E.+Sleebsauthor=K.+Zobelauthor=K.+N.+Lowesauthor=J.+M.+Adamsauthor=J.+B.+Baellauthor=P.+M.+Colmanauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=P.+Gibbonsauthor=W.+J.+A.+Kerstenauthor=S.+Kulasegaramauthor=R.+M.+Mossauthor=J.+P.+Parisotauthor=B.+J.+Smithauthor=I.+P.+Streetauthor=H.+Yangauthor=D.+C.+S.+Huangauthor=K.+G.+Watson&title=Structure-guided+design+of+a+selective+BCL-XL+inhibitor&doi=10.1038%2Fnchembio.1246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of a selective BCL-XL inhibitor</span></div><div class="casAuthors">Lessene, Guillaume; Czabotar, Peter E.; Sleebs, Brad E.; Zobel, Kerry; Lowes, Kym N.; Adams, Jerry M.; Baell, Jonathan B.; Colman, Peter M.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Gibbons, Paul; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">390-397</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prosurvival BCL-2 family protein BCL-XL is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics.  Enhancing apoptotic responses by inhibiting BCL-XL will most likely have widespread utility in cancer treatment and, instead of inhibiting multiple prosurvival BCL-2 family members, a BCL-XL-selective inhibitor would be expected to minimize the toxicity to normal tissues.  We describe the use of a high-throughput screen to discover a new series of small mols. targeting BCL-XL and their structure-guided development by medicinal chem.  The optimized compd., WEHI-539 (7), has high affinity (subnanomolar) and selectivity for BCL-XL and potently kills cells by selectively antagonizing its prosurvival activity.  WEHI-539 will be an invaluable tool for distinguishing the roles of BCL-XL from those of its prosurvival relatives, both in normal cells and notably in malignant tumor cells, many of which may prove to rely upon BCL-XL for their sustained growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9LM-ZVEscrVg90H21EOLACvtfcHk0liH0CkWu-rScg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D&md5=c9179ea71db5b72968b0b0e9f8a03eeb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1246%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%2BA.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520selective%2520BCL-XL%2520inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D390%26epage%3D397%26doi%3D10.1038%2Fnchembio.1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.1021/ml5001867</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5001867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1088-1093&author=Z.+F.+Taoauthor=L.+Hasvoldauthor=L.+Wangauthor=X.+L.+Wangauthor=A.+M.+Petrosauthor=C.+H.+Parkauthor=E.+R.+Boghaertauthor=N.+D.+Catronauthor=J.+Chenauthor=P.+M.+Colmanauthor=P.+E.+Czabotarauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=R.+A.+Judgeauthor=M.+F.+T.+Koehlerauthor=P.+J.+Kovarauthor=G.+Lesseneauthor=M.+J.+Mittenauthor=C.+O.+Ndubakuauthor=P.+Nimmerauthor=H.+E.+Purkeyauthor=A.+Oleksijewauthor=D.+C.+Phillipsauthor=B.+E.+Sleebsauthor=B.+J.+Smithauthor=M.+L.+Smithauthor=S.+K.+Tahirauthor=K.+G.+Watsonauthor=Y.+Xiaoauthor=J.+Xueauthor=H.+C.+Zhangauthor=K.+Zobelauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=J.+D.+Leversonauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Discovery+of+a+Potent+and+Selective+BCL-XL+Inhibitor+with+in+Vivo+Activity&doi=10.1021%2Fml5001867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity</span></div><div class="casAuthors">Tao, Zhi-Fu; Hasvold, Lisa; Wang, Le; Wang, Xilu; Petros, Andrew M.; Park, Chang H.; Boghaert, Erwin R.; Catron, Nathaniel D.; Chen, Jun; Colman, Peter M.; Czabotar, Peter E.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Hymowitz, Sarah G.; Jin, Sha; Judge, Russell A.; Koehler, Michael F. T.; Kovar, Peter J.; Lessene, Guillaume; Mitten, Michael J.; Ndubaku, Chudi O.; Nimmer, Paul; Purkey, Hans E.; Oleksijew, Anatol; Phillips, Darren C.; Sleebs, Brad E.; Smith, Brian J.; Smith, Morey L.; Tahir, Stephen K.; Watson, Keith G.; Xiao, Yu; Xue, John; Zhang, Haichao; Zobel, Kerry; Rosenberg, Saul H.; Tse, Chris; Leverson, Joel D.; Elmore, Steven W.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1088-1093</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A-1155463 I, a highly potent and selective BCL-XL inhibitor, was discovered through NMR fragment screening and structure-based design.  This compd. is substantially more potent against BCL-XL-dependent cell lines relative to the recently reported inhibitor, WEHI-539, while possessing none of its inherent pharmaceutical liabilities.  A-1155463 caused a mechanism-based and reversible thrombocytopenia in mice and inhibited H146 small cell lung cancer xenograft tumor growth in vivo following multiple doses.  A-1155463 thus represents an excellent tool mol. for studying BCL-XL biol. as well as a productive lead structure for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGRbIa-4nxbVg90H21EOLACvtfcHk0lgkB8DoiJV0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN&md5=5d2fffa59286214efac3f320a701215a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fml5001867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5001867%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%2BL.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Selective%2520BCL-XL%2520Inhibitor%2520with%2520in%2520Vivo%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1088%26epage%3D1093%26doi%3D10.1021%2Fml5001867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rye, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulasegaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided rescaffolding of selective antagonists of BCL-XL</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1021/ml500030p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500030p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksF2qsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=662-667&author=M.+Koehlerauthor=P.+Bergeronauthor=E.+F.+Chooauthor=K.+Lauauthor=C.+O.+Ndubakuauthor=D.+Dudleyauthor=P.+Gibbonsauthor=B.+E.+Sleebsauthor=C.+S.+Ryeauthor=G.+Nikolakopoulosauthor=C.+Buiauthor=S.+Kulasegaramauthor=W.+J.+A.+Kerstenauthor=B.+J.+Smithauthor=P.+E.+Czabotarauthor=P.+M.+Colmanauthor=D.+C.+S.+Huangauthor=J.+B.+Baellauthor=K.+G.+Watsonauthor=L.+Hasvoldauthor=Z.-F.+Taoauthor=L.+Wangauthor=A.+J.+Souersauthor=S.+W.+Elmoreauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=G.+Lessene&title=Structure-guided+rescaffolding+of+selective+antagonists+of+BCL-XL&doi=10.1021%2Fml500030p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL</span></div><div class="casAuthors">Koehler, Michael F. T.; Bergeron, Philippe; Choo, Edna F.; Lau, Kevin; Ndubaku, Chudi; Dudley, Danette; Gibbons, Paul; Sleebs, Brad E.; Rye, Carl S.; Nikolakopoulos, George; Bui, Chinh; Kulasegaram, Sanji; Kersten, Wilhelmus J. A.; Smith, Brian J.; Czabotar, Peter E.; Colman, Peter M.; Huang, David C. S.; Baell, Jonathan B.; Watson, Keith G.; Hasvold, Lisa; Tao, Zhi-Fu; Wang, Le; Souers, Andrew J.; Elmore, Steven W.; Flygare, John A.; Fairbrother, Wayne J.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">662-667</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the promise of BCL-2 antagonists in combating chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL), interest in addnl. selective antagonists of antiapoptotic proteins has grown.  Beginning with a series of selective, potent BCL-XL antagonists contg. an undesirable hydrazone functionality, in silico design and X-ray crystallog. were utilized to develop alternative scaffolds that retained the selectivity and potency of the starting compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDw4Nd2OnGILVg90H21EOLACvtfcHk0lgkB8DoiJV0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksF2qsLo%253D&md5=5ec41c8878d510405909a64b746b3e8f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml500030p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500030p%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DM.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DDudley%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DRye%26aufirst%3DC.%2BS.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26aulast%3DBui%26aufirst%3DC.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DStructure-guided%2520rescaffolding%2520of%2520selective%2520antagonists%2520of%2520BCL-XL%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D662%26epage%3D667%26doi%3D10.1021%2Fml500030p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">279ra240</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa4642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1126%2Fscitranslmed.aaa4642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&author=J.+D.+Leversonauthor=D.+C.+Phillipsauthor=M.+J.+Mittenauthor=E.+R.+Boghaertauthor=D.+Diazauthor=S.+K.+Tahirauthor=L.+D.+Belmontauthor=P.+Nimmerauthor=Y.+Xiaoauthor=X.+M.+Maauthor=K.+N.+Lowesauthor=P.+Kovarauthor=J.+Chenauthor=S.+Jinauthor=M.+Smithauthor=J.+Xueauthor=H.+Zhangauthor=A.+Oleksijewauthor=T.+J.+Magocauthor=K.+S.+Vaidyaauthor=D.+H.+Albertauthor=J.+M.+Tarrantauthor=N.+Laauthor=L.+Wangauthor=Z.+F.+Taoauthor=M.+D.+Wendtauthor=D.+Sampathauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=D.+C.+Huangauthor=W.+J.+Fairbrotherauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Exploiting+selective+BCL-2+family+inhibitors+to+dissect+cell+survival+dependencies+and+define+improved+strategies+for+cancer+therapy&doi=10.1126%2Fscitranslmed.aaa4642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa4642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa4642%26sid%3Dliteratum%253Aachs%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DBelmont%26aufirst%3DL.%2BD.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%2BM.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DVaidya%26aufirst%3DK.%2BS.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTarrant%26aufirst%3DJ.%2BM.%26aulast%3DLa%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DExploiting%2520selective%2520BCL-2%2520family%2520inhibitors%2520to%2520dissect%2520cell%2520survival%2520dependencies%2520and%2520define%2520improved%2520strategies%2520for%2520cancer%2520therapy%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26doi%3D10.1126%2Fscitranslmed.aaa4642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2019.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.ddtec.2019.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=31200855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BB3M3mvFWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=15-27&author=M.+Petterssonauthor=C.+M.+Crews&title=PROteolysis+TArgeting+Chimeras+%28PROTACs%29+-+Past%2C+present+and+future&doi=10.1016%2Fj.ddtec.2019.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future</span></div><div class="casAuthors">Pettersson Mariell; Crews Craig M</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today. Technologies</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The majority of currently used therapeutics are small molecule-based and utilize occupancy-driven pharmacology as the mode of action (MOA), in which the protein function is modulated via temporary inhibition.  New modalities that operate using alternative MOAs are essential for tapping into the "undruggable" proteome.  The PROteolysis Targeting Chimera (PROTAC) technology provides an attractive new approach that utilizes an event-driven MOA.  Small molecule-based heterobifunctional PROTACs modulate protein target levels by hijacking the ubiquitin-proteasome system to induce degradation of the target.  Here, we address important milestones in the development of the PROTAC technology, as well as emphasize key findings from this previous year and highlight future directions of this promising drug discovery modality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCRHissLLXoRfKb6ELK8t0fW6udTcc2eYi9-KQ5_QH_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3mvFWkuw%253D%253D&md5=c629f3128321e136f1f247e05ee6f182</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2019.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2019.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DPROteolysis%2520TArgeting%2520Chimeras%2520%2528PROTACs%2529%2520-%2520Past%252C%2520present%2520and%2520future%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2019%26volume%3D31%26spage%3D15%26epage%3D27%26doi%3D10.1016%2Fj.ddtec.2019.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogojina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hromas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopleva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1938</span>– <span class="NLM_lpage">1947</span>, <span class="refDoi"> DOI: 10.1038/s41591-019-0668-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fs41591-019-0668-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=31792461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1yjsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=1938-1947&author=S.+Khanauthor=X.+Zhangauthor=D.+Lvauthor=Q.+Zhangauthor=Y.+Heauthor=P.+Zhangauthor=X.+Liuauthor=D.+Thummuriauthor=Y.+Yuanauthor=J.+S.+Wiegandauthor=J.+Peiauthor=W.+Zhangauthor=A.+Sharmaauthor=C.+R.+McCurdyauthor=V.+M.+Kuruvillaauthor=N.+Baranauthor=A.+A.+Ferrandoauthor=Y.+M.+Kimauthor=A.+Rogojinaauthor=P.+J.+Houghtonauthor=G.+Huangauthor=R.+Hromasauthor=M.+Konoplevaauthor=G.+Zhengauthor=D.+Zhou&title=A+selective+BCL-XL+PROTAC+degrader+achieves+safe+and+potent+antitumor+activity&doi=10.1038%2Fs41591-019-0668-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity</span></div><div class="casAuthors">Khan, Sajid; Zhang, Xuan; Lv, Dongwen; Zhang, Qi; He, Yonghan; Zhang, Peiyi; Liu, Xingui; Thummuri, Dinesh; Yuan, Yaxia; Wiegand, Janet S.; Pei, Jing; Zhang, Weizhou; Sharma, Abhisheak; McCurdy, Christopher R.; Kuruvilla, Vinitha M.; Baran, Natalia; Ferrando, Adolfo A.; Kim, Yong-mi; Rogojina, Anna; Houghton, Peter J.; Huang, Guangcun; Hromas, Robert; Konopleva, Marina; Zheng, Guangrong; Zhou, Daohong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1938-1947</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">B-cell lymphoma extra large (BCL-XL) is a well-validated cancer target.  However, the on-target and dose-limiting thrombocytopenia limits the use of BCL-XL inhibitors, such as ABT263, as safe and effective anticancer agents.  To reduce the toxicity of ABT263, we converted it into DT2216, a BCL-XL proteolysis-targeting chimera (PROTAC), that targets BCL-XL to the Von Hippel-Lindau (VHL) E3 ligase for degrdn.  We found that DT2216 was more potent against various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets than ABT263 in vitro because VHL is poorly expressed in platelets.  In vivo, DT2216 effectively inhibits the growth of several xenograft tumors as a single agent or in combination with other chemotherapeutic agents, without causing appreciable thrombocytopenia.  These findings demonstrate the potential to use PROTAC technol. to reduce on-target drug toxicities and rescue the therapeutic potential of previously undruggable targets.  Furthermore, DT2216 may be developed as a safe first-in-class anticancer agent targeting BCL-XL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGposmmgxVNCRLVg90H21EOLACvtfcHk0lgPvtqNlP685A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1yjsrrO&md5=b07678c880569acac428ec479f002974</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41591-019-0668-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-019-0668-z%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DWiegand%26aufirst%3DJ.%2BS.%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DKuruvilla%26aufirst%3DV.%2BM.%26aulast%3DBaran%26aufirst%3DN.%26aulast%3DFerrando%26aufirst%3DA.%2BA.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DRogojina%26aufirst%3DA.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHromas%26aufirst%3DR.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DD.%26atitle%3DA%2520selective%2520BCL-XL%2520PROTAC%2520degrader%2520achieves%2520safe%2520and%2520potent%2520antitumor%2520activity%26jtitle%3DNat.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D1938%26epage%3D1947%26doi%3D10.1038%2Fs41591-019-0668-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budamagunta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elisseeff, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campisi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">1996</span> <span class="refDoi"> DOI: 10.1038/s41467-020-15838-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fs41467-020-15838-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=32332723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1amtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=Y.+Heauthor=X.+Zhangauthor=J.+Changauthor=H.+N.+Kimauthor=P.+Zhangauthor=Y.+Wangauthor=S.+Khanauthor=X.+Liuauthor=X.+Zhangauthor=D.+Lvauthor=L.+Songauthor=W.+Liauthor=D.+Thummuriauthor=Y.+Yuanauthor=J.+S.+Wiegandauthor=Y.+T.+Ortizauthor=V.+Budamaguntaauthor=J.+H.+Elisseeffauthor=J.+Campisiauthor=M.+Almeidaauthor=G.+Zhengauthor=D.+Zhou&title=Using+proteolysis-targeting+chimera+technology+to+reduce+navitoclax+platelet+toxicity+and+improve+its+senolytic+activity&doi=10.1038%2Fs41467-020-15838-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity</span></div><div class="casAuthors">He, Yonghan; Zhang, Xuan; Chang, Jianhui; Kim, Ha-Neui; Zhang, Peiyi; Wang, Yingying; Khan, Sajid; Liu, Xingui; Zhang, Xin; Lv, Dongwen; Song, Lin; Li, Wen; Thummuri, Dinesh; Yuan, Yaxia; Wiegand, Janet S.; Ortiz, Yuma T.; Budamagunta, Vivekananda; Elisseeff, Jennifer H.; Campisi, Judith; Almeida, Maria; Zheng, Guangrong; Zhou, Daohong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1996</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Small mols. that selectively kill senescent cells (SCs), termed senolytics, have the potential to prevent and treat various age-related diseases and extend healthspan.  The use of Bcl-xl inhibitors as senolytics is largely limited by their on-target and dose-limiting platelet toxicity.  Here, we report the use of proteolysis-targeting chimera (PROTAC) technol. to reduce the platelet toxicity of navitoclax (also known as ABT263), a Bcl-2 and Bcl-xl dual inhibitor, by converting it into PZ15227 (PZ), a Bcl-xl PROTAC, which targets Bcl-xl to the cereblon (CRBN) E3 ligase for degrdn.  Compared to ABT263, PZ is less toxic to platelets, but equally or slightly more potent against SCs because CRBN is poorly expressed in platelets.  PZ effectively clears SCs and rejuvenates tissue stem and progenitor cells in naturally aged mice without causing severe thrombocytopenia.  With further improvement, Bcl-xl PROTACs have the potential to become safer and more potent senolytic agents than Bcl-xl inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA89Bee3qtEbVg90H21EOLACvtfcHk0lgauCmpj2EJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1amtrc%253D&md5=bb66a0a79d0180c8abbee076324ec6b3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15838-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15838-0%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BN.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DWiegand%26aufirst%3DJ.%2BS.%26aulast%3DOrtiz%26aufirst%3DY.%2BT.%26aulast%3DBudamagunta%26aufirst%3DV.%26aulast%3DElisseeff%26aufirst%3DJ.%2BH.%26aulast%3DCampisi%26aufirst%3DJ.%26aulast%3DAlmeida%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DD.%26atitle%3DUsing%2520proteolysis-targeting%2520chimera%2520technology%2520to%2520reduce%2520navitoclax%2520platelet%2520toxicity%2520and%2520improve%2520its%2520senolytic%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26doi%3D10.1038%2Fs41467-020-15838-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span> <span> </span><span class="NLM_article-title">Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">14765</span>– <span class="NLM_lpage">14768</span>, <span class="refDoi"> DOI: 10.1039/C9CC07217A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1039%2FC9CC07217A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=31754664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOltbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2019&pages=14765-14768&author=X.+Zhangauthor=D.+Thummuriauthor=Y.+Heauthor=X.+Liuauthor=P.+Zhangauthor=D.+Zhouauthor=G.+Zheng&title=Utilizing+PROTAC+technology+to+address+the+on-target+platelet+toxicity+associated+with+inhibition+of+BCL-XL&doi=10.1039%2FC9CC07217A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL</span></div><div class="casAuthors">Zhang, Xuan; Thummuri, Dinesh; He, Yonghan; Liu, Xingui; Zhang, Peiyi; Zhou, Daohong; Zheng, Guangrong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">98</span>),
    <span class="NLM_cas:pages">14765-14768</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BCL-XL, an antiapoptotic BCL-2 family protein, plays a key role in cancer cell survival.  However, the potential of BCL-XL as an anticancer target has been hampered by the on-target platelet toxicity because platelets depend on BCL-XL to maintain their viability.  Here the authors report the development of a PROTAC BCL-XL degrader, XZ424, which has increased selectivity for BCL-XL-dependent MOLT-4 cells over human platelets compared with conventional BCL-XL inhibitors.  This proof-of-concept study demonstrates the potential of utilizing a PROTAC approach to achieve tissue selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDxjYaEBmDFLVg90H21EOLACvtfcHk0lgauCmpj2EJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOltbfL&md5=7180b9454a9eb9ae0e9e8a2255fe187e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC9CC07217A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CC07217A%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DUtilizing%2520PROTAC%2520technology%2520to%2520address%2520the%2520on-target%2520platelet%2520toxicity%2520associated%2520with%2520inhibition%2520of%2520BCL-XL%26jtitle%3DChem.%2520Commun.%26date%3D2019%26volume%3D55%26spage%3D14765%26epage%3D14768%26doi%3D10.1039%2FC9CC07217A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL inhibitor that achieves complete tumor regression with minimal platelet toxicity</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70464-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2FS0959-8049%2814%2970464-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=109-110&author=L.+Baiauthor=J.+Chenauthor=L.+Liuauthor=D.+McEachernauthor=A.+Aguilarauthor=H.+Zhouauthor=C.+Y.+Yangauthor=H.+Wangauthor=J.+Wenauthor=G.+Wangauthor=Y.+Zhaiauthor=M.+Guoauthor=D.+Yangauthor=S.+Wang&title=BM-1252+%28APG-1252%29%3A+a+potent+dual+specific+Bcl-2%2FBcl-xL+inhibitor+that+achieves+complete+tumor+regression+with+minimal+platelet+toxicity&doi=10.1016%2FS0959-8049%2814%2970464-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970464-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970464-2%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DBM-1252%2520%2528APG-1252%2529%253A%2520a%2520potent%2520dual%2520specific%2520Bcl-2%252FBcl-xL%2520inhibitor%2520that%2520achieves%2520complete%2520tumor%2520regression%2520with%2520minimal%2520platelet%2520toxicity%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D109%26epage%3D110%26doi%3D10.1016%2FS0959-8049%2814%2970464-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Cinical trial: ABBV-155 (NCT03595059).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinworth, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopacka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queisser, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benowitz, A. B.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into PROTAC-Mediated Degradation of Bcl-xL</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2316</span>– <span class="NLM_lpage">2323</span>, <span class="refDoi"> DOI: 10.1021/acschembio.0c00266</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVaqtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=2316-2323&author=C.+W.+Chungauthor=H.+Daiauthor=E.+Fernandezauthor=C.+P.+Tinworthauthor=I.+Churcherauthor=J.+Cryanauthor=J.+Denyerauthor=J.+D.+Harlingauthor=A.+Konopackaauthor=M.+A.+Queisserauthor=C.+J.+Tameauthor=G.+Wattauthor=F.+Jiangauthor=D.+Qianauthor=A.+B.+Benowitz&title=Structural+Insights+into+PROTAC-Mediated+Degradation+of+Bcl-xL&doi=10.1021%2Facschembio.0c00266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights into PROTAC-Mediated Degradation of Bcl-xL</span></div><div class="casAuthors">Chung, Chun-wa; Dai, Han; Fernandez, Esther; Tinworth, Christopher P.; Churcher, Ian; Cryan, Jenni; Denyer, Jane; Harling, John D.; Konopacka, Agnieszka; Queisser, Markus A.; Tame, Christopher J.; Watt, Gillian; Jiang, Fan; Qian, Dongming; Benowitz, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2316-2323</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bcl-2 family of proteins, such as Bcl-xL and Bcl-2, play key roles in cancer cell survival.  Structural studies of Bcl-xL formed the foundation for the development of the first Bcl-2 family inhibitors and FDA approved drugs.  Recently, Proteolysis Targeting Chimeras (PROTACs) that degrade Bcl-xL have been proposed as a therapeutic modality with the potential to enhance potency and reduce toxicity vs. antagonists.  However, no ternary complex structures of Bcl-xL with a PROTAC and an E3 ligase have been successfully detd. to guide this approach.  Herein, we report the design, characterization, and X-ray structure of a VHL E3 ligase-recruiting Bcl-xL PROTAC degrader.  The 1.9 Å heterotetrameric structure, composed of (ElonginB:ElonginC:VHL):PROTAC:Bcl-xL, reveals an extensive network of neo-interactions, between the E3 ligase and the target protein, and between noncognate parts of the PROTAC and partner proteins.  This work illustrates the challenges assocd. with the rational design of bifunctional mols. where interactions involve composite interfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDxft5W6P5dLVg90H21EOLACvtfcHk0liIedEuvHBw0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVaqtrrI&md5=47494084f4d496adf3c8427e1fbb96f0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00266%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DFernandez%26aufirst%3DE.%26aulast%3DTinworth%26aufirst%3DC.%2BP.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DCryan%26aufirst%3DJ.%26aulast%3DDenyer%26aufirst%3DJ.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DKonopacka%26aufirst%3DA.%26aulast%3DQueisser%26aufirst%3DM.%2BA.%26aulast%3DTame%26aufirst%3DC.%2BJ.%26aulast%3DWatt%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DBenowitz%26aufirst%3DA.%2BB.%26atitle%3DStructural%2520Insights%2520into%2520PROTAC-Mediated%2520Degradation%2520of%2520Bcl-xL%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D2316%26epage%3D2323%26doi%3D10.1021%2Facschembio.0c00266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toovey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1323</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/jm401948b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401948b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Ohtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1323-1343&author=R.+M.+Bradyauthor=A.+Vomauthor=M.+J.+Royauthor=N.+Tooveyauthor=B.+J.+Smithauthor=R.+M.+Mossauthor=E.+Hatzisauthor=D.+C.+Huangauthor=J.+P.+Parisotauthor=H.+Yangauthor=I.+P.+Streetauthor=P.+M.+Colmanauthor=P.+E.+Czabotarauthor=J.+B.+Baellauthor=G.+Lessene&title=De-Novo+Designed+Library+of+Benzoylureas+as+Inhibitors+of+BCL-XL%3A+Synthesis%2C+Structural+and+Biochemical+Characterization&doi=10.1021%2Fjm401948b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization</span></div><div class="casAuthors">Brady, Ryan M.; Vom, Amelia; Roy, Michael J.; Toovey, Nathan; Smith, Brian J.; Moss, Rebecca M.; Hatzis, Effie; Huang, David C. S.; Parisot, John P.; Yang, Hong; Street, Ian P.; Colman, Peter M.; Czabotar, Peter E.; Baell, Jonathan B.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1323-1343</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prosurvival BCL-2 proteins are attractive yet challenging targets for medicinal chemists.  Their involvement in the initiation and progression of many, if not all, tumors makes them prime targets for developing new anticancer therapies.  The authors present their approach based on de novo structure-based drug design.  Using known structural information from complexes engaging opposing members of the BCL-2 family of proteins, the authors designed peptidomimetic compds. using a benzoylurea scaffold to reproduce key interactions between these proteins.  A library stemming from the initial de novo designed scaffold led to the discovery of ligands with low micromolar potency (KD = 4 μM) and selectivity for BCL-XL.  These compds. bind in the canonical BH3 binding groove in a binding mode distinct from previously known BCL-2 inhibitors.  The results of this study provide insight into the design of a new class of antagonists targeting a challenging class of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGXdS67zzfLVg90H21EOLACvtfcHk0liIedEuvHBw0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Ohtrg%253D&md5=6fe9dfa070aae91cd20cc543df0cf260</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm401948b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401948b%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DR.%2BM.%26aulast%3DVom%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DM.%2BJ.%26aulast%3DToovey%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DHatzis%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DDe-Novo%2520Designed%2520Library%2520of%2520Benzoylureas%2520as%2520Inhibitors%2520of%2520BCL-XL%253A%2520Synthesis%252C%2520Structural%2520and%2520Biochemical%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1323%26epage%3D1343%26doi%3D10.1021%2Fjm401948b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowsky, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson-Kaufman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4318</span>– <span class="NLM_lpage">4322</span>, <span class="refDoi"> DOI: 10.1002/anie.200805761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1002%2Fanie.200805761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms12ju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4318-4322&author=E.+F.+Leeauthor=J.+D.+Sadowskyauthor=B.+J.+Smithauthor=P.+E.+Czabotarauthor=K.+J.+Peterson-Kaufmanauthor=P.+M.+Colmanauthor=S.+H.+Gellmanauthor=W.+D.+Fairlie&title=High-resolution+structural+characterization+of+a+helical+alpha%2Fbeta-peptide+foldamer+bound+to+the+anti-apoptotic+protein+Bcl-xL&doi=10.1002%2Fanie.200805761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Structural Characterization of a Helical α/β-Peptide Foldamer Bound to the Anti-Apoptotic Protein Bcl-xL</span></div><div class="casAuthors">Lee, Erinna F.; Sadowsky, Jack D.; Smith, Brian J.; Czabotar, Peter E.; Peterson-Kaufman, Kimberly J.; Colman, Peter M.; Gellman, Samuel H.; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4318-4322</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Get into the groove: The first high-resoln. structure of a foldamer bound to a protein target is described (see picture; foldamer in sticks).  The foldamer consists of α- and β-amino acid residues and is bound to the anti-apoptotic protein Bcl-xL.  The overall binding mode and key interactions obsd. in the foldamer/Bcl-xL complex mimic those seen in complexes of Bcl-xL with natural α-peptide ligands.  Addnl. contacts in the foldamer/Bcl-xL complex involving β-amino acid residues appear to contribute to binding affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR_cyd5bGyhrVg90H21EOLACvtfcHk0liIedEuvHBw0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms12ju7c%253D&md5=58773073fa799ff4bd2c0ce4ab9df348</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805761%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DSadowsky%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DPeterson-Kaufman%26aufirst%3DK.%2BJ.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DHigh-resolution%2520structural%2520characterization%2520of%2520a%2520helical%2520alpha%252Fbeta-peptide%2520foldamer%2520bound%2520to%2520the%2520anti-apoptotic%2520protein%2520Bcl-xL%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D4318%26epage%3D4322%26doi%3D10.1002%2Fanie.200805761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulasegaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5514</span>– <span class="NLM_lpage">5540</span>, <span class="refDoi"> DOI: 10.1021/jm400556w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400556w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFWqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5514-5540&author=B.+E.+Sleebsauthor=W.+J.+Kerstenauthor=S.+Kulasegaramauthor=G.+Nikolakopoulosauthor=E.+Hatzisauthor=R.+M.+Mossauthor=J.+P.+Parisotauthor=H.+Yangauthor=P.+E.+Czabotarauthor=W.+D.+Fairlieauthor=E.+F.+Leeauthor=J.+M.+Adamsauthor=L.+Chenauthor=M.+F.+van+Delftauthor=K.+N.+Lowesauthor=A.+Weiauthor=D.+C.+Huangauthor=P.+M.+Colmanauthor=I.+P.+Streetauthor=J.+B.+Baellauthor=K.+Watsonauthor=G.+Lessene&title=Discovery+of+Potent+and+Selective+Benzothiazole+Hydrazone+Inhibitors+of+Bcl-XL&doi=10.1021%2Fjm400556w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL</span></div><div class="casAuthors">Sleebs, Brad E.; Kersten, Wilhemus J. A.; Kulasegaram, Sanji; Nikolakopoulos, George; Hatzis, Effie; Moss, Rebecca M.; Parisot, John P.; Yang, Hong; Czabotar, Peter E.; Fairlie, W. Douglas; Lee, Erinna F.; Adams, Jerry M.; Chen, Lin; van Delft, Mark F.; Lowes, Kym N.; Wei, Andrew; Huang, David C. S.; Colman, Peter M.; Street, Ian P.; Baell, Jonathan B.; Watson, Keith; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5514-5540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Developing potent mols. that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery.  The authors describe the hit-to-lead development of selective Bcl-XL inhibitors originating from a high-throughput screening campaign.  Small structural changes to the hit compd. increased binding affinity more than 300-fold (to IC50 < 20 nM).  This mol. series exhibits drug-like characteristics, low mol. wts. (Mw < 450), and unprecedented selectivity for Bcl-XL.  Surface plasmon resonance expts. afford strong evidence of binding affinity within the hydrophobic groove of Bcl-XL.  Biol. expts. using engineered Mcl-1 deficient mouse embryonic fibroblasts (MEFs, reliant only on Bcl-XL for survival) and Bax/Bak deficient MEFs (insensitive to selective activation of Bcl-2-driven apoptosis) support a mechanism-based induction of apoptosis.  This manuscript describes the first series of selective small-mol. inhibitors of Bcl-XL and provides promising leads for the development of efficacious therapeutics against solid tumors and chemoresistant cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiXxReqpND3bVg90H21EOLACvtfcHk0ljOtrXgq_FxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFWqu74%253D&md5=768bc99955848fbb39a0370806ae7551</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400556w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400556w%26sid%3Dliteratum%253Aachs%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26aulast%3DHatzis%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DWatson%26aufirst%3DK.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Selective%2520Benzothiazole%2520Hydrazone%2520Inhibitors%2520of%2520Bcl-XL%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5514%26epage%3D5540%26doi%3D10.1021%2Fjm400556w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gable, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of the two fundamental conformations of benzoylureas and elucidation of the factors that facilitate their conformational interchange</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">6511</span>– <span class="NLM_lpage">6525</span>, <span class="refDoi"> DOI: 10.1021/jo900871a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo900871a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFyisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=6511-6525&author=G.+Lesseneauthor=B.+J.+Smithauthor=R.+W.+Gableauthor=J.+B.+Baell&title=Characterization+of+the+two+fundamental+conformations+of+benzoylureas+and+elucidation+of+the+factors+that+facilitate+their+conformational+interchange&doi=10.1021%2Fjo900871a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Two Fundamental Conformations of Benzoylureas and Elucidation of the Factors That Facilitate Their Conformational Interchange</span></div><div class="casAuthors">Lessene, Guillaume; Smith, Brian J.; Gable, Robert W.; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6511-6525</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability of the benzoylurea core to mimic α helixes relies on its ability to form an intramol. hydrogen bond.  The conformational behavior of benzoylureas is investigated in depth in this study via the use of NMR, IR, X-ray, and computational anal.  The results show that the closed conformation maintained by an intramol. hydrogen bond is favored in most of the cases studied except when steric and electronic effects combined with a solvent possessing a high hydrogen bond accepting ability, such as DMSO, are involved.  The study highlights the propensity for benzoylureas to switch conformation depending on the environment of the mol. for a particular set of substituents.  We anticipate that our summary of the phenomenon of internal hydrogen bonding and its anal. may further serve as a useful ref. source for future workers in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZzc6T5M4Hi7Vg90H21EOLACvtfcHk0ljOtrXgq_FxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFyisrg%253D&md5=1411ab46480be5dd289f6ca47319b935</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo900871a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900871a%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DGable%26aufirst%3DR.%2BW.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DCharacterization%2520of%2520the%2520two%2520fundamental%2520conformations%2520of%2520benzoylureas%2520and%2520elucidation%2520of%2520the%2520factors%2520that%2520facilitate%2520their%2520conformational%2520interchange%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D6511%26epage%3D6525%26doi%3D10.1021%2Fjo900871a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of A-1331852, a First-in-Class, Potent and Orally-Bioavailable BCL-XL Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1829</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00568</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00568" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFequro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1829&author=L.+Wangauthor=G.+A.+Dohertyauthor=A.+S.+Juddauthor=Z.-F.+Taoauthor=T.+M.+Hansenauthor=R.+R.+Freyauthor=X.+Songauthor=M.+Brunckoauthor=A.+R.+Kunzerauthor=X.+Wangauthor=M.+D.+Wendtauthor=J.+A.+Flygareauthor=N.+D.+Catronauthor=R.+A.+Judgeauthor=C.+H.+Parkauthor=S.+Shekharauthor=D.+C.+Phillipsauthor=P.+Nimmerauthor=M.+L.+Smithauthor=S.+K.+Tahirauthor=Y.+Xiaoauthor=J.+Xueauthor=H.+Zhangauthor=P.+N.+Leauthor=M.+J.+Mittenauthor=E.+R.+Boghaertauthor=W.+Gaoauthor=P.+Kovarauthor=E.+F.+Chooauthor=D.+Diazauthor=W.+J.+Fairbrotherauthor=S.+W.+Elmoreauthor=D.+Sampathauthor=J.+D.+Leversonauthor=A.+J.+Souers&title=Discovery+of+A-1331852%2C+a+First-in-Class%2C+Potent+and+Orally-Bioavailable+BCL-XL+Inhibitor&doi=10.1021%2Facsmedchemlett.9b00568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor</span></div><div class="casAuthors">Wang, Le; Doherty, George A.; Judd, Andrew S.; Tao, Zhi-Fu; Hansen, T. Matthew; Frey, Robin R.; Song, Xiaohong; Bruncko, Milan; Kunzer, Aaron R.; Wang, Xilu; Wendt, Michael D.; Flygare, John A.; Catron, Nathaniel D.; Judge, Russell A.; Park, Chang H.; Shekhar, Shashank; Phillips, Darren C.; Nimmer, Paul; Smith, Morey L.; Tahir, Stephen K.; Xiao, Yu; Xue, John; Zhang, Haichao; Le, Phuong N.; Mitten, Michael J.; Boghaert, Erwin R.; Gao, Wenqing; Kovar, Peter; Choo, Edna F.; Diaz, Dolores; Fairbrother, Wayne J.; Elmore, Steven W.; Sampath, Deepak; Leverson, Joel D.; Souers, Andrew James</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1836</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the discovery of A-1331852(I), a first-in-class orally active BCL-XL inhibitor that selectively and potently induces apoptosis in BCL-XL dependent tumor cells.  This mol. was generated by re-engineering our previously reported BCL-XL inhibitor A-1155463 using structure-based drug design.  Key design elements included rigidification of the A-1155463 pharmacophore and introduction of sp3-rich moieties capable of generating highly productive interactions within the key P4 pocket of BCL-XL.  A-1331852 has since been used as a crit. tool mol. for further exploring BCL-2 family protein biol., while also representing an attractive entry into a drug discovery program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG7mIYuAWKT7Vg90H21EOLACvtfcHk0ljOtrXgq_FxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFequro%253D&md5=bd9414dfc9ef195818d0f58b4e3f0546</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00568%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DJudd%26aufirst%3DA.%2BS.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DHansen%26aufirst%3DT.%2BM.%26aulast%3DFrey%26aufirst%3DR.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DShekhar%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLe%26aufirst%3DP.%2BN.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520A-1331852%252C%2520a%2520First-in-Class%252C%2520Potent%2520and%2520Orally-Bioavailable%2520BCL-XL%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26spage%3D1829%26doi%3D10.1021%2Facsmedchemlett.9b00568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of ABT-737 complexed with Bcl-x(L): implications for selectivity of antagonists of the Bcl-2 family</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4402178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fsj.cdd.4402178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17572662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFymur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1711-1713&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=B.+J.+Smithauthor=K.+Deshayesauthor=K.+Zobelauthor=P.+M.+Colmanauthor=W.+D.+Fairlie&title=Crystal+structure+of+ABT-737+complexed+with+Bcl-x%28L%29%3A+implications+for+selectivity+of+antagonists+of+the+Bcl-2+family&doi=10.1038%2Fsj.cdd.4402178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of ABT-737 complexed with Bcl-XL: implications for selectivity of antagonists of the Bcl-2 family</span></div><div class="casAuthors">Lee, E. F.; Czabotar, P. E.; Smith, B. J.; Deshayes, K.; Zobel, K.; Colman, P. M.; Fairlie, W. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1711-1713</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A description on 2.2 Å resoln. crystal structure of ABT-737 bound to hBcl-xL (PDB entry: 2YXJ) is presented.  Based on insights from this, a satn. mutagenesis of the second and fourth hydrophobic residues (h2 and h4) in Bim BH3 was performed to understand better the target selectivity of ABT-737.  The structure of the Mcl-1:Bim BH3 complex reveals that the protein backbone fold on the side of this pocket formed by the helix c1-3 is very much different in Mcl-1 compared to Bcl-xL.  This difference leads to different landscapes for the mol. surface at p2 (and p1) in the two proteins.  Furthermore, the plasticity of the Bcl-xL p2 pocket, which appears to be important for binding both BH3 ligands and ABT-737, may well be related to the different fold of its α-3 compared to its counterpart in Mcl-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Natc3TN3qbVg90H21EOLACvtfcHk0lijGcEC-cFk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFymur4%253D&md5=a51e264f92d4623a99dcdfa84f3b2520</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402178%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DCrystal%2520structure%2520of%2520ABT-737%2520complexed%2520with%2520Bcl-x%2528L%2529%253A%2520implications%2520for%2520selectivity%2520of%2520antagonists%2520of%2520the%2520Bcl-2%2520family%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D1711%26epage%3D1713%26doi%3D10.1038%2Fsj.cdd.4402178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. X.</span></span> <span> </span><span class="NLM_article-title">Rate Constants and Mechanisms of Protein-Ligand Binding</span>. <i>Annu. Rev. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1146/annurev-biophys-070816-033639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1146%2Fannurev-biophys-070816-033639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28375732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=105-130&author=X.+Pangauthor=H.+X.+Zhou&title=Rate+Constants+and+Mechanisms+of+Protein-Ligand+Binding&doi=10.1146%2Fannurev-biophys-070816-033639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Rate Constants and Mechanisms of Protein-Ligand Binding</span></div><div class="casAuthors">Pang, Xiaodong; Zhou, Huan-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-130</span>CODEN:
                <span class="NLM_cas:coden">ARBNCV</span>;
        ISSN:<span class="NLM_cas:issn">1936-122X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Whereas protein-ligand binding affinities have long-established prominence, binding rate consts. and binding mechanisms have gained increasing attention in recent years.  Both new computational methods and new exptl. techniques have been developed to characterize the latter properties.  It is now realized that binding mechanisms, like binding rate consts., can and should be quant. detd.  In this review, we summarize studies and synthesize ideas on several topics in the hope of providing a coherent picture of and phys. insight into binding kinetics.  The topics include microscopic formulation of the kinetic problem and its redn. to simple rate equations; computation of binding rate consts.; quant. detn. of binding mechanisms; and elucidation of phys. factors that control binding rate consts. and mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolxe5yT7M4qbVg90H21EOLACvtfcHk0lijGcEC-cFk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFShsLg%253D&md5=4c5e45432a451c56994b5c14eceba5d8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biophys-070816-033639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biophys-070816-033639%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%2BX.%26atitle%3DRate%2520Constants%2520and%2520Mechanisms%2520of%2520Protein-Ligand%2520Binding%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%26date%3D2017%26volume%3D46%26spage%3D105%26epage%3D130%26doi%3D10.1146%2Fannurev-biophys-070816-033639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. X.</span></span> <span> </span><span class="NLM_article-title">Fundamental aspects of protein-protein association kinetics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">860</span>, <span class="refDoi"> DOI: 10.1021/cr800373w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr800373w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=839-860&author=G.+Schreiberauthor=G.+Haranauthor=H.+X.+Zhou&title=Fundamental+aspects+of+protein-protein+association+kinetics&doi=10.1021%2Fcr800373w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Fundamental Aspects of Protein-Protein Association Kinetics</span></div><div class="casAuthors">Schreiber, G.; Haran, G.; Zhou, H.-X.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">839-860</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review focuses on recent advances in deciphering the kinetic pathway of protein complex formation, the nature of the precomplex formed through diffusion (which the authors term the "transient complex"), the transition state and other intermediates (such as the so-called encounter complex) along the assocn. pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBsx0HWzD2W7Vg90H21EOLACvtfcHk0lijGcEC-cFk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWns7w%253D&md5=fbc492ede3242af279ee42705d23fdec</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcr800373w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800373w%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DG.%26aulast%3DHaran%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DH.%2BX.%26atitle%3DFundamental%2520aspects%2520of%2520protein-protein%2520association%2520kinetics%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D839%26epage%3D860%26doi%3D10.1021%2Fcr800373w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muchmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlan, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1038/381335a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2F381335a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=8692274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADyaK28XjtFOmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=335-341&author=S.+W.+Muchmoreauthor=M.+Sattlerauthor=H.+Liangauthor=R.+P.+Meadowsauthor=J.+E.+Harlanauthor=H.+S.+Yoonauthor=D.+Nettesheimauthor=B.+S.+Changauthor=C.+B.+Thompsonauthor=S.+L.+Wongauthor=S.+L.+Ngauthor=S.+W.+Fesik&title=X-ray+and+NMR+structure+of+human+Bcl-xL%2C+an+inhibitor+of+programmed+cell+death&doi=10.1038%2F381335a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death</span></div><div class="casAuthors">Muchmore, Steven W.; Sattler, Michael; Liang, Heng; Meadows, Robert P.; Harlan, John E.; Yoon, Ho; Nettesheim, David; Chang, Brian S.; Thompson, Craig B.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6580</span>),
    <span class="NLM_cas:pages">335-341</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The Bcl-2 family of proteins regulate programmed cell death by an unknown mechanism.  Here we describe the crystal and soln. structures of a Bcl-2 family member, Bcl-xL.  The structures consist of two central, primarily hydrophobic α-helixes, which are surrounded by amphipathic helixes.  A 60-residue loop connecting helixes α1 and α2 was found to be flexible and non-essential for anti-apoptotic activity.  The three functionally important Bcl-2 homol. regions (BH1, BH2 and BH3) are in close spatial proximity and form an elongated hydrophobic cleft that may represent the binding site for other Bcl-2 family members.  The arrangement of the α-helixes in Bcl-xL is reminiscent fo the membrane translocation domain of bacterial toxins, in particular diphtheria toxin and the colicins.  The structural similarity may provide a clue to the mechanism of action of the Bcl-2 family of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9UwUI0QWye7Vg90H21EOLACvtfcHk0lhC6AhoEPlRrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFOmtro%253D&md5=5284b54cc002b615d3c2dbbda48892cc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2F381335a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381335a0%26sid%3Dliteratum%253Aachs%26aulast%3DMuchmore%26aufirst%3DS.%2BW.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DHarlan%26aufirst%3DJ.%2BE.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DB.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DWong%26aufirst%3DS.%2BL.%26aulast%3DNg%26aufirst%3DS.%2BL.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DX-ray%2520and%2520NMR%2520structure%2520of%2520human%2520Bcl-xL%252C%2520an%2520inhibitor%2520of%2520programmed%2520cell%2520death%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D335%26epage%3D341%26doi%3D10.1038%2F381335a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardak, A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">Mutations to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">7123</span>– <span class="NLM_lpage">7131</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.161281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M110.161281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=21199865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=7123-7131&author=P.+E.+Czabotarauthor=E.+F.+Leeauthor=G.+V.+Thompsonauthor=A.+Z.+Wardakauthor=W.+D.+Fairlieauthor=P.+M.+Colman&title=Mutations+to+Bax+beyond+the+BH3+domain+disrupts+interactions+with+pro-survival+proteins+and+promotes+apoptosis&doi=10.1074%2Fjbc.M110.161281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis</span></div><div class="casAuthors">Czabotar, Peter E.; Lee, Erinna F.; Thompson, Geoff V.; Wardak, Ahmad Z.; Fairlie, W. Douglas; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7123-7131</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pro-survival members of the Bcl-2 family of proteins restrain the pro-apoptotic activity of Bax, either directly through interactions with Bax or indirectly by sequestration of activator BH3-only proteins, or both.  Mutations in Bax that promote apoptosis can provide insight into how Bax is regulated.  Here, we describe crystal structures of the pro-survival proteins Mcl-1 and Bcl-xL in complex with a 34-mer peptide from Bax that encompasses its BH3 domain.  These structures reveal canonical interactions between four signature hydrophobic amino acids from the BaxBH3 domain and the BH3-binding groove of the pro-survival proteins.  In both structures, Met-74 from the Bax peptide engages with the BH3-binding groove in a fifth hydrophobic interaction.  Various Bax Met-74 mutants disrupt interactions between Bax and all pro-survival proteins, but these Bax mutants retain pro-apoptotic activity.  Bax/Bak-deficient mouse embryonic fibroblast cells reconstituted with several Bax Met-74 mutants are more sensitive to the BH3 mimetic compd. ABT-737 as compared with cells expressing wild-type Bax.  Furthermore, the cells expressing Bax Met-74 mutants are less viable in colony assays even in the absence of an external apoptotic stimulus.  These results support a model in which direct restraint of Bax by pro-survival Bcl-2 proteins is a barrier to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHxAJk9k5T7bVg90H21EOLACvtfcHk0lhC6AhoEPlRrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyqsrs%253D&md5=f90a9cb154329e8f163a412d9bb0c4bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161281%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DThompson%26aufirst%3DG.%2BV.%26aulast%3DWardak%26aufirst%3DA.%2BZ.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DMutations%2520to%2520Bax%2520beyond%2520the%2520BH3%2520domain%2520disrupts%2520interactions%2520with%2520pro-survival%2520proteins%2520and%2520promotes%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D7123%26epage%3D7131%26doi%3D10.1074%2Fjbc.M110.161281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boersma, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowsky, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1110/ps.032896.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1110%2Fps.032896.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18467496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1ehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1232-1240&author=M.+D.+Boersmaauthor=J.+D.+Sadowskyauthor=Y.+A.+Tomitaauthor=S.+H.+Gellman&title=Hydrophile+scanning+as+a+complement+to+alanine+scanning+for+exploring+and+manipulating+protein-protein+recognition%3A+application+to+the+Bim+BH3+domain&doi=10.1110%2Fps.032896.107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain</span></div><div class="casAuthors">Boersma, Melissa D.; Sadowsky, Jack D.; Tomita, York A.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1232-1240</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Alanine scanning has been widely employed as a method of identifying side chains that play important roles in protein-protein and protein-peptide interactions.  Here the authors show how an analogous and complementary technique, hydrophile scanning, can provide addnl. insight on such interactions.  Mutation of a wild-type residue to alanine removes most of the side-chain atoms, and the effect of this removal is typically interpreted to indicate contribution of the deleted side chain to the stability of the complex.  Hydrophile scanning involves systematic mutation of wild-type residues to a cationic or anionic residue (lysine or glutamic acid, in this case).  The authors find that the results of these mutations provide insights on interactions between polypeptide surfaces that are complementary to the information obtained via alanine scanning.  The authors have applied this technique to a peptide that corresponds to the BH3 domain of the pro-apoptotic protein Bim.  The wild-type Bim BH3 domain binds strongly to the anti-apoptotic proteins Bcl-xL and Mcl-1.  Combining information from the alanine, lysine, and glutamic acid scans has enabled the authors to identify Bim BH3 domain mutants contg. only two or three sequence changes that bind very selectively either to Bcl-xL or Mcl-1.  The authors' findings suggest that hydrophile scanning may prove to be a broadly useful tool for revealing sources of protein-protein recognition and for engineering selectivity into natural sequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNNvHzBPVk-bVg90H21EOLACvtfcHk0lhC6AhoEPlRrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1ehs7c%253D&md5=620a6bd7c1e3107c3746d16b4345f9b0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1110%2Fps.032896.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.032896.107%26sid%3Dliteratum%253Aachs%26aulast%3DBoersma%26aufirst%3DM.%2BD.%26aulast%3DSadowsky%26aufirst%3DJ.%2BD.%26aulast%3DTomita%26aufirst%3DY.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DHydrophile%2520scanning%2520as%2520a%2520complement%2520to%2520alanine%2520scanning%2520for%2520exploring%2520and%2520manipulating%2520protein-protein%2520recognition%253A%2520application%2520to%2520the%2520Bim%2520BH3%2520domain%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D1232%26epage%3D1240%26doi%3D10.1110%2Fps.032896.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martineau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClellan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1021/jm061152t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061152t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=641-662&author=M.+Brunckoauthor=T.+K.+Oostauthor=B.+A.+Belliauthor=H.+Dingauthor=M.+K.+Josephauthor=A.+Kunzerauthor=D.+Martineauauthor=W.+J.+McClellanauthor=M.+Mittenauthor=S.+C.+Ngauthor=P.+M.+Nimmerauthor=T.+Oltersdorfauthor=C.+M.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Shoemakerauthor=X.+Songauthor=X.+Wangauthor=M.+D.+Wendtauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Studies+leading+to+potent%2C+dual+inhibitors+of+Bcl-2+and+Bcl-xL&doi=10.1021%2Fjm061152t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL</span></div><div class="casAuthors">Bruncko, Milan; Oost, Thorsten K.; Belli, Barbara A.; Ding, Hong; Joseph, Mary K.; Kunzer, Aaron; Martineau, Darlene; McClellan, William J.; Mitten, Michael; Ng, Shi-Chung; Nimmer, Paul M.; Oltersdorf, Tilman; Park, Cheol-Min; Petros, Andrew M.; Shoemaker, Alexander R.; Song, Xiaohong; Wang, Xilu; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-662</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of the antiapoptotic proteins Bcl-2 and Bcl-xL provides a common mechanism through which cancer cells gain a survival advantage and become resistant to conventional chemotherapy.  Inhibition of these prosurvival proteins is an attractive strategy for cancer therapy.  We recently described the discovery of a selective Bcl-xL antagonist that potentiates the antitumor activity of chemotherapy and radiation.  Here we describe the use of structure-guided design to exploit a deep hydrophobic binding pocket on the surface of these proteins to develop the first dual, subnanomolar inhibitors of Bcl-xL and Bcl-2.  This study culminated in the identification of 2 (I), which exhibited EC50 values of 8 nM and 30 nM in Bcl-2 and Bcl-xL dependent cells, resp.  Compd. 2 demonstrated single agent efficacy against human follicular lymphoma cell lines that overexpress Bcl-2, and efficacy in a murine xenograft model of lymphoma when given both as a single agent and in combination with etoposide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2G6VoJIheLVg90H21EOLACvtfcHk0liwbnZ8gdDZXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D&md5=e7bf502c69c4247c39ce7e070984b3a6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm061152t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061152t%26sid%3Dliteratum%253Aachs%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DMitten%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DStudies%2520leading%2520to%2520potent%252C%2520dual%2520inhibitors%2520of%2520Bcl-2%2520and%2520Bcl-xL%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D641%26epage%3D662%26doi%3D10.1021%2Fjm061152t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">The Molecular Origin of Enthalpy/Entropy Compensation in Biomolecular Recognition</span>. <i>Annu. Rev. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1146/annurev-biophys-070816-033743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1146%2Fannurev-biophys-070816-033743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=29505727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVyis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=223-250&author=J.+M.+Foxauthor=M.+Zhaoauthor=M.+J.+Finkauthor=K.+Kangauthor=G.+M.+Whitesides&title=The+Molecular+Origin+of+Enthalpy%2FEntropy+Compensation+in+Biomolecular+Recognition&doi=10.1146%2Fannurev-biophys-070816-033743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Origin of Enthalpy/Entropy Compensation in Biomolecular Recognition</span></div><div class="casAuthors">Fox, Jerome M.; Zhao, Mengxia; Fink, Michael J.; Kang, Kyungtae; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">223-250</span>CODEN:
                <span class="NLM_cas:coden">ARBNCV</span>;
        ISSN:<span class="NLM_cas:issn">1936-122X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Biomol. recognition can be stubborn; changes in the structures of assocg. mols., or the environments in which they assoc., often yield compensating changes in enthalpies and entropies of binding and no net change in affinities.  This phenomenon-termed enthalpy/entropy (H/S) compensation-hinders efforts in biomol. design, and its incidence-often a surprise to experimentalists-makes interactions between biomols. difficult to predict.  Although characterizing H/S compensation requires exptl. care, it is unquestionably a real phenomenon that has, from an engineering perspective, useful phys. origins.  Studying H/S compensation can help illuminate the still-murky roles of water and dynamics in biomol. recognition and self-assembly.  This review summarizes known sources of H/S compensation (real and perceived) and lays out a conceptual framework for understanding and dissecting-and, perhaps, avoiding or exploiting-this phenomenon in biophys. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIy5VOmn0lBLVg90H21EOLACvtfcHk0liwbnZ8gdDZXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVyis7c%253D&md5=ab4fe78c91e6c37f14fa969b9b4ef602</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biophys-070816-033743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biophys-070816-033743%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DJ.%2BM.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DFink%26aufirst%3DM.%2BJ.%26aulast%3DKang%26aufirst%3DK.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DThe%2520Molecular%2520Origin%2520of%2520Enthalpy%252FEntropy%2520Compensation%2520in%2520Biomolecular%2520Recognition%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%26date%3D2018%26volume%3D47%26spage%3D223%26epage%3D250%26doi%3D10.1146%2Fannurev-biophys-070816-033743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bissantz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5061</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0liwbnZ8gdDZXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span> <span> </span><span class="NLM_article-title">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.molcel.2004.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15694340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=393-403&author=L.+Chenauthor=S.+N.+Willisauthor=A.+Weiauthor=B.+J.+Smithauthor=J.+I.+Fletcherauthor=M.+G.+Hindsauthor=P.+M.+Colmanauthor=C.+L.+Dayauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Differential+targeting+of+prosurvival+Bcl-2+proteins+by+their+BH3-only+ligands+allows+complementary+apoptotic+function&doi=10.1016%2Fj.molcel.2004.12.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span></div><div class="casAuthors">Chen, Lin; Willis, Simon N.; Wei, Andrew; Smith, Brian J.; Fletcher, Jamie I.; Hinds, Mark G.; Colman, Peter M.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis is initiated when Bcl-2 and its prosurvival relatives are engaged by proapoptotic BH3-only proteins via interaction of its BH3 domain with a groove on the Bcl-2-like proteins.  These interactions have been considered promiscuous, but our anal. of the affinity of eight BH3 peptides for five Bcl-2-like proteins has revealed that the interactions vary over 10,000-fold in affinity, and accordingly, only certain protein pairs assoc. inside cells.  Bim and Puma potently engaged all the prosurvival proteins comparably.  Bad, however, bound tightly to Bcl-2, Bcl-xL, and Bcl-w but only weakly to A1 and not to Mcl-1.  Strikingly, Noxa bound only Mcl-1 and A1.  In accord with their complementary binding, Bad and Noxa cooperated to induce potent killing.  The results suggest that apoptosis relies on selective interactions between particular subsets of these proteins and that it should be feasible to discover BH3-mimetic drugs that inactivate specific prosurvival targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHzR4DFj95LbVg90H21EOLACvtfcHk0ljIKMa9pzm-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D&md5=702d041ad86552b3581fed5198a96d7b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DDifferential%2520targeting%2520of%2520prosurvival%2520Bcl-2%2520proteins%2520by%2520their%2520BH3-only%2520ligands%2520allows%2520complementary%2520apoptotic%2520function%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D17%26spage%3D393%26epage%3D403%26doi%3D10.1016%2Fj.molcel.2004.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span> <span> </span><span class="NLM_article-title">Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1294</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1101/gad.1304105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1101%2Fgad.1304105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15901672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1ymsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1294-1305&author=S.+N.+Willisauthor=L.+Chenauthor=G.+Dewsonauthor=A.+Weiauthor=E.+Naikauthor=J.+I.+Fletcherauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Proapoptotic+Bak+is+sequestered+by+Mcl-1+and+Bcl-xL%2C+but+not+Bcl-2%2C+until+displaced+by+BH3-only+proteins&doi=10.1101%2Fgad.1304105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins</span></div><div class="casAuthors">Willis, Simon N.; Chen, Lin; Dewson, Grant; Wei, Andrew; Naik, Edwina; Fletcher, Jamie I.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1294-1305</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Commitment of cells to apoptosis is governed largely by the interaction between members of the Bcl-2 protein family.  Its three subfamilies have distinct roles: The BH3-only proteins trigger apoptosis by binding via their BH3 domain to prosurvival relatives, while the proapoptotic Bax and Bak have an essential downstream role involving permeabilization of organellar membranes and induction of caspase activation.  The authors have investigated the regulation of Bak and find that, in healthy cells, Bak assocs. with Mcl-1 and Bcl-xL but surprisingly not Bcl-2, Bcl-w, or A1.  These interactions require the Bak BH3 domain, which is also necessary for Bak dimerization and killing activity.  When cytotoxic signals activate BH3-only proteins that can engage both Mcl-1 and Bcl-xL (such as Noxa plus Bad), Bak is displaced and induces cell death.  Accordingly, the BH3-only protein Noxa could bind to Mcl-1, displace Bak, and promote Mcl-1 degrdn., but Bak-mediated cell death also required neutralization of Bcl-xL by other BH3-only proteins.  The results indicate that Bak is held in check solely by Mcl-1 and Bcl-xL and induces apoptosis only if freed from both.  The finding that different prosurvival proteins have selective roles has notable implications for the design of anti-cancer drugs that target the Bcl-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQ9-pKH_odbVg90H21EOLACvtfcHk0ljIKMa9pzm-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1ymsr4%253D&md5=2970c2ff81489e4bb04b9f1f9a0c1d8c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1101%2Fgad.1304105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1304105%26sid%3Dliteratum%253Aachs%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDewson%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DProapoptotic%2520Bak%2520is%2520sequestered%2520by%2520Mcl-1%2520and%2520Bcl-xL%252C%2520but%2520not%2520Bcl-2%252C%2520until%2520displaced%2520by%2520BH3-only%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D2005%26volume%3D19%26spage%3D1294%26epage%3D1305%26doi%3D10.1101%2Fgad.1304105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue-Yamauchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jebiwott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietanza, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kris, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">16078</span> <span class="refDoi"> DOI: 10.1038/ncomms16078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fncomms16078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28714472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=A.+Inoue-Yamauchiauthor=P.+S.+Jengauthor=K.+Kimauthor=H.+C.+Chenauthor=S.+Hanauthor=Y.+T.+Ganesanauthor=K.+Ishizawaauthor=S.+Jebiwottauthor=Y.+Dongauthor=M.+C.+Pietanzaauthor=M.+D.+Hellmannauthor=M.+G.+Krisauthor=J.+J.+Hsiehauthor=E.+H.+Cheng&title=Targeting+the+differential+addiction+to+anti-apoptotic+BCL-2+family+for+cancer+therapy&doi=10.1038%2Fncomms16078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the differential addiction to anti-apoptotic bcl-2 family for cancer therapy</span></div><div class="casAuthors">Inoue-Yamauchi, Akane; Jeng, Paul S.; Kim, Kwanghee; Chen, Hui-Chen; Han, Song; Ganesan, Yogesh Tengarai; Ishizawa, Kota; Jebiwott, Sylvia; Dong, Yiyu; Pietanza, Maria C.; Hellmann, Matthew D.; Kris, Mark G.; Hsieh, James J.; Cheng, Emily H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16078</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">BCL-2 family proteins are central regulators of mitochondrial apoptosis and validated anti-cancer targets.  Using small cell lung cancer (SCLC) as a model, we demonstrated the presence of differential addiction of cancer cells to anti-apoptotic BCL-2, BCL-XL or MCL-1, which correlated with the resp. protein expression ratio.  ABT-263 (navitoclax), a BCL-2/BCL-XL inhibitor, prevented BCL-XL from sequestering activator BH3-only mols. (BH3s) and BAX but not BAK.  Consequently, ABT-263 failed to kill BCL-XL-addicted cells with low activator BH3s and BCL-XL overabundance conferred resistance to ABT-263.  High-throughput screening identified anthracyclines including doxorubicin and CDK9 inhibitors including dinaciclib that synergized with ABT-263 through downregulation of MCL-1.  As doxorubicin and dinaciclib also reduced BCL-XL, the combinations of BCL-2 inhibitor ABT-199 (venetoclax) with doxorubicin or dinaciclib provided effective therapeutic strategies for SCLC.  Altogether, our study highlights the need for mechanism-guided targeting of anti-apoptotic BCL-2 proteins to effectively activate the mitochondrial cell death program to kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSK9zWKD-3jrVg90H21EOLACvtfcHk0ljIKMa9pzm-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrjJ&md5=dcc3892b577fb9fea70039619183017d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms16078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms16078%26sid%3Dliteratum%253Aachs%26aulast%3DInoue-Yamauchi%26aufirst%3DA.%26aulast%3DJeng%26aufirst%3DP.%2BS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%2BC.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGanesan%26aufirst%3DY.%2BT.%26aulast%3DIshizawa%26aufirst%3DK.%26aulast%3DJebiwott%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DPietanza%26aufirst%3DM.%2BC.%26aulast%3DHellmann%26aufirst%3DM.%2BD.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DHsieh%26aufirst%3DJ.%2BJ.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26atitle%3DTargeting%2520the%2520differential%2520addiction%2520to%2520anti-apoptotic%2520BCL-2%2520family%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fncomms16078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClellan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martineau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1181</span>, <span class="refDoi"> DOI: 10.1021/jm050754u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050754u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1165-1181&author=M.+D.+Wendtauthor=W.+Shenauthor=A.+Kunzerauthor=W.+J.+McClellanauthor=M.+Brunckoauthor=T.+K.+Oostauthor=H.+Dingauthor=M.+K.+Josephauthor=H.+Zhangauthor=P.+M.+Nimmerauthor=S.+C.+Ngauthor=A.+R.+Shoemakerauthor=A.+M.+Petrosauthor=A.+Oleksijewauthor=K.+Marshauthor=J.+Bauchauthor=T.+Oltersdorfauthor=B.+A.+Belliauthor=D.+Martineauauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+and+structure-activity+relationship+of+antagonists+of+B-cell+lymphoma+2+family+proteins+with+chemopotentiation+activity+in+vitro+and+in+vivo&doi=10.1021%2Fjm050754u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo</span></div><div class="casAuthors">Wendt, Michael D.; Shen, Wang; Kunzer, Aaron; McClellan, William J.; Bruncko, Milan; Oost, Thorsten K.; Ding, Hong; Joseph, Mary K.; Zhang, Haichao; Nimmer, Paul M.; Ng, Shi-Chung; Shoemaker, Alexander R.; Petros, Andrew M.; Oleksijew, Anatol; Marsh, Kennan; Bauch, Joy; Oltersdorf, Tilman; Belli, Barbara A.; Martineau, Darlene; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1165-1181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of a rationally designed potentiator of cancer chemotherapy, via inhibition of Bcl-XL function, is described.  Lead compds. generated by NMR screening and directed parallel synthesis displayed sub-μM binding but were strongly deactivated in the presence of serum.  The dominant component of serum deactivation was identified as domain III of human serum albumin (HSA); NMR soln. structures of inhibitors bound to both Bcl-XL and HSA domain III indicated two potential optimization sites for sepn. of affinities.  Modifications at both sites resulted in compds. with improved Bcl-XL binding and greatly increased activity in the presence of human serum, culminating in 73R, which bound to Bcl-XL with a Ki of 0.8 nM.  In a cellular assay 73R reversed the protection afforded by Bcl-XL overexpression against cytokine deprivation in FL5.12 cells with an EC50 of 0.47 μM.  73R showed little effect on the viability of the human non small cell lung cancer cell line A549.  However, consistent with the proposed mechanism, 73R potentiated the activity of paclitaxel and UV irradn. in vitro and potentiated the antitumor efficacy of paclitaxel in a mouse xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcJMZIao1pbVg90H21EOLACvtfcHk0lgk1gIFUXXtRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D&md5=a0311af587e06f1adf0f87d356137435</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm050754u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050754u%26sid%3Dliteratum%253Aachs%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520of%2520antagonists%2520of%2520B-cell%2520lymphoma%25202%2520family%2520proteins%2520with%2520chemopotentiation%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1165%26epage%3D1181%26doi%3D10.1021%2Fjm050754u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of conformationally constrained benzoylureas as BH3-mimetics</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5230</span>– <span class="NLM_lpage">5237</span>, <span class="refDoi"> DOI: 10.1039/c2ob25618e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1039%2Fc2ob25618e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=22648632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFWnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=5230-5237&author=R.+M.+Bradyauthor=E.+Hatzisauthor=T.+Connorauthor=I.+P.+Streetauthor=J.+B.+Baellauthor=G.+Lessene&title=Synthesis+of+conformationally+constrained+benzoylureas+as+BH3-mimetics&doi=10.1039%2Fc2ob25618e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of conformationally constrained benzoylureas as BH3-mimetics</span></div><div class="casAuthors">Brady, Ryan M.; Hatzis, Effie; Connor, Theresa; Street, Ian P.; Baell, Jonathan B.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">5230-5237</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The design of small mols. that mimic the BH3 domain and bind to Bcl-2 proteins has emerged as a promising approach to discovering novel anti-cancer therapeutics.  We reveal the design and synthesis of conformationally constrained benzoylurea scaffolds as conformational probes.  Central to helix mimicry, the intramol. hydrogen bond in the benzoylurea plays a key role in the pre-organization of the acyclic substrates for cyclization via ring closing metathesis, providing efficient access to the constrained mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWg4tXEh8N4rVg90H21EOLACvtfcHk0lgk1gIFUXXtRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFWnsLk%253D&md5=dd8cdf6992a76755d6272f61559752b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25618e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25618e%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DR.%2BM.%26aulast%3DHatzis%26aufirst%3DE.%26aulast%3DConnor%26aufirst%3DT.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520conformationally%2520constrained%2520benzoylureas%2520as%2520BH3-mimetics%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D5230%26epage%3D5237%26doi%3D10.1039%2Fc2ob25618e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Gioia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barattucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaccorsi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leggio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minuti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temperini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, C.</span></span> <span> </span><span class="NLM_article-title">Deprotection/reprotection of the amino group in α-amino acids and peptides. A one-pot procedure in [Bmim][BF4] ionic liquid</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2686</span>, <span class="refDoi"> DOI: 10.1039/C3RA46599C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1039%2FC3RA46599C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=2678-2686&author=M.+L.+Di%0AGioiaauthor=A.+Barattucciauthor=P.+Bonaccorsiauthor=A.+Leggioauthor=L.+Minutiauthor=E.+Romioauthor=A.+Temperiniauthor=C.+Siciliano&title=Deprotection%2Freprotection+of+the+amino+group+in+%CE%B1-amino+acids+and+peptides.+A+one-pot+procedure+in+%5BBmim%5D%5BBF4%5D+ionic+liquid&doi=10.1039%2FC3RA46599C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Deprotection/reprotection of the amino group in α-amino acids and peptides. A one-pot procedure in [Bmim][BF4] ionic liquid</span></div><div class="casAuthors">Di Gioia, M. L.; Barattucci, A.; Bonaccorsi, P.; Leggio, A.; Minuti, L.; Romio, E.; Temperini, A.; Siciliano, C.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2686</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This paper presents an efficient one-pot protocol for the sequential deprotection/reprotection of an α-amino group in an α-amino acid and dipeptide Me esters.  [Bmim][BF4] is used as the solvent in the entire process.  In particular, the use of the ionic liq. allows for rapid and clean removal of the 4-nitrobenzenesulfonyl (nosyl) group and for facile subsequent tert-butyloxycarbonylation of the free α-amino function under very mild conditions.  N-BOC-α-amino acid as well as peptide derivs. are isolated in excellent yields, and do not require any further purifn.  Abs. configurations of the precursors are totally preserved during the process.  The synthesis of the target compds. was achieved using N-nosyl-group-protected amino acids as starting materials, such as N-[(4-nitrophenyl)sulfonyl]-L-valine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-phenylalanine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-leucine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-isoleucine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-alanine Me ester, N-[(4-nitrophenyl)sulfonyl]-D-phenylalanine Me ester, N-[(4-nitrophenyl)sulfonyl]-O-(phenylmethyl)-L-tyrosine Me ester, N-[(4-nitrophenyl)sulfonyl]-S-(phenylmethyl)-L-cysteine Me ester.  The studied compds. included dipeptides, N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl-L-alanine Me ester, N-[(1,1-dimethylethoxy)carbonyl]-D-phenylalanyl-L-alanine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-leucyl-L-alanine Me ester, N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl-L-alanine Me ester.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvHlJdAGLSsrVg90H21EOLACvtfcHk0lgk1gIFUXXtRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtLnI&md5=af18c07b0f32c5239adbd611e20aba67</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1039%2FC3RA46599C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3RA46599C%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGioia%26aufirst%3DM.%2BL.%26aulast%3DBarattucci%26aufirst%3DA.%26aulast%3DBonaccorsi%26aufirst%3DP.%26aulast%3DLeggio%26aufirst%3DA.%26aulast%3DMinuti%26aufirst%3DL.%26aulast%3DRomio%26aufirst%3DE.%26aulast%3DTemperini%26aufirst%3DA.%26aulast%3DSiciliano%26aufirst%3DC.%26atitle%3DDeprotection%252Freprotection%2520of%2520the%2520amino%2520group%2520in%2520%25CE%25B1-amino%2520acids%2520and%2520peptides.%2520A%2520one-pot%2520procedure%2520in%2520%255BBmim%255D%255BBF4%255D%2520ionic%2520liquid%26jtitle%3DRSC%2520Adv.%26date%3D2014%26volume%3D4%26spage%3D2678%26epage%3D2686%26doi%3D10.1039%2FC3RA46599C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.ejmech.2012.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=22841280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12mtLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=176-187&author=Y.+Jiaauthor=X.+Dongauthor=P.+Zhouauthor=X.+Liuauthor=L.+Panauthor=H.+Xinauthor=Y.+Z.+Zhuauthor=Y.+Wang&title=The+synthesis+and+biological+evaluation+of+novel+Danshensu-cysteine+analog+conjugates+as+cardiovascular-protective+agents&doi=10.1016%2Fj.ejmech.2012.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents</span></div><div class="casAuthors">Jia, Yaoling; Dong, Xiaoyi; Zhou, Pengfei; Liu, Xinhua; Pan, Lilong; Xin, Hong; Zhu, Yi Zhun; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">176-187</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel amide and thioester conjugates between danshensu and cysteine derivs. have been designed and synthesized based on the strategy of "medicinal chem. hybridization".  Pharmacol. evaluation indicated that seven amide conjugates and thioester conjugates exhibited obvious protective effects on H2O2-induced human umbilical vein endothelial cells (HUVECs).  Pretreated with these conjugates could increase glutathione (GSH) activity and decrease malondialdehyde (MDA) level.  Further study on mechanism of compd. I revealed that it was related to its mitochondrial-protective effect and regulation of apoptosis-related proteins expression (Bax, p53, PARP, caspase-3, caspase-9 and Bcl-2).  These results indicate that these danshensu-cysteine analog conjugates possess significant cardiovascular-protective effects and merit further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrseq17I3umsLVg90H21EOLACvtfcHk0lhyDpI2u1BOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12mtLvP&md5=cac2dc3c7b0a2ae287e0eb43626ea260</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%2BZ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520Danshensu-cysteine%2520analog%2520conjugates%2520as%2520cardiovascular-protective%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D176%26epage%3D187%26doi%3D10.1016%2Fj.ejmech.2012.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Expeditious Synthesis of Phenanthrenes via CuBr2-Catalyzed Coupling of Terminal Alkynes and N-Tosylhydrazones Derived from O-Formyl Biphenyls</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5020</span>– <span class="NLM_lpage">5023</span>, <span class="refDoi"> DOI: 10.1021/ol201788v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol201788v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2itrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=5020-5023&author=F.+Yeauthor=Y.+Shiauthor=L.+Zhouauthor=Q.+Xiaoauthor=Y.+Zhangauthor=J.+Wang&title=Expeditious+Synthesis+of+Phenanthrenes+via+CuBr2-Catalyzed+Coupling+of+Terminal+Alkynes+and+N-Tosylhydrazones+Derived+from+O-Formyl+Biphenyls&doi=10.1021%2Fol201788v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Expeditious synthesis of phenanthrenes via CuBr2-catalyzed coupling of terminal alkynes and N-tosylhydrazones derived from O-formyl biphenyls</span></div><div class="casAuthors">Ye, Fei; Shi, Yi; Zhou, Lei; Xiao, Qing; Zhang, Yan; Wang, Jianbo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5020-5023</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new method for the synthesis of phenanthrenes e. g., I, II via ligand-free CuBr2-catalyzed coupling/cyclization of terminal alkynes with N-tosylhydrazones derived from o-formyl biphenyls has been developed.  This new synthesis has wide range of functional group compatibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_eZmLgaxkXLVg90H21EOLACvtfcHk0lhyDpI2u1BOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2itrrL&md5=eafc2bffd1e78fdede08dde696686707</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fol201788v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol201788v%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DExpeditious%2520Synthesis%2520of%2520Phenanthrenes%2520via%2520CuBr2-Catalyzed%2520Coupling%2520of%2520Terminal%2520Alkynes%2520and%2520N-Tosylhydrazones%2520Derived%2520from%2520O-Formyl%2520Biphenyls%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D5020%26epage%3D5023%26doi%3D10.1021%2Fol201788v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsube, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity study of L-amino acid-based N-type calcium channel blockers</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1901</span>– <span class="NLM_lpage">1913</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00558-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2FS0968-0896%2802%2900558-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12659776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlGjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1901-1913&author=T.+Sekoauthor=M.+Katoauthor=H.+Kohnoauthor=S.+Onoauthor=K.+Hashimuraauthor=H.+Takimizuauthor=K.+Nakaiauthor=H.+Maegawaauthor=N.+Katsubeauthor=M.+Toda&title=Structure-activity+study+of+L-amino+acid-based+N-type+calcium+channel+blockers&doi=10.1016%2FS0968-0896%2802%2900558-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity study of L-amino acid-based N-type calcium channel blockers</span></div><div class="casAuthors">Seko, Takuya; Kato, Masashi; Kohno, Hiroshi; Ono, Shizuka; Hashimura, Kazuya; Takimizu, Hideyuki; Nakai, Katsuhiko; Maegawa, Hitoshi; Katsube, Nobuo; Toda, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1901-1913</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Synthesis and structure-activity relationship (SAR) study of L-amino acid-based N-type calcium channel blockers are described.  The compds. synthesized were evaluated for inhibitory activity against both N-type and L-type calcium channels focusing on selectivity to reduce cardiovascular side effects due to blocking of L-type calcium channels.  In the course of screening of our compd. library, N-(t-butoxycarbonyl)-L-aspartic acid deriv. was identified as an initial lead compd. for a new series of N-type calcium channel blockers, which inhibited calcium influx into IMR-32 human neuroblastoma cells with an IC50 of 3.4 μM.  N-(t-butoxycarbonyl)-L-aspartic acid deriv. also exhibited blockade of N-type calcium channel current in electrophysiol. expt. using IMR-32 cells (34% inhibition at 10 μM, n=3).  As a consequence of conversion of amino acid residue of N-(t-butoxycarbonyl)-L-aspartic acid deriv., another aspartic acid deriv., that include N-(t-butoxycarbonyl)-L-cysteine, was found to be a potent N-type calcium channel blocker with an IC50 of 0.61 μM.  Thus, L-cysteine was selected as a potential structural motif for further modification.  Optimization of C- and N-terminals of L-cysteine using S-cyclohexylmethyl-L-cysteine as a central scaffold led to another potent and selective N-type calcium channel blocker, which showed improved inhibitory potency (IC50 0.12 μM) and 12-fold selectivity for N-type calcium channels over L-type channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3sTX4iULeQrVg90H21EOLACvtfcHk0lhyDpI2u1BOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlGjsr0%253D&md5=d6ffd0d87c91636409a6312d1757fc63</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900558-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900558-8%26sid%3Dliteratum%253Aachs%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKohno%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DHashimura%26aufirst%3DK.%26aulast%3DTakimizu%26aufirst%3DH.%26aulast%3DNakai%26aufirst%3DK.%26aulast%3DMaegawa%26aufirst%3DH.%26aulast%3DKatsube%26aufirst%3DN.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DStructure-activity%2520study%2520of%2520L-amino%2520acid-based%2520N-type%2520calcium%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1901%26epage%3D1913%26doi%3D10.1016%2FS0968-0896%2802%2900558-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idomoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakiuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, K.</span></span> <span> </span><span class="NLM_article-title">Rigid Molecular Tripod with an Adamantane Framework and Thiol Legs. Synthesis and Observation of an Ordered Monolayer on Au(111)</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1362</span>– <span class="NLM_lpage">1369</span>, <span class="refDoi"> DOI: 10.1021/jo051863j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo051863j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1362-1369&author=T.+Kitagawaauthor=Y.+Idomotoauthor=H.+Matsubaraauthor=D.+Hobaraauthor=T.+Kakiuchiauthor=T.+Okazakiauthor=K.+Komatsu&title=Rigid+Molecular+Tripod+with+an+Adamantane+Framework+and+Thiol+Legs.+Synthesis+and+Observation+of+an+Ordered+Monolayer+on+Au%28111%29&doi=10.1021%2Fjo051863j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Rigid Molecular Tripod with an Adamantane Framework and Thiol Legs. Synthesis and Observation of an Ordered Monolayer on Au(111)</span></div><div class="casAuthors">Kitagawa, Toshikazu; Idomoto, Yuichi; Matsubara, Hiroaki; Hobara, Daisuke; Kakiuchi, Takashi; Okazaki, Takao; Komatsu, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1362-1369</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tripod-shaped trithiols 1-3, contg. CH2SH groups at the three bridgehead positions of the adamantane framework and a halogen-contg. group [Br (1), p-BrC6H4 (2), or p-IC6H4 (3)] at the fourth bridgehead, were synthesized, and self-assembled monolayers (SAMs) were prepd. on atomically flat Au(111) surfaces.  The three-point chemisorption of these tripods was confirmed by polarization modulation IR reflection absorption spectroscopy, which showed the absence of a S-H stretching band.  Scanning tunneling microscopy of the SAM of 1 exhibited a hexagonal arrangement of the adsorbed mol. with a lattice const. of 8.7 Å.  A unidirectionally oriented, head-to-tail array of 1, which allows the close approach of neighboring mols., is proposed as a reasonable model of the two-dimensional crystal, where the adsorbed sulfur atoms form a quasi-(√3 × √3)R30° lattice.  The charge of the electrochem. reductive desorption of the SAM of 1 was in good agreement with the expected surface coverage, while the SAMs of 2 and 3 showed somewhat less (ca. 70%) charge.  The large neg. redn. peak potentials, obsd. for the SAM of 1, are taken to indicate a tight anchoring of this tripod by three sulfur atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqiZmDwGtupbVg90H21EOLACvtfcHk0ljseUrg17JllQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1Omug%253D%253D&md5=1549426413eeb3181c9e8992c152b040</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjo051863j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051863j%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DT.%26aulast%3DIdomoto%26aufirst%3DY.%26aulast%3DMatsubara%26aufirst%3DH.%26aulast%3DHobara%26aufirst%3DD.%26aulast%3DKakiuchi%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DK.%26atitle%3DRigid%2520Molecular%2520Tripod%2520with%2520an%2520Adamantane%2520Framework%2520and%2520Thiol%2520Legs.%2520Synthesis%2520and%2520Observation%2520of%2520an%2520Ordered%2520Monolayer%2520on%2520Au%2528111%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1362%26epage%3D1369%26doi%3D10.1021%2Fjo051863j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Hydrazine-Sensitive Thiol Protecting Group for Peptide and Protein Chemistry</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1021/ol1028755</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol1028755" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Oluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=568-571&author=F.+Shenauthor=Z.-P.+Zhangauthor=J.-B.+Liauthor=Y.+Linauthor=L.+Liu&title=Hydrazine-Sensitive+Thiol+Protecting+Group+for+Peptide+and+Protein+Chemistry&doi=10.1021%2Fol1028755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazine-Sensitive Thiol Protecting Group for Peptide and Protein Chemistry</span></div><div class="casAuthors">Shen, Fei; Zhang, Zhi-Ping; Li, Jia-Bin; Lin, Yun; Liu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">568-571</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the search for a new Cys side-chain protecting group that is compatible to the solid-phase peptide synthesis yet can be removed under mild conditions, the Hqm and Hgm groups that are readily deprotected by using aq. hydrazine have been developed.  The utility of these groups for peptide and protein chem. is tested by the total synthesis of a peptide antibiotic trifolitoxin and the human neutrophil defensin hNP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eHFzmMauV7Vg90H21EOLACvtfcHk0ljseUrg17JllQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Oluw%253D%253D&md5=0ead35eb76f781157b579023f584a2cb</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fol1028755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1028755%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.-P.%26aulast%3DLi%26aufirst%3DJ.-B.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DHydrazine-Sensitive%2520Thiol%2520Protecting%2520Group%2520for%2520Peptide%2520and%2520Protein%2520Chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D568%26epage%3D571%26doi%3D10.1021%2Fol1028755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the degradation of Mcl-1 induced by BH3 domains</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">6217</span>– <span class="NLM_lpage">6222</span>, <span class="refDoi"> DOI: 10.1073/pnas.0701297104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1073%2Fpnas.0701297104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17389404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=6217-6222&author=P.+E.+Czabotarauthor=E.+F.+Leeauthor=M.+F.+van+Delftauthor=C.+L.+Dayauthor=B.+J.+Smithauthor=D.+C.+Huangauthor=W.+D.+Fairlieauthor=M.+G.+Hindsauthor=P.+M.+Colman&title=Structural+insights+into+the+degradation+of+Mcl-1+induced+by+BH3+domains&doi=10.1073%2Fpnas.0701297104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the degradation of MCl-1 induced by BH3 domains</span></div><div class="casAuthors">Czabotar, Peter E.; Lee, Erinna F.; van Delft, Mark F.; Day, Catherine L.; Smith, Brian J.; Huang, David C. S.; Fairlie, W. Douglas; Hinds, Mark G.; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6217-6222</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apoptosis is held in check by prosurvival proteins of the Bcl-2 family.  The distantly related BH3-only proteins bind to and antagonize Bcl-2 proteins, thereby promoting apoptosis.  Whereas binding of the BH3-only protein Noxa to prosurvival Mcl-1 induces Mcl-1 degrdn. by the proteasome, binding of another BH3-only ligand, Bim, elevates Mcl-1 protein levels.  We compared the three- dimensional structures of the complexes formed between BH3 peptides of both Bim and Noxa, and we show that a discrete C-terminal sequence of the Noxa BH3 is necessary to instigate Mcl-1 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkT9u8IpxRLVg90H21EOLACvtfcHk0ljKMekWhQPliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D&md5=f91d0194ce195855706f69364b7e6fb6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701297104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701297104%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520insights%2520into%2520the%2520degradation%2520of%2520Mcl-1%2520induced%2520by%2520BH3%2520domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D6217%26epage%3D6222%26doi%3D10.1073%2Fpnas.0701297104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puthalakath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1083/jcb.200708096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1083%2Fjcb.200708096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18209102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFOntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=341-355&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=M.+F.+van+Delftauthor=E.+M.+Michalakauthor=M.+J.+Boyleauthor=S.+N.+Willisauthor=H.+Puthalakathauthor=P.+Bouilletauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=A+novel+BH3+ligand+that+selectively+targets+Mcl-1+reveals+that+apoptosis+can+proceed+without+Mcl-1+degradation&doi=10.1083%2Fjcb.200708096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span></div><div class="casAuthors">Lee, Erinna F.; Czabotar, Peter E.; van Delft, Mark F.; Michalak, Ewa M.; Boyle, Michelle J.; Willis, Simon N.; Puthalakath, Hamsa; Bouillet, Philippe; Colman, Peter M.; Huang, David C. S.; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-355</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Like Bcl-2, Mcl-1 is an important survival factor for many cancers, its expression contributing to chemo-resistance and disease relapse.  However, unlike other prosurvival Bcl-2-like proteins, Mcl-1 stability is acutely regulated.  For example, the Bcl-2 homol. 3 (BH3)-only protein Noxa, which preferentially binds to Mcl-1, also targets it for proteasomal degrdn.  In this paper, we describe the discovery and characterization of a novel BH3-like ligand derived from Bim, BimS2A, which is highly selective for Mcl-1.  Unlike Noxa, BimS2A is unable to trigger Mcl-1 degrdn., yet, like Noxa, BimS2A promotes cell killing only when Bcl-xL is absent or neutralized.  Furthermore, killing by endogenous Bim is not assocd. with Mcl-1 degrdn.  Thus, functional inactivation of Mcl-1 does not always require its elimination.  Rather, it can be efficiently antagonized by a BH3-like ligand tightly engaging its binding groove, which is confirmed here with a structural study.  Our data have important implications for the discovery of compds. that might kill cells whose survival depends on Mcl-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruZGyqGo5NVLVg90H21EOLACvtfcHk0ljKMekWhQPliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFOntLc%253D&md5=62d71ec6b3055718e48bd164af70b792</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200708096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200708096%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DMichalak%26aufirst%3DE.%2BM.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520BH3%2520ligand%2520that%2520selectively%2520targets%2520Mcl-1%2520reveals%2520that%2520apoptosis%2520can%2520proceed%2520without%2520Mcl-1%2520degradation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D341%26epage%3D355%26doi%3D10.1083%2Fjcb.200708096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson-Annan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parma, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lithgow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span> <span> </span><span class="NLM_article-title">Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1083/jcb.200302144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1083%2Fjcb.200302144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12952938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFeqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2003&pages=877-887&author=J.+Wilson-Annanauthor=L.+A.+O%E2%80%99Reillyauthor=S.+A.+Crawfordauthor=G.+Hausmannauthor=J.+G.+Beaumontauthor=L.+P.+Parmaauthor=L.+Chenauthor=M.+Lackmannauthor=T.+Lithgowauthor=M.+G.+Hindsauthor=C.+L.+Dayauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Proapoptotic+BH3-only+proteins+trigger+membrane+integration+of+prosurvival+Bcl-w+and+neutralize+its+activity&doi=10.1083%2Fjcb.200302144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity</span></div><div class="casAuthors">Wilson-Annan, Julie; O'Reilly, Lorraine A.; Crawford, Simon A.; Hausmann, George; Beaumont, Jennifer G.; Parma, Loes P.; Chen, Lin; Lackmann, Martin; Lithgow, Trevor; Hinds, Mark G.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">877-887</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Prosurvival Bcl-2-like proteins, like Bcl-w, are thought to function on organelles such as the mitochondrion and to be targeted to them by their hydrophobic C-terminal domain.  We unexpectedly found, however, that the membrane assocn. of Bcl-w was enhanced during apoptosis.  In healthy cells, Bcl-w was loosely attached to the mitochondrial membrane, but it was converted into an integral membrane protein by cytotoxic signals that induce binding of BH3-only proteins, such as Bim, or by the addn. of BH3 peptides to lysates.  As the structure of Bcl-w has revealed that its C-terminal domain occupies the hydrophobic groove where BH3 ligands bind, displacement of that domain by a BH3 ligand would displace the hydrophobic C-terminal residues, allowing their insertion into the membrane.  To det. whether BH3 ligation is sufficient to induce the enhanced membrane affinity, or to render Bcl-w proapoptotic, we mimicked their complex by tethering the Bim BH3 domain to the N-terminus of Bcl-w.  The chimera indeed bound avidly to membranes, in a fashion requiring the C-terminal domain, but neither promoted nor inhibited apoptosis.  These results suggest that ligation of a proapoptotic BH3-only protein alters the conformation of Bcl-w, enhances membrane assocn., and neutralizes its survival function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-wxUtCsWbQLVg90H21EOLACvtfcHk0ljKMekWhQPliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFeqsb4%253D&md5=ce72e6b1c03b8bb87fb716ca61611b71</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200302144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200302144%26sid%3Dliteratum%253Aachs%26aulast%3DWilson-Annan%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DL.%2BA.%26aulast%3DCrawford%26aufirst%3DS.%2BA.%26aulast%3DHausmann%26aufirst%3DG.%26aulast%3DBeaumont%26aufirst%3DJ.%2BG.%26aulast%3DParma%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DLithgow%26aufirst%3DT.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DProapoptotic%2520BH3-only%2520proteins%2520trigger%2520membrane%2520integration%2520of%2520prosurvival%2520Bcl-w%2520and%2520neutralize%2520its%2520activity%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D162%26spage%3D877%26epage%3D887%26doi%3D10.1083%2Fjcb.200302144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span> <span> </span><span class="NLM_article-title">Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">4738</span>– <span class="NLM_lpage">4744</span>, <span class="refDoi"> DOI: 10.1074/jbc.M411434200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M411434200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15550399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=4738-4744&author=C.+L.+Dayauthor=L.+Chenauthor=S.+J.+Richardsonauthor=P.+J.+Harrisonauthor=D.+C.+Huangauthor=M.+G.+Hinds&title=Solution+structure+of+prosurvival+Mcl-1+and+characterization+of+its+binding+by+proapoptotic+BH3-only+ligands&doi=10.1074%2Fjbc.M411434200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands</span></div><div class="casAuthors">Day, Catherine L.; Chen, Lin; Richardson, Sarah J.; Harrison, Penny J.; Huang, David C. S.; Hinds, Mark G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4738-4744</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The B cell lymphoma-2 (Bcl-2) homologs myeloid cell leukemia-1 (Mcl-1) and A1 are prosurvival factors that selectively bind a subset of proapoptotic Bcl homol. (BH) 3-only proteins.  To investigate the mol. basis of the selectivity, we detd. the soln. structure of the C-terminal Bcl-2-like domain of Mcl-1.  This domain shares features expected of a prosurvival Bcl-2 protein, having a helical fold centered on a core hydrophobic helix and a surface-exposed hydrophobic groove for binding its cognate partners.  A no. of residues in the binding groove differentiate Mcl-1 from its homologs, and in contrast to other Bcl-2 homologs, Mcl-1 has a binding groove in a conformation intermediate between the open structures characterized by peptide complexes and the closed state obsd. in unliganded structures.  Mutagenesis of potential binding site residues was used to probe the contributions of groove residues to the binding properties of Mcl-1.  Although mutations in Mcl-1 had little impact on binding, a single mutation in the BH3-only ligand Bad enabled it to bind both Mcl-1 and A1 while retaining its binding to Bcl-2, Bcl-xL, and Bcl-w.  Elucidating the selective action of certain BH3-only ligands is required for delineating their mode of action and will aid the search for effective BH3-mimetic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_87u59NCfZrVg90H21EOLACvtfcHk0litWim6YR0zmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVymtrk%253D&md5=d700c096886315d72cd3d6c3045bb5bd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M411434200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M411434200%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DHarrison%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26atitle%3DSolution%2520structure%2520of%2520prosurvival%2520Mcl-1%2520and%2520characterization%2520of%2520its%2520binding%2520by%2520proapoptotic%2520BH3-only%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D4738%26epage%3D4744%26doi%3D10.1074%2Fjbc.M411434200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skea, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span> <span> </span><span class="NLM_article-title">The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1497</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1093/emboj/cdg144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1093%2Femboj%2Fcdg144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12660157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFeqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1497-1507&author=M.+G.+Hindsauthor=M.+Lackmannauthor=G.+L.+Skeaauthor=P.+J.+Harrisonauthor=D.+C.+S.+Huangauthor=C.+L.+Day&title=The+structure+of+Bcl-w+reveals+a+role+for+the+C-terminal+residues+in+modulating+biological+activity&doi=10.1093%2Femboj%2Fcdg144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity</span></div><div class="casAuthors">Hinds, Mark G.; Lackmann, Martin; Skea, Gretchen L.; Harrison, Penny J.; Huang, David C. S.; Day, Catherine L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1497-1507</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Pro-survival Bcl-2-related proteins, crit. regulators of apoptosis, contain a hydrophobic groove targeted for binding by the BH3 domain of the pro-apoptotic BH3-only proteins.  The soln. structure of the pro-survival protein Bcl-w, presented here, reveals that the binding groove is not freely accessible as predicted by previous structures of pro-survival Bcl-2-like mols.  Unexpectedly, the groove appears to be occluded by the C-terminal residues.  Binding and kinetic data suggest that the C-terminal residues of Bcl-w and Bcl-xL modulate pro-survival activity by regulating ligand access to the groove.  Binding of the BH3-only proteins, crit. for cell death initiation, is likely to displace the hydrophobic C-terminal region of Bcl-w and Bcl-xL. Moreover, Bcl-w does not act only by sequestering the BH3-only proteins.  Therefore, pro-survival Bcl-2-like mols. probably control the activation of downstream effectors by a mechanism that remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjaQRzNkFxpbVg90H21EOLACvtfcHk0litWim6YR0zmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFeqsbo%253D&md5=a5c752acfc65696f7bfa5f8ac125aef9</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg144%26sid%3Dliteratum%253Aachs%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DSkea%26aufirst%3DG.%2BL.%26aulast%3DHarrison%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DThe%2520structure%2520of%2520Bcl-w%2520reveals%2520a%2520role%2520for%2520the%2520C-terminal%2520residues%2520in%2520modulating%2520biological%2520activity%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D1497%26epage%3D1507%26doi%3D10.1093%2Femboj%2Fcdg144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smits, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span> <span> </span><span class="NLM_article-title">Structural plasticity underpins promiscuous binding of the prosurvival protein A1</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1016/j.str.2008.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.str.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18462686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslGrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=818-829&author=C.+Smitsauthor=P.+E.+Czabotarauthor=M.+G.+Hindsauthor=C.+L.+Day&title=Structural+plasticity+underpins+promiscuous+binding+of+the+prosurvival+protein+A1&doi=10.1016%2Fj.str.2008.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Plasticity Underpins Promiscuous Binding of the Prosurvival Protein A1</span></div><div class="casAuthors">Smits, Callum; Czabotar, Peter E.; Hinds, Mark G.; Day, Catherine L.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">818-829</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Apoptotic pathways are regulated by protein-protein interactions.  Interaction of the BH3 domains of proapoptotic Bcl-2 family proteins with the hydrophobic groove of prosurvival proteins is crit.  Whereas some BH3 domains bind in a promiscuous manner, others exhibit considerable selectivity and the sequence characteristics that distinguish these activities are unclear.  In this study, crystal structures of complexes between the prosurvival protein A1 and the BH3 domains from Puma, Bmf, Bak, and Bid have been solved.  The structure of A1 is similar to that of other prosurvival proteins, although features, such as an acidic patch in the binding groove, may allow specific therapeutic modulation of apoptosis.  Significant conformational plasticity was obsd. in the intermol. interactions and these differences explain some of the variation in affinity.  This study, in combination with published data, suggests that interactions between conserved residues demarcate optimal binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNEG1WF4B87Vg90H21EOLACvtfcHk0litWim6YR0zmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslGrt7Y%253D&md5=86eaac63d47c56dd2db927263db52bda</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DC.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DStructural%2520plasticity%2520underpins%2520promiscuous%2520binding%2520of%2520the%2520prosurvival%2520protein%2520A1%26jtitle%3DStructure%26date%3D2008%26volume%3D16%26spage%3D818%26epage%3D829%26doi%3D10.1016%2Fj.str.2008.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kvansakul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span> <span> </span><span class="NLM_article-title">Preparing Samples for Crystallization of Bcl-2 Family Complexes</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1419</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3581-9_16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1007%2F978-1-4939-3581-9_16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=27108442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BC28bjtVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1419&publication_year=2016&pages=213-229&author=M.+Kvansakulauthor=P.+E.+Czabotar&title=Preparing+Samples+for+Crystallization+of+Bcl-2+Family+Complexes&doi=10.1007%2F978-1-4939-3581-9_16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Preparing Samples for Crystallization of Bcl-2 Family Complexes</span></div><div class="casAuthors">Kvansakul Marc; Kvansakul Marc; Czabotar Peter E; Czabotar Peter E</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular biology (Clifton, N.J.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1419</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-resolution protein structures determined by X-ray crystallography or NMR have proven invaluable for deciphering the molecular mechanisms underlying the function of a vast range of proteins.  Here, we describe methods to generate complexes of proteins belonging to the Bcl-2 family of proteins with either biological ligands or small molecule antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVyeBrcwhIMScOqQTSkOffW6udTcc2eaVx7xnIpnT17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bjtVOnuw%253D%253D&md5=f84006d4c42346ccb574b0ac59f84f5c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3581-9_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3581-9_16%26sid%3Dliteratum%253Aachs%26aulast%3DKvansakul%26aufirst%3DM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26atitle%3DPreparing%2520Samples%2520for%2520Crystallization%2520of%2520Bcl-2%2520Family%2520Complexes%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1419%26spage%3D213%26epage%3D229%26doi%3D10.1007%2F978-1-4939-3581-9_16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kvansakul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perugini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1564</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1038/cdd.2008.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fcdd.2008.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18551131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1564-1571&author=M.+Kvansakulauthor=H.+Yangauthor=W.+D.+Fairlieauthor=P.+E.+Czabotarauthor=S.+F.+Fischerauthor=M.+A.+Peruginiauthor=D.+C.+Huangauthor=P.+M.+Colman&title=Vaccinia+virus+anti-apoptotic+F1L+is+a+novel+Bcl-2-like+domain-swapped+dimer+that+binds+a+highly+selective+subset+of+BH3-containing+death+ligands&doi=10.1038%2Fcdd.2008.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands</span></div><div class="casAuthors">Kvansakul, M.; Yang, H.; Fairlie, W. D.; Czabotar, P. E.; Fischer, S. F.; Perugini, M. A.; Huang, D. C. S.; Colman, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1564-1571</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an important part of the host's defense mechanism for eliminating invading pathogens.  Some viruses express proteins homologous in sequence and function to mammalian pro-survival Bcl-2 proteins.  Anti-apoptotic F1L expressed by vaccinia virus is essential for survival of infected cells, but it bears no discernable sequence homol. to proteins other than its immediate orthologues in related pox viruses.  Here we report that the crystal structure of F1L reveals a Bcl-2-like fold with an unusual N-terminal extension.  The protein forms a novel domain-swapped dimer in which the α1 helix is the exchanged domain.  Binding studies reveal an atypical BH3-binding profile, with sub-micromolar affinity only for the BH3 peptide of pro-apoptotic Bim and low micromolar affinity for the BH3 peptides of Bak and Bax.  This binding interaction is sensitive to F1L mutations within the predicted canonical BH3-binding groove, suggesting parallels between how vaccinia virus F1L and myxoma virus M11L bind BH3 domains.  Structural comparison of F1L with other Bcl-2 family members reveals a novel sequence signature that redefines the BH4 domain as a structural motif present in both pro- and anti-apoptotic Bcl-2 members, including viral Bcl-2-like proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjBB-HZ2WS9LVg90H21EOLACvtfcHk0li1U8XveOZAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jM&md5=6bd081cf184c076a68c51b94ed001306</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.83%26sid%3Dliteratum%253Aachs%26aulast%3DKvansakul%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DFischer%26aufirst%3DS.%2BF.%26aulast%3DPerugini%26aufirst%3DM.%2BA.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DVaccinia%2520virus%2520anti-apoptotic%2520F1L%2520is%2520a%2520novel%2520Bcl-2-like%2520domain-swapped%2520dimer%2520that%2520binds%2520a%2520highly%2520selective%2520subset%2520of%2520BH3-containing%2520death%2520ligands%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2008%26volume%3D15%26spage%3D1564%26epage%3D1571%26doi%3D10.1038%2Fcdd.2008.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1926</span>, <span class="refDoi"> DOI: 10.1021/jm101596e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101596e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1914-1926&author=B.+E.+Sleebsauthor=P.+E.+Czabotarauthor=W.+J.+Fairbrotherauthor=W.+D.+Fairlieauthor=J.+A.+Flygareauthor=D.+C.+Huangauthor=W.+J.+Kerstenauthor=M.+F.+Koehlerauthor=G.+Lesseneauthor=K.+Lowesauthor=J.+P.+Parisotauthor=B.+J.+Smithauthor=M.+L.+Smithauthor=A.+J.+Souersauthor=I.+P.+Streetauthor=H.+Yangauthor=J.+B.+Baell&title=Quinazoline+sulfonamides+as+dual+binders+of+the+proteins+B-cell+lymphoma+2+and+B-cell+lymphoma+extra+long+with+potent+proapoptotic+cell-based+activity&doi=10.1021%2Fjm101596e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Large with Potent Proapoptotic Cell-Based Activity</span></div><div class="casAuthors">Sleebs, Brad E.; Czabotar, Peter E.; Fairbrother, Wayne J.; Fairlie, W. Douglas; Flygare, John A.; Huang, David C. S.; Kersten, Wilhelmus J. A.; Koehler, Michael F. T.; Lessene, Guillaume; Lowes, Kym; Parisot, John P.; Smith, Brian J.; Smith, Morey L.; Souers, Andrew J.; Street, Ian P.; Yang, Hong; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1914-1926</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ABT-737 and ABT-263 are potent inhibitors of the BH3 antiapoptotic proteins, Bcl-xL and Bcl-2.  This class of putative anticancer agents invariantly contains an acylsulfonamide core.  We have designed and synthesized a series of novel quinazoline-based inhibitors of Bcl-2 and Bcl-xL that contain a heterocyclic alternative to the acylsulfonamide.  These compds. exhibit submicromolar, mechanism-based activity in human small-cell lung carcinoma cell lines in the presence of 10% human serum.  This comprises the first successful demonstration of a quinazoline sulfonamide core serving as an effective benzoylsulfonamide bioisostere.  Addnl., these novel quinazolines comprise only the second known class of Bcl-2 family protein inhibitors to induce mechanism-based cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdUw3pDj4wb7Vg90H21EOLACvtfcHk0li1U8XveOZAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislagsr0%253D&md5=b0f4d8c5856ccb403a97b7029fb3249c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm101596e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101596e%26sid%3Dliteratum%253Aachs%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DLowes%26aufirst%3DK.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DQuinazoline%2520sulfonamides%2520as%2520dual%2520binders%2520of%2520the%2520proteins%2520B-cell%2520lymphoma%25202%2520and%2520B-cell%2520lymphoma%2520extra%2520long%2520with%2520potent%2520proapoptotic%2520cell-based%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1914%26epage%3D1926%26doi%3D10.1021%2Fjm101596e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perugini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">31315</span>– <span class="NLM_lpage">31326</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.048009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M109.048009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=19748896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=31315-31326&author=E.+F.+Leeauthor=A.+Fedorovaauthor=K.+Zobelauthor=M.+J.+Boyleauthor=H.+Yangauthor=M.+A.+Peruginiauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=K.+Deshayesauthor=W.+D.+Fairlie&title=Novel+Bcl-2+homology-3+domain-like+sequences+identified+from+screening+randomized+peptide+libraries+for+inhibitors+of+the+pro-survival+Bcl-2+proteins&doi=10.1074%2Fjbc.M109.048009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bcl-2 Homology-3 Domain-like Sequences Identified from Screening Randomized Peptide Libraries for Inhibitors of the Pro-survival Bcl-2 Proteins</span></div><div class="casAuthors">Lee, Erinna F.; Fedorova, Anna; Zobel, Kerry; Boyle, Michelle J.; Yang, Hong; Perugini, Matthew A.; Colman, Peter M.; Huang, David C. S.; Deshayes, Kurt; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">31315-31326</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Interactions between Bcl-2 homol.-3 (BH3)-only proteins and their pro-survival Bcl-2 family binding partners initiate the intrinsic apoptosis pathway.  These interactions are mediated by a short helical motif, the BH3 domain, on the BH3-only protein, which inserts into a hydrophobic groove on the pro-survival mol.  To identify novel peptidic ligands that bind Mcl-1, a pro-survival protein relative of Bcl-2, both human and mouse Mcl-1 were screened against large randomized phage-displayed peptide libraries.  We identified a no. of 16-mer peptides with sub-micromolar affinity that were highly selective for Mcl-1, as well as being somewhat selective for the species of Mcl-1 (human or mouse) against which the library was panned.  Interestingly, these sequences all strongly resembled natural BH3 domain sequences.  By switching residues within the best of the human Mcl-1-binding sequences, or extending beyond the core sequence identified, we were able to alter the pro-survival protein interaction profile of this peptide such that it now bound all members tightly and was a potent killer when introduced into cells.  Introduction of an amide lock constraint within this sequence also increased its helicity and binding to pro-survival proteins.  These data provide new insights into the determinants of BH3 domain:pro-survival protein affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZREzEPHNG0bVg90H21EOLACvtfcHk0lgKCocfLJ7Jqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjsr7K&md5=6ed173df20b09ea7042dbfa9a1769d3a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.048009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.048009%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DFedorova%26aufirst%3DA.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DPerugini%26aufirst%3DM.%2BA.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DNovel%2520Bcl-2%2520homology-3%2520domain-like%2520sequences%2520identified%2520from%2520screening%2520randomized%2520peptide%2520libraries%2520for%2520inhibitors%2520of%2520the%2520pro-survival%2520Bcl-2%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D31315%26epage%3D31326%26doi%3D10.1074%2Fjbc.M109.048009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakthianandeswaren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djajawi, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. N.</span></span> <span> </span><span class="NLM_article-title">Defining the susceptibility of colorectal cancers to BH3-mimetic compounds</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">735</span> <span class="refDoi"> DOI: 10.1038/s41419-020-02815-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fs41419-020-02815-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=32913182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFajsb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=M.+J.+Luoauthor=M.+Palmieriauthor=C.+D.+Riffkinauthor=A.+Sakthianandeswarenauthor=T.+M.+Djajawiauthor=Y.+Hirokawaauthor=V.+Shuttleworthauthor=D.+H.+Segalauthor=C.+A.+Whiteauthor=D.+Nhuauthor=G.+Lesseneauthor=M.+Leeauthor=P.+Gibbsauthor=D.+C.+S.+Huangauthor=O.+M.+Sieberauthor=J.+N.+Gong&title=Defining+the+susceptibility+of+colorectal+cancers+to+BH3-mimetic+compounds&doi=10.1038%2Fs41419-020-02815-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the susceptibility of colorectal cancers to BH3-mimetic compounds</span></div><div class="casAuthors">Luo, Ming-Jie; Palmieri, Michelle; Riffkin, Chris D.; Sakthianandeswaren, Anuratha; Djajawi, Tirta Mario; Hirokawa, Yumiko; Shuttleworth, Victoria; Segal, David H.; White, Christine A.; Nhu, Duong; Lessene, Guillaume; Lee, Margaret; Gibbs, Peter; Huang, David C. S.; Sieber, Oliver M.; Gong, Jia-nan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">735</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Novel targets are required to improve the outcomes for patients with colorectal cancers.  In this regard, the selective inhibitor of the pro-survival protein BCL2, venetoclax, has proven highly effective in several hematol. malignancies.  In addn. to BCL2, potent and highly selective small mol. inhibitors of its relatives, BCLxL and MCL1, are now available, prompting us to investigate the susceptibility of colorectal cancers to the inhibition of one or more of these pro-survival proteins.  While targeting BCLxL, but not BCL2 or MCL1, on its own had some impact, most (15/17) of the immortalized colorectal cancer cell lines studied were efficiently killed by the combined targeting of BCLxL and MCL1.  Importantly, these in vitro findings were confirmed in a xenograft model and, interestingly, in all (5/5) patient derived tumor organoids evaluated.  Our results lend strong support to the notion that BCLxL and MCL1 are highly promising targets for further evaluation in efforts to improve the treatment of colorectal cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUYom-1p_FwbVg90H21EOLACvtfcHk0lgKCocfLJ7Jqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFajsb%252FM&md5=6937286944d019d3ff2e4aa67a8a30df</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fs41419-020-02815-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-020-02815-0%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DM.%2BJ.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DSakthianandeswaren%26aufirst%3DA.%26aulast%3DDjajawi%26aufirst%3DT.%2BM.%26aulast%3DHirokawa%26aufirst%3DY.%26aulast%3DShuttleworth%26aufirst%3DV.%26aulast%3DSegal%26aufirst%3DD.%2BH.%26aulast%3DWhite%26aufirst%3DC.%2BA.%26aulast%3DNhu%26aufirst%3DD.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DGibbs%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DSieber%26aufirst%3DO.%2BM.%26aulast%3DGong%26aufirst%3DJ.%2BN.%26atitle%3DDefining%2520the%2520susceptibility%2520of%2520colorectal%2520cancers%2520to%2520BH3-mimetic%2520compounds%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2020%26volume%3D11%26doi%3D10.1038%2Fs41419-020-02815-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">13123</span>– <span class="NLM_lpage">13132</span>, <span class="refDoi"> DOI: 10.1074/jbc.M700492200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M700492200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17337444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVShsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=13123-13132&author=A.+Obersteinauthor=P.+D.+Jeffreyauthor=Y.+Shi&title=Crystal+structure+of+the+Bcl-XL-Beclin+1+peptide+complex%3A+Beclin+1+is+a+novel+BH3-only+protein&doi=10.1074%2Fjbc.M700492200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Bcl-XL-Beclin 1 Peptide Complex: Beclin 1 is a Novel BH3-only Protein</span></div><div class="casAuthors">Oberstein, Adam; Jeffrey, Philip D.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">13123-13132</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bcl-2 family proteins are key regulators of apoptosis and have recently been shown to modulate autophagy.  The tumor suppressor Beclin 1 has been proposed to coordinate both apoptosis and autophagy through direct interaction with anti-apoptotic family members Bcl-2 and/or Bcl-XL.  However, the mol. basis for this interaction remains enigmatic.  Here we report that Beclin 1 contains a conserved BH3 domain, which is both necessary and sufficient for its interaction with Bcl-XL.  We also report the crystal structure of a Beclin BH3 peptide in complex with Bcl-XL at 2.5Å resoln.  Reminiscent of previously detd. Bcl-XL-BH3 structures, the amphipathic BH3 helix of Beclin 1 bound to a conserved hydrophobic groove of Bcl-XL.  These results define Beclin 1 as a novel BH3-only protein, implying that Beclin 1 may have a direct role in initiating apoptotic signaling.  We propose that this putative apoptotic function may be linked to the ability of Beclin 1 to suppress tumor formation in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5w9q6LcS4LVg90H21EOLACvtfcHk0lgKCocfLJ7Jqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVShsLk%253D&md5=2b505da129b2e5dfaad8be3b44d823c6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M700492200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M700492200%26sid%3Dliteratum%253Aachs%26aulast%3DOberstein%26aufirst%3DA.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520the%2520Bcl-XL-Beclin%25201%2520peptide%2520complex%253A%2520Beclin%25201%2520is%2520a%2520novel%2520BH3-only%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D13123%26epage%3D13132%26doi%3D10.1074%2Fjbc.M700492200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span>; <span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">[20] Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>.  <i>Methods in Enzymology</i>; <span class="NLM_publisher-name">Elsevier B.V.</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">276</span>, pp  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minor&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3D%255B20%255D%2520Processing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMethods%2520in%2520Enzymology%26pub%3DElsevier%2520B.V%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lipscJ0Zgf0fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lipscJ0Zgf0fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lipscJ0Zgf0fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Sharff, A.</span>; <span class="NLM_string-name">Smart, O. S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>BUSTER</i>, version 2.10.3; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O. S.</span>; <span class="NLM_string-name">Womack, T. O.</span>; <span class="NLM_string-name">Sharff, A.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Bricogne, G.</span></span> <i>Grade</i>, version 1.105; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=O.+S.+Smart&author=T.+O.+Womack&author=A.+Sharff&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=C.+Vonrhein&author=G.+Bricogne&title=Grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DO.%2BS.%26jtitle%3DGrade%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver-Fay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeyink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W375</span>– <span class="NLM_lpage">W383</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-W383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2ebescqK41AkNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3DW383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McPhillips, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhillips, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phizackerley, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.</span></span> <span> </span><span class="NLM_article-title">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span>. <i>J. Synchrotron Radiat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1107/S0909049502015170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0909049502015170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12409628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=401-406&author=T.+M.+McPhillipsauthor=S.+E.+McPhillipsauthor=H.+J.+Chiuauthor=A.+E.+Cohenauthor=A.+M.+Deaconauthor=P.+J.+Ellisauthor=E.+Garmanauthor=A.+Gonzalezauthor=N.+K.+Sauterauthor=R.+P.+Phizackerleyauthor=S.+M.+Soltisauthor=P.+Kuhn&title=Blu-Ice+and+the+Distributed+Control+System%3A+software+for+data+acquisition+and+instrument+control+at+macromolecular+crystallography+beamlines&doi=10.1107%2FS0909049502015170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span></div><div class="casAuthors">McPhillips, Timothy M.; McPhillips, Scott E.; Chiu, Hsiu Ju; Cohen, Aina E.; Deacon, Ashley M.; Ellis, Paul J.; Garman, Elspeth; Gonzalez, Ana; Sauter, Nicholas K.; Phizackerley, R. Paul; Soltis, S. Michael; Kuhn, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-406</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Blu-Ice and Distributed Control System (DCS) software packages were developed to provide unified control over the disparate hardware resources available at a macromol. crystallog. beamline.  Blu-Ice is a user interface that provides scientific experimenters and beamline support staff with intuitive graphical tools for collecting diffraction data and configuring beamlines for expts.  Blu-Ice communicates with the hardware at a beamline via DCS, an instrument-control and data-acquisition package designed to integrate hardware resources in a highly heterogeneous networked computing environment.  Together, Blu-Ice and DCS provide a flexible platform for increasing the ease of use, the level of automation and the remote accessibility of beamlines.  Blu-Ice and DCS are currently installed on four Stanford Synchrotron Radiation Lab. crystallog. beamlines and are being implemented at sister light sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVsQUIFJPBLVg90H21EOLACvtfcHk0ljBGdfRbIQF6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D&md5=c77228bd50890463f3e43e981a2e238a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1107%2FS0909049502015170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049502015170%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhillips%26aufirst%3DT.%2BM.%26aulast%3DMcPhillips%26aufirst%3DS.%2BE.%26aulast%3DChiu%26aufirst%3DH.%2BJ.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DDeacon%26aufirst%3DA.%2BM.%26aulast%3DEllis%26aufirst%3DP.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DPhizackerley%26aufirst%3DR.%2BP.%26aulast%3DSoltis%26aufirst%3DS.%2BM.%26aulast%3DKuhn%26aufirst%3DP.%26atitle%3DBlu-Ice%2520and%2520the%2520Distributed%2520Control%2520System%253A%2520software%2520for%2520data%2520acquisition%2520and%2520instrument%2520control%2520at%2520macromolecular%2520crystallography%2520beamlines%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2002%26volume%3D9%26spage%3D401%26epage%3D406%26doi%3D10.1107%2FS0909049502015170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljBGdfRbIQF6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':[],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structures of <b>ABT-737</b> (<b>1</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and novel benzoylurea hit <b>2</b>. (b) Crystal structure of <b>2</b> in complex with BCL-X<sub>L</sub>, determined to 2.15 Å (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, carbon: light blue, BCL-X<sub>L</sub> in surface representation in gray), showing canonical hydrophobic pockets p2 and p4 and a cryptic pocket p5 along the BH3-binding groove. (c) Overlaid crystal structures of <b>2</b> (from the BCL-X<sub>L</sub>:<b>2</b> complex) with the BIM BH3 peptide (from the BCL-X<sub>L</sub>:BIM<sup>BH3</sup> complex, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FDL">3FDL</a>, magenta),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> highlighting key conserved residues of the BH3 domain including hydrophobic amino acids h1–h4 and Asp99 (that form an important salt bridge interaction with Arg139 of BCL-X<sub>L</sub>). (d) Compounds <b>3</b>–<b>6</b> were synthesized to explore the negative structure–activity relationship (SAR) and validate the observed binding mode of <b>2</b> with BCL-X<sub>L</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Displacement of the side chain of Tyr195 of BCL-X<sub>L</sub> creates the cryptic p5 binding pocket. (a) The side chain of Tyr195 is displaced by the <i>S</i>-benzyl moiety of <b>2</b> in the BCL-X<sub>L</sub>:<b>2</b> complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, carbon: light blue), forming a cryptic p5 pocket that is lined by the C-terminus of the α8 helix and side chains of Trp137, Phe191, Leu194, and Tyr195 of BCL-X<sub>L</sub>. (b, c) Crystal structure of <i>apo</i> BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAZ">1MAZ</a>), (b) surface representation and (c) colored by <i>B</i>-factor (dark blue, low <i>B</i>-factor; red, high <i>B</i>-factor),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the side chain of Tyr195 lines the hydrophobic groove adjacent to the p2, p3, and p4 ligand binding pockets. <i>B</i>-factor analysis suggests that the region of BCL-X<sub>L</sub> in which Tyr195 lies (extending from the C-terminal end of the α8 helix), in addition to the α3 helix and α2–3 hinge regions, all exhibit some structural flexibility. (d) The cryptic p5 pocket is not present in any structure of BCL-X<sub>L</sub> bound to native ligands such as in the BCL-X<sub>L</sub>:BAX<sup>BH3</sup> structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PL7">3PL7</a>; overlaid with <b>2</b> from the BCL-X<sub>L</sub>:<b>2</b> complex).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In many of these structures, a pocket that could be termed the “canonical p5” pocket exists, into which residues turn up from the h4 residue inset, in this case Met74 of the BAX<sup>BH3</sup>. The cryptic p5 pocket is adjacent to this as demonstrated by the position of the <i>S</i>-phenyl moiety of <b>2</b> in this overlay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key interactions between acidic moieties of <b>2</b> and <b>ABT-737</b> (<b>1</b>) with BCL-X<sub>L</sub>. (a) Key interactions of compound <b>2</b> with Asn136 of BCL-X<sub>L</sub>. (b, c) Side-by-side comparison of the crystal structures of <b>ABT-737</b> (<b>1</b>) with BCL-X<sub>L</sub> (magenta, shown in stick conformation, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ">2YXJ</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and the primary conformation of <b>2</b> with BCL-X<sub>L</sub> (light blue). A hydrogen-bond interaction is apparent between the backbone −NH atom of Gly138 of BCL-X<sub>L</sub> and the carbonyl oxygen atom of the acylsulfonamide moiety of <b>ABT-737</b> (<b>1</b>). Notably, the thioether of the <i>S</i>-benzyl moiety of <b>2</b> (primary conformation, light blue) occupies a similar position, which suggested possibilities for further elaboration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Overlaid X-ray crystal structures of compound <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, carbon: light blue) and <b>ABT-737</b> (<b>1</b>) (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ">2YXJ</a>, carbon: magenta)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> both bound to BCL-X<sub>L</sub>, indicating sites for scaffold grafting (BCL-X<sub>L</sub> from the BCL-X<sub>L</sub>:<b>ABT-737</b> (<b>1</b>) complex is shown in surface representation in gray). (b) Bis-biphenyl compound <b>7</b> and tetrahydroisoquinoline <b>8</b> designed with a chlorobiphenyl extension to access the cryptic p2 pocket. (c) X-ray crystal structure of compound <b>7</b> bound to BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVE">6UVE</a>, carbon: dark blue). (d) X-ray crystal structure of compound <b>8</b> bound to BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVC">6UVC</a>, carbon: light orange). (e) Overlays of compounds <b>7</b> with <b>2</b> and <b>8</b> with <b>ABT-737</b> (<b>1</b>), all in their BCL-X<sub>L</sub> bound poise.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray crystal structure of <b>12</b> in complex with BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVF">6UVF</a>, carbon: light green). (b) X-ray crystal structure of <b>13</b> in complex with BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVG">6UVG</a>, carbon: dark green). (c) X-ray crystal structure of tetrahydroisoquinoline <b>15</b> in complex with BCL-X<sub>L</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVH">6UVH</a>, carbon: orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MEFs (wild-type, WT; <i>MCL-1</i><sup>–/–</sup>; or <i>MCL-1</i><sup>–/–</sup>/<i>BAX</i><sup>–/–</sup>/<i>BAK</i><sup>–/–</sup>) were cultured for 24 h in the presence of varying concentrations of (a) <b>ABT-737</b> (<b>1</b>), (b) <b>6</b>, or (c) <b>15</b> in an FMA medium containing 1% fetal calf serum (FCS) and then harvested, stained using propidium iodide (PI), and analyzed by flow cytometry. Viability plots for each titration series depict the percentage of live cells (PI negative, normalized to vehicle control, mean ± SEM of three independent experiments), which were fitted using nonlinear regression to determine the corresponding EC<sub>50</sub> values. (d) Plot showing the percentage of cells with released cytochrome <i>c</i> from mitochondria. Data are shown as mean ± SEM and are representative of four independent experiments ***<i>p</i> < 0.001 (multiple unpaired <i>t</i> test, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf" class="ext-link">Figure S7</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) thionyl chloride, MeOH, 0 °C to room temperature (r.t.); (b) HCl (4 M) in dioxane; (c) (bromomethyl)cyclohexane, tetrabutylammonium iodide (TBAI) (3 mol %), NaOH (2 N, aq)/EtOH (1:1); (d) <i>meta</i>-chloroperoxybenzoic acid (<i>m</i>-CPBA), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (e) triflic anhydride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.; (f) trimethylphosphine, tetrahydrofuran (THF); (g) <b>25</b>, K<sub>2</sub>CO<sub>3</sub>, 18-crown-6, CH<sub>3</sub>CN; (h) trifluoroacetic acid (TFA).</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA) and then 4-methylbenzylamine and dimethylformamide (DMF); (b) (i) trimethylsilyl trifluoromethanesulfonate (TMSOTf), NEt<sub>3</sub>, Et<sub>2</sub>O; (ii) COCl<sub>2</sub> 20% in toluene, 0 °C to r.t.; (c) 2-(benzylthio)ethanaminium chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (d) <b>19</b>, NEt<sub>3</sub>, propylene oxide, CH<sub>2</sub>Cl<sub>2</sub>; (e) NEt<sub>3</sub>, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (f) <i>N</i>,<i>O</i>-bistrimethylsilylacetamide, propylene oxide, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (g) <b>39</b>, <b>40</b>, <b>41</b>, <b>42</b>, <b>43</b>, <b>44</b>, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.; (h) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (i) 4-bromo-<i>N</i>-propylbenzamide, phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, sat Na<sub>2</sub>CO<sub>3</sub> EtOH. (j) CH<sub>3</sub>CN or CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/medium/jm0c01771_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01771/20210506/images/large/jm0c01771_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01771&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: conditions: (a) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) HCl (4 M) in dioxane; (c) 4-chloro-phenylboronic acid, Pd(OAc)<sub>2</sub> (5 mol %), tetra-<i>n</i>-butylammonium bromide (1 mol %), K<sub>2</sub>CO<sub>3</sub>, acetone/water (1:1), 40 °C; (d) 1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride, NEt<sub>3</sub>, sodium triacetoxyborohydride, CH<sub>2</sub>Cl<sub>2</sub>, r.t.; (e) LiOH, MeOH/water/THF (1:1:3), r.t.; (f) HBTU, DIEA and then 4-methylbenzylamine, DMF; (g) (1) TMSOTf, NEt<sub>3</sub>, Et<sub>2</sub>O; (2) COCl<sub>2</sub> 20% in toluene, 0 °C to r.t.; (h) NEt<sub>3</sub>, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (i) <i>N</i>,<i>O</i>-bistrimethylsilylacetamide, propylene oxide, CH<sub>3</sub>CN, or CH<sub>2</sub>Cl<sub>2</sub>; (j) <b>56</b> or <b>57</b>, CH<sub>3</sub>CN or CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.; (k) CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 77 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span> <span> </span><span class="NLM_article-title">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1038/nrm3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnrm3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=24355989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=49-63&author=P.+E.+Czabotarauthor=G.+Lesseneauthor=A.+Strasserauthor=J.+M.+Adams&title=Control+of+apoptosis+by+the+BCL-2+protein+family%3A+implications+for+physiology+and+therapy&doi=10.1038%2Fnrm3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume; Strasser, Andreas; Adams, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-63</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The BCL-2 protein family dets. the commitment of cells to apoptosis, an ancient cell suicide program that is essential for development, tissue homeostasis and immunity.  Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischemic conditions and drive neurodegeneration.  We discuss the biochem., structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold.  These mechanistic insights into the functions of the BCL-2 family are illuminating the physiol. control of apoptosis, the pathol. consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVpm2heUGBbVg90H21EOLACvtfcHk0lisR56E9cmdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI&md5=c18d528c2819c2df93b6798e62132372</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3722%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DControl%2520of%2520apoptosis%2520by%2520the%2520BCL-2%2520protein%2520family%253A%2520implications%2520for%2520physiology%2520and%2520therapy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D49%26epage%3D63%26doi%3D10.1038%2Fnrm3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amundson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornace, A. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6101</span>– <span class="NLM_lpage">6110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=11085534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6101-6110&author=S.+A.+Amundsonauthor=T.+G.+Myersauthor=D.+Scudieroauthor=S.+Kitadaauthor=J.+C.+Reedauthor=A.+J.+Fornace&title=An+informatics+approach+identifying+markers+of+chemosensitivity+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span></div><div class="casAuthors">Amundson, Sally A.; Myers, Timothy G.; Scudiero, Dominic; Kitada, Shinichi; Reed, John C.; Fornace, Albert J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6101-6110</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have used a sensitive and reproducible method of measuring mRNA expression to compare basal levels of 10 transcripts in the 60 cell lines of the National Cancer Institute's in vitro anticancer drug screen (NCI-ACDS) under conditions of exponential growth.  The strongest correlation among these target genes was between levels of CIP1/WAF1 and BAX.  Levels of the three major growth arrest and DNA damage-inducible gene transcripts, (GADD34, GADD45, and GADD153), which are coordinately regulated in response to many stresses, were also correlated across the 60 cell lines.  Although the stress induction of several of the transcripts studied here has been shown to be dependent on wild-type p53 status, basal levels of only CIP1/WAF1 and BAX were found to correlate with p53 status.  As expected, basal expression of O6 alkyl guanine alkyl-transferase correlated well with resistance to O6-alkylating agents (r = -0.44) but not with resistance to alkylators with different mechanisms of action (r = -0.04).  When basal expression levels of the 10 genes across the NCI-ACDS panel were compared with sensitivities to a panel of 122 std. chemotherapy agents, the most striking relationship was a strong neg. correlation (r = -0.3) between basal BCL-X levels and sensitivity to drugs in all of the mechanistic classes except one class of antimetabolites.  Sensitivities to a maximally diverse sample of 1200 from 70,000 compds. tested in the NCI-ACDS of agents were also neg. correlated with BCL-X levels.  A novel application of factor anal. revealed that the newly discovered assocns. were independent of previously demonstrated sensitivity factors such as p53 mutation status and native population doubling time.  A similar pattern of correlation was seen for Bcl-XL protein levels.  Conversely, BAX and BCL2, two other genes assocd. with regulation of apoptosis, showed no overall correlation with drug sensitivities.  This suggests that BCL-X may play a unique role in general resistance to cytotoxic agents, with the cell lines demonstrating relative resistance to 70,000 cytotoxic agents in the NCI-ACDS being characterized by high BCL-X expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDcpza2WFJbVg90H21EOLACvtfcHk0lisR56E9cmdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D&md5=0da385ff6e48e7351d16036c1a8fcf2e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmundson%26aufirst%3DS.%2BA.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DFornace%26aufirst%3DA.%2BJ.%26atitle%3DAn%2520informatics%2520approach%2520identifying%2520markers%2520of%2520chemosensitivity%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D6101%26epage%3D6110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlacher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span> <span> </span><span class="NLM_article-title">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fsj.cdd.4401940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=16645634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1325-1338&author=V.+Labiauthor=M.+Erlacherauthor=S.+Kiesslingauthor=A.+Villunger&title=BH3-only+proteins+in+cell+death+initiation%2C+malignant+disease+and+anticancer+therapy&doi=10.1038%2Fsj.cdd.4401940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span></div><div class="casAuthors">Labi, V.; Erlacher, M.; Kiessling, S.; Villunger, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1325-1338</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Induction of apoptosis in tumor cells, either by direct activation of the death receptor pathway using agonistic antibodies or recombinant ligands, or direct triggering of the Bcl-2-regulated intrinsic apoptosis pathway by small mol. drugs, carries high hopes to overcome the shortcomings of current anticancer therapies.  The latter therapy concept builds on a more detailed understanding of how Bcl-2-like mols. maintain mitochondrial integrity and how BH3-only proteins and Bax/Bak-like mols. can undermine it.  Means to unleash the apoptotic potential of BH3-only proteins in tumor cells, or bypass the need for BH3-only proteins by blocking possible interactions of Bcl-2-like prosurvival mols. with Bax and/or Bak allowing their direct activation, constitute interesting options for the design of novel anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpeJbnadPqLVg90H21EOLACvtfcHk0lisR56E9cmdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D&md5=c714f82592b1c8fe9df9d385c104414d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401940%26sid%3Dliteratum%253Aachs%26aulast%3DLabi%26aufirst%3DV.%26aulast%3DErlacher%26aufirst%3DM.%26aulast%3DKiessling%26aufirst%3DS.%26aulast%3DVillunger%26aufirst%3DA.%26atitle%3DBH3-only%2520proteins%2520in%2520cell%2520death%2520initiation%252C%2520malignant%2520disease%2520and%2520anticancer%2520therapy%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2006%26volume%3D13%26spage%3D1325%26epage%3D1338%26doi%3D10.1038%2Fsj.cdd.4401940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">BCL-2 family antagonists for cancer therapy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1038/nrd2658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnrd2658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=19043450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVenu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=989-1000&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=P.+M.+Colman&title=BCL-2+family+antagonists+for+cancer+therapy&doi=10.1038%2Fnrd2658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">BCL-2 family antagonists for cancer therapy</span></div><div class="casAuthors">Lessene, Guillaume; Czabotar, Peter E.; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">989-1000</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Overexpression of members of the BCL-2 family of pro-survival proteins is commonly assocd. with unfavorable pathogenesis in cancer.  The convergence of cytotoxic stress signals on the extended BCL-2 protein family provides the biol. rationale for directly targeting this family to induce apoptotic cell death.  Recently, several compds. have been described that inhibit the interaction between BCL-2 family members and their natural ligand, a helical peptide sequence known as the BH3 domain.  Here, we review preclin. and clin. data on these compds., and recommend four criteria that define antagonists of the BCL-2 protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov_A5gU_EESbVg90H21EOLACvtfcHk0lisR56E9cmdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVenu73P&md5=14886161a66c3ed7f754061fa964e1ed</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd2658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2658%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DBCL-2%2520family%2520antagonists%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D989%26epage%3D1000%26doi%3D10.1038%2Fnrd2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnrd.2016.253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28209992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=A.+Ashkenaziauthor=W.+J.+Fairbrotherauthor=J.+D.+Leversonauthor=A.+J.+Souers&title=From+basic+apoptosis+discoveries+to+advanced+selective+BCL-2+family+inhibitors&doi=10.1038%2Fnrd.2016.253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span></div><div class="casAuthors">Ashkenazi, Avi; Fairbrother, Wayne J.; Leverson, Joel D.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the B cell lymphoma 2 (BCL-2) gene family have a central role in regulating programmed cell death by controlling pro-apoptotic and anti-apoptotic intracellular signals.  In cancer, apoptosis evasion through dysregulation of specific BCL-2 family genes is a recurring event; accordingly, selective inhibition of specific anti-apoptotic BCL-2 family proteins represents an exciting therapeutic opportunity.  A combination of NMR (NMR)-based screening and structure-based drug design has yielded the first bona fide BCL-2 homol. 3 (BH3) mimetics, including the BCL-2 and BCL-XL dual antagonist navitoclax, which is the first BCL-2 family inhibitor to show efficacy in patients with cancer.  Clin. experience with navitoclax prompted the generation of the highly selective BCL-2 inhibitor venetoclax, which is now approved in the United States for the treatment of patients with chronic lymphocytic leukemia with 17p deletion who have received at least one prior therapy.  Recent advances have also been made in the development of potent and selective inhibitors of BCL-XL and myeloid cell leukemia 1 (MCL1), which are addnl. BCL-2 family members with established anti-apoptotic roles in cancer.  Here we review the latest progress in direct and selective targeting of BCL-2 family proteins for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXzAZwyiZQ9LVg90H21EOLACvtfcHk0ljtEjX_MbpuhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D&md5=ac65b9fbff59988cafb9e381dc0de405</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.253%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DFrom%2520basic%2520apoptosis%2520discoveries%2520to%2520advanced%2520selective%2520BCL-2%2520family%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1038%2Fnrd.2016.253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrington, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarlinton, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntington, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, A. M.</span></span> <span> </span><span class="NLM_article-title">The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1038/icb.2017.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Ficb.2017.72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28875977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kgtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=870-877&author=E.+M.+Carringtonauthor=D.+M.+Tarlintonauthor=D.+H.+Grayauthor=N.+D.+Huntingtonauthor=Y.+Zhanauthor=A.+M.+Lew&title=The+life+and+death+of+immune+cell+types%3A+the+role+of+BCL-2+anti-apoptotic+molecules&doi=10.1038%2Ficb.2017.72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules</span></div><div class="casAuthors">Carrington, Emma M.; Tarlinton, David M.; Gray, Daniel H.; Huntington, Nicholas D.; Zhan, Yifan; Lew, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">870-877</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Targeting survival mechanisms of immune cells may provide an avenue for immune intervention to dampen unwanted responses (e.g. autoimmunity, immunopathol. and transplant rejection) or enhance beneficial ones (e.g. immune deficiency, microbial defense and cancer immunotherapy).  The selective survival mechanisms of the various immune cell types also avails the possibility of specific tailoring of such interventions.  Here, we review the role of the BCL-2 anti-apoptotic family members (BCL-2, BCL-XL, BCL-W, MCL-1 and A1) on cell death/survival of the major immune cell types, for example, T, NK, B, dendritic cell (DC) lineages.  There is both selectivity and redundancy among this family.  Selectivity comes partly from the expression levels in each of the cell types.  For example, plasmacytoid DC express abundant BCL-2 and are susceptible to BCL-2 antagonism or deficiency, whereas conventional DC express abundant A1 and are susceptible to A1 deficiency.  There is, however, also functional redundancy; for example, overexpression of MCL-1 can override BCL-2 antagonism in plasmacytoid DC.  Moreover, susceptibility to another anti-apoptotic family member can be unmasked, when one or other member is removed.  These dual principles of selectivity and redundancy should guide the use of antagonists for manipulating immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYUxL7-EGOA7Vg90H21EOLACvtfcHk0ljtEjX_MbpuhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kgtr%252FM&md5=7e248871ae81ea1c9749af9a210d9960</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Ficb.2017.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.2017.72%26sid%3Dliteratum%253Aachs%26aulast%3DCarrington%26aufirst%3DE.%2BM.%26aulast%3DTarlinton%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DD.%2BH.%26aulast%3DHuntington%26aufirst%3DN.%2BD.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DLew%26aufirst%3DA.%2BM.%26atitle%3DThe%2520life%2520and%2520death%2520of%2520immune%2520cell%2520types%253A%2520the%2520role%2520of%2520BCL-2%2520anti-apoptotic%2520molecules%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D95%26spage%3D870%26epage%3D877%26doi%3D10.1038%2Ficb.2017.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0ljtEjX_MbpuhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szlavik, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragno, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Toumelin-Braizat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanrion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moujalled, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csekei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paczal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radics, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proszenyak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studeny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lysiak-Auvity, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grave, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galbraith, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guasconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauquil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guigal-Stephan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geneste, O.</span></span> <span> </span><span class="NLM_article-title">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>538</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1038/nature19830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnature19830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=27760111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=538&publication_year=2016&pages=477-482&author=A.+Kotschyauthor=Z.+Szlavikauthor=J.+Murrayauthor=J.+Davidsonauthor=A.+L.+Maragnoauthor=G.+Le+Toumelin-Braizatauthor=M.+Chanrionauthor=G.+L.+Kellyauthor=J.+N.+Gongauthor=D.+M.+Moujalledauthor=A.+Brunoauthor=M.+Csekeiauthor=A.+Paczalauthor=Z.+B.+Szaboauthor=S.+Siposauthor=G.+Radicsauthor=A.+Proszenyakauthor=B.+Balintauthor=L.+Ondiauthor=G.+Blaskoauthor=A.+Robertsonauthor=A.+Surgenorauthor=P.+Dokurnoauthor=I.+Chenauthor=N.+Matassovaauthor=J.+Smithauthor=C.+Pedderauthor=C.+Grahamauthor=A.+Studenyauthor=G.+Lysiak-Auvityauthor=A.+M.+Girardauthor=F.+Graveauthor=D.+Segalauthor=C.+D.+Riffkinauthor=G.+Pomilioauthor=L.+C.+Galbraithauthor=B.+J.+Aubreyauthor=M.+S.+Brennanauthor=M.+J.+Heroldauthor=C.+Changauthor=G.+Guasconiauthor=N.+Cauquilauthor=F.+Melchioreauthor=N.+Guigal-Stephanauthor=B.+Lockhartauthor=F.+Collandauthor=J.+A.+Hickmanauthor=A.+W.+Robertsauthor=D.+C.+Huangauthor=A.+H.+Weiauthor=A.+Strasserauthor=G.+Lesseneauthor=O.+Geneste&title=The+MCL1+inhibitor+S63845+is+tolerable+and+effective+in+diverse+cancer+models&doi=10.1038%2Fnature19830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span></div><div class="casAuthors">Kotschy Andras; Szlavik Zoltan; Csekei Marton; Paczal Attila; Szabo Zoltan B; Sipos Szabolcs; Radics Gabor; Proszenyak Agnes; Balint Balazs; Ondi Levente; Blasko Gabor; Murray James; Davidson James; Robertson Alan; Surgenor Allan; Dokurno Pawel; Chen Ijen; Matassova Natalia; Smith Julia; Pedder Christopher; Graham Christopher; Maragno Ana Leticia; Le Toumelin-Braizat Gaetane; Chanrion Maia; Bruno Alain; Studeny Aurelie; Lysiak-Auvity Gaelle; Girard Anne-Marie; Grave Fabienne; Guasconi Ghislaine; Cauquil Nicolas; Colland Frederic; Hickman John A; Geneste Olivier; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Moujalled Donia M; Pomilio Giovanna; Wei Andrew H; Aubrey Brandon J; Roberts Andrew W; Melchiore Fabien; Guigal-Stephan Nolwen; Lockhart Brian; Roberts Andrew W; Wei Andrew H; Lessene Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">538</span>
        (<span class="NLM_cas:issue">7626</span>),
    <span class="NLM_cas:pages">477-482</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Avoidance of apoptosis is critical for the development and sustained growth of tumours.  The pro-survival protein myeloid cell leukemia 1 (MCL1) is overexpressed in many cancers, but the development of small molecules targeting this protein that are amenable for clinical testing has been challenging.  Here we describe S63845, a small molecule that specifically binds with high affinity to the BH3-binding groove of MCL1.  Our mechanistic studies demonstrate that S63845 potently kills MCL1-dependent cancer cells, including multiple myeloma, leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway.  In vivo, S63845 shows potent anti-tumour activity with an acceptable safety margin as a single agent in several cancers.  Moreover, MCL1 inhibition, either alone or in combination with other anti-cancer drugs, proved effective against several solid cancer-derived cell lines.  These results point towards MCL1 as a target for the treatment of a wide range of tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7C_gQBh3bx0EgZCMqtRBifW6udTcc2eYii4mX31T7Xbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D&md5=c435a7621b84063133e41e0cdbad3ac8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature19830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19830%26sid%3Dliteratum%253Aachs%26aulast%3DKotschy%26aufirst%3DA.%26aulast%3DSzlavik%26aufirst%3DZ.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DJ.%26aulast%3DMaragno%26aufirst%3DA.%2BL.%26aulast%3DLe%2BToumelin-Braizat%26aufirst%3DG.%26aulast%3DChanrion%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DGong%26aufirst%3DJ.%2BN.%26aulast%3DMoujalled%26aufirst%3DD.%2BM.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DCsekei%26aufirst%3DM.%26aulast%3DPaczal%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DZ.%2BB.%26aulast%3DSipos%26aufirst%3DS.%26aulast%3DRadics%26aufirst%3DG.%26aulast%3DProszenyak%26aufirst%3DA.%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DOndi%26aufirst%3DL.%26aulast%3DBlasko%26aufirst%3DG.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DPedder%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DC.%26aulast%3DStudeny%26aufirst%3DA.%26aulast%3DLysiak-Auvity%26aufirst%3DG.%26aulast%3DGirard%26aufirst%3DA.%2BM.%26aulast%3DGrave%26aufirst%3DF.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DGalbraith%26aufirst%3DL.%2BC.%26aulast%3DAubrey%26aufirst%3DB.%2BJ.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGuasconi%26aufirst%3DG.%26aulast%3DCauquil%26aufirst%3DN.%26aulast%3DMelchiore%26aufirst%3DF.%26aulast%3DGuigal-Stephan%26aufirst%3DN.%26aulast%3DLockhart%26aufirst%3DB.%26aulast%3DColland%26aufirst%3DF.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DGeneste%26aufirst%3DO.%26atitle%3DThe%2520MCL1%2520inhibitor%2520S63845%2520is%2520tolerable%2520and%2520effective%2520in%2520diverse%2520cancer%2520models%26jtitle%3DNature%26date%3D2016%26volume%3D538%26spage%3D477%26epage%3D482%26doi%3D10.1038%2Fnature19830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragno, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanrion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalaoui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geneste, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visvader, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindeman, G. J.</span></span> <span> </span><span class="NLM_article-title">Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaam7049</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aam7049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1126%2Fscitranslmed.aam7049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28768804" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=D.+Merinoauthor=J.+R.+Whittleauthor=F.+Vaillantauthor=A.+Serranoauthor=J.+N.+Gongauthor=G.+Ginerauthor=A.+L.+Maragnoauthor=M.+Chanrionauthor=E.+Schneiderauthor=B.+Palauthor=X.+Liauthor=G.+Dewsonauthor=J.+Graselauthor=K.+Liuauthor=N.+Lalaouiauthor=D.+Segalauthor=M.+J.+Heroldauthor=D.+C.+S.+Huangauthor=G.+K.+Smythauthor=O.+Genesteauthor=G.+Lesseneauthor=J.+E.+Visvaderauthor=G.+J.+Lindeman&title=Synergistic+action+of+the+MCL-1+inhibitor+S63845+with+current+therapies+in+preclinical+models+of+triple-negative+and+HER2-amplified+breast+cancer&doi=10.1126%2Fscitranslmed.aam7049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aam7049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aam7049%26sid%3Dliteratum%253Aachs%26aulast%3DMerino%26aufirst%3DD.%26aulast%3DWhittle%26aufirst%3DJ.%2BR.%26aulast%3DVaillant%26aufirst%3DF.%26aulast%3DSerrano%26aufirst%3DA.%26aulast%3DGong%26aufirst%3DJ.%2BN.%26aulast%3DGiner%26aufirst%3DG.%26aulast%3DMaragno%26aufirst%3DA.%2BL.%26aulast%3DChanrion%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DPal%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDewson%26aufirst%3DG.%26aulast%3DGrasel%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLalaoui%26aufirst%3DN.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DSmyth%26aufirst%3DG.%2BK.%26aulast%3DGeneste%26aufirst%3DO.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DVisvader%26aufirst%3DJ.%2BE.%26aulast%3DLindeman%26aufirst%3DG.%2BJ.%26atitle%3DSynergistic%2520action%2520of%2520the%2520MCL-1%2520inhibitor%2520S63845%2520with%2520current%2520therapies%2520in%2520preclinical%2520models%2520of%2520triple-negative%2520and%2520HER2-amplified%2520breast%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aam7049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caenepeel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmontes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poppe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paras, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taygerly, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vimolratana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zancanella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cajulis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greninger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanaghan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moujalled, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. E.</span></span> <span> </span><span class="NLM_article-title">AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1597</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-18-0387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1158%2F2159-8290.CD-18-0387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=30254093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFOmsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1582-1597&author=S.+Caenepeelauthor=S.+P.+Brownauthor=B.+Belmontesauthor=G.+Moodyauthor=K.+S.+Keeganauthor=D.+Chuiauthor=D.+A.+Whittingtonauthor=X.+Huangauthor=L.+Poppeauthor=A.+C.+Chengauthor=M.+Cardozoauthor=J.+Houzeauthor=Y.+Liauthor=B.+Lucasauthor=N.+A.+Parasauthor=X.+Wangauthor=J.+P.+Taygerlyauthor=M.+Vimolratanaauthor=M.+Zancanellaauthor=L.+Zhuauthor=E.+Cajulisauthor=T.+Osgoodauthor=J.+Sunauthor=L.+Damonauthor=R.+K.+Eganauthor=P.+Greningerauthor=J.+D.+McClanaghanauthor=J.+Gongauthor=D.+Moujalledauthor=G.+Pomilioauthor=P.+Beltranauthor=C.+H.+Benesauthor=A.+W.+Robertsauthor=D.+C.+Huangauthor=A.+Weiauthor=J.+Canonauthor=A.+Coxonauthor=P.+E.+Hughes&title=AMG+176%2C+a+Selective+MCL1+Inhibitor%2C+Is+Effective+in+Hematologic+Cancer+Models+Alone+and+in+Combination+with+Established+Therapies&doi=10.1158%2F2159-8290.CD-18-0387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies</span></div><div class="casAuthors">Caenepeel, Sean; Brown, Sean P.; Belmontes, Brian; Moody, Gordon; Keegan, Kathleen S.; Chui, Danny; Whittington, Douglas A.; Huang, Xin; Poppe, Leszek; Cheng, Alan C.; Cardozo, Mario; Houze, Jonathan; Li, Yunxiao; Lucas, Brian; Paras, Nick A.; Wang, Xianghong; Taygerly, Joshua P.; Vimolratana, Marc; Zancanella, Manuel; Zhu, Liusheng; Cajulis, Elaina; Osgood, Tao; Sun, Jan; Damon, Leah; Egan, Regina K.; Greninger, Patricia; McClanaghan, Joseph D.; Gong, Jianan; Moujalled, Donia; Pomilio, Giovanna; Beltran, Pedro; Benes, Cyril H.; Roberts, Andrew W.; Huang, David C.; Wei, Andrew; Canon, Jude; Coxon, Angela; Hughes, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1582-1597</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The prosurvival BCL2 family member MCL1 is frequently dysregulated in cancer.  To overcome the significant challenges assocd. with inhibition of MCL1 protein-protein interactions, we rigorously applied small-mol. conformational restriction, which culminated in the discovery of AMG 176, the first selective MCL1 inhibitor to be studied in humans.  We demonstrate that MCL1 inhibition induces a rapid and committed step toward apoptosis in subsets of hematol. cancer cell lines, tumor xenograft models, and primary patient samples.  With the use of a human MCL1 knock-in mouse, we demonstrate that MCL1 inhibition at active doses of AMG 176 is tolerated and correlates with clear pharmacodynamic effects, demonstrated by redns. in B cells, monocytes, and neutrophils.  Furthermore, the combination of AMG 176 and venetoclax is synergistic in acute myeloid leukemia (AML) tumor models and in primary patient samples at tolerated doses.  These results highlight the therapeutic promise of AMG 176 and the potential for combinations with other BH3 mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUtMExVVtn5rVg90H21EOLACvtfcHk0lgq9RtKcArg_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOmsb7E&md5=795a713908c3635bbd5e9fc3d95f3ae0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-18-0387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-18-0387%26sid%3Dliteratum%253Aachs%26aulast%3DCaenepeel%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DBelmontes%26aufirst%3DB.%26aulast%3DMoody%26aufirst%3DG.%26aulast%3DKeegan%26aufirst%3DK.%2BS.%26aulast%3DChui%26aufirst%3DD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DPoppe%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DParas%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTaygerly%26aufirst%3DJ.%2BP.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DZancanella%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DCajulis%26aufirst%3DE.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DDamon%26aufirst%3DL.%26aulast%3DEgan%26aufirst%3DR.%2BK.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DMcClanaghan%26aufirst%3DJ.%2BD.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DMoujalled%26aufirst%3DD.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DBeltran%26aufirst%3DP.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DP.%2BE.%26atitle%3DAMG%2520176%252C%2520a%2520Selective%2520MCL1%2520Inhibitor%252C%2520Is%2520Effective%2520in%2520Hematologic%2520Cancer%2520Models%2520Alone%2520and%2520in%2520Combination%2520with%2520Established%2520Therapies%26jtitle%3DCancer%2520Discovery%26date%3D2018%26volume%3D8%26spage%3D1582%26epage%3D1597%26doi%3D10.1158%2F2159-8290.CD-18-0387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">Clinical trials: AMG176 (NCT02675452) and S64315 (NCT02992483 and NCT02979366).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span> <span> </span><span class="NLM_article-title">BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.ccell.2018.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=30537511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVygsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=879-891&author=D.+Merinoauthor=G.+L.+Kellyauthor=G.+Lesseneauthor=A.+H.+Weiauthor=A.+W.+Robertsauthor=A.+Strasser&title=BH3-Mimetic+Drugs%3A+Blazing+the+Trail+for+New+Cancer+Medicines&doi=10.1016%2Fj.ccell.2018.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines</span></div><div class="casAuthors">Merino, Delphine; Kelly, Gemma L.; Lessene, Guillaume; Wei, Andrew H.; Roberts, Andrew W.; Strasser, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-891</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Defects in apoptotic cell death can promote cancer and impair responses of malignant cells to anti-cancer therapy.  Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell death effectors, BAX and BAK, in check.  The BH3-only proteins initiate apoptosis by neutralizing the pro-survival BCL-2 proteins.  Structural anal. and medicinal chem. led to the development of small-mol. drugs that mimic the function of the BH3-only proteins to kill cancer cells.  The BCL-2 inhibitor venetoclax has been approved for treatment of refractory chronic lymphocytic leukemia and this drug and inhibitors of pro-survival MCL-1 and BCL-XL are being tested in diverse malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN0ldhkK5l4rVg90H21EOLACvtfcHk0lgq9RtKcArg_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVygsLjL&md5=7e7676b1b19255208900c38dc6c4b028</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMerino%26aufirst%3DD.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DBH3-Mimetic%2520Drugs%253A%2520Blazing%2520the%2520Trail%2520for%2520New%2520Cancer%2520Medicines%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D879%26epage%3D891%26doi%3D10.1016%2Fj.ccell.2018.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1987</span>, <span class="refDoi"> DOI: 10.1111/bph.12431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1111%2Fbph.12431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=24117105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=1973-1987&author=M.+J.+Royauthor=A.+Vomauthor=P.+E.+Czabotarauthor=G.+Lessene&title=Cell+death+and+the+mitochondria%3A+therapeutic+targeting+of+the+BCL-2+family-driven+pathway&doi=10.1111%2Fbph.12431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span></div><div class="casAuthors">Roy, M. J.; Vom, A.; Czabotar, P. E.; Lessene, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1973-1987</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The principal biol. role of mitochondria is to supply energy to cells; although intriguingly, evolution has bestowed another essential function upon these cellular organelles: under physiol. stress, mitochondria become the cornerstone of apoptotic cell death.  Specifically, mitochondrial outer membrane permeabilization (MOMP) allows cell death factors such as cytochrome c to be released into the cytoplasm, thus inducing caspase activation and the eventual destruction of essential cellular components.  Proteins of the B-cell lymphoma 2 (BCL-2) family control the tightly regulated pathway that causes MOMP.  The equil. between pro-survival and pro-apoptotic members of the BCL-2 family dictates the fate of cells, the homeostasis of organs and, by extension, the health of whole organisms.  Dysregulation of this equil. is involved in a large no. of diseases such as cancer, autoimmunity and neurodegenerative conditions.  Modulating the activity of the BCL-2 family of proteins with small mols. or peptides is an attractive but challenging therapeutic goal.  This review highlights the latest developments in this field and provides evidence that this strategy is likely to have a pos. effect on the treatment of still poorly addressed medical conditions.  Linked Articles : This article is part of a themed issue on Mitochondrial Pharmacol.: Energy, Injury & Beyond.  To view the other articles in this issue visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6jmhqr3darVg90H21EOLACvtfcHk0liNHnCugnMesg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D&md5=001a31bfa87a2f4864bd8606a9e61ab4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fbph.12431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12431%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BJ.%26aulast%3DVom%26aufirst%3DA.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DCell%2520death%2520and%2520the%2520mitochondria%253A%2520therapeutic%2520targeting%2520of%2520the%2520BCL-2%2520family-driven%2520pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D1973%26epage%3D1987%26doi%3D10.1111%2Fbph.12431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderquist, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, A.</span></span> <span> </span><span class="NLM_article-title">BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2011</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1158%2F1535-7163.MCT-16-0031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=27535975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=2011-2017&author=R.+S.+Soderquistauthor=A.+Eastman&title=BCL2+Inhibitors+as+Anticancer+Drugs%3A+A+Plethora+of+Misleading+BH3+Mimetics&doi=10.1158%2F1535-7163.MCT-16-0031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0031%26sid%3Dliteratum%253Aachs%26aulast%3DSoderquist%26aufirst%3DR.%2BS.%26aulast%3DEastman%26aufirst%3DA.%26atitle%3DBCL2%2520Inhibitors%2520as%2520Anticancer%2520Drugs%253A%2520A%2520Plethora%2520of%2520Misleading%2520BH3%2520Mimetics%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D2011%26epage%3D2017%26doi%3D10.1158%2F1535-7163.MCT-16-0031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckwerth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsmeyer, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1038/nature03579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+L.+Wangauthor=M.+D.+Wendtauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+Bcl-2+family+proteins+induces+regression+of+solid+tumours&doi=10.1038%2Fnature03579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0liNHnCugnMesg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%2BL.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681%26doi%3D10.1038%2Fnature03579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adickes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6902</span>– <span class="NLM_lpage">6915</span>, <span class="refDoi"> DOI: 10.1021/jm800669s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800669s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6902-6915&author=C.+M.+Parkauthor=M.+Brunckoauthor=J.+Adickesauthor=J.+Bauchauthor=H.+Dingauthor=A.+Kunzerauthor=K.+C.+Marshauthor=P.+Nimmerauthor=A.+R.+Shoemakerauthor=X.+Songauthor=S.+K.+Tahirauthor=C.+Tseauthor=X.+Wangauthor=M.+D.+Wendtauthor=X.+Yangauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+of+an+orally+bioavailable+small+molecule+inhibitor+of+prosurvival+B-cell+lymphoma+2+proteins&doi=10.1021%2Fjm800669s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins</span></div><div class="casAuthors">Park, Cheol-Min; Bruncko, Milan; Adickes, Jessica; Bauch, Joy; Ding, Hong; Kunzer, Aaron; Marsh, Kennan C.; Nimmer, Paul; Shoemaker, Alexander R.; Song, Xiaohong; Tahir, Stephen K.; Tse, Christin; Wang, Xilu; Wendt, Michael D.; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6902-6915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of prosurvival proteins such as Bcl-2 and Bcl-XL has been correlated with tumorigenesis and resistance to chemotherapy, and thus, the development of antagonists of these proteins may provide a novel means for the treatment of cancer.  We recently described the discovery of 1 (ABT-737), which binds Bcl-2, Bcl-XL, and Bcl-w with high affinity, shows robust antitumor activity in murine tumor xenograft models, but is not orally bioavailable.  Herein, we report that targeted modifications at three key positions of 1 resulted in a 20-fold improvement in the pharmacokinetic/pharmacodynamic relationship (PK/PD) between oral exposure (AUC) and in vitro efficacy in human tumor cell lines (EC50).  The resulting compd., 2 (ABT-263), is orally efficacious in an established xenograft model of human small cell lung cancer, inducing complete tumor regressions in all animals.  Compd. 2 is currently in multiple phase 1 clin. trials in patients with small cell lung cancer and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF1JFNLCqAULVg90H21EOLACvtfcHk0ljQM_SB5gyXRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE&md5=83975ec5e8f642abc3507d35d00c9e14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800669s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800669s%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520prosurvival%2520B-cell%2520lymphoma%25202%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6902%26epage%3D6915%26doi%3D10.1021%2Fjm800669s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">A potent and highly efficacious Bcl-2/Bcl-xL inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3048</span>– <span class="NLM_lpage">3067</span>, <span class="refDoi"> DOI: 10.1021/jm4001105</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3048-3067&author=A.+Aguilarauthor=H.+Zhouauthor=J.+Chenauthor=L.+Liuauthor=L.+Baiauthor=D.+McEachernauthor=C.+Y.+Yangauthor=J.+Meagherauthor=J.+Stuckeyauthor=S.+Wang&title=A+potent+and+highly+efficacious+Bcl-2%2FBcl-xL+inhibitor&doi=10.1021%2Fjm4001105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Highly Efficacious Bcl-2/Bcl-xL Inhibitor</span></div><div class="casAuthors">Aguilar, Angelo; Zhou, Haibin; Chen, Jianfang; Liu, Liu; Bai, Longchuan; McEachern, Donna; Yang, Chao-Yie; Meagher, Jennifer; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3048-3067</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our previously reported Bcl-2/Bcl-xL inhibitor, 4 (IV), effectively inhibited tumor growth but failed to achieve complete regression in vivo.  We have now performed extensive modifications on its pyrrole core structure, which has culminated in the discovery of 32 (XXXII, BM-1074).  Compd. 32 binds to Bcl-2 and Bcl-xL proteins with Ki values of <1 nM and inhibits cancer cell growth with IC50 values of 1-2 nM in four small-cell lung cancer cell lines sensitive to potent and specific Bcl-2/Bcl-xL inhibitors.  Compd. 32 is capable of achieving rapid, complete, and durable tumor regression in vivo at a well-tolerated dose schedule.  Compd. 32 is the most potent and efficacious Bcl-2/Bcl-xL inhibitor reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK3lfcoeXrKrVg90H21EOLACvtfcHk0ljQM_SB5gyXRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgt7s%253D&md5=d53c2ee284a4f02d63fb225cf70c840a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm4001105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001105%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DMeagher%26aufirst%3DJ.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520highly%2520efficacious%2520Bcl-2%252FBcl-xL%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3048%26epage%3D3067%26doi%3D10.1021%2Fjm4001105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mceachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6149</span>– <span class="NLM_lpage">6161</span>, <span class="refDoi"> DOI: 10.1021/jm300608w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300608w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2nsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6149-6161&author=H.+Zhouauthor=A.+Aguilarauthor=J.+Chenauthor=L.+Baiauthor=L.+Liuauthor=J.+L.+Meagherauthor=C.-Y.+Yangauthor=D.+Mceachernauthor=X.+Congauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Structure-based+design+of+potent+Bcl-2%2FBcl-xL+inhibitors+with+strong+in+vivo+antitumor+activity&doi=10.1021%2Fjm300608w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent Bcl-2/Bcl-xL Inhibitors with Strong in Vivo Antitumor Activity</span></div><div class="casAuthors">Zhou, Haibin; Aguilar, Angelo; Chen, Jianfang; Bai, Longchuan; Liu, Liu; Meagher, Jennifer L.; Yang, Chao-Yie; McEachern, Donna; Cong, Xin; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6149-6161</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bcl-2 and Bcl-xL are key apoptosis regulators and attractive cancer therapeutic targets.  We have designed and optimized a class of small-mol. inhibitors of Bcl-2 and Bcl-xL contg. a 4,5-diphenyl-1H-pyrrole-3-carboxylic acid core structure.  A 1.4 Å resoln. crystal structure of a lead compd., 12 (I), complexed with Bcl-xL has provided a basis for our optimization.  The most potent compds., 14 and 15, bind to Bcl-2 and Bcl-xL with subnanomolar Ki values and are potent antagonists of Bcl-2 and Bcl-xL in functional assays.  Compds. 14 and 15 inhibit cell growth with low nanomolar IC50 values in multiple small-cell lung cancer cell lines and induce robust apoptosis in cancer cells at concns. as low as 10 nM.  Compd. 14 also achieves strong antitumor activity in an animal model of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiUKfevMz_HLVg90H21EOLACvtfcHk0ljQM_SB5gyXRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2nsrw%253D&md5=3583461cedaaba286dcdd972b6a4d2ee</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm300608w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300608w%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMceachern%26aufirst%3DD.%26aulast%3DCong%26aufirst%3DX.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520Bcl-2%252FBcl-xL%2520inhibitors%2520with%2520strong%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6149%26epage%3D6161%26doi%3D10.1021%2Fjm300608w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogoe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span> <span> </span><span class="NLM_article-title">Towards the next generation of dual Bcl-2/Bcl-xL inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3026</span>– <span class="NLM_lpage">3033</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.bmcl.2014.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=24881567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslKnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3026-3033&author=J.+G.+Varnesauthor=T.+Geroauthor=S.+Huangauthor=R.+B.+Dieboldauthor=C.+Ogoeauthor=P.+T.+Groverauthor=M.+Suauthor=P.+Mukherjeeauthor=J.+C.+Saehauthor=T.+MacIntyreauthor=G.+Repikauthor=K.+Dillmanauthor=K.+Bythauthor=D.+J.+Russellauthor=S.+Ioannidis&title=Towards+the+next+generation+of+dual+Bcl-2%2FBcl-xL+inhibitors&doi=10.1016%2Fj.bmcl.2014.05.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the next generation of dual Bcl-2/Bcl-xL inhibitors</span></div><div class="casAuthors">Varnes, Jeffrey G.; Gero, Thomas; Huang, Shan; Diebold, R. Bruce; Ogoe, Claude; Grover, Paul T.; Su, Mei; Mukherjee, Prasenjit; Saeh, Jamal Carlos; MacIntyre, Terry; Repik, Galina; Dillman, Keith; Byth, Kate; Russell, Daniel John; Ioannidis, Stephanos</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3026-3033</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structural modifications of the left-hand side of compd. 1 were identified which retained or improved potent binding to Bcl-2 and Bcl-xL in in vitro biochem. assays and had strong activity in an RS4;11 apoptotic cellular assay.  For example, sulfoxide diastereomer 13 maintained good binding affinity and comparable cellular potency to 1 while improving aq. soly.  The corresponding diastereomer (14) was significantly less potent in the cell, and docking studies suggest that this is due to a stereochem. preference for the RS vs. SS sulfoxide.  Appending a dimethylaminoethoxy side chain (27) adjacent to the benzylic position of the biphenyl moiety of 1 improved cellular activity by approx. three-fold, and this activity was corroborated in cell lines overexpressing Bcl-2 and Bcl-xL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUiUWy_AfaB7Vg90H21EOLACvtfcHk0liamf_vCVz5kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslKnsLo%253D&md5=d5648bae79edddff5f6181c88e605ffc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DGero%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DDiebold%26aufirst%3DR.%2BB.%26aulast%3DOgoe%26aufirst%3DC.%26aulast%3DGrover%26aufirst%3DP.%2BT.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DRepik%26aufirst%3DG.%26aulast%3DDillman%26aufirst%3DK.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DRussell%26aufirst%3DD.%2BJ.%26aulast%3DIoannidis%26aufirst%3DS.%26atitle%3DTowards%2520the%2520next%2520generation%2520of%2520dual%2520Bcl-2%252FBcl-xL%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3026%26epage%3D3033%26doi%3D10.1016%2Fj.bmcl.2014.05.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balachander, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criscione, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubinski, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWeeney, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaaks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coker, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newbold, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secrist, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, F. D.</span></span> <span> </span><span class="NLM_article-title">AZD4320, a dual inhibitor of Bcl-2 and Bcl-xL, induces tumor regression in hematological cancer models without dose-limiting thrombocytopenia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">6535</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-20-0863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1158%2F1078-0432.CCR-20-0863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=32988967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3MXotVGnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=6535&author=S.+B.+Balachanderauthor=S.+W.+Criscioneauthor=K.+F.+Bythauthor=J.+Cidadoauthor=A.+Adamauthor=T.+MacIntyreauthor=S.+Wenauthor=D.+Lawsonauthor=K.+Burkeauthor=T.+J.+Lubinskiauthor=J.+W.+Tynerauthor=S.+E.+Kurtzauthor=S.+K.+McWeeneyauthor=J.+Varnesauthor=R.+B.+Dieboldauthor=T.+W.+Geroauthor=S.+Ioannidisauthor=E.+J.+Hennessyauthor=W.+McCoullauthor=J.+C.+Saehauthor=P.+Lewisauthor=A.+Tabatabaiauthor=O.+Tavanaauthor=N.+Suauthor=A.+Schullerauthor=M.+J.+Garnettauthor=P.+Jaaksauthor=E.+A.+Cokerauthor=G.+P.+Gregoryauthor=A.+Newboldauthor=R.+W.+Johnstoneauthor=E.+Ganglauthor=M.+Wildauthor=M.+Zindaauthor=J.+P.+Secristauthor=B.+R.+Daviesauthor=S.+E.+Fawellauthor=F.+D.+Gibbons&title=AZD4320%2C+a+dual+inhibitor+of+Bcl-2+and+Bcl-xL%2C+induces+tumor+regression+in+hematological+cancer+models+without+dose-limiting+thrombocytopenia&doi=10.1158%2F1078-0432.CCR-20-0863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">AZD4320, a dual inhibitor of Bcl-2 and Bcl-xL induces tumor regression in hematologic cancer models without dose-limiting thrombocytopenia</span></div><div class="casAuthors">Balachander, Srividya B.; Criscione, Steven W.; Byth, Kate F.; Cidado, Justin; Adam, Ammar; Lewis, Paula; Macintyre, Terry; Wen, Shenghua; Lawson, Deborah; Burke, Kathleen; Lubinski, Tristan; Tyner, Jeffrey W.; Kurtz, Stephen E.; McWeeney, Shannon K.; Varnes, Jeffrey; Diebold, R. Bruce; Gero, Thomas; Ioannidis, Stephanos; Hennessy, Edward J.; McCouII, William; Saeh, Jamal C.; Tabatabai, Areya; Tavana, Omid; Su, Nancy; Schuller, Alwin; Garnett, Mathew J.; Jaaks, Patricia; Coker, Elizabeth A.; Gregory, Gareth P.; Newbold, Andrea; Johnstone, Ricky W.; Wild, Eric Gangl Martin; Zinda, Michael; Secrist, J. Paul; Davies, Barry R.; Fawell, Stephen E.; Gibbons, Francis D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6535-6549</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Targeting Bcl-2 family members upregulated in multiple cancers has emerged as an important area of cancer therapeutics.  While venetoclax, a Bd-2-selective inhibitor, has had success in the clinic, another family member, Bcl-xL, has also emerged as an important target and as a mechanism of resistance.  Therefore we developed a dual Bcl-2/Bcl-xL inhibitor that broadens the therapeutic activity while minimizing Bcl-xL-mediated thrombocytopenia.  Exptl. Design: We used structure-based chem. to design a small-mol. inhibitor of Bcl-2 and Bcl-xL and assessed the activity against in vitro cell lines, patient samples, and in vivo models.  We applied pharmacokinetic/pharmacodynamic (PK/PD) modeling to integrate our understanding of on-target activity of the dual inhibitor in tumors and platelets across dose levels and over time.  Results: We discovered AZD4320, which has nanomolar affinity for Bcl-2 and Bcl-xL, and mechanistically drives cell death through the mitochondrial apoptotic pathway.  AZD4320 demonstrates activity in both Bcl-2- and Bcl-xL-dependent hematol. cancer cell lines and enhanced activity in acute myeloid leukemia (AML) patient samples compared with the Bcl-2-selective agent venetoclax.  A single i.v. bolus dose of AZD4320 induces tumor regression with transient thrombocytopenia, which recovers in less than a week, suggesting a clin. weekly schedule would enable targeting of Bcl-2/Bcl-xL-dependent tumors without incurring dose-limiting thrombocytopenia.  AZD4320 demonstrates monotherapy activity in patient-derived AML and venetoclax-resistant xenograft models.  Conclusions: AZD4320 is a potent mol. with manageable thrombocytopenia risk to explore the utility of a dual Bcl-2/Bcl-xL inhibitor across a broad range of tumor types with dysregulation of Bcl-2 prosurvival proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5tdvs9jbok7Vg90H21EOLACvtfcHk0liamf_vCVz5kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXotVGnt74%253D&md5=901f40195f0307681862db007936afcb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-20-0863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-20-0863%26sid%3Dliteratum%253Aachs%26aulast%3DBalachander%26aufirst%3DS.%2BB.%26aulast%3DCriscione%26aufirst%3DS.%2BW.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DCidado%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DK.%26aulast%3DLubinski%26aufirst%3DT.%2BJ.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DKurtz%26aufirst%3DS.%2BE.%26aulast%3DMcWeeney%26aufirst%3DS.%2BK.%26aulast%3DVarnes%26aufirst%3DJ.%26aulast%3DDiebold%26aufirst%3DR.%2BB.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DTabatabai%26aufirst%3DA.%26aulast%3DTavana%26aufirst%3DO.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DSchuller%26aufirst%3DA.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DJaaks%26aufirst%3DP.%26aulast%3DCoker%26aufirst%3DE.%2BA.%26aulast%3DGregory%26aufirst%3DG.%2BP.%26aulast%3DNewbold%26aufirst%3DA.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DWild%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26atitle%3DAZD4320%252C%2520a%2520dual%2520inhibitor%2520of%2520Bcl-2%2520and%2520Bcl-xL%252C%2520induces%2520tumor%2520regression%2520in%2520hematological%2520cancer%2520models%2520without%2520dose-limiting%2520thrombocytopenia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2020%26spage%3D6535%26doi%3D10.1158%2F1078-0432.CCR-20-0863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulasegaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of a selective BCL-XL inhibitor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fnchembio.1246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=23603658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=390-397&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=B.+E.+Sleebsauthor=K.+Zobelauthor=K.+N.+Lowesauthor=J.+M.+Adamsauthor=J.+B.+Baellauthor=P.+M.+Colmanauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=P.+Gibbonsauthor=W.+J.+A.+Kerstenauthor=S.+Kulasegaramauthor=R.+M.+Mossauthor=J.+P.+Parisotauthor=B.+J.+Smithauthor=I.+P.+Streetauthor=H.+Yangauthor=D.+C.+S.+Huangauthor=K.+G.+Watson&title=Structure-guided+design+of+a+selective+BCL-XL+inhibitor&doi=10.1038%2Fnchembio.1246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of a selective BCL-XL inhibitor</span></div><div class="casAuthors">Lessene, Guillaume; Czabotar, Peter E.; Sleebs, Brad E.; Zobel, Kerry; Lowes, Kym N.; Adams, Jerry M.; Baell, Jonathan B.; Colman, Peter M.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Gibbons, Paul; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">390-397</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prosurvival BCL-2 family protein BCL-XL is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics.  Enhancing apoptotic responses by inhibiting BCL-XL will most likely have widespread utility in cancer treatment and, instead of inhibiting multiple prosurvival BCL-2 family members, a BCL-XL-selective inhibitor would be expected to minimize the toxicity to normal tissues.  We describe the use of a high-throughput screen to discover a new series of small mols. targeting BCL-XL and their structure-guided development by medicinal chem.  The optimized compd., WEHI-539 (7), has high affinity (subnanomolar) and selectivity for BCL-XL and potently kills cells by selectively antagonizing its prosurvival activity.  WEHI-539 will be an invaluable tool for distinguishing the roles of BCL-XL from those of its prosurvival relatives, both in normal cells and notably in malignant tumor cells, many of which may prove to rely upon BCL-XL for their sustained growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9LM-ZVEscrVg90H21EOLACvtfcHk0ljZNG-2y_YU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D&md5=c9179ea71db5b72968b0b0e9f8a03eeb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1246%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%2BA.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520selective%2520BCL-XL%2520inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D390%26epage%3D397%26doi%3D10.1038%2Fnchembio.1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.1021/ml5001867</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5001867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1088-1093&author=Z.+F.+Taoauthor=L.+Hasvoldauthor=L.+Wangauthor=X.+L.+Wangauthor=A.+M.+Petrosauthor=C.+H.+Parkauthor=E.+R.+Boghaertauthor=N.+D.+Catronauthor=J.+Chenauthor=P.+M.+Colmanauthor=P.+E.+Czabotarauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=R.+A.+Judgeauthor=M.+F.+T.+Koehlerauthor=P.+J.+Kovarauthor=G.+Lesseneauthor=M.+J.+Mittenauthor=C.+O.+Ndubakuauthor=P.+Nimmerauthor=H.+E.+Purkeyauthor=A.+Oleksijewauthor=D.+C.+Phillipsauthor=B.+E.+Sleebsauthor=B.+J.+Smithauthor=M.+L.+Smithauthor=S.+K.+Tahirauthor=K.+G.+Watsonauthor=Y.+Xiaoauthor=J.+Xueauthor=H.+C.+Zhangauthor=K.+Zobelauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=J.+D.+Leversonauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Discovery+of+a+Potent+and+Selective+BCL-XL+Inhibitor+with+in+Vivo+Activity&doi=10.1021%2Fml5001867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity</span></div><div class="casAuthors">Tao, Zhi-Fu; Hasvold, Lisa; Wang, Le; Wang, Xilu; Petros, Andrew M.; Park, Chang H.; Boghaert, Erwin R.; Catron, Nathaniel D.; Chen, Jun; Colman, Peter M.; Czabotar, Peter E.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Hymowitz, Sarah G.; Jin, Sha; Judge, Russell A.; Koehler, Michael F. T.; Kovar, Peter J.; Lessene, Guillaume; Mitten, Michael J.; Ndubaku, Chudi O.; Nimmer, Paul; Purkey, Hans E.; Oleksijew, Anatol; Phillips, Darren C.; Sleebs, Brad E.; Smith, Brian J.; Smith, Morey L.; Tahir, Stephen K.; Watson, Keith G.; Xiao, Yu; Xue, John; Zhang, Haichao; Zobel, Kerry; Rosenberg, Saul H.; Tse, Chris; Leverson, Joel D.; Elmore, Steven W.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1088-1093</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A-1155463 I, a highly potent and selective BCL-XL inhibitor, was discovered through NMR fragment screening and structure-based design.  This compd. is substantially more potent against BCL-XL-dependent cell lines relative to the recently reported inhibitor, WEHI-539, while possessing none of its inherent pharmaceutical liabilities.  A-1155463 caused a mechanism-based and reversible thrombocytopenia in mice and inhibited H146 small cell lung cancer xenograft tumor growth in vivo following multiple doses.  A-1155463 thus represents an excellent tool mol. for studying BCL-XL biol. as well as a productive lead structure for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGRbIa-4nxbVg90H21EOLACvtfcHk0ljZNG-2y_YU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN&md5=5d2fffa59286214efac3f320a701215a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fml5001867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5001867%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%2BL.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Selective%2520BCL-XL%2520Inhibitor%2520with%2520in%2520Vivo%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1088%26epage%3D1093%26doi%3D10.1021%2Fml5001867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rye, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulasegaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided rescaffolding of selective antagonists of BCL-XL</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1021/ml500030p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500030p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksF2qsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=662-667&author=M.+Koehlerauthor=P.+Bergeronauthor=E.+F.+Chooauthor=K.+Lauauthor=C.+O.+Ndubakuauthor=D.+Dudleyauthor=P.+Gibbonsauthor=B.+E.+Sleebsauthor=C.+S.+Ryeauthor=G.+Nikolakopoulosauthor=C.+Buiauthor=S.+Kulasegaramauthor=W.+J.+A.+Kerstenauthor=B.+J.+Smithauthor=P.+E.+Czabotarauthor=P.+M.+Colmanauthor=D.+C.+S.+Huangauthor=J.+B.+Baellauthor=K.+G.+Watsonauthor=L.+Hasvoldauthor=Z.-F.+Taoauthor=L.+Wangauthor=A.+J.+Souersauthor=S.+W.+Elmoreauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=G.+Lessene&title=Structure-guided+rescaffolding+of+selective+antagonists+of+BCL-XL&doi=10.1021%2Fml500030p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL</span></div><div class="casAuthors">Koehler, Michael F. T.; Bergeron, Philippe; Choo, Edna F.; Lau, Kevin; Ndubaku, Chudi; Dudley, Danette; Gibbons, Paul; Sleebs, Brad E.; Rye, Carl S.; Nikolakopoulos, George; Bui, Chinh; Kulasegaram, Sanji; Kersten, Wilhelmus J. A.; Smith, Brian J.; Czabotar, Peter E.; Colman, Peter M.; Huang, David C. S.; Baell, Jonathan B.; Watson, Keith G.; Hasvold, Lisa; Tao, Zhi-Fu; Wang, Le; Souers, Andrew J.; Elmore, Steven W.; Flygare, John A.; Fairbrother, Wayne J.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">662-667</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the promise of BCL-2 antagonists in combating chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL), interest in addnl. selective antagonists of antiapoptotic proteins has grown.  Beginning with a series of selective, potent BCL-XL antagonists contg. an undesirable hydrazone functionality, in silico design and X-ray crystallog. were utilized to develop alternative scaffolds that retained the selectivity and potency of the starting compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDw4Nd2OnGILVg90H21EOLACvtfcHk0lhqPgC2bgvnMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksF2qsLo%253D&md5=5ec41c8878d510405909a64b746b3e8f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml500030p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500030p%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DM.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DDudley%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DRye%26aufirst%3DC.%2BS.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26aulast%3DBui%26aufirst%3DC.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DStructure-guided%2520rescaffolding%2520of%2520selective%2520antagonists%2520of%2520BCL-XL%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D662%26epage%3D667%26doi%3D10.1021%2Fml500030p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">279ra240</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa4642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1126%2Fscitranslmed.aaa4642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&author=J.+D.+Leversonauthor=D.+C.+Phillipsauthor=M.+J.+Mittenauthor=E.+R.+Boghaertauthor=D.+Diazauthor=S.+K.+Tahirauthor=L.+D.+Belmontauthor=P.+Nimmerauthor=Y.+Xiaoauthor=X.+M.+Maauthor=K.+N.+Lowesauthor=P.+Kovarauthor=J.+Chenauthor=S.+Jinauthor=M.+Smithauthor=J.+Xueauthor=H.+Zhangauthor=A.+Oleksijewauthor=T.+J.+Magocauthor=K.+S.+Vaidyaauthor=D.+H.+Albertauthor=J.+M.+Tarrantauthor=N.+Laauthor=L.+Wangauthor=Z.+F.+Taoauthor=M.+D.+Wendtauthor=D.+Sampathauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=D.+C.+Huangauthor=W.+J.+Fairbrotherauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Exploiting+selective+BCL-2+family+inhibitors+to+dissect+cell+survival+dependencies+and+define+improved+strategies+for+cancer+therapy&doi=10.1126%2Fscitranslmed.aaa4642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa4642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa4642%26sid%3Dliteratum%253Aachs%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DBelmont%26aufirst%3DL.%2BD.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%2BM.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DVaidya%26aufirst%3DK.%2BS.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTarrant%26aufirst%3DJ.%2BM.%26aulast%3DLa%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DExploiting%2520selective%2520BCL-2%2520family%2520inhibitors%2520to%2520dissect%2520cell%2520survival%2520dependencies%2520and%2520define%2520improved%2520strategies%2520for%2520cancer%2520therapy%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26doi%3D10.1126%2Fscitranslmed.aaa4642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2019.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.ddtec.2019.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=31200855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BB3M3mvFWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=15-27&author=M.+Petterssonauthor=C.+M.+Crews&title=PROteolysis+TArgeting+Chimeras+%28PROTACs%29+-+Past%2C+present+and+future&doi=10.1016%2Fj.ddtec.2019.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future</span></div><div class="casAuthors">Pettersson Mariell; Crews Craig M</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today. Technologies</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The majority of currently used therapeutics are small molecule-based and utilize occupancy-driven pharmacology as the mode of action (MOA), in which the protein function is modulated via temporary inhibition.  New modalities that operate using alternative MOAs are essential for tapping into the "undruggable" proteome.  The PROteolysis Targeting Chimera (PROTAC) technology provides an attractive new approach that utilizes an event-driven MOA.  Small molecule-based heterobifunctional PROTACs modulate protein target levels by hijacking the ubiquitin-proteasome system to induce degradation of the target.  Here, we address important milestones in the development of the PROTAC technology, as well as emphasize key findings from this previous year and highlight future directions of this promising drug discovery modality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCRHissLLXoRfKb6ELK8t0fW6udTcc2eZ9G0oXG6RNiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3mvFWkuw%253D%253D&md5=c629f3128321e136f1f247e05ee6f182</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2019.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2019.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DPROteolysis%2520TArgeting%2520Chimeras%2520%2528PROTACs%2529%2520-%2520Past%252C%2520present%2520and%2520future%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2019%26volume%3D31%26spage%3D15%26epage%3D27%26doi%3D10.1016%2Fj.ddtec.2019.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogojina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hromas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopleva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1938</span>– <span class="NLM_lpage">1947</span>, <span class="refDoi"> DOI: 10.1038/s41591-019-0668-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fs41591-019-0668-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=31792461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1yjsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=1938-1947&author=S.+Khanauthor=X.+Zhangauthor=D.+Lvauthor=Q.+Zhangauthor=Y.+Heauthor=P.+Zhangauthor=X.+Liuauthor=D.+Thummuriauthor=Y.+Yuanauthor=J.+S.+Wiegandauthor=J.+Peiauthor=W.+Zhangauthor=A.+Sharmaauthor=C.+R.+McCurdyauthor=V.+M.+Kuruvillaauthor=N.+Baranauthor=A.+A.+Ferrandoauthor=Y.+M.+Kimauthor=A.+Rogojinaauthor=P.+J.+Houghtonauthor=G.+Huangauthor=R.+Hromasauthor=M.+Konoplevaauthor=G.+Zhengauthor=D.+Zhou&title=A+selective+BCL-XL+PROTAC+degrader+achieves+safe+and+potent+antitumor+activity&doi=10.1038%2Fs41591-019-0668-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity</span></div><div class="casAuthors">Khan, Sajid; Zhang, Xuan; Lv, Dongwen; Zhang, Qi; He, Yonghan; Zhang, Peiyi; Liu, Xingui; Thummuri, Dinesh; Yuan, Yaxia; Wiegand, Janet S.; Pei, Jing; Zhang, Weizhou; Sharma, Abhisheak; McCurdy, Christopher R.; Kuruvilla, Vinitha M.; Baran, Natalia; Ferrando, Adolfo A.; Kim, Yong-mi; Rogojina, Anna; Houghton, Peter J.; Huang, Guangcun; Hromas, Robert; Konopleva, Marina; Zheng, Guangrong; Zhou, Daohong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1938-1947</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">B-cell lymphoma extra large (BCL-XL) is a well-validated cancer target.  However, the on-target and dose-limiting thrombocytopenia limits the use of BCL-XL inhibitors, such as ABT263, as safe and effective anticancer agents.  To reduce the toxicity of ABT263, we converted it into DT2216, a BCL-XL proteolysis-targeting chimera (PROTAC), that targets BCL-XL to the Von Hippel-Lindau (VHL) E3 ligase for degrdn.  We found that DT2216 was more potent against various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets than ABT263 in vitro because VHL is poorly expressed in platelets.  In vivo, DT2216 effectively inhibits the growth of several xenograft tumors as a single agent or in combination with other chemotherapeutic agents, without causing appreciable thrombocytopenia.  These findings demonstrate the potential to use PROTAC technol. to reduce on-target drug toxicities and rescue the therapeutic potential of previously undruggable targets.  Furthermore, DT2216 may be developed as a safe first-in-class anticancer agent targeting BCL-XL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGposmmgxVNCRLVg90H21EOLACvtfcHk0lg2oxka6A6G-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1yjsrrO&md5=b07678c880569acac428ec479f002974</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41591-019-0668-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-019-0668-z%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DWiegand%26aufirst%3DJ.%2BS.%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DKuruvilla%26aufirst%3DV.%2BM.%26aulast%3DBaran%26aufirst%3DN.%26aulast%3DFerrando%26aufirst%3DA.%2BA.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DRogojina%26aufirst%3DA.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHromas%26aufirst%3DR.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DD.%26atitle%3DA%2520selective%2520BCL-XL%2520PROTAC%2520degrader%2520achieves%2520safe%2520and%2520potent%2520antitumor%2520activity%26jtitle%3DNat.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D1938%26epage%3D1947%26doi%3D10.1038%2Fs41591-019-0668-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budamagunta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elisseeff, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campisi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">1996</span> <span class="refDoi"> DOI: 10.1038/s41467-020-15838-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fs41467-020-15838-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=32332723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1amtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=Y.+Heauthor=X.+Zhangauthor=J.+Changauthor=H.+N.+Kimauthor=P.+Zhangauthor=Y.+Wangauthor=S.+Khanauthor=X.+Liuauthor=X.+Zhangauthor=D.+Lvauthor=L.+Songauthor=W.+Liauthor=D.+Thummuriauthor=Y.+Yuanauthor=J.+S.+Wiegandauthor=Y.+T.+Ortizauthor=V.+Budamaguntaauthor=J.+H.+Elisseeffauthor=J.+Campisiauthor=M.+Almeidaauthor=G.+Zhengauthor=D.+Zhou&title=Using+proteolysis-targeting+chimera+technology+to+reduce+navitoclax+platelet+toxicity+and+improve+its+senolytic+activity&doi=10.1038%2Fs41467-020-15838-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity</span></div><div class="casAuthors">He, Yonghan; Zhang, Xuan; Chang, Jianhui; Kim, Ha-Neui; Zhang, Peiyi; Wang, Yingying; Khan, Sajid; Liu, Xingui; Zhang, Xin; Lv, Dongwen; Song, Lin; Li, Wen; Thummuri, Dinesh; Yuan, Yaxia; Wiegand, Janet S.; Ortiz, Yuma T.; Budamagunta, Vivekananda; Elisseeff, Jennifer H.; Campisi, Judith; Almeida, Maria; Zheng, Guangrong; Zhou, Daohong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1996</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Small mols. that selectively kill senescent cells (SCs), termed senolytics, have the potential to prevent and treat various age-related diseases and extend healthspan.  The use of Bcl-xl inhibitors as senolytics is largely limited by their on-target and dose-limiting platelet toxicity.  Here, we report the use of proteolysis-targeting chimera (PROTAC) technol. to reduce the platelet toxicity of navitoclax (also known as ABT263), a Bcl-2 and Bcl-xl dual inhibitor, by converting it into PZ15227 (PZ), a Bcl-xl PROTAC, which targets Bcl-xl to the cereblon (CRBN) E3 ligase for degrdn.  Compared to ABT263, PZ is less toxic to platelets, but equally or slightly more potent against SCs because CRBN is poorly expressed in platelets.  PZ effectively clears SCs and rejuvenates tissue stem and progenitor cells in naturally aged mice without causing severe thrombocytopenia.  With further improvement, Bcl-xl PROTACs have the potential to become safer and more potent senolytic agents than Bcl-xl inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA89Bee3qtEbVg90H21EOLACvtfcHk0lg2oxka6A6G-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1amtrc%253D&md5=bb66a0a79d0180c8abbee076324ec6b3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15838-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15838-0%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BN.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DWiegand%26aufirst%3DJ.%2BS.%26aulast%3DOrtiz%26aufirst%3DY.%2BT.%26aulast%3DBudamagunta%26aufirst%3DV.%26aulast%3DElisseeff%26aufirst%3DJ.%2BH.%26aulast%3DCampisi%26aufirst%3DJ.%26aulast%3DAlmeida%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DD.%26atitle%3DUsing%2520proteolysis-targeting%2520chimera%2520technology%2520to%2520reduce%2520navitoclax%2520platelet%2520toxicity%2520and%2520improve%2520its%2520senolytic%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26doi%3D10.1038%2Fs41467-020-15838-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span> <span> </span><span class="NLM_article-title">Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">14765</span>– <span class="NLM_lpage">14768</span>, <span class="refDoi"> DOI: 10.1039/C9CC07217A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1039%2FC9CC07217A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=31754664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOltbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2019&pages=14765-14768&author=X.+Zhangauthor=D.+Thummuriauthor=Y.+Heauthor=X.+Liuauthor=P.+Zhangauthor=D.+Zhouauthor=G.+Zheng&title=Utilizing+PROTAC+technology+to+address+the+on-target+platelet+toxicity+associated+with+inhibition+of+BCL-XL&doi=10.1039%2FC9CC07217A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL</span></div><div class="casAuthors">Zhang, Xuan; Thummuri, Dinesh; He, Yonghan; Liu, Xingui; Zhang, Peiyi; Zhou, Daohong; Zheng, Guangrong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">98</span>),
    <span class="NLM_cas:pages">14765-14768</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BCL-XL, an antiapoptotic BCL-2 family protein, plays a key role in cancer cell survival.  However, the potential of BCL-XL as an anticancer target has been hampered by the on-target platelet toxicity because platelets depend on BCL-XL to maintain their viability.  Here the authors report the development of a PROTAC BCL-XL degrader, XZ424, which has increased selectivity for BCL-XL-dependent MOLT-4 cells over human platelets compared with conventional BCL-XL inhibitors.  This proof-of-concept study demonstrates the potential of utilizing a PROTAC approach to achieve tissue selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDxjYaEBmDFLVg90H21EOLACvtfcHk0lg2oxka6A6G-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOltbfL&md5=7180b9454a9eb9ae0e9e8a2255fe187e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC9CC07217A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CC07217A%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DUtilizing%2520PROTAC%2520technology%2520to%2520address%2520the%2520on-target%2520platelet%2520toxicity%2520associated%2520with%2520inhibition%2520of%2520BCL-XL%26jtitle%3DChem.%2520Commun.%26date%3D2019%26volume%3D55%26spage%3D14765%26epage%3D14768%26doi%3D10.1039%2FC9CC07217A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL inhibitor that achieves complete tumor regression with minimal platelet toxicity</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70464-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2FS0959-8049%2814%2970464-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=109-110&author=L.+Baiauthor=J.+Chenauthor=L.+Liuauthor=D.+McEachernauthor=A.+Aguilarauthor=H.+Zhouauthor=C.+Y.+Yangauthor=H.+Wangauthor=J.+Wenauthor=G.+Wangauthor=Y.+Zhaiauthor=M.+Guoauthor=D.+Yangauthor=S.+Wang&title=BM-1252+%28APG-1252%29%3A+a+potent+dual+specific+Bcl-2%2FBcl-xL+inhibitor+that+achieves+complete+tumor+regression+with+minimal+platelet+toxicity&doi=10.1016%2FS0959-8049%2814%2970464-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970464-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970464-2%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DBM-1252%2520%2528APG-1252%2529%253A%2520a%2520potent%2520dual%2520specific%2520Bcl-2%252FBcl-xL%2520inhibitor%2520that%2520achieves%2520complete%2520tumor%2520regression%2520with%2520minimal%2520platelet%2520toxicity%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D109%26epage%3D110%26doi%3D10.1016%2FS0959-8049%2814%2970464-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Cinical trial: ABBV-155 (NCT03595059).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinworth, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopacka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queisser, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benowitz, A. B.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into PROTAC-Mediated Degradation of Bcl-xL</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2316</span>– <span class="NLM_lpage">2323</span>, <span class="refDoi"> DOI: 10.1021/acschembio.0c00266</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVaqtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=2316-2323&author=C.+W.+Chungauthor=H.+Daiauthor=E.+Fernandezauthor=C.+P.+Tinworthauthor=I.+Churcherauthor=J.+Cryanauthor=J.+Denyerauthor=J.+D.+Harlingauthor=A.+Konopackaauthor=M.+A.+Queisserauthor=C.+J.+Tameauthor=G.+Wattauthor=F.+Jiangauthor=D.+Qianauthor=A.+B.+Benowitz&title=Structural+Insights+into+PROTAC-Mediated+Degradation+of+Bcl-xL&doi=10.1021%2Facschembio.0c00266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights into PROTAC-Mediated Degradation of Bcl-xL</span></div><div class="casAuthors">Chung, Chun-wa; Dai, Han; Fernandez, Esther; Tinworth, Christopher P.; Churcher, Ian; Cryan, Jenni; Denyer, Jane; Harling, John D.; Konopacka, Agnieszka; Queisser, Markus A.; Tame, Christopher J.; Watt, Gillian; Jiang, Fan; Qian, Dongming; Benowitz, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2316-2323</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bcl-2 family of proteins, such as Bcl-xL and Bcl-2, play key roles in cancer cell survival.  Structural studies of Bcl-xL formed the foundation for the development of the first Bcl-2 family inhibitors and FDA approved drugs.  Recently, Proteolysis Targeting Chimeras (PROTACs) that degrade Bcl-xL have been proposed as a therapeutic modality with the potential to enhance potency and reduce toxicity vs. antagonists.  However, no ternary complex structures of Bcl-xL with a PROTAC and an E3 ligase have been successfully detd. to guide this approach.  Herein, we report the design, characterization, and X-ray structure of a VHL E3 ligase-recruiting Bcl-xL PROTAC degrader.  The 1.9 Å heterotetrameric structure, composed of (ElonginB:ElonginC:VHL):PROTAC:Bcl-xL, reveals an extensive network of neo-interactions, between the E3 ligase and the target protein, and between noncognate parts of the PROTAC and partner proteins.  This work illustrates the challenges assocd. with the rational design of bifunctional mols. where interactions involve composite interfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDxft5W6P5dLVg90H21EOLACvtfcHk0ljemJZ-6zP60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVaqtrrI&md5=47494084f4d496adf3c8427e1fbb96f0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00266%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DFernandez%26aufirst%3DE.%26aulast%3DTinworth%26aufirst%3DC.%2BP.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DCryan%26aufirst%3DJ.%26aulast%3DDenyer%26aufirst%3DJ.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DKonopacka%26aufirst%3DA.%26aulast%3DQueisser%26aufirst%3DM.%2BA.%26aulast%3DTame%26aufirst%3DC.%2BJ.%26aulast%3DWatt%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DBenowitz%26aufirst%3DA.%2BB.%26atitle%3DStructural%2520Insights%2520into%2520PROTAC-Mediated%2520Degradation%2520of%2520Bcl-xL%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D2316%26epage%3D2323%26doi%3D10.1021%2Facschembio.0c00266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toovey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1323</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/jm401948b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401948b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Ohtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1323-1343&author=R.+M.+Bradyauthor=A.+Vomauthor=M.+J.+Royauthor=N.+Tooveyauthor=B.+J.+Smithauthor=R.+M.+Mossauthor=E.+Hatzisauthor=D.+C.+Huangauthor=J.+P.+Parisotauthor=H.+Yangauthor=I.+P.+Streetauthor=P.+M.+Colmanauthor=P.+E.+Czabotarauthor=J.+B.+Baellauthor=G.+Lessene&title=De-Novo+Designed+Library+of+Benzoylureas+as+Inhibitors+of+BCL-XL%3A+Synthesis%2C+Structural+and+Biochemical+Characterization&doi=10.1021%2Fjm401948b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization</span></div><div class="casAuthors">Brady, Ryan M.; Vom, Amelia; Roy, Michael J.; Toovey, Nathan; Smith, Brian J.; Moss, Rebecca M.; Hatzis, Effie; Huang, David C. S.; Parisot, John P.; Yang, Hong; Street, Ian P.; Colman, Peter M.; Czabotar, Peter E.; Baell, Jonathan B.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1323-1343</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prosurvival BCL-2 proteins are attractive yet challenging targets for medicinal chemists.  Their involvement in the initiation and progression of many, if not all, tumors makes them prime targets for developing new anticancer therapies.  The authors present their approach based on de novo structure-based drug design.  Using known structural information from complexes engaging opposing members of the BCL-2 family of proteins, the authors designed peptidomimetic compds. using a benzoylurea scaffold to reproduce key interactions between these proteins.  A library stemming from the initial de novo designed scaffold led to the discovery of ligands with low micromolar potency (KD = 4 μM) and selectivity for BCL-XL.  These compds. bind in the canonical BH3 binding groove in a binding mode distinct from previously known BCL-2 inhibitors.  The results of this study provide insight into the design of a new class of antagonists targeting a challenging class of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGXdS67zzfLVg90H21EOLACvtfcHk0ljemJZ-6zP60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Ohtrg%253D&md5=6fe9dfa070aae91cd20cc543df0cf260</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm401948b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401948b%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DR.%2BM.%26aulast%3DVom%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DM.%2BJ.%26aulast%3DToovey%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DHatzis%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DDe-Novo%2520Designed%2520Library%2520of%2520Benzoylureas%2520as%2520Inhibitors%2520of%2520BCL-XL%253A%2520Synthesis%252C%2520Structural%2520and%2520Biochemical%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1323%26epage%3D1343%26doi%3D10.1021%2Fjm401948b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowsky, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson-Kaufman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4318</span>– <span class="NLM_lpage">4322</span>, <span class="refDoi"> DOI: 10.1002/anie.200805761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1002%2Fanie.200805761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms12ju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4318-4322&author=E.+F.+Leeauthor=J.+D.+Sadowskyauthor=B.+J.+Smithauthor=P.+E.+Czabotarauthor=K.+J.+Peterson-Kaufmanauthor=P.+M.+Colmanauthor=S.+H.+Gellmanauthor=W.+D.+Fairlie&title=High-resolution+structural+characterization+of+a+helical+alpha%2Fbeta-peptide+foldamer+bound+to+the+anti-apoptotic+protein+Bcl-xL&doi=10.1002%2Fanie.200805761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Structural Characterization of a Helical α/β-Peptide Foldamer Bound to the Anti-Apoptotic Protein Bcl-xL</span></div><div class="casAuthors">Lee, Erinna F.; Sadowsky, Jack D.; Smith, Brian J.; Czabotar, Peter E.; Peterson-Kaufman, Kimberly J.; Colman, Peter M.; Gellman, Samuel H.; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4318-4322</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Get into the groove: The first high-resoln. structure of a foldamer bound to a protein target is described (see picture; foldamer in sticks).  The foldamer consists of α- and β-amino acid residues and is bound to the anti-apoptotic protein Bcl-xL.  The overall binding mode and key interactions obsd. in the foldamer/Bcl-xL complex mimic those seen in complexes of Bcl-xL with natural α-peptide ligands.  Addnl. contacts in the foldamer/Bcl-xL complex involving β-amino acid residues appear to contribute to binding affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR_cyd5bGyhrVg90H21EOLACvtfcHk0lh46tuyY_3qxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms12ju7c%253D&md5=58773073fa799ff4bd2c0ce4ab9df348</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805761%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DSadowsky%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DPeterson-Kaufman%26aufirst%3DK.%2BJ.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DHigh-resolution%2520structural%2520characterization%2520of%2520a%2520helical%2520alpha%252Fbeta-peptide%2520foldamer%2520bound%2520to%2520the%2520anti-apoptotic%2520protein%2520Bcl-xL%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D4318%26epage%3D4322%26doi%3D10.1002%2Fanie.200805761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulasegaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5514</span>– <span class="NLM_lpage">5540</span>, <span class="refDoi"> DOI: 10.1021/jm400556w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400556w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFWqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5514-5540&author=B.+E.+Sleebsauthor=W.+J.+Kerstenauthor=S.+Kulasegaramauthor=G.+Nikolakopoulosauthor=E.+Hatzisauthor=R.+M.+Mossauthor=J.+P.+Parisotauthor=H.+Yangauthor=P.+E.+Czabotarauthor=W.+D.+Fairlieauthor=E.+F.+Leeauthor=J.+M.+Adamsauthor=L.+Chenauthor=M.+F.+van+Delftauthor=K.+N.+Lowesauthor=A.+Weiauthor=D.+C.+Huangauthor=P.+M.+Colmanauthor=I.+P.+Streetauthor=J.+B.+Baellauthor=K.+Watsonauthor=G.+Lessene&title=Discovery+of+Potent+and+Selective+Benzothiazole+Hydrazone+Inhibitors+of+Bcl-XL&doi=10.1021%2Fjm400556w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL</span></div><div class="casAuthors">Sleebs, Brad E.; Kersten, Wilhemus J. A.; Kulasegaram, Sanji; Nikolakopoulos, George; Hatzis, Effie; Moss, Rebecca M.; Parisot, John P.; Yang, Hong; Czabotar, Peter E.; Fairlie, W. Douglas; Lee, Erinna F.; Adams, Jerry M.; Chen, Lin; van Delft, Mark F.; Lowes, Kym N.; Wei, Andrew; Huang, David C. S.; Colman, Peter M.; Street, Ian P.; Baell, Jonathan B.; Watson, Keith; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5514-5540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Developing potent mols. that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery.  The authors describe the hit-to-lead development of selective Bcl-XL inhibitors originating from a high-throughput screening campaign.  Small structural changes to the hit compd. increased binding affinity more than 300-fold (to IC50 < 20 nM).  This mol. series exhibits drug-like characteristics, low mol. wts. (Mw < 450), and unprecedented selectivity for Bcl-XL.  Surface plasmon resonance expts. afford strong evidence of binding affinity within the hydrophobic groove of Bcl-XL.  Biol. expts. using engineered Mcl-1 deficient mouse embryonic fibroblasts (MEFs, reliant only on Bcl-XL for survival) and Bax/Bak deficient MEFs (insensitive to selective activation of Bcl-2-driven apoptosis) support a mechanism-based induction of apoptosis.  This manuscript describes the first series of selective small-mol. inhibitors of Bcl-XL and provides promising leads for the development of efficacious therapeutics against solid tumors and chemoresistant cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiXxReqpND3bVg90H21EOLACvtfcHk0lh46tuyY_3qxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFWqu74%253D&md5=768bc99955848fbb39a0370806ae7551</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400556w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400556w%26sid%3Dliteratum%253Aachs%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26aulast%3DHatzis%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DWatson%26aufirst%3DK.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Selective%2520Benzothiazole%2520Hydrazone%2520Inhibitors%2520of%2520Bcl-XL%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5514%26epage%3D5540%26doi%3D10.1021%2Fjm400556w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gable, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of the two fundamental conformations of benzoylureas and elucidation of the factors that facilitate their conformational interchange</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">6511</span>– <span class="NLM_lpage">6525</span>, <span class="refDoi"> DOI: 10.1021/jo900871a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo900871a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFyisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=6511-6525&author=G.+Lesseneauthor=B.+J.+Smithauthor=R.+W.+Gableauthor=J.+B.+Baell&title=Characterization+of+the+two+fundamental+conformations+of+benzoylureas+and+elucidation+of+the+factors+that+facilitate+their+conformational+interchange&doi=10.1021%2Fjo900871a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Two Fundamental Conformations of Benzoylureas and Elucidation of the Factors That Facilitate Their Conformational Interchange</span></div><div class="casAuthors">Lessene, Guillaume; Smith, Brian J.; Gable, Robert W.; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6511-6525</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability of the benzoylurea core to mimic α helixes relies on its ability to form an intramol. hydrogen bond.  The conformational behavior of benzoylureas is investigated in depth in this study via the use of NMR, IR, X-ray, and computational anal.  The results show that the closed conformation maintained by an intramol. hydrogen bond is favored in most of the cases studied except when steric and electronic effects combined with a solvent possessing a high hydrogen bond accepting ability, such as DMSO, are involved.  The study highlights the propensity for benzoylureas to switch conformation depending on the environment of the mol. for a particular set of substituents.  We anticipate that our summary of the phenomenon of internal hydrogen bonding and its anal. may further serve as a useful ref. source for future workers in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZzc6T5M4Hi7Vg90H21EOLACvtfcHk0lh46tuyY_3qxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFyisrg%253D&md5=1411ab46480be5dd289f6ca47319b935</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo900871a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900871a%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DGable%26aufirst%3DR.%2BW.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DCharacterization%2520of%2520the%2520two%2520fundamental%2520conformations%2520of%2520benzoylureas%2520and%2520elucidation%2520of%2520the%2520factors%2520that%2520facilitate%2520their%2520conformational%2520interchange%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D6511%26epage%3D6525%26doi%3D10.1021%2Fjo900871a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of A-1331852, a First-in-Class, Potent and Orally-Bioavailable BCL-XL Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1829</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00568</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00568" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFequro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1829&author=L.+Wangauthor=G.+A.+Dohertyauthor=A.+S.+Juddauthor=Z.-F.+Taoauthor=T.+M.+Hansenauthor=R.+R.+Freyauthor=X.+Songauthor=M.+Brunckoauthor=A.+R.+Kunzerauthor=X.+Wangauthor=M.+D.+Wendtauthor=J.+A.+Flygareauthor=N.+D.+Catronauthor=R.+A.+Judgeauthor=C.+H.+Parkauthor=S.+Shekharauthor=D.+C.+Phillipsauthor=P.+Nimmerauthor=M.+L.+Smithauthor=S.+K.+Tahirauthor=Y.+Xiaoauthor=J.+Xueauthor=H.+Zhangauthor=P.+N.+Leauthor=M.+J.+Mittenauthor=E.+R.+Boghaertauthor=W.+Gaoauthor=P.+Kovarauthor=E.+F.+Chooauthor=D.+Diazauthor=W.+J.+Fairbrotherauthor=S.+W.+Elmoreauthor=D.+Sampathauthor=J.+D.+Leversonauthor=A.+J.+Souers&title=Discovery+of+A-1331852%2C+a+First-in-Class%2C+Potent+and+Orally-Bioavailable+BCL-XL+Inhibitor&doi=10.1021%2Facsmedchemlett.9b00568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor</span></div><div class="casAuthors">Wang, Le; Doherty, George A.; Judd, Andrew S.; Tao, Zhi-Fu; Hansen, T. Matthew; Frey, Robin R.; Song, Xiaohong; Bruncko, Milan; Kunzer, Aaron R.; Wang, Xilu; Wendt, Michael D.; Flygare, John A.; Catron, Nathaniel D.; Judge, Russell A.; Park, Chang H.; Shekhar, Shashank; Phillips, Darren C.; Nimmer, Paul; Smith, Morey L.; Tahir, Stephen K.; Xiao, Yu; Xue, John; Zhang, Haichao; Le, Phuong N.; Mitten, Michael J.; Boghaert, Erwin R.; Gao, Wenqing; Kovar, Peter; Choo, Edna F.; Diaz, Dolores; Fairbrother, Wayne J.; Elmore, Steven W.; Sampath, Deepak; Leverson, Joel D.; Souers, Andrew James</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1836</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the discovery of A-1331852(I), a first-in-class orally active BCL-XL inhibitor that selectively and potently induces apoptosis in BCL-XL dependent tumor cells.  This mol. was generated by re-engineering our previously reported BCL-XL inhibitor A-1155463 using structure-based drug design.  Key design elements included rigidification of the A-1155463 pharmacophore and introduction of sp3-rich moieties capable of generating highly productive interactions within the key P4 pocket of BCL-XL.  A-1331852 has since been used as a crit. tool mol. for further exploring BCL-2 family protein biol., while also representing an attractive entry into a drug discovery program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG7mIYuAWKT7Vg90H21EOLACvtfcHk0li3w-C0CRaSsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFequro%253D&md5=bd9414dfc9ef195818d0f58b4e3f0546</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00568%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DJudd%26aufirst%3DA.%2BS.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DHansen%26aufirst%3DT.%2BM.%26aulast%3DFrey%26aufirst%3DR.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DShekhar%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLe%26aufirst%3DP.%2BN.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520A-1331852%252C%2520a%2520First-in-Class%252C%2520Potent%2520and%2520Orally-Bioavailable%2520BCL-XL%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26spage%3D1829%26doi%3D10.1021%2Facsmedchemlett.9b00568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of ABT-737 complexed with Bcl-x(L): implications for selectivity of antagonists of the Bcl-2 family</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4402178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fsj.cdd.4402178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17572662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFymur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1711-1713&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=B.+J.+Smithauthor=K.+Deshayesauthor=K.+Zobelauthor=P.+M.+Colmanauthor=W.+D.+Fairlie&title=Crystal+structure+of+ABT-737+complexed+with+Bcl-x%28L%29%3A+implications+for+selectivity+of+antagonists+of+the+Bcl-2+family&doi=10.1038%2Fsj.cdd.4402178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of ABT-737 complexed with Bcl-XL: implications for selectivity of antagonists of the Bcl-2 family</span></div><div class="casAuthors">Lee, E. F.; Czabotar, P. E.; Smith, B. J.; Deshayes, K.; Zobel, K.; Colman, P. M.; Fairlie, W. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1711-1713</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A description on 2.2 Å resoln. crystal structure of ABT-737 bound to hBcl-xL (PDB entry: 2YXJ) is presented.  Based on insights from this, a satn. mutagenesis of the second and fourth hydrophobic residues (h2 and h4) in Bim BH3 was performed to understand better the target selectivity of ABT-737.  The structure of the Mcl-1:Bim BH3 complex reveals that the protein backbone fold on the side of this pocket formed by the helix c1-3 is very much different in Mcl-1 compared to Bcl-xL.  This difference leads to different landscapes for the mol. surface at p2 (and p1) in the two proteins.  Furthermore, the plasticity of the Bcl-xL p2 pocket, which appears to be important for binding both BH3 ligands and ABT-737, may well be related to the different fold of its α-3 compared to its counterpart in Mcl-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Natc3TN3qbVg90H21EOLACvtfcHk0li3w-C0CRaSsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFymur4%253D&md5=a51e264f92d4623a99dcdfa84f3b2520</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402178%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DCrystal%2520structure%2520of%2520ABT-737%2520complexed%2520with%2520Bcl-x%2528L%2529%253A%2520implications%2520for%2520selectivity%2520of%2520antagonists%2520of%2520the%2520Bcl-2%2520family%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D1711%26epage%3D1713%26doi%3D10.1038%2Fsj.cdd.4402178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. X.</span></span> <span> </span><span class="NLM_article-title">Rate Constants and Mechanisms of Protein-Ligand Binding</span>. <i>Annu. Rev. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1146/annurev-biophys-070816-033639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1146%2Fannurev-biophys-070816-033639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28375732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=105-130&author=X.+Pangauthor=H.+X.+Zhou&title=Rate+Constants+and+Mechanisms+of+Protein-Ligand+Binding&doi=10.1146%2Fannurev-biophys-070816-033639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Rate Constants and Mechanisms of Protein-Ligand Binding</span></div><div class="casAuthors">Pang, Xiaodong; Zhou, Huan-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-130</span>CODEN:
                <span class="NLM_cas:coden">ARBNCV</span>;
        ISSN:<span class="NLM_cas:issn">1936-122X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Whereas protein-ligand binding affinities have long-established prominence, binding rate consts. and binding mechanisms have gained increasing attention in recent years.  Both new computational methods and new exptl. techniques have been developed to characterize the latter properties.  It is now realized that binding mechanisms, like binding rate consts., can and should be quant. detd.  In this review, we summarize studies and synthesize ideas on several topics in the hope of providing a coherent picture of and phys. insight into binding kinetics.  The topics include microscopic formulation of the kinetic problem and its redn. to simple rate equations; computation of binding rate consts.; quant. detn. of binding mechanisms; and elucidation of phys. factors that control binding rate consts. and mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolxe5yT7M4qbVg90H21EOLACvtfcHk0lix951fjVNRHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFShsLg%253D&md5=4c5e45432a451c56994b5c14eceba5d8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biophys-070816-033639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biophys-070816-033639%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%2BX.%26atitle%3DRate%2520Constants%2520and%2520Mechanisms%2520of%2520Protein-Ligand%2520Binding%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%26date%3D2017%26volume%3D46%26spage%3D105%26epage%3D130%26doi%3D10.1146%2Fannurev-biophys-070816-033639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. X.</span></span> <span> </span><span class="NLM_article-title">Fundamental aspects of protein-protein association kinetics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">860</span>, <span class="refDoi"> DOI: 10.1021/cr800373w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr800373w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=839-860&author=G.+Schreiberauthor=G.+Haranauthor=H.+X.+Zhou&title=Fundamental+aspects+of+protein-protein+association+kinetics&doi=10.1021%2Fcr800373w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Fundamental Aspects of Protein-Protein Association Kinetics</span></div><div class="casAuthors">Schreiber, G.; Haran, G.; Zhou, H.-X.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">839-860</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review focuses on recent advances in deciphering the kinetic pathway of protein complex formation, the nature of the precomplex formed through diffusion (which the authors term the "transient complex"), the transition state and other intermediates (such as the so-called encounter complex) along the assocn. pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBsx0HWzD2W7Vg90H21EOLACvtfcHk0lix951fjVNRHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWns7w%253D&md5=fbc492ede3242af279ee42705d23fdec</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcr800373w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800373w%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DG.%26aulast%3DHaran%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DH.%2BX.%26atitle%3DFundamental%2520aspects%2520of%2520protein-protein%2520association%2520kinetics%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D839%26epage%3D860%26doi%3D10.1021%2Fcr800373w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muchmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlan, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1038/381335a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2F381335a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=8692274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADyaK28XjtFOmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=335-341&author=S.+W.+Muchmoreauthor=M.+Sattlerauthor=H.+Liangauthor=R.+P.+Meadowsauthor=J.+E.+Harlanauthor=H.+S.+Yoonauthor=D.+Nettesheimauthor=B.+S.+Changauthor=C.+B.+Thompsonauthor=S.+L.+Wongauthor=S.+L.+Ngauthor=S.+W.+Fesik&title=X-ray+and+NMR+structure+of+human+Bcl-xL%2C+an+inhibitor+of+programmed+cell+death&doi=10.1038%2F381335a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death</span></div><div class="casAuthors">Muchmore, Steven W.; Sattler, Michael; Liang, Heng; Meadows, Robert P.; Harlan, John E.; Yoon, Ho; Nettesheim, David; Chang, Brian S.; Thompson, Craig B.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6580</span>),
    <span class="NLM_cas:pages">335-341</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The Bcl-2 family of proteins regulate programmed cell death by an unknown mechanism.  Here we describe the crystal and soln. structures of a Bcl-2 family member, Bcl-xL.  The structures consist of two central, primarily hydrophobic α-helixes, which are surrounded by amphipathic helixes.  A 60-residue loop connecting helixes α1 and α2 was found to be flexible and non-essential for anti-apoptotic activity.  The three functionally important Bcl-2 homol. regions (BH1, BH2 and BH3) are in close spatial proximity and form an elongated hydrophobic cleft that may represent the binding site for other Bcl-2 family members.  The arrangement of the α-helixes in Bcl-xL is reminiscent fo the membrane translocation domain of bacterial toxins, in particular diphtheria toxin and the colicins.  The structural similarity may provide a clue to the mechanism of action of the Bcl-2 family of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9UwUI0QWye7Vg90H21EOLACvtfcHk0lix951fjVNRHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFOmtro%253D&md5=5284b54cc002b615d3c2dbbda48892cc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2F381335a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381335a0%26sid%3Dliteratum%253Aachs%26aulast%3DMuchmore%26aufirst%3DS.%2BW.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DHarlan%26aufirst%3DJ.%2BE.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DB.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DWong%26aufirst%3DS.%2BL.%26aulast%3DNg%26aufirst%3DS.%2BL.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DX-ray%2520and%2520NMR%2520structure%2520of%2520human%2520Bcl-xL%252C%2520an%2520inhibitor%2520of%2520programmed%2520cell%2520death%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D335%26epage%3D341%26doi%3D10.1038%2F381335a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardak, A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">Mutations to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">7123</span>– <span class="NLM_lpage">7131</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.161281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M110.161281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=21199865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=7123-7131&author=P.+E.+Czabotarauthor=E.+F.+Leeauthor=G.+V.+Thompsonauthor=A.+Z.+Wardakauthor=W.+D.+Fairlieauthor=P.+M.+Colman&title=Mutations+to+Bax+beyond+the+BH3+domain+disrupts+interactions+with+pro-survival+proteins+and+promotes+apoptosis&doi=10.1074%2Fjbc.M110.161281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis</span></div><div class="casAuthors">Czabotar, Peter E.; Lee, Erinna F.; Thompson, Geoff V.; Wardak, Ahmad Z.; Fairlie, W. Douglas; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7123-7131</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pro-survival members of the Bcl-2 family of proteins restrain the pro-apoptotic activity of Bax, either directly through interactions with Bax or indirectly by sequestration of activator BH3-only proteins, or both.  Mutations in Bax that promote apoptosis can provide insight into how Bax is regulated.  Here, we describe crystal structures of the pro-survival proteins Mcl-1 and Bcl-xL in complex with a 34-mer peptide from Bax that encompasses its BH3 domain.  These structures reveal canonical interactions between four signature hydrophobic amino acids from the BaxBH3 domain and the BH3-binding groove of the pro-survival proteins.  In both structures, Met-74 from the Bax peptide engages with the BH3-binding groove in a fifth hydrophobic interaction.  Various Bax Met-74 mutants disrupt interactions between Bax and all pro-survival proteins, but these Bax mutants retain pro-apoptotic activity.  Bax/Bak-deficient mouse embryonic fibroblast cells reconstituted with several Bax Met-74 mutants are more sensitive to the BH3 mimetic compd. ABT-737 as compared with cells expressing wild-type Bax.  Furthermore, the cells expressing Bax Met-74 mutants are less viable in colony assays even in the absence of an external apoptotic stimulus.  These results support a model in which direct restraint of Bax by pro-survival Bcl-2 proteins is a barrier to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHxAJk9k5T7bVg90H21EOLACvtfcHk0ljjqhkmoICmHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyqsrs%253D&md5=f90a9cb154329e8f163a412d9bb0c4bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161281%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DThompson%26aufirst%3DG.%2BV.%26aulast%3DWardak%26aufirst%3DA.%2BZ.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DMutations%2520to%2520Bax%2520beyond%2520the%2520BH3%2520domain%2520disrupts%2520interactions%2520with%2520pro-survival%2520proteins%2520and%2520promotes%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D7123%26epage%3D7131%26doi%3D10.1074%2Fjbc.M110.161281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boersma, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowsky, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1110/ps.032896.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1110%2Fps.032896.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18467496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1ehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1232-1240&author=M.+D.+Boersmaauthor=J.+D.+Sadowskyauthor=Y.+A.+Tomitaauthor=S.+H.+Gellman&title=Hydrophile+scanning+as+a+complement+to+alanine+scanning+for+exploring+and+manipulating+protein-protein+recognition%3A+application+to+the+Bim+BH3+domain&doi=10.1110%2Fps.032896.107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain</span></div><div class="casAuthors">Boersma, Melissa D.; Sadowsky, Jack D.; Tomita, York A.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1232-1240</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Alanine scanning has been widely employed as a method of identifying side chains that play important roles in protein-protein and protein-peptide interactions.  Here the authors show how an analogous and complementary technique, hydrophile scanning, can provide addnl. insight on such interactions.  Mutation of a wild-type residue to alanine removes most of the side-chain atoms, and the effect of this removal is typically interpreted to indicate contribution of the deleted side chain to the stability of the complex.  Hydrophile scanning involves systematic mutation of wild-type residues to a cationic or anionic residue (lysine or glutamic acid, in this case).  The authors find that the results of these mutations provide insights on interactions between polypeptide surfaces that are complementary to the information obtained via alanine scanning.  The authors have applied this technique to a peptide that corresponds to the BH3 domain of the pro-apoptotic protein Bim.  The wild-type Bim BH3 domain binds strongly to the anti-apoptotic proteins Bcl-xL and Mcl-1.  Combining information from the alanine, lysine, and glutamic acid scans has enabled the authors to identify Bim BH3 domain mutants contg. only two or three sequence changes that bind very selectively either to Bcl-xL or Mcl-1.  The authors' findings suggest that hydrophile scanning may prove to be a broadly useful tool for revealing sources of protein-protein recognition and for engineering selectivity into natural sequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNNvHzBPVk-bVg90H21EOLACvtfcHk0ljjqhkmoICmHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1ehs7c%253D&md5=620a6bd7c1e3107c3746d16b4345f9b0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1110%2Fps.032896.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.032896.107%26sid%3Dliteratum%253Aachs%26aulast%3DBoersma%26aufirst%3DM.%2BD.%26aulast%3DSadowsky%26aufirst%3DJ.%2BD.%26aulast%3DTomita%26aufirst%3DY.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DHydrophile%2520scanning%2520as%2520a%2520complement%2520to%2520alanine%2520scanning%2520for%2520exploring%2520and%2520manipulating%2520protein-protein%2520recognition%253A%2520application%2520to%2520the%2520Bim%2520BH3%2520domain%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D1232%26epage%3D1240%26doi%3D10.1110%2Fps.032896.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martineau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClellan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1021/jm061152t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061152t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=641-662&author=M.+Brunckoauthor=T.+K.+Oostauthor=B.+A.+Belliauthor=H.+Dingauthor=M.+K.+Josephauthor=A.+Kunzerauthor=D.+Martineauauthor=W.+J.+McClellanauthor=M.+Mittenauthor=S.+C.+Ngauthor=P.+M.+Nimmerauthor=T.+Oltersdorfauthor=C.+M.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Shoemakerauthor=X.+Songauthor=X.+Wangauthor=M.+D.+Wendtauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Studies+leading+to+potent%2C+dual+inhibitors+of+Bcl-2+and+Bcl-xL&doi=10.1021%2Fjm061152t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL</span></div><div class="casAuthors">Bruncko, Milan; Oost, Thorsten K.; Belli, Barbara A.; Ding, Hong; Joseph, Mary K.; Kunzer, Aaron; Martineau, Darlene; McClellan, William J.; Mitten, Michael; Ng, Shi-Chung; Nimmer, Paul M.; Oltersdorf, Tilman; Park, Cheol-Min; Petros, Andrew M.; Shoemaker, Alexander R.; Song, Xiaohong; Wang, Xilu; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-662</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of the antiapoptotic proteins Bcl-2 and Bcl-xL provides a common mechanism through which cancer cells gain a survival advantage and become resistant to conventional chemotherapy.  Inhibition of these prosurvival proteins is an attractive strategy for cancer therapy.  We recently described the discovery of a selective Bcl-xL antagonist that potentiates the antitumor activity of chemotherapy and radiation.  Here we describe the use of structure-guided design to exploit a deep hydrophobic binding pocket on the surface of these proteins to develop the first dual, subnanomolar inhibitors of Bcl-xL and Bcl-2.  This study culminated in the identification of 2 (I), which exhibited EC50 values of 8 nM and 30 nM in Bcl-2 and Bcl-xL dependent cells, resp.  Compd. 2 demonstrated single agent efficacy against human follicular lymphoma cell lines that overexpress Bcl-2, and efficacy in a murine xenograft model of lymphoma when given both as a single agent and in combination with etoposide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2G6VoJIheLVg90H21EOLACvtfcHk0ljjqhkmoICmHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D&md5=e7bf502c69c4247c39ce7e070984b3a6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm061152t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061152t%26sid%3Dliteratum%253Aachs%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DMitten%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DStudies%2520leading%2520to%2520potent%252C%2520dual%2520inhibitors%2520of%2520Bcl-2%2520and%2520Bcl-xL%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D641%26epage%3D662%26doi%3D10.1021%2Fjm061152t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">The Molecular Origin of Enthalpy/Entropy Compensation in Biomolecular Recognition</span>. <i>Annu. Rev. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1146/annurev-biophys-070816-033743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1146%2Fannurev-biophys-070816-033743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=29505727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVyis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=223-250&author=J.+M.+Foxauthor=M.+Zhaoauthor=M.+J.+Finkauthor=K.+Kangauthor=G.+M.+Whitesides&title=The+Molecular+Origin+of+Enthalpy%2FEntropy+Compensation+in+Biomolecular+Recognition&doi=10.1146%2Fannurev-biophys-070816-033743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Origin of Enthalpy/Entropy Compensation in Biomolecular Recognition</span></div><div class="casAuthors">Fox, Jerome M.; Zhao, Mengxia; Fink, Michael J.; Kang, Kyungtae; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">223-250</span>CODEN:
                <span class="NLM_cas:coden">ARBNCV</span>;
        ISSN:<span class="NLM_cas:issn">1936-122X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Biomol. recognition can be stubborn; changes in the structures of assocg. mols., or the environments in which they assoc., often yield compensating changes in enthalpies and entropies of binding and no net change in affinities.  This phenomenon-termed enthalpy/entropy (H/S) compensation-hinders efforts in biomol. design, and its incidence-often a surprise to experimentalists-makes interactions between biomols. difficult to predict.  Although characterizing H/S compensation requires exptl. care, it is unquestionably a real phenomenon that has, from an engineering perspective, useful phys. origins.  Studying H/S compensation can help illuminate the still-murky roles of water and dynamics in biomol. recognition and self-assembly.  This review summarizes known sources of H/S compensation (real and perceived) and lays out a conceptual framework for understanding and dissecting-and, perhaps, avoiding or exploiting-this phenomenon in biophys. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIy5VOmn0lBLVg90H21EOLACvtfcHk0lgNY6w2TL2bYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVyis7c%253D&md5=ab4fe78c91e6c37f14fa969b9b4ef602</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biophys-070816-033743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biophys-070816-033743%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DJ.%2BM.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DFink%26aufirst%3DM.%2BJ.%26aulast%3DKang%26aufirst%3DK.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DThe%2520Molecular%2520Origin%2520of%2520Enthalpy%252FEntropy%2520Compensation%2520in%2520Biomolecular%2520Recognition%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%26date%3D2018%26volume%3D47%26spage%3D223%26epage%3D250%26doi%3D10.1146%2Fannurev-biophys-070816-033743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bissantz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5061</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0lgNY6w2TL2bYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span> <span> </span><span class="NLM_article-title">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.molcel.2004.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15694340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=393-403&author=L.+Chenauthor=S.+N.+Willisauthor=A.+Weiauthor=B.+J.+Smithauthor=J.+I.+Fletcherauthor=M.+G.+Hindsauthor=P.+M.+Colmanauthor=C.+L.+Dayauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Differential+targeting+of+prosurvival+Bcl-2+proteins+by+their+BH3-only+ligands+allows+complementary+apoptotic+function&doi=10.1016%2Fj.molcel.2004.12.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span></div><div class="casAuthors">Chen, Lin; Willis, Simon N.; Wei, Andrew; Smith, Brian J.; Fletcher, Jamie I.; Hinds, Mark G.; Colman, Peter M.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis is initiated when Bcl-2 and its prosurvival relatives are engaged by proapoptotic BH3-only proteins via interaction of its BH3 domain with a groove on the Bcl-2-like proteins.  These interactions have been considered promiscuous, but our anal. of the affinity of eight BH3 peptides for five Bcl-2-like proteins has revealed that the interactions vary over 10,000-fold in affinity, and accordingly, only certain protein pairs assoc. inside cells.  Bim and Puma potently engaged all the prosurvival proteins comparably.  Bad, however, bound tightly to Bcl-2, Bcl-xL, and Bcl-w but only weakly to A1 and not to Mcl-1.  Strikingly, Noxa bound only Mcl-1 and A1.  In accord with their complementary binding, Bad and Noxa cooperated to induce potent killing.  The results suggest that apoptosis relies on selective interactions between particular subsets of these proteins and that it should be feasible to discover BH3-mimetic drugs that inactivate specific prosurvival targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHzR4DFj95LbVg90H21EOLACvtfcHk0lgNY6w2TL2bYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D&md5=702d041ad86552b3581fed5198a96d7b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DDifferential%2520targeting%2520of%2520prosurvival%2520Bcl-2%2520proteins%2520by%2520their%2520BH3-only%2520ligands%2520allows%2520complementary%2520apoptotic%2520function%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D17%26spage%3D393%26epage%3D403%26doi%3D10.1016%2Fj.molcel.2004.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span> <span> </span><span class="NLM_article-title">Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1294</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1101/gad.1304105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1101%2Fgad.1304105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15901672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1ymsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1294-1305&author=S.+N.+Willisauthor=L.+Chenauthor=G.+Dewsonauthor=A.+Weiauthor=E.+Naikauthor=J.+I.+Fletcherauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Proapoptotic+Bak+is+sequestered+by+Mcl-1+and+Bcl-xL%2C+but+not+Bcl-2%2C+until+displaced+by+BH3-only+proteins&doi=10.1101%2Fgad.1304105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins</span></div><div class="casAuthors">Willis, Simon N.; Chen, Lin; Dewson, Grant; Wei, Andrew; Naik, Edwina; Fletcher, Jamie I.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1294-1305</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Commitment of cells to apoptosis is governed largely by the interaction between members of the Bcl-2 protein family.  Its three subfamilies have distinct roles: The BH3-only proteins trigger apoptosis by binding via their BH3 domain to prosurvival relatives, while the proapoptotic Bax and Bak have an essential downstream role involving permeabilization of organellar membranes and induction of caspase activation.  The authors have investigated the regulation of Bak and find that, in healthy cells, Bak assocs. with Mcl-1 and Bcl-xL but surprisingly not Bcl-2, Bcl-w, or A1.  These interactions require the Bak BH3 domain, which is also necessary for Bak dimerization and killing activity.  When cytotoxic signals activate BH3-only proteins that can engage both Mcl-1 and Bcl-xL (such as Noxa plus Bad), Bak is displaced and induces cell death.  Accordingly, the BH3-only protein Noxa could bind to Mcl-1, displace Bak, and promote Mcl-1 degrdn., but Bak-mediated cell death also required neutralization of Bcl-xL by other BH3-only proteins.  The results indicate that Bak is held in check solely by Mcl-1 and Bcl-xL and induces apoptosis only if freed from both.  The finding that different prosurvival proteins have selective roles has notable implications for the design of anti-cancer drugs that target the Bcl-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQ9-pKH_odbVg90H21EOLACvtfcHk0lgNY6w2TL2bYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1ymsr4%253D&md5=2970c2ff81489e4bb04b9f1f9a0c1d8c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1101%2Fgad.1304105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1304105%26sid%3Dliteratum%253Aachs%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDewson%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DProapoptotic%2520Bak%2520is%2520sequestered%2520by%2520Mcl-1%2520and%2520Bcl-xL%252C%2520but%2520not%2520Bcl-2%252C%2520until%2520displaced%2520by%2520BH3-only%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D2005%26volume%3D19%26spage%3D1294%26epage%3D1305%26doi%3D10.1101%2Fgad.1304105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue-Yamauchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jebiwott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietanza, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kris, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">16078</span> <span class="refDoi"> DOI: 10.1038/ncomms16078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fncomms16078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=28714472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=A.+Inoue-Yamauchiauthor=P.+S.+Jengauthor=K.+Kimauthor=H.+C.+Chenauthor=S.+Hanauthor=Y.+T.+Ganesanauthor=K.+Ishizawaauthor=S.+Jebiwottauthor=Y.+Dongauthor=M.+C.+Pietanzaauthor=M.+D.+Hellmannauthor=M.+G.+Krisauthor=J.+J.+Hsiehauthor=E.+H.+Cheng&title=Targeting+the+differential+addiction+to+anti-apoptotic+BCL-2+family+for+cancer+therapy&doi=10.1038%2Fncomms16078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the differential addiction to anti-apoptotic bcl-2 family for cancer therapy</span></div><div class="casAuthors">Inoue-Yamauchi, Akane; Jeng, Paul S.; Kim, Kwanghee; Chen, Hui-Chen; Han, Song; Ganesan, Yogesh Tengarai; Ishizawa, Kota; Jebiwott, Sylvia; Dong, Yiyu; Pietanza, Maria C.; Hellmann, Matthew D.; Kris, Mark G.; Hsieh, James J.; Cheng, Emily H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16078</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">BCL-2 family proteins are central regulators of mitochondrial apoptosis and validated anti-cancer targets.  Using small cell lung cancer (SCLC) as a model, we demonstrated the presence of differential addiction of cancer cells to anti-apoptotic BCL-2, BCL-XL or MCL-1, which correlated with the resp. protein expression ratio.  ABT-263 (navitoclax), a BCL-2/BCL-XL inhibitor, prevented BCL-XL from sequestering activator BH3-only mols. (BH3s) and BAX but not BAK.  Consequently, ABT-263 failed to kill BCL-XL-addicted cells with low activator BH3s and BCL-XL overabundance conferred resistance to ABT-263.  High-throughput screening identified anthracyclines including doxorubicin and CDK9 inhibitors including dinaciclib that synergized with ABT-263 through downregulation of MCL-1.  As doxorubicin and dinaciclib also reduced BCL-XL, the combinations of BCL-2 inhibitor ABT-199 (venetoclax) with doxorubicin or dinaciclib provided effective therapeutic strategies for SCLC.  Altogether, our study highlights the need for mechanism-guided targeting of anti-apoptotic BCL-2 proteins to effectively activate the mitochondrial cell death program to kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSK9zWKD-3jrVg90H21EOLACvtfcHk0ljjQpxaoPfyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrjJ&md5=dcc3892b577fb9fea70039619183017d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms16078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms16078%26sid%3Dliteratum%253Aachs%26aulast%3DInoue-Yamauchi%26aufirst%3DA.%26aulast%3DJeng%26aufirst%3DP.%2BS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%2BC.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGanesan%26aufirst%3DY.%2BT.%26aulast%3DIshizawa%26aufirst%3DK.%26aulast%3DJebiwott%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DPietanza%26aufirst%3DM.%2BC.%26aulast%3DHellmann%26aufirst%3DM.%2BD.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DHsieh%26aufirst%3DJ.%2BJ.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26atitle%3DTargeting%2520the%2520differential%2520addiction%2520to%2520anti-apoptotic%2520BCL-2%2520family%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fncomms16078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClellan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martineau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1181</span>, <span class="refDoi"> DOI: 10.1021/jm050754u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050754u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1165-1181&author=M.+D.+Wendtauthor=W.+Shenauthor=A.+Kunzerauthor=W.+J.+McClellanauthor=M.+Brunckoauthor=T.+K.+Oostauthor=H.+Dingauthor=M.+K.+Josephauthor=H.+Zhangauthor=P.+M.+Nimmerauthor=S.+C.+Ngauthor=A.+R.+Shoemakerauthor=A.+M.+Petrosauthor=A.+Oleksijewauthor=K.+Marshauthor=J.+Bauchauthor=T.+Oltersdorfauthor=B.+A.+Belliauthor=D.+Martineauauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+and+structure-activity+relationship+of+antagonists+of+B-cell+lymphoma+2+family+proteins+with+chemopotentiation+activity+in+vitro+and+in+vivo&doi=10.1021%2Fjm050754u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo</span></div><div class="casAuthors">Wendt, Michael D.; Shen, Wang; Kunzer, Aaron; McClellan, William J.; Bruncko, Milan; Oost, Thorsten K.; Ding, Hong; Joseph, Mary K.; Zhang, Haichao; Nimmer, Paul M.; Ng, Shi-Chung; Shoemaker, Alexander R.; Petros, Andrew M.; Oleksijew, Anatol; Marsh, Kennan; Bauch, Joy; Oltersdorf, Tilman; Belli, Barbara A.; Martineau, Darlene; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1165-1181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of a rationally designed potentiator of cancer chemotherapy, via inhibition of Bcl-XL function, is described.  Lead compds. generated by NMR screening and directed parallel synthesis displayed sub-μM binding but were strongly deactivated in the presence of serum.  The dominant component of serum deactivation was identified as domain III of human serum albumin (HSA); NMR soln. structures of inhibitors bound to both Bcl-XL and HSA domain III indicated two potential optimization sites for sepn. of affinities.  Modifications at both sites resulted in compds. with improved Bcl-XL binding and greatly increased activity in the presence of human serum, culminating in 73R, which bound to Bcl-XL with a Ki of 0.8 nM.  In a cellular assay 73R reversed the protection afforded by Bcl-XL overexpression against cytokine deprivation in FL5.12 cells with an EC50 of 0.47 μM.  73R showed little effect on the viability of the human non small cell lung cancer cell line A549.  However, consistent with the proposed mechanism, 73R potentiated the activity of paclitaxel and UV irradn. in vitro and potentiated the antitumor efficacy of paclitaxel in a mouse xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcJMZIao1pbVg90H21EOLACvtfcHk0ljjQpxaoPfyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D&md5=a0311af587e06f1adf0f87d356137435</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm050754u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050754u%26sid%3Dliteratum%253Aachs%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520of%2520antagonists%2520of%2520B-cell%2520lymphoma%25202%2520family%2520proteins%2520with%2520chemopotentiation%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1165%26epage%3D1181%26doi%3D10.1021%2Fjm050754u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of conformationally constrained benzoylureas as BH3-mimetics</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5230</span>– <span class="NLM_lpage">5237</span>, <span class="refDoi"> DOI: 10.1039/c2ob25618e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1039%2Fc2ob25618e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=22648632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFWnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=5230-5237&author=R.+M.+Bradyauthor=E.+Hatzisauthor=T.+Connorauthor=I.+P.+Streetauthor=J.+B.+Baellauthor=G.+Lessene&title=Synthesis+of+conformationally+constrained+benzoylureas+as+BH3-mimetics&doi=10.1039%2Fc2ob25618e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of conformationally constrained benzoylureas as BH3-mimetics</span></div><div class="casAuthors">Brady, Ryan M.; Hatzis, Effie; Connor, Theresa; Street, Ian P.; Baell, Jonathan B.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">5230-5237</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The design of small mols. that mimic the BH3 domain and bind to Bcl-2 proteins has emerged as a promising approach to discovering novel anti-cancer therapeutics.  We reveal the design and synthesis of conformationally constrained benzoylurea scaffolds as conformational probes.  Central to helix mimicry, the intramol. hydrogen bond in the benzoylurea plays a key role in the pre-organization of the acyclic substrates for cyclization via ring closing metathesis, providing efficient access to the constrained mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWg4tXEh8N4rVg90H21EOLACvtfcHk0lh0QOU-DKOnuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFWnsLk%253D&md5=dd8cdf6992a76755d6272f61559752b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25618e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25618e%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DR.%2BM.%26aulast%3DHatzis%26aufirst%3DE.%26aulast%3DConnor%26aufirst%3DT.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520conformationally%2520constrained%2520benzoylureas%2520as%2520BH3-mimetics%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D5230%26epage%3D5237%26doi%3D10.1039%2Fc2ob25618e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Gioia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barattucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaccorsi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leggio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minuti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temperini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, C.</span></span> <span> </span><span class="NLM_article-title">Deprotection/reprotection of the amino group in α-amino acids and peptides. A one-pot procedure in [Bmim][BF4] ionic liquid</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2686</span>, <span class="refDoi"> DOI: 10.1039/C3RA46599C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1039%2FC3RA46599C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=2678-2686&author=M.+L.+Di%0AGioiaauthor=A.+Barattucciauthor=P.+Bonaccorsiauthor=A.+Leggioauthor=L.+Minutiauthor=E.+Romioauthor=A.+Temperiniauthor=C.+Siciliano&title=Deprotection%2Freprotection+of+the+amino+group+in+%CE%B1-amino+acids+and+peptides.+A+one-pot+procedure+in+%5BBmim%5D%5BBF4%5D+ionic+liquid&doi=10.1039%2FC3RA46599C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Deprotection/reprotection of the amino group in α-amino acids and peptides. A one-pot procedure in [Bmim][BF4] ionic liquid</span></div><div class="casAuthors">Di Gioia, M. L.; Barattucci, A.; Bonaccorsi, P.; Leggio, A.; Minuti, L.; Romio, E.; Temperini, A.; Siciliano, C.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2686</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This paper presents an efficient one-pot protocol for the sequential deprotection/reprotection of an α-amino group in an α-amino acid and dipeptide Me esters.  [Bmim][BF4] is used as the solvent in the entire process.  In particular, the use of the ionic liq. allows for rapid and clean removal of the 4-nitrobenzenesulfonyl (nosyl) group and for facile subsequent tert-butyloxycarbonylation of the free α-amino function under very mild conditions.  N-BOC-α-amino acid as well as peptide derivs. are isolated in excellent yields, and do not require any further purifn.  Abs. configurations of the precursors are totally preserved during the process.  The synthesis of the target compds. was achieved using N-nosyl-group-protected amino acids as starting materials, such as N-[(4-nitrophenyl)sulfonyl]-L-valine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-phenylalanine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-leucine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-isoleucine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-alanine Me ester, N-[(4-nitrophenyl)sulfonyl]-D-phenylalanine Me ester, N-[(4-nitrophenyl)sulfonyl]-O-(phenylmethyl)-L-tyrosine Me ester, N-[(4-nitrophenyl)sulfonyl]-S-(phenylmethyl)-L-cysteine Me ester.  The studied compds. included dipeptides, N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl-L-alanine Me ester, N-[(1,1-dimethylethoxy)carbonyl]-D-phenylalanyl-L-alanine Me ester, N-[(4-nitrophenyl)sulfonyl]-L-leucyl-L-alanine Me ester, N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl-L-alanine Me ester.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvHlJdAGLSsrVg90H21EOLACvtfcHk0lh0QOU-DKOnuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtLnI&md5=af18c07b0f32c5239adbd611e20aba67</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1039%2FC3RA46599C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3RA46599C%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGioia%26aufirst%3DM.%2BL.%26aulast%3DBarattucci%26aufirst%3DA.%26aulast%3DBonaccorsi%26aufirst%3DP.%26aulast%3DLeggio%26aufirst%3DA.%26aulast%3DMinuti%26aufirst%3DL.%26aulast%3DRomio%26aufirst%3DE.%26aulast%3DTemperini%26aufirst%3DA.%26aulast%3DSiciliano%26aufirst%3DC.%26atitle%3DDeprotection%252Freprotection%2520of%2520the%2520amino%2520group%2520in%2520%25CE%25B1-amino%2520acids%2520and%2520peptides.%2520A%2520one-pot%2520procedure%2520in%2520%255BBmim%255D%255BBF4%255D%2520ionic%2520liquid%26jtitle%3DRSC%2520Adv.%26date%3D2014%26volume%3D4%26spage%3D2678%26epage%3D2686%26doi%3D10.1039%2FC3RA46599C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.ejmech.2012.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=22841280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12mtLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=176-187&author=Y.+Jiaauthor=X.+Dongauthor=P.+Zhouauthor=X.+Liuauthor=L.+Panauthor=H.+Xinauthor=Y.+Z.+Zhuauthor=Y.+Wang&title=The+synthesis+and+biological+evaluation+of+novel+Danshensu-cysteine+analog+conjugates+as+cardiovascular-protective+agents&doi=10.1016%2Fj.ejmech.2012.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents</span></div><div class="casAuthors">Jia, Yaoling; Dong, Xiaoyi; Zhou, Pengfei; Liu, Xinhua; Pan, Lilong; Xin, Hong; Zhu, Yi Zhun; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">176-187</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel amide and thioester conjugates between danshensu and cysteine derivs. have been designed and synthesized based on the strategy of "medicinal chem. hybridization".  Pharmacol. evaluation indicated that seven amide conjugates and thioester conjugates exhibited obvious protective effects on H2O2-induced human umbilical vein endothelial cells (HUVECs).  Pretreated with these conjugates could increase glutathione (GSH) activity and decrease malondialdehyde (MDA) level.  Further study on mechanism of compd. I revealed that it was related to its mitochondrial-protective effect and regulation of apoptosis-related proteins expression (Bax, p53, PARP, caspase-3, caspase-9 and Bcl-2).  These results indicate that these danshensu-cysteine analog conjugates possess significant cardiovascular-protective effects and merit further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrseq17I3umsLVg90H21EOLACvtfcHk0lh0QOU-DKOnuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12mtLvP&md5=cac2dc3c7b0a2ae287e0eb43626ea260</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%2BZ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520Danshensu-cysteine%2520analog%2520conjugates%2520as%2520cardiovascular-protective%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D176%26epage%3D187%26doi%3D10.1016%2Fj.ejmech.2012.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Expeditious Synthesis of Phenanthrenes via CuBr2-Catalyzed Coupling of Terminal Alkynes and N-Tosylhydrazones Derived from O-Formyl Biphenyls</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5020</span>– <span class="NLM_lpage">5023</span>, <span class="refDoi"> DOI: 10.1021/ol201788v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol201788v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2itrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=5020-5023&author=F.+Yeauthor=Y.+Shiauthor=L.+Zhouauthor=Q.+Xiaoauthor=Y.+Zhangauthor=J.+Wang&title=Expeditious+Synthesis+of+Phenanthrenes+via+CuBr2-Catalyzed+Coupling+of+Terminal+Alkynes+and+N-Tosylhydrazones+Derived+from+O-Formyl+Biphenyls&doi=10.1021%2Fol201788v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Expeditious synthesis of phenanthrenes via CuBr2-catalyzed coupling of terminal alkynes and N-tosylhydrazones derived from O-formyl biphenyls</span></div><div class="casAuthors">Ye, Fei; Shi, Yi; Zhou, Lei; Xiao, Qing; Zhang, Yan; Wang, Jianbo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5020-5023</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new method for the synthesis of phenanthrenes e. g., I, II via ligand-free CuBr2-catalyzed coupling/cyclization of terminal alkynes with N-tosylhydrazones derived from o-formyl biphenyls has been developed.  This new synthesis has wide range of functional group compatibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_eZmLgaxkXLVg90H21EOLACvtfcHk0lh0QOU-DKOnuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2itrrL&md5=eafc2bffd1e78fdede08dde696686707</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fol201788v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol201788v%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DExpeditious%2520Synthesis%2520of%2520Phenanthrenes%2520via%2520CuBr2-Catalyzed%2520Coupling%2520of%2520Terminal%2520Alkynes%2520and%2520N-Tosylhydrazones%2520Derived%2520from%2520O-Formyl%2520Biphenyls%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D5020%26epage%3D5023%26doi%3D10.1021%2Fol201788v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsube, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity study of L-amino acid-based N-type calcium channel blockers</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1901</span>– <span class="NLM_lpage">1913</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00558-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2FS0968-0896%2802%2900558-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12659776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlGjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1901-1913&author=T.+Sekoauthor=M.+Katoauthor=H.+Kohnoauthor=S.+Onoauthor=K.+Hashimuraauthor=H.+Takimizuauthor=K.+Nakaiauthor=H.+Maegawaauthor=N.+Katsubeauthor=M.+Toda&title=Structure-activity+study+of+L-amino+acid-based+N-type+calcium+channel+blockers&doi=10.1016%2FS0968-0896%2802%2900558-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity study of L-amino acid-based N-type calcium channel blockers</span></div><div class="casAuthors">Seko, Takuya; Kato, Masashi; Kohno, Hiroshi; Ono, Shizuka; Hashimura, Kazuya; Takimizu, Hideyuki; Nakai, Katsuhiko; Maegawa, Hitoshi; Katsube, Nobuo; Toda, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1901-1913</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Synthesis and structure-activity relationship (SAR) study of L-amino acid-based N-type calcium channel blockers are described.  The compds. synthesized were evaluated for inhibitory activity against both N-type and L-type calcium channels focusing on selectivity to reduce cardiovascular side effects due to blocking of L-type calcium channels.  In the course of screening of our compd. library, N-(t-butoxycarbonyl)-L-aspartic acid deriv. was identified as an initial lead compd. for a new series of N-type calcium channel blockers, which inhibited calcium influx into IMR-32 human neuroblastoma cells with an IC50 of 3.4 μM.  N-(t-butoxycarbonyl)-L-aspartic acid deriv. also exhibited blockade of N-type calcium channel current in electrophysiol. expt. using IMR-32 cells (34% inhibition at 10 μM, n=3).  As a consequence of conversion of amino acid residue of N-(t-butoxycarbonyl)-L-aspartic acid deriv., another aspartic acid deriv., that include N-(t-butoxycarbonyl)-L-cysteine, was found to be a potent N-type calcium channel blocker with an IC50 of 0.61 μM.  Thus, L-cysteine was selected as a potential structural motif for further modification.  Optimization of C- and N-terminals of L-cysteine using S-cyclohexylmethyl-L-cysteine as a central scaffold led to another potent and selective N-type calcium channel blocker, which showed improved inhibitory potency (IC50 0.12 μM) and 12-fold selectivity for N-type calcium channels over L-type channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3sTX4iULeQrVg90H21EOLACvtfcHk0lhJ0qB2hUKVHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlGjsr0%253D&md5=d6ffd0d87c91636409a6312d1757fc63</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900558-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900558-8%26sid%3Dliteratum%253Aachs%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKohno%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DHashimura%26aufirst%3DK.%26aulast%3DTakimizu%26aufirst%3DH.%26aulast%3DNakai%26aufirst%3DK.%26aulast%3DMaegawa%26aufirst%3DH.%26aulast%3DKatsube%26aufirst%3DN.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DStructure-activity%2520study%2520of%2520L-amino%2520acid-based%2520N-type%2520calcium%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1901%26epage%3D1913%26doi%3D10.1016%2FS0968-0896%2802%2900558-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idomoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakiuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, K.</span></span> <span> </span><span class="NLM_article-title">Rigid Molecular Tripod with an Adamantane Framework and Thiol Legs. Synthesis and Observation of an Ordered Monolayer on Au(111)</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1362</span>– <span class="NLM_lpage">1369</span>, <span class="refDoi"> DOI: 10.1021/jo051863j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo051863j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1362-1369&author=T.+Kitagawaauthor=Y.+Idomotoauthor=H.+Matsubaraauthor=D.+Hobaraauthor=T.+Kakiuchiauthor=T.+Okazakiauthor=K.+Komatsu&title=Rigid+Molecular+Tripod+with+an+Adamantane+Framework+and+Thiol+Legs.+Synthesis+and+Observation+of+an+Ordered+Monolayer+on+Au%28111%29&doi=10.1021%2Fjo051863j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Rigid Molecular Tripod with an Adamantane Framework and Thiol Legs. Synthesis and Observation of an Ordered Monolayer on Au(111)</span></div><div class="casAuthors">Kitagawa, Toshikazu; Idomoto, Yuichi; Matsubara, Hiroaki; Hobara, Daisuke; Kakiuchi, Takashi; Okazaki, Takao; Komatsu, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1362-1369</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tripod-shaped trithiols 1-3, contg. CH2SH groups at the three bridgehead positions of the adamantane framework and a halogen-contg. group [Br (1), p-BrC6H4 (2), or p-IC6H4 (3)] at the fourth bridgehead, were synthesized, and self-assembled monolayers (SAMs) were prepd. on atomically flat Au(111) surfaces.  The three-point chemisorption of these tripods was confirmed by polarization modulation IR reflection absorption spectroscopy, which showed the absence of a S-H stretching band.  Scanning tunneling microscopy of the SAM of 1 exhibited a hexagonal arrangement of the adsorbed mol. with a lattice const. of 8.7 Å.  A unidirectionally oriented, head-to-tail array of 1, which allows the close approach of neighboring mols., is proposed as a reasonable model of the two-dimensional crystal, where the adsorbed sulfur atoms form a quasi-(√3 × √3)R30° lattice.  The charge of the electrochem. reductive desorption of the SAM of 1 was in good agreement with the expected surface coverage, while the SAMs of 2 and 3 showed somewhat less (ca. 70%) charge.  The large neg. redn. peak potentials, obsd. for the SAM of 1, are taken to indicate a tight anchoring of this tripod by three sulfur atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqiZmDwGtupbVg90H21EOLACvtfcHk0lhJ0qB2hUKVHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1Omug%253D%253D&md5=1549426413eeb3181c9e8992c152b040</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjo051863j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051863j%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DT.%26aulast%3DIdomoto%26aufirst%3DY.%26aulast%3DMatsubara%26aufirst%3DH.%26aulast%3DHobara%26aufirst%3DD.%26aulast%3DKakiuchi%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DK.%26atitle%3DRigid%2520Molecular%2520Tripod%2520with%2520an%2520Adamantane%2520Framework%2520and%2520Thiol%2520Legs.%2520Synthesis%2520and%2520Observation%2520of%2520an%2520Ordered%2520Monolayer%2520on%2520Au%2528111%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1362%26epage%3D1369%26doi%3D10.1021%2Fjo051863j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Hydrazine-Sensitive Thiol Protecting Group for Peptide and Protein Chemistry</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1021/ol1028755</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol1028755" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Oluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=568-571&author=F.+Shenauthor=Z.-P.+Zhangauthor=J.-B.+Liauthor=Y.+Linauthor=L.+Liu&title=Hydrazine-Sensitive+Thiol+Protecting+Group+for+Peptide+and+Protein+Chemistry&doi=10.1021%2Fol1028755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazine-Sensitive Thiol Protecting Group for Peptide and Protein Chemistry</span></div><div class="casAuthors">Shen, Fei; Zhang, Zhi-Ping; Li, Jia-Bin; Lin, Yun; Liu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">568-571</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the search for a new Cys side-chain protecting group that is compatible to the solid-phase peptide synthesis yet can be removed under mild conditions, the Hqm and Hgm groups that are readily deprotected by using aq. hydrazine have been developed.  The utility of these groups for peptide and protein chem. is tested by the total synthesis of a peptide antibiotic trifolitoxin and the human neutrophil defensin hNP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eHFzmMauV7Vg90H21EOLACvtfcHk0lhJ0qB2hUKVHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Oluw%253D%253D&md5=0ead35eb76f781157b579023f584a2cb</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fol1028755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1028755%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.-P.%26aulast%3DLi%26aufirst%3DJ.-B.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DHydrazine-Sensitive%2520Thiol%2520Protecting%2520Group%2520for%2520Peptide%2520and%2520Protein%2520Chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D568%26epage%3D571%26doi%3D10.1021%2Fol1028755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the degradation of Mcl-1 induced by BH3 domains</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">6217</span>– <span class="NLM_lpage">6222</span>, <span class="refDoi"> DOI: 10.1073/pnas.0701297104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1073%2Fpnas.0701297104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17389404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=6217-6222&author=P.+E.+Czabotarauthor=E.+F.+Leeauthor=M.+F.+van+Delftauthor=C.+L.+Dayauthor=B.+J.+Smithauthor=D.+C.+Huangauthor=W.+D.+Fairlieauthor=M.+G.+Hindsauthor=P.+M.+Colman&title=Structural+insights+into+the+degradation+of+Mcl-1+induced+by+BH3+domains&doi=10.1073%2Fpnas.0701297104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the degradation of MCl-1 induced by BH3 domains</span></div><div class="casAuthors">Czabotar, Peter E.; Lee, Erinna F.; van Delft, Mark F.; Day, Catherine L.; Smith, Brian J.; Huang, David C. S.; Fairlie, W. Douglas; Hinds, Mark G.; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6217-6222</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apoptosis is held in check by prosurvival proteins of the Bcl-2 family.  The distantly related BH3-only proteins bind to and antagonize Bcl-2 proteins, thereby promoting apoptosis.  Whereas binding of the BH3-only protein Noxa to prosurvival Mcl-1 induces Mcl-1 degrdn. by the proteasome, binding of another BH3-only ligand, Bim, elevates Mcl-1 protein levels.  We compared the three- dimensional structures of the complexes formed between BH3 peptides of both Bim and Noxa, and we show that a discrete C-terminal sequence of the Noxa BH3 is necessary to instigate Mcl-1 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkT9u8IpxRLVg90H21EOLACvtfcHk0lgkLBR99294Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D&md5=f91d0194ce195855706f69364b7e6fb6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701297104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701297104%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520insights%2520into%2520the%2520degradation%2520of%2520Mcl-1%2520induced%2520by%2520BH3%2520domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D6217%26epage%3D6222%26doi%3D10.1073%2Fpnas.0701297104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puthalakath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1083/jcb.200708096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1083%2Fjcb.200708096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18209102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFOntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=341-355&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=M.+F.+van+Delftauthor=E.+M.+Michalakauthor=M.+J.+Boyleauthor=S.+N.+Willisauthor=H.+Puthalakathauthor=P.+Bouilletauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=A+novel+BH3+ligand+that+selectively+targets+Mcl-1+reveals+that+apoptosis+can+proceed+without+Mcl-1+degradation&doi=10.1083%2Fjcb.200708096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span></div><div class="casAuthors">Lee, Erinna F.; Czabotar, Peter E.; van Delft, Mark F.; Michalak, Ewa M.; Boyle, Michelle J.; Willis, Simon N.; Puthalakath, Hamsa; Bouillet, Philippe; Colman, Peter M.; Huang, David C. S.; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-355</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Like Bcl-2, Mcl-1 is an important survival factor for many cancers, its expression contributing to chemo-resistance and disease relapse.  However, unlike other prosurvival Bcl-2-like proteins, Mcl-1 stability is acutely regulated.  For example, the Bcl-2 homol. 3 (BH3)-only protein Noxa, which preferentially binds to Mcl-1, also targets it for proteasomal degrdn.  In this paper, we describe the discovery and characterization of a novel BH3-like ligand derived from Bim, BimS2A, which is highly selective for Mcl-1.  Unlike Noxa, BimS2A is unable to trigger Mcl-1 degrdn., yet, like Noxa, BimS2A promotes cell killing only when Bcl-xL is absent or neutralized.  Furthermore, killing by endogenous Bim is not assocd. with Mcl-1 degrdn.  Thus, functional inactivation of Mcl-1 does not always require its elimination.  Rather, it can be efficiently antagonized by a BH3-like ligand tightly engaging its binding groove, which is confirmed here with a structural study.  Our data have important implications for the discovery of compds. that might kill cells whose survival depends on Mcl-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruZGyqGo5NVLVg90H21EOLACvtfcHk0lgkLBR99294Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFOntLc%253D&md5=62d71ec6b3055718e48bd164af70b792</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200708096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200708096%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DMichalak%26aufirst%3DE.%2BM.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520BH3%2520ligand%2520that%2520selectively%2520targets%2520Mcl-1%2520reveals%2520that%2520apoptosis%2520can%2520proceed%2520without%2520Mcl-1%2520degradation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D341%26epage%3D355%26doi%3D10.1083%2Fjcb.200708096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson-Annan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parma, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lithgow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span> <span> </span><span class="NLM_article-title">Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1083/jcb.200302144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1083%2Fjcb.200302144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12952938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFeqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2003&pages=877-887&author=J.+Wilson-Annanauthor=L.+A.+O%E2%80%99Reillyauthor=S.+A.+Crawfordauthor=G.+Hausmannauthor=J.+G.+Beaumontauthor=L.+P.+Parmaauthor=L.+Chenauthor=M.+Lackmannauthor=T.+Lithgowauthor=M.+G.+Hindsauthor=C.+L.+Dayauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Proapoptotic+BH3-only+proteins+trigger+membrane+integration+of+prosurvival+Bcl-w+and+neutralize+its+activity&doi=10.1083%2Fjcb.200302144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity</span></div><div class="casAuthors">Wilson-Annan, Julie; O'Reilly, Lorraine A.; Crawford, Simon A.; Hausmann, George; Beaumont, Jennifer G.; Parma, Loes P.; Chen, Lin; Lackmann, Martin; Lithgow, Trevor; Hinds, Mark G.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">877-887</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Prosurvival Bcl-2-like proteins, like Bcl-w, are thought to function on organelles such as the mitochondrion and to be targeted to them by their hydrophobic C-terminal domain.  We unexpectedly found, however, that the membrane assocn. of Bcl-w was enhanced during apoptosis.  In healthy cells, Bcl-w was loosely attached to the mitochondrial membrane, but it was converted into an integral membrane protein by cytotoxic signals that induce binding of BH3-only proteins, such as Bim, or by the addn. of BH3 peptides to lysates.  As the structure of Bcl-w has revealed that its C-terminal domain occupies the hydrophobic groove where BH3 ligands bind, displacement of that domain by a BH3 ligand would displace the hydrophobic C-terminal residues, allowing their insertion into the membrane.  To det. whether BH3 ligation is sufficient to induce the enhanced membrane affinity, or to render Bcl-w proapoptotic, we mimicked their complex by tethering the Bim BH3 domain to the N-terminus of Bcl-w.  The chimera indeed bound avidly to membranes, in a fashion requiring the C-terminal domain, but neither promoted nor inhibited apoptosis.  These results suggest that ligation of a proapoptotic BH3-only protein alters the conformation of Bcl-w, enhances membrane assocn., and neutralizes its survival function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-wxUtCsWbQLVg90H21EOLACvtfcHk0lgkLBR99294Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFeqsb4%253D&md5=ce72e6b1c03b8bb87fb716ca61611b71</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200302144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200302144%26sid%3Dliteratum%253Aachs%26aulast%3DWilson-Annan%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DL.%2BA.%26aulast%3DCrawford%26aufirst%3DS.%2BA.%26aulast%3DHausmann%26aufirst%3DG.%26aulast%3DBeaumont%26aufirst%3DJ.%2BG.%26aulast%3DParma%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DLithgow%26aufirst%3DT.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DProapoptotic%2520BH3-only%2520proteins%2520trigger%2520membrane%2520integration%2520of%2520prosurvival%2520Bcl-w%2520and%2520neutralize%2520its%2520activity%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D162%26spage%3D877%26epage%3D887%26doi%3D10.1083%2Fjcb.200302144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span> <span> </span><span class="NLM_article-title">Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">4738</span>– <span class="NLM_lpage">4744</span>, <span class="refDoi"> DOI: 10.1074/jbc.M411434200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M411434200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15550399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=4738-4744&author=C.+L.+Dayauthor=L.+Chenauthor=S.+J.+Richardsonauthor=P.+J.+Harrisonauthor=D.+C.+Huangauthor=M.+G.+Hinds&title=Solution+structure+of+prosurvival+Mcl-1+and+characterization+of+its+binding+by+proapoptotic+BH3-only+ligands&doi=10.1074%2Fjbc.M411434200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands</span></div><div class="casAuthors">Day, Catherine L.; Chen, Lin; Richardson, Sarah J.; Harrison, Penny J.; Huang, David C. S.; Hinds, Mark G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4738-4744</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The B cell lymphoma-2 (Bcl-2) homologs myeloid cell leukemia-1 (Mcl-1) and A1 are prosurvival factors that selectively bind a subset of proapoptotic Bcl homol. (BH) 3-only proteins.  To investigate the mol. basis of the selectivity, we detd. the soln. structure of the C-terminal Bcl-2-like domain of Mcl-1.  This domain shares features expected of a prosurvival Bcl-2 protein, having a helical fold centered on a core hydrophobic helix and a surface-exposed hydrophobic groove for binding its cognate partners.  A no. of residues in the binding groove differentiate Mcl-1 from its homologs, and in contrast to other Bcl-2 homologs, Mcl-1 has a binding groove in a conformation intermediate between the open structures characterized by peptide complexes and the closed state obsd. in unliganded structures.  Mutagenesis of potential binding site residues was used to probe the contributions of groove residues to the binding properties of Mcl-1.  Although mutations in Mcl-1 had little impact on binding, a single mutation in the BH3-only ligand Bad enabled it to bind both Mcl-1 and A1 while retaining its binding to Bcl-2, Bcl-xL, and Bcl-w.  Elucidating the selective action of certain BH3-only ligands is required for delineating their mode of action and will aid the search for effective BH3-mimetic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_87u59NCfZrVg90H21EOLACvtfcHk0lgCbXXaznydRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVymtrk%253D&md5=d700c096886315d72cd3d6c3045bb5bd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M411434200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M411434200%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DHarrison%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26atitle%3DSolution%2520structure%2520of%2520prosurvival%2520Mcl-1%2520and%2520characterization%2520of%2520its%2520binding%2520by%2520proapoptotic%2520BH3-only%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D4738%26epage%3D4744%26doi%3D10.1074%2Fjbc.M411434200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skea, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span> <span> </span><span class="NLM_article-title">The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1497</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1093/emboj/cdg144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1093%2Femboj%2Fcdg144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12660157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFeqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1497-1507&author=M.+G.+Hindsauthor=M.+Lackmannauthor=G.+L.+Skeaauthor=P.+J.+Harrisonauthor=D.+C.+S.+Huangauthor=C.+L.+Day&title=The+structure+of+Bcl-w+reveals+a+role+for+the+C-terminal+residues+in+modulating+biological+activity&doi=10.1093%2Femboj%2Fcdg144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity</span></div><div class="casAuthors">Hinds, Mark G.; Lackmann, Martin; Skea, Gretchen L.; Harrison, Penny J.; Huang, David C. S.; Day, Catherine L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1497-1507</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Pro-survival Bcl-2-related proteins, crit. regulators of apoptosis, contain a hydrophobic groove targeted for binding by the BH3 domain of the pro-apoptotic BH3-only proteins.  The soln. structure of the pro-survival protein Bcl-w, presented here, reveals that the binding groove is not freely accessible as predicted by previous structures of pro-survival Bcl-2-like mols.  Unexpectedly, the groove appears to be occluded by the C-terminal residues.  Binding and kinetic data suggest that the C-terminal residues of Bcl-w and Bcl-xL modulate pro-survival activity by regulating ligand access to the groove.  Binding of the BH3-only proteins, crit. for cell death initiation, is likely to displace the hydrophobic C-terminal region of Bcl-w and Bcl-xL. Moreover, Bcl-w does not act only by sequestering the BH3-only proteins.  Therefore, pro-survival Bcl-2-like mols. probably control the activation of downstream effectors by a mechanism that remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjaQRzNkFxpbVg90H21EOLACvtfcHk0lgCbXXaznydRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFeqsbo%253D&md5=a5c752acfc65696f7bfa5f8ac125aef9</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg144%26sid%3Dliteratum%253Aachs%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DSkea%26aufirst%3DG.%2BL.%26aulast%3DHarrison%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DThe%2520structure%2520of%2520Bcl-w%2520reveals%2520a%2520role%2520for%2520the%2520C-terminal%2520residues%2520in%2520modulating%2520biological%2520activity%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D1497%26epage%3D1507%26doi%3D10.1093%2Femboj%2Fcdg144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smits, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span> <span> </span><span class="NLM_article-title">Structural plasticity underpins promiscuous binding of the prosurvival protein A1</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1016/j.str.2008.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2Fj.str.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18462686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslGrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=818-829&author=C.+Smitsauthor=P.+E.+Czabotarauthor=M.+G.+Hindsauthor=C.+L.+Day&title=Structural+plasticity+underpins+promiscuous+binding+of+the+prosurvival+protein+A1&doi=10.1016%2Fj.str.2008.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Plasticity Underpins Promiscuous Binding of the Prosurvival Protein A1</span></div><div class="casAuthors">Smits, Callum; Czabotar, Peter E.; Hinds, Mark G.; Day, Catherine L.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">818-829</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Apoptotic pathways are regulated by protein-protein interactions.  Interaction of the BH3 domains of proapoptotic Bcl-2 family proteins with the hydrophobic groove of prosurvival proteins is crit.  Whereas some BH3 domains bind in a promiscuous manner, others exhibit considerable selectivity and the sequence characteristics that distinguish these activities are unclear.  In this study, crystal structures of complexes between the prosurvival protein A1 and the BH3 domains from Puma, Bmf, Bak, and Bid have been solved.  The structure of A1 is similar to that of other prosurvival proteins, although features, such as an acidic patch in the binding groove, may allow specific therapeutic modulation of apoptosis.  Significant conformational plasticity was obsd. in the intermol. interactions and these differences explain some of the variation in affinity.  This study, in combination with published data, suggests that interactions between conserved residues demarcate optimal binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNEG1WF4B87Vg90H21EOLACvtfcHk0lgCbXXaznydRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslGrt7Y%253D&md5=86eaac63d47c56dd2db927263db52bda</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DC.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DStructural%2520plasticity%2520underpins%2520promiscuous%2520binding%2520of%2520the%2520prosurvival%2520protein%2520A1%26jtitle%3DStructure%26date%3D2008%26volume%3D16%26spage%3D818%26epage%3D829%26doi%3D10.1016%2Fj.str.2008.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kvansakul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span> <span> </span><span class="NLM_article-title">Preparing Samples for Crystallization of Bcl-2 Family Complexes</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1419</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3581-9_16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1007%2F978-1-4939-3581-9_16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=27108442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BC28bjtVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1419&publication_year=2016&pages=213-229&author=M.+Kvansakulauthor=P.+E.+Czabotar&title=Preparing+Samples+for+Crystallization+of+Bcl-2+Family+Complexes&doi=10.1007%2F978-1-4939-3581-9_16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Preparing Samples for Crystallization of Bcl-2 Family Complexes</span></div><div class="casAuthors">Kvansakul Marc; Kvansakul Marc; Czabotar Peter E; Czabotar Peter E</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular biology (Clifton, N.J.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1419</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-resolution protein structures determined by X-ray crystallography or NMR have proven invaluable for deciphering the molecular mechanisms underlying the function of a vast range of proteins.  Here, we describe methods to generate complexes of proteins belonging to the Bcl-2 family of proteins with either biological ligands or small molecule antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVyeBrcwhIMScOqQTSkOffW6udTcc2eaOd34F9VmgOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bjtVOnuw%253D%253D&md5=f84006d4c42346ccb574b0ac59f84f5c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3581-9_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3581-9_16%26sid%3Dliteratum%253Aachs%26aulast%3DKvansakul%26aufirst%3DM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26atitle%3DPreparing%2520Samples%2520for%2520Crystallization%2520of%2520Bcl-2%2520Family%2520Complexes%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1419%26spage%3D213%26epage%3D229%26doi%3D10.1007%2F978-1-4939-3581-9_16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kvansakul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perugini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span> <span> </span><span class="NLM_article-title">Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1564</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1038/cdd.2008.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fcdd.2008.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=18551131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1564-1571&author=M.+Kvansakulauthor=H.+Yangauthor=W.+D.+Fairlieauthor=P.+E.+Czabotarauthor=S.+F.+Fischerauthor=M.+A.+Peruginiauthor=D.+C.+Huangauthor=P.+M.+Colman&title=Vaccinia+virus+anti-apoptotic+F1L+is+a+novel+Bcl-2-like+domain-swapped+dimer+that+binds+a+highly+selective+subset+of+BH3-containing+death+ligands&doi=10.1038%2Fcdd.2008.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands</span></div><div class="casAuthors">Kvansakul, M.; Yang, H.; Fairlie, W. D.; Czabotar, P. E.; Fischer, S. F.; Perugini, M. A.; Huang, D. C. S.; Colman, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1564-1571</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an important part of the host's defense mechanism for eliminating invading pathogens.  Some viruses express proteins homologous in sequence and function to mammalian pro-survival Bcl-2 proteins.  Anti-apoptotic F1L expressed by vaccinia virus is essential for survival of infected cells, but it bears no discernable sequence homol. to proteins other than its immediate orthologues in related pox viruses.  Here we report that the crystal structure of F1L reveals a Bcl-2-like fold with an unusual N-terminal extension.  The protein forms a novel domain-swapped dimer in which the α1 helix is the exchanged domain.  Binding studies reveal an atypical BH3-binding profile, with sub-micromolar affinity only for the BH3 peptide of pro-apoptotic Bim and low micromolar affinity for the BH3 peptides of Bak and Bax.  This binding interaction is sensitive to F1L mutations within the predicted canonical BH3-binding groove, suggesting parallels between how vaccinia virus F1L and myxoma virus M11L bind BH3 domains.  Structural comparison of F1L with other Bcl-2 family members reveals a novel sequence signature that redefines the BH4 domain as a structural motif present in both pro- and anti-apoptotic Bcl-2 members, including viral Bcl-2-like proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjBB-HZ2WS9LVg90H21EOLACvtfcHk0ljJ-biQEKag-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jM&md5=6bd081cf184c076a68c51b94ed001306</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.83%26sid%3Dliteratum%253Aachs%26aulast%3DKvansakul%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DFischer%26aufirst%3DS.%2BF.%26aulast%3DPerugini%26aufirst%3DM.%2BA.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DVaccinia%2520virus%2520anti-apoptotic%2520F1L%2520is%2520a%2520novel%2520Bcl-2-like%2520domain-swapped%2520dimer%2520that%2520binds%2520a%2520highly%2520selective%2520subset%2520of%2520BH3-containing%2520death%2520ligands%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2008%26volume%3D15%26spage%3D1564%26epage%3D1571%26doi%3D10.1038%2Fcdd.2008.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1926</span>, <span class="refDoi"> DOI: 10.1021/jm101596e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101596e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1914-1926&author=B.+E.+Sleebsauthor=P.+E.+Czabotarauthor=W.+J.+Fairbrotherauthor=W.+D.+Fairlieauthor=J.+A.+Flygareauthor=D.+C.+Huangauthor=W.+J.+Kerstenauthor=M.+F.+Koehlerauthor=G.+Lesseneauthor=K.+Lowesauthor=J.+P.+Parisotauthor=B.+J.+Smithauthor=M.+L.+Smithauthor=A.+J.+Souersauthor=I.+P.+Streetauthor=H.+Yangauthor=J.+B.+Baell&title=Quinazoline+sulfonamides+as+dual+binders+of+the+proteins+B-cell+lymphoma+2+and+B-cell+lymphoma+extra+long+with+potent+proapoptotic+cell-based+activity&doi=10.1021%2Fjm101596e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Large with Potent Proapoptotic Cell-Based Activity</span></div><div class="casAuthors">Sleebs, Brad E.; Czabotar, Peter E.; Fairbrother, Wayne J.; Fairlie, W. Douglas; Flygare, John A.; Huang, David C. S.; Kersten, Wilhelmus J. A.; Koehler, Michael F. T.; Lessene, Guillaume; Lowes, Kym; Parisot, John P.; Smith, Brian J.; Smith, Morey L.; Souers, Andrew J.; Street, Ian P.; Yang, Hong; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1914-1926</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ABT-737 and ABT-263 are potent inhibitors of the BH3 antiapoptotic proteins, Bcl-xL and Bcl-2.  This class of putative anticancer agents invariantly contains an acylsulfonamide core.  We have designed and synthesized a series of novel quinazoline-based inhibitors of Bcl-2 and Bcl-xL that contain a heterocyclic alternative to the acylsulfonamide.  These compds. exhibit submicromolar, mechanism-based activity in human small-cell lung carcinoma cell lines in the presence of 10% human serum.  This comprises the first successful demonstration of a quinazoline sulfonamide core serving as an effective benzoylsulfonamide bioisostere.  Addnl., these novel quinazolines comprise only the second known class of Bcl-2 family protein inhibitors to induce mechanism-based cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdUw3pDj4wb7Vg90H21EOLACvtfcHk0ljJ-biQEKag-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislagsr0%253D&md5=b0f4d8c5856ccb403a97b7029fb3249c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm101596e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101596e%26sid%3Dliteratum%253Aachs%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DLowes%26aufirst%3DK.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DQuinazoline%2520sulfonamides%2520as%2520dual%2520binders%2520of%2520the%2520proteins%2520B-cell%2520lymphoma%25202%2520and%2520B-cell%2520lymphoma%2520extra%2520long%2520with%2520potent%2520proapoptotic%2520cell-based%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1914%26epage%3D1926%26doi%3D10.1021%2Fjm101596e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perugini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span> <span> </span><span class="NLM_article-title">Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">31315</span>– <span class="NLM_lpage">31326</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.048009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M109.048009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=19748896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=31315-31326&author=E.+F.+Leeauthor=A.+Fedorovaauthor=K.+Zobelauthor=M.+J.+Boyleauthor=H.+Yangauthor=M.+A.+Peruginiauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=K.+Deshayesauthor=W.+D.+Fairlie&title=Novel+Bcl-2+homology-3+domain-like+sequences+identified+from+screening+randomized+peptide+libraries+for+inhibitors+of+the+pro-survival+Bcl-2+proteins&doi=10.1074%2Fjbc.M109.048009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bcl-2 Homology-3 Domain-like Sequences Identified from Screening Randomized Peptide Libraries for Inhibitors of the Pro-survival Bcl-2 Proteins</span></div><div class="casAuthors">Lee, Erinna F.; Fedorova, Anna; Zobel, Kerry; Boyle, Michelle J.; Yang, Hong; Perugini, Matthew A.; Colman, Peter M.; Huang, David C. S.; Deshayes, Kurt; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">31315-31326</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Interactions between Bcl-2 homol.-3 (BH3)-only proteins and their pro-survival Bcl-2 family binding partners initiate the intrinsic apoptosis pathway.  These interactions are mediated by a short helical motif, the BH3 domain, on the BH3-only protein, which inserts into a hydrophobic groove on the pro-survival mol.  To identify novel peptidic ligands that bind Mcl-1, a pro-survival protein relative of Bcl-2, both human and mouse Mcl-1 were screened against large randomized phage-displayed peptide libraries.  We identified a no. of 16-mer peptides with sub-micromolar affinity that were highly selective for Mcl-1, as well as being somewhat selective for the species of Mcl-1 (human or mouse) against which the library was panned.  Interestingly, these sequences all strongly resembled natural BH3 domain sequences.  By switching residues within the best of the human Mcl-1-binding sequences, or extending beyond the core sequence identified, we were able to alter the pro-survival protein interaction profile of this peptide such that it now bound all members tightly and was a potent killer when introduced into cells.  Introduction of an amide lock constraint within this sequence also increased its helicity and binding to pro-survival proteins.  These data provide new insights into the determinants of BH3 domain:pro-survival protein affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZREzEPHNG0bVg90H21EOLACvtfcHk0lhLsBxfCGZBzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjsr7K&md5=6ed173df20b09ea7042dbfa9a1769d3a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.048009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.048009%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DFedorova%26aufirst%3DA.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DPerugini%26aufirst%3DM.%2BA.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DNovel%2520Bcl-2%2520homology-3%2520domain-like%2520sequences%2520identified%2520from%2520screening%2520randomized%2520peptide%2520libraries%2520for%2520inhibitors%2520of%2520the%2520pro-survival%2520Bcl-2%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D31315%26epage%3D31326%26doi%3D10.1074%2Fjbc.M109.048009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakthianandeswaren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djajawi, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. N.</span></span> <span> </span><span class="NLM_article-title">Defining the susceptibility of colorectal cancers to BH3-mimetic compounds</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">735</span> <span class="refDoi"> DOI: 10.1038/s41419-020-02815-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1038%2Fs41419-020-02815-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=32913182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFajsb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=M.+J.+Luoauthor=M.+Palmieriauthor=C.+D.+Riffkinauthor=A.+Sakthianandeswarenauthor=T.+M.+Djajawiauthor=Y.+Hirokawaauthor=V.+Shuttleworthauthor=D.+H.+Segalauthor=C.+A.+Whiteauthor=D.+Nhuauthor=G.+Lesseneauthor=M.+Leeauthor=P.+Gibbsauthor=D.+C.+S.+Huangauthor=O.+M.+Sieberauthor=J.+N.+Gong&title=Defining+the+susceptibility+of+colorectal+cancers+to+BH3-mimetic+compounds&doi=10.1038%2Fs41419-020-02815-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the susceptibility of colorectal cancers to BH3-mimetic compounds</span></div><div class="casAuthors">Luo, Ming-Jie; Palmieri, Michelle; Riffkin, Chris D.; Sakthianandeswaren, Anuratha; Djajawi, Tirta Mario; Hirokawa, Yumiko; Shuttleworth, Victoria; Segal, David H.; White, Christine A.; Nhu, Duong; Lessene, Guillaume; Lee, Margaret; Gibbs, Peter; Huang, David C. S.; Sieber, Oliver M.; Gong, Jia-nan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">735</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Novel targets are required to improve the outcomes for patients with colorectal cancers.  In this regard, the selective inhibitor of the pro-survival protein BCL2, venetoclax, has proven highly effective in several hematol. malignancies.  In addn. to BCL2, potent and highly selective small mol. inhibitors of its relatives, BCLxL and MCL1, are now available, prompting us to investigate the susceptibility of colorectal cancers to the inhibition of one or more of these pro-survival proteins.  While targeting BCLxL, but not BCL2 or MCL1, on its own had some impact, most (15/17) of the immortalized colorectal cancer cell lines studied were efficiently killed by the combined targeting of BCLxL and MCL1.  Importantly, these in vitro findings were confirmed in a xenograft model and, interestingly, in all (5/5) patient derived tumor organoids evaluated.  Our results lend strong support to the notion that BCLxL and MCL1 are highly promising targets for further evaluation in efforts to improve the treatment of colorectal cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUYom-1p_FwbVg90H21EOLACvtfcHk0lhLsBxfCGZBzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFajsb%252FM&md5=6937286944d019d3ff2e4aa67a8a30df</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fs41419-020-02815-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-020-02815-0%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DM.%2BJ.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DSakthianandeswaren%26aufirst%3DA.%26aulast%3DDjajawi%26aufirst%3DT.%2BM.%26aulast%3DHirokawa%26aufirst%3DY.%26aulast%3DShuttleworth%26aufirst%3DV.%26aulast%3DSegal%26aufirst%3DD.%2BH.%26aulast%3DWhite%26aufirst%3DC.%2BA.%26aulast%3DNhu%26aufirst%3DD.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DGibbs%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DSieber%26aufirst%3DO.%2BM.%26aulast%3DGong%26aufirst%3DJ.%2BN.%26atitle%3DDefining%2520the%2520susceptibility%2520of%2520colorectal%2520cancers%2520to%2520BH3-mimetic%2520compounds%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2020%26volume%3D11%26doi%3D10.1038%2Fs41419-020-02815-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">13123</span>– <span class="NLM_lpage">13132</span>, <span class="refDoi"> DOI: 10.1074/jbc.M700492200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1074%2Fjbc.M700492200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17337444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVShsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=13123-13132&author=A.+Obersteinauthor=P.+D.+Jeffreyauthor=Y.+Shi&title=Crystal+structure+of+the+Bcl-XL-Beclin+1+peptide+complex%3A+Beclin+1+is+a+novel+BH3-only+protein&doi=10.1074%2Fjbc.M700492200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Bcl-XL-Beclin 1 Peptide Complex: Beclin 1 is a Novel BH3-only Protein</span></div><div class="casAuthors">Oberstein, Adam; Jeffrey, Philip D.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">13123-13132</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bcl-2 family proteins are key regulators of apoptosis and have recently been shown to modulate autophagy.  The tumor suppressor Beclin 1 has been proposed to coordinate both apoptosis and autophagy through direct interaction with anti-apoptotic family members Bcl-2 and/or Bcl-XL.  However, the mol. basis for this interaction remains enigmatic.  Here we report that Beclin 1 contains a conserved BH3 domain, which is both necessary and sufficient for its interaction with Bcl-XL.  We also report the crystal structure of a Beclin BH3 peptide in complex with Bcl-XL at 2.5Å resoln.  Reminiscent of previously detd. Bcl-XL-BH3 structures, the amphipathic BH3 helix of Beclin 1 bound to a conserved hydrophobic groove of Bcl-XL.  These results define Beclin 1 as a novel BH3-only protein, implying that Beclin 1 may have a direct role in initiating apoptotic signaling.  We propose that this putative apoptotic function may be linked to the ability of Beclin 1 to suppress tumor formation in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5w9q6LcS4LVg90H21EOLACvtfcHk0lhd_Q6wvYXPfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVShsLk%253D&md5=2b505da129b2e5dfaad8be3b44d823c6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M700492200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M700492200%26sid%3Dliteratum%253Aachs%26aulast%3DOberstein%26aufirst%3DA.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520the%2520Bcl-XL-Beclin%25201%2520peptide%2520complex%253A%2520Beclin%25201%2520is%2520a%2520novel%2520BH3-only%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D13123%26epage%3D13132%26doi%3D10.1074%2Fjbc.M700492200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span>; <span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">[20] Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>.  <i>Methods in Enzymology</i>; <span class="NLM_publisher-name">Elsevier B.V.</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">276</span>, pp  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minor&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3D%255B20%255D%2520Processing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMethods%2520in%2520Enzymology%26pub%3DElsevier%2520B.V%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhd_Q6wvYXPfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhd_Q6wvYXPfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0liEXIbajJ5uvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Sharff, A.</span>; <span class="NLM_string-name">Smart, O. S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>BUSTER</i>, version 2.10.3; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O. S.</span>; <span class="NLM_string-name">Womack, T. O.</span>; <span class="NLM_string-name">Sharff, A.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Bricogne, G.</span></span> <i>Grade</i>, version 1.105; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=O.+S.+Smart&author=T.+O.+Womack&author=A.+Sharff&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=C.+Vonrhein&author=G.+Bricogne&title=Grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DO.%2BS.%26jtitle%3DGrade%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver-Fay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeyink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W375</span>– <span class="NLM_lpage">W383</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-W383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eZIrT2BAjvFCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3DW383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McPhillips, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhillips, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phizackerley, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.</span></span> <span> </span><span class="NLM_article-title">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span>. <i>J. Synchrotron Radiat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1107/S0909049502015170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0909049502015170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=12409628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=401-406&author=T.+M.+McPhillipsauthor=S.+E.+McPhillipsauthor=H.+J.+Chiuauthor=A.+E.+Cohenauthor=A.+M.+Deaconauthor=P.+J.+Ellisauthor=E.+Garmanauthor=A.+Gonzalezauthor=N.+K.+Sauterauthor=R.+P.+Phizackerleyauthor=S.+M.+Soltisauthor=P.+Kuhn&title=Blu-Ice+and+the+Distributed+Control+System%3A+software+for+data+acquisition+and+instrument+control+at+macromolecular+crystallography+beamlines&doi=10.1107%2FS0909049502015170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span></div><div class="casAuthors">McPhillips, Timothy M.; McPhillips, Scott E.; Chiu, Hsiu Ju; Cohen, Aina E.; Deacon, Ashley M.; Ellis, Paul J.; Garman, Elspeth; Gonzalez, Ana; Sauter, Nicholas K.; Phizackerley, R. Paul; Soltis, S. Michael; Kuhn, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-406</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Blu-Ice and Distributed Control System (DCS) software packages were developed to provide unified control over the disparate hardware resources available at a macromol. crystallog. beamline.  Blu-Ice is a user interface that provides scientific experimenters and beamline support staff with intuitive graphical tools for collecting diffraction data and configuring beamlines for expts.  Blu-Ice communicates with the hardware at a beamline via DCS, an instrument-control and data-acquisition package designed to integrate hardware resources in a highly heterogeneous networked computing environment.  Together, Blu-Ice and DCS provide a flexible platform for increasing the ease of use, the level of automation and the remote accessibility of beamlines.  Blu-Ice and DCS are currently installed on four Stanford Synchrotron Radiation Lab. crystallog. beamlines and are being implemented at sister light sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVsQUIFJPBLVg90H21EOLACvtfcHk0lgy1APs0p9Btg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D&md5=c77228bd50890463f3e43e981a2e238a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1107%2FS0909049502015170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049502015170%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhillips%26aufirst%3DT.%2BM.%26aulast%3DMcPhillips%26aufirst%3DS.%2BE.%26aulast%3DChiu%26aufirst%3DH.%2BJ.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DDeacon%26aufirst%3DA.%2BM.%26aulast%3DEllis%26aufirst%3DP.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DPhizackerley%26aufirst%3DR.%2BP.%26aulast%3DSoltis%26aufirst%3DS.%2BM.%26aulast%3DKuhn%26aufirst%3DP.%26atitle%3DBlu-Ice%2520and%2520the%2520Distributed%2520Control%2520System%253A%2520software%2520for%2520data%2520acquisition%2520and%2520instrument%2520control%2520at%2520macromolecular%2520crystallography%2520beamlines%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2002%26volume%3D9%26spage%3D401%26epage%3D406%26doi%3D10.1107%2FS0909049502015170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgy1APs0p9Btg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD','PDB','6UVD'); return false;">PDB: 6UVD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FDL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FDL','PDB','3FDL'); return false;">PDB: 3FDL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAZ','PDB','1MAZ'); return false;">PDB: 1MAZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PL7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PL7','PDB','3PL7'); return false;">PDB: 3PL7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YXJ','PDB','2YXJ'); return false;">PDB: 2YXJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVE','PDB','6UVE'); return false;">PDB: 6UVE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVC','PDB','6UVC'); return false;">PDB: 6UVC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVF','PDB','6UVF'); return false;">PDB: 6UVF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVG','PDB','6UVG'); return false;">PDB: 6UVG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVH','PDB','6UVH'); return false;">PDB: 6UVH</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01771">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65764"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01771?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01771</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Overview of the benzoylurea scaffold (Figure S1), detailed overview of the BCL-X<sub>L</sub>:<b>2</b> complex (Figure S2), overview of the SPR competition experiment (Figure S3), detailed overview of adamantyl substituent binding in the cryptic p5 pocket of BCL-X<sub>L</sub> (Figure S5), additional cellular data for inhibitors (Figure S6); cytochrome <i>c</i> release assay using MEFs (Figure S7); describing data collection and refinement statistics for protein crystallography (Tables S1 and S2); chemistry, <sup>1</sup>H and <sup>13</sup>C NMR spectra; and purity of key compounds by HPLC-UV (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula SMILES strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_001.pdf">jm0c01771_si_001.pdf (13.14 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01771/suppl_file/jm0c01771_si_002.csv">jm0c01771_si_002.csv (7.97 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB accession codes for BCL-X<sub>L</sub> in complex with <b>2</b>, <b>7</b>, <b>8</b>, <b>12</b>, <b>13</b>, and <b>15</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVD">6UVD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVE">6UVE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVC">6UVC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVF">6UVF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVG">6UVG</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UVH">6UVH</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01771&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01771%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01771" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799cf5b2bb53d2a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
